<SEC-DOCUMENT>0001360604-24-000093.txt : 20240802
<SEC-HEADER>0001360604-24-000093.hdr.sgml : 20240802
<ACCEPTANCE-DATETIME>20240802063240
ACCESSION NUMBER:		0001360604-24-000093
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		73
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240802
DATE AS OF CHANGE:		20240802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Healthcare Realty Trust Inc
		CENTRAL INDEX KEY:			0001360604
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35568
		FILM NUMBER:		241168773

	BUSINESS ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-269-8175

	MAIL ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHCARE TRUST OF AMERICA, INC.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, Inc.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, LP
		DATE OF NAME CHANGE:	20160802
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hr-20240630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e,d:82b2eb8af02545bbaeb7c706ae9573fb-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:hr="http://healthcarerealty.com/20240630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hr-20240630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001360604</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:TypeOfRevenueExtensibleList" id="f-129">http://fasb.org/us-gaap/2024#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TypeOfRevenueExtensibleList" id="f-130">http://fasb.org/us-gaap/2024#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:TypeOfRevenueExtensibleList" id="f-131">http://fasb.org/us-gaap/2024#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:TypeOfRevenueExtensibleList" id="f-132">http://fasb.org/us-gaap/2024#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-265" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1149">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hr-20240630.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="property"><xbrli:measure>hr:property</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>hr:state</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="variable_interest_entity"><xbrli:measure>hr:variable_interest_entity</xbrli:measure></xbrli:unit><xbrli:unit id="note_receivable"><xbrli:measure>hr:note_receivable</xbrli:measure></xbrli:unit><xbrli:unit id="joint_venture"><xbrli:measure>hr:joint_venture</xbrli:measure></xbrli:unit><xbrli:unit id="loan"><xbrli:measure>hr:loan</xbrli:measure></xbrli:unit><xbrli:unit id="financing_receivable"><xbrli:measure>hr:financing_receivable</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>hr:lease</xbrli:measure></xbrli:unit><xbrli:unit id="derivative"><xbrli:measure>hr:derivative</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:OtherInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hr:OneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PowayCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColumbusOHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AZ</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:Florida1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SanAngeloTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SanAngeloTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-12</xbrli:startDate><xbrli:endDate>2024-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-20</xbrli:startDate><xbrli:endDate>2024-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-23</xbrli:startDate><xbrli:endDate>2024-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DenverCOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DenverCOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-30</xbrli:startDate><xbrli:endDate>2024-05-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-06</xbrli:startDate><xbrli:endDate>2024-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MinneapolisMNMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MinneapolisMNMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-21</xbrli:startDate><xbrli:endDate>2024-06-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroRaleighNCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroRaleighNCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-28</xbrli:startDate><xbrli:endDate>2024-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:NewYorkNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PhiladelphiaPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:NewYorkNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PhiladelphiaPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SeattleWAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-23</xbrli:startDate><xbrli:endDate>2024-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroNCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-06</xbrli:startDate><xbrli:endDate>2024-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:ActiveDevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:RedevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:CompletedDevelpomentAndRedevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-30</xbrli:startDate><xbrli:endDate>2024-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesDUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:OtherMembersOfSeniorManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-30</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-30</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_1"></div><div style="min-height:18pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:140%">  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:12pt;font-weight:400;line-height:140%"> UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:490.50pt"><tr><td style="width:1.0pt"/><td style="width:18.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:121.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:345.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Mark One)</span></div><div><span><br/></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">For the quarterly period ended: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2024</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OR</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div><span><br/></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-35568</ix:nonNumeric> (Healthcare Realty Trust Incorporated)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">HEALTHCARE REALTY TRUST INCORPORATED</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.194%"><tr><td style="width:1.0%"/><td style="width:19.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">20-4738467</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">3310 West End Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite 700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">37203</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">615</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">269-8175</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Registrant's telephone number, including area code)</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.583%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">www.healthcarerealty.com</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Internet address)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.472%"><tr><td style="width:1.0%"/><td style="width:39.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.353%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Class A Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">HR</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Sections&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.  &#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:123.00pt"><tr><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:34.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:10.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.777%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.194%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:3.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.888%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.444%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">&#9744;</td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.638%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.961%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.102%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">As of July&#160;26, 2024, the Registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">363,030,249</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">s</span><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">hares of Common Stock outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.348%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr></table></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_13"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">HEALTHCARE REALTY TRUST INCORPORATED</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">June&#160;30, 2024 </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Table of Contents</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.006%"><tr><td style="width:1.0%"/><td style="width:13.776%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:73.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.438%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART I - FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_19">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_19">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_28">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_28">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_31">Condensed Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_31">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_34">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</a> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_34">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_40">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_40">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_43">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_43">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_79">Item&#160;2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_79">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_94">Item 3</a>&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_94">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_94">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_97">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_97">34</a></span></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART II - OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_103">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_106">Item&#160;1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_106">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_106">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_109">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_109">Unregistered Sales of Equity </a><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_109">Securities </a><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_109">and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_109">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Item 5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_112">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_115">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_115">35</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_118">37</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_16"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_19"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1.  Financial Statements</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_22"></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.788%"><tr><td style="width:1.0%"/><td style="width:60.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">JUNE 30, 2024</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DECEMBER 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Real estate properties</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-31">1,287,532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-32">1,343,265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-33">10,436,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-34">10,881,373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-35">764,730</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-36">836,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Personal property</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="f-37">12,501</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="f-38">12,718</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-39">122,413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-40">122,602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-41">81,401</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-42">82,209</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="f-43">97,732</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="f-44">60,727</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-45">59,871</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-46">59,871</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-47">12,862,398</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-48">13,399,067</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-49">2,427,709</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-50">2,226,853</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties, net</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-51">10,434,689</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-52">11,172,214</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-53">41,765</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-54">25,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-55">34,530</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-56">8,834</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-57">261,976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-58">275,975</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-59">374,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-60">311,511</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="f-61">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-62">250,530</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-63">655,826</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-64">592,368</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-65">11,803,627</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-66">12,637,131</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-67">5,148,153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-68">4,994,859</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">195,884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">211,994</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-71">1,805</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="f-72">295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-73">230,601</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-74">229,714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-75">75,199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-76">74,503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-77">177,293</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-78">202,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-79">5,828,935</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-80">5,714,349</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-81"/></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-82"/></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-83">3,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-84">3,868</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-85"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-86">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-87"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-88">200,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-89"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-91"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-92">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-93">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Class A Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-95"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-96">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-98">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-99"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-100">364,327</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-102">380,964</ix:nonFraction></ix:nonFraction> shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-103">3,643</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-104">3,810</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-105">9,340,028</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-106">9,602,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-107">6,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-108">10,741</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net income attributable to common stockholders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="f-109">574,178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="f-110">1,028,794</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="f-111">4,037,693</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="f-112">3,801,793</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-113">5,887,142</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-114">6,822,662</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-115">83,675</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-116">96,252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-117">5,970,817</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-118">6,918,914</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-119">11,803,627</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">12,637,131</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_28"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three and Six Months Ended June&#160;30, 2024 and 2023 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.706%"><tr><td style="width:1.0%"/><td style="width:48.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rental income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-121">308,135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-122">329,680</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-123">626,211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-124">653,773</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-125">3,865</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-126">4,233</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-127">8,403</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-128">8,448</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-129"><span style="-sec-ix-hidden:f-130"><span style="-sec-ix-hidden:f-131"><span style="-sec-ix-hidden:f-132">Other operating</span></span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-133">4,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-134">4,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-135">8,513</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-136">8,847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-137">316,322</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-138">338,143</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-139">643,127</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-140">671,068</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-141">117,719</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-142">125,395</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-143">238,798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-144">247,436</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">14,002</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-146">15,464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-147">28,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">30,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-149">431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-150">669</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-151">826</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-152">956</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:fixed-zero" scale="3" id="f-153">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-154">15,670</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:fixed-zero" scale="3" id="f-155">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-156">10,815</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-157">173,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-158">183,193</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-159">351,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-160">367,671</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-161">305,629</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-162">309,051</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-163">620,008</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-164">635,647</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-165">38,338</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-166">7,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-167">38,360</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-168">8,162</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-169">62,457</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-170">65,334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-171">123,510</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-172">129,092</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-173">132,118</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-174">55,215</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-175">148,055</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-176">86,637</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="f-177">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="f-178">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="f-179">250,530</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="f-180">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-181">146</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-182">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-183">568</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-184">797</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest and other (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-185">248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-186">592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-187">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-188">1,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-189">156,631</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-190">112,818</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-191">484,276</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-192">207,225</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss </span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-193">145,938</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">83,726</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">461,157</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">171,804</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-197">2,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-198">967</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-199">6,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-200">1,920</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss attributable to common stockholders</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-201">143,780</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">82,759</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">454,616</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">169,884</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-205">0.39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-206">0.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-207">1.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-208">0.45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-209">0.39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-210">0.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-211">1.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-212">0.45</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-213">372,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-214">378,897</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-215">375,962</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-216">378,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-217">372,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-218">378,897</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-219">375,962</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-220">378,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_31"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three and Six Months Ended June&#160;30, 2024 and 2023 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.371%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED<br/>&#160;June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss </span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-221">145,938</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-222">83,726</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-223">461,157</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-224">171,804</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-225">3,662</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-226">3,419</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-227">7,528</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-228">5,703</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-229">5,891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-230">21,523</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-231">25,501</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-232">12,981</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-233">2,229</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-234">18,104</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-235">17,973</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-236">7,278</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive loss </span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-237">143,709</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-238">65,622</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-239">443,184</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-240">164,526</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less: comprehensive loss attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-241">2,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-242">745</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-243">6,295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-244">1,830</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive loss attributable to common stockholders</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-245">141,585</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-246">64,877</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-247">436,889</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-248">162,696</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div><div style="margin-bottom:6pt;margin-top:14pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended June&#160;30, 2024 and 2023</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative <br/>Net Income </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-249">3,815</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-250">9,609,530</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-251">4,791</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-252">717,958</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-253">3,920,199</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-254">6,415,895</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-255">87,243</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-256">6,503,138</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-257">3,880</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-258">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-259">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-260">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-261">3,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-262">3,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-263">3,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="f-264">172</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-265">272,881</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-266">273,053</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-267">273,053</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-268">143,780</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-269">143,780</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-270">2,158</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-271">145,938</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-272">3,611</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-273">3,611</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-274">51</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-275">3,662</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps <br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-276">5,806</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-277">5,806</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-278">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-279">5,891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="f-280">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-281">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-282">117,494</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-283">117,494</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-284">1,444</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-285">118,938</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2024</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-286">3,643</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-287">9,340,028</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-288">6,986</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-289">574,178</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-290">4,037,693</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-291">5,887,142</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-292">83,675</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-293">5,970,817</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-294">3,875</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Net Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-295">3,808</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-296">9,591,194</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-297">8,554</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-298">1,219,930</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-299">3,447,750</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-300">7,358,628</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-301">106,211</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-302">7,464,839</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-303">2,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-304">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-305">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-306">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-307">112</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-308">112</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-309">112</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-310">3,924</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-311">3,924</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-312">3,924</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-313">82,759</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-314">82,759</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="f-315">967</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-316">83,726</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-317">3,377</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-318">3,377</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-319">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-320">3,419</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-321">21,259</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-322">21,259</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-323">264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-324">21,523</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" scale="3" id="f-325">487</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-326">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-327">118,191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-328">118,191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-329">1,448</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-330">119,639</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-331">3,808</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-332">9,595,033</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-333">9,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-334">1,137,171</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-335">3,565,941</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-336">7,179,399</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-337">104,018</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-338">7,283,417</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-339">2,487</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Six Months Ended June&#160;30, 2024 and 2023</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative <br/>Net Income </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-340">3,810</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-341">9,602,592</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-342">10,741</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-343">1,028,794</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-344">3,801,793</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-345">6,822,662</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-346">96,252</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-347">6,918,914</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-348">3,868</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-349">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-350">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-351">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-352">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-353">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-354">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Conversion of OP Units to common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="f-355">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:num-dot-decimal" scale="3" id="f-356">3,410</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:num-dot-decimal" scale="3" id="f-357">3,412</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:num-dot-decimal" scale="3" id="f-358">3,412</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-360">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-361">6,941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-362">6,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-363">6,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="f-364">172</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-365">272,881</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-366">273,053</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-367">273,053</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-368">454,616</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-369">454,616</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-370">6,541</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-371">461,157</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-372">7,424</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-373">7,424</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-374">104</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-375">7,528</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps <br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-376">25,151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-377">25,151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-378">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-379">25,501</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" scale="3" id="f-380">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="f-381">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders (<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-382">0.62</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-383">235,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-384">235,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-385">2,870</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-386">238,770</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2024</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-387">3,643</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-388">9,340,028</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-389">6,986</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-390">574,178</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-391">4,037,693</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-392">5,887,142</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-393">83,675</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-394">5,970,817</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-395">3,875</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Net Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-396">3,806</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-397">9,587,637</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-398">2,140</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-399">1,307,055</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-400">3,329,562</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-401">7,571,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-402">108,742</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-403">7,679,818</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-404">2,014</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-405">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-406">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-407">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-408">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-409">1,595</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-410">1,596</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-411">1,596</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-412">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-413">8,913</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-414">8,916</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-415">8,916</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-416">169,884</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-417">169,884</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-418">1,920</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-419">171,804</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-420">5,635</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-421">5,635</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-422">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-423">5,703</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-424">12,823</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-425">12,823</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-426">158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-427">12,981</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" scale="3" id="f-428">473</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders (<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-429">0.62</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-430">236,379</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-431">236,379</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-432">2,894</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-433">239,273</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-434">3,808</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-435">9,595,033</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-436">9,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-437">1,137,171</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-438">3,565,941</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-439">7,179,399</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-440">104,018</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-441">7,283,417</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-442">2,487</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_40"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Healthcare</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Six Months Ended June&#160;30, 2024 and 2023 </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-443">461,157</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-444">171,804</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by operating activities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-445">351,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-446">367,671</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="f-447">23,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="f-448">23,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-449">6,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-450">8,916</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent receivable (lessor)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="f-451">14,198</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="f-452">19,313</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent on operating leases (lessee)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:StraightlineRentLiability" format="ixt:num-dot-decimal" scale="3" id="f-453">1,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:StraightlineRentLiability" format="ixt:num-dot-decimal" scale="3" id="f-454">3,062</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-455">38,360</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-456">8,162</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-457">148,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-458">86,637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="f-459">250,530</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-461">568</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-462">797</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-463">2,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-464">3,031</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest from financing and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" scale="3" id="f-465">478</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" scale="3" id="f-466">488</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, including right-of-use-assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-467">4,257</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-468">17,502</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-469">23,131</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-470">38,601</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="f-471">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-472">16,673</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-473">244,304</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-474">254,322</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisitions of real estate</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-476">39,301</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development of real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="f-477">31,901</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="f-478">17,594</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-479">117,775</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-480">94,013</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Funding of mortgages and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-481">3,466</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-482">11,503</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-484">3,824</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" scale="3" id="f-485">475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireFinanceReceivables" scale="3" id="f-486">780</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests" scale="3" id="f-487">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-488">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from sales of real estate properties and additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-489">303,475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-490">160,870</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from notes receivable repayments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" scale="3" id="f-491">567</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-493">151,388</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-494">6,145</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net borrowings (repayments) on unsecured credit facility</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-495">250,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-496">31,000</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayment on term loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfMediumTermNotes" format="ixt:num-dot-decimal" scale="3" id="f-497">100,000</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RepaymentsOfMediumTermNotes" format="ixt:fixed-zero" scale="3" id="f-498">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayments of notes and bonds payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-499">17,746</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-500">1,340</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-501">235,618</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-502">236,105</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-503">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-504">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="f-505">321</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-506">1,842</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:PaymentsForRepurchasesOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-507">273,053</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:PaymentsForRepurchasesOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-509">2,399</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-510">2,546</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance and assumption costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="f-511">563</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="f-512">438</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments made on finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-513">30</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-514">40</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-515">379,626</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-516">273,234</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-517">16,066</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-518">25,057</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-519">25,699</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-520">60,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-521">41,765</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-522">35,904</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED<br/>JUNE 30,</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-523">103,708</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-524">106,985</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage note receivables taken in connection with sale of real estate</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:num-dot-decimal" scale="3" id="f-526">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Invoices accrued for construction, tenant improvements and other capitalized costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-527">39,016</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-528">30,956</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="3" id="f-529">1,916</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="3" id="f-530">1,282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from dispositions held in escrow</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ProceedsFromDispositionsHeldInEscrow" format="ixt:num-dot-decimal" scale="3" id="f-531">96,008</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ProceedsFromDispositionsHeldInEscrow" format="ixt:fixed-zero" scale="3" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contribution of real estate properties into unconsolidated joint venture</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-533">66,547</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" format="ixt:fixed-zero" scale="3" id="f-534">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are an integral part of these financial statements.</span></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_43"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-535" continuedAt="f-535-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_46"></div><ix:continuation id="f-535-1" continuedAt="f-535-2"><ix:nonNumeric contextRef="c-1" name="hr:NatureOfOperationsPolicyTextBlock" id="f-536" continuedAt="f-536-1" escape="true"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated (the "Company") is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June&#160;30, 2024, the Company had gross investments of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="hr:InvestmentInRealEstatePropertiesAndMortgageNotes" format="ixt:num-dot-decimal" scale="9" id="f-537">12.9</ix:nonFraction>&#160;billion in <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfRealEstateInvestments" scale="0" id="f-538">629</ix:nonFraction> con</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">solidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property, excluding held for sale assets. </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of June&#160;30, 2024, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y <ix:nonFraction unitRef="number" contextRef="c-81" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-539">36</ix:nonFraction>% in <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfPropertiesHeldInUnconsolidatedJointVentures" scale="0" id="f-540">44</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in unconsolidated joint ventures. See Note 2 below for more details regarding the Company's unconsolidated joint ventures. </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in <ix:nonFraction unitRef="state" contextRef="c-3" decimals="INF" name="hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates" scale="0" id="f-541">35</ix:nonFraction> states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y <ix:nonFraction unitRef="sqft" contextRef="c-3" decimals="-5" name="hr:ApproximateSquareFeetInvestedInByCompany" scale="6" id="f-542">37.2</ix:nonFraction> million square feet. The Company provided leasing and property management services to <ix:nonFraction unitRef="number" contextRef="c-3" decimals="2" name="hr:LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" scale="-2" id="f-543">92</ix:nonFraction>% of its portfolio</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">nationwide as of June&#160;30, 2024.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022, by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#8220;OP&#8221;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;). The combined company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-82" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-544">0.01</ix:nonFraction> par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is structured as an umbrella partnership REIT under which substantially all of its business is conducted through the OP, the day-to-day management of which is exclusively controlled by the Company.  As of June&#160;30, 2024, the Company owned <ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-545">98.6</ix:nonFraction>% of the issued and outstanding units of the OP, with other investors owning the remaining <ix:nonFraction unitRef="number" contextRef="c-84" decimals="4" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="f-546">1.4</ix:nonFraction>% of the OP's issued and outstanding units.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-536-1">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-547" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2024 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-548" continuedAt="f-548-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-535-2" continuedAt="f-535-3"><ix:continuation id="f-548-1" continuedAt="f-548-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events, such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns <ix:nonFraction unitRef="number" contextRef="c-85" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-549">100</ix:nonFraction>% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than <ix:nonFraction unitRef="number" contextRef="c-3" decimals="INF" name="hr:EquityOwnershipForConsolidationPercent" scale="-2" id="f-550">100</ix:nonFraction>% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-548-2">The OP is <ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-551">98.6</ix:nonFraction>% owned by the Company.  Other holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June&#160;30, 2024, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="-5" name="us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-552">5.3</ix:nonFraction>&#160;million OP Units, or <ix:nonFraction unitRef="number" contextRef="c-84" decimals="4" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="f-553">1.4</ix:nonFraction>% of OP Units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP.</ix:continuation>  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="c-3" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-554">four</ix:nonFraction> consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  <ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="f-555" continuedAt="f-555-1" escape="true">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</ix:nonNumeric></span></div><ix:continuation id="f-555-1"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.318%"><tr><td style="width:1.0%"/><td style="width:68.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total real estate properties, net</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-556">112,694</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-557">3,205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="hr:ReceivablesAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-558">2,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-559">118,455</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-560">7,848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-561">7,848</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-562">3,194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Partners' equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-563">108,612</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net loss </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="hr:CumulativeNetLossAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="f-564">1,199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total partners' equity</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-565">107,413</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-566">118,455</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="c-88" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-567">three</ix:nonFraction> unconsolidated VIEs consisting of <ix:nonFraction unitRef="note_receivable" contextRef="c-88" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-568">two</ix:nonFraction> notes receivables and <ix:nonFraction unitRef="joint_venture" contextRef="c-89" decimals="INF" name="hr:NumberOfJointVentures" format="ixt-sec:numwordsen" scale="0" id="f-569">one</ix:nonFraction> joint venture.  The Company does not have the power or economic interests to direct the activities of these VIEs on a </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-535-3" continuedAt="f-535-4"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-570" continuedAt="f-570-1" escape="true">As a result, the Company accounts for the <ix:nonFraction unitRef="note_receivable" contextRef="c-88" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-571">two</ix:nonFraction> notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</ix:nonNumeric></span></div><ix:continuation id="f-570-1"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"/><td style="width:21.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-572">20,500</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-573">20,500</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-574">7,111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-575">7,211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="hr:JointVentureCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-576">59,239</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-577">59,239</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in <ix:nonFraction unitRef="property" contextRef="c-92" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-578">seven</ix:nonFraction> properties.</span></div></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-579" escape="true">As of June&#160;30, 2024, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</ix:nonNumeric>  See Note 2 below for more details regarding the Company's unconsolidated joint ventures.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-580" continuedAt="f-580-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><ix:continuation id="f-580-1"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></ix:continuation><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-581" continuedAt="f-581-1" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Redeemable Non-Controlling Interests</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-581-1">The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</ix:continuation>  As of June&#160;30, 2024, the Company had redeemable non-controlling interests of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-582">3.9</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-583" continuedAt="f-583-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Asset Impairment</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-583-1">The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.</ix:continuation>  During the three and six months ended June&#160;30, 2024, the Company recognized real estate impairments totaling $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ImpairmentOfRealEstate" format="ixt:num-dot-decimal" scale="6" id="f-584">120.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ImpairmentOfRealEstate" format="ixt:num-dot-decimal" scale="6" id="f-585">136.9</ix:nonFraction>&#160;million, respectively, as a result of completed and planned disposition activity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, <ix:nonFraction unitRef="property" contextRef="c-93" decimals="INF" name="hr:NumberOfPropertiesMeasuredAtFairValue" scale="0" id="f-586">16</ix:nonFraction> real estate properties totaling $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-587">265.6</ix:nonFraction>&#160;million were measured at fair value using level 3 fair value hierarchy.  The level 3 fair value techniques included brokerage estimates, letters of intent, and unexecuted purchase and sale agreements, less estimated closing costs. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-588" continuedAt="f-588-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Goodwill Impairment</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-588-1">During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment. As a result, a goodwill evaluation was performed. The Company's current operations are carried out through a single reporting unit with a carrying value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-8" name="hr:ReportingUnitCarryingValue" format="ixt:num-dot-decimal" scale="9" id="f-589">12.0</ix:nonFraction>&#160;billion. The Company determined that the carrying value exceeded estimated fair value and therefore an impairment of goodwill was recorded. The Company recorded a $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-590">250.5</ix:nonFraction>&#160;million full impairment of its goodwill, which is recorded as a non-cash charge in &#8220;Impairment of goodwill&#8221; in the Condensed Consolidated Statements of Operations.</ix:continuation> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-535-4" continuedAt="f-535-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:LessorLeasesPolicyTextBlock" id="f-591" continuedAt="f-591-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-591-1" continuedAt="f-591-2">In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-592" continuedAt="f-592-1" escape="true">See below for additional information regarding the Company's financing receivables.</ix:nonNumeric></span></div><ix:continuation id="f-592-1" continuedAt="f-592-2"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.629%"><tr><td style="width:1.0%"/><td style="width:26.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-95" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-593">5.72</ix:nonFraction>%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-594">115,056</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-96" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-595">6.48</ix:nonFraction>%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-596">7,357</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-597">122,413</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><ix:continuation id="f-591-2" continuedAt="f-591-3"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-591-3" continuedAt="f-591-4">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held to maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.</ix:continuation>  As of June&#160;30, 2024, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:RealEstateNotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-598">168.8</ix:nonFraction>&#160;million.</span></div><ix:continuation id="f-592-2"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.685%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>JUN 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RECEIVABLE (OTHER ASSETS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-97" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-599">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-600">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-601">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-602">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-603">5,196</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:num-dot-decimal" scale="3" id="f-604">3,067</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-605">46,762</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/21/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/20/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-98" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-606">9.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-607">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-608">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-609">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-610">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:fixed-zero" scale="3" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-612">6,036</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-613">60,119</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-614">60,119</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-615">942</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-616">5,196</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:num-dot-decimal" scale="3" id="f-617">3,067</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-618">52,798</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/02/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-100" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-619">7.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-620">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-621">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-622">551</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-623">11,201</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:fixed-zero" scale="3" id="f-624">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-625">20,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-101" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-626">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-627">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-628">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-629">1,211</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-630">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-631">100</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-632">7,111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-102" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-633">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-634">65,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-635">35,623</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-636">532</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-637">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-638">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-639">36,121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-103" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-640">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-641">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-642">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" scale="3" id="f-643">178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-644">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:fixed-zero" scale="3" id="f-645">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-646">45,178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-104" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-647">9.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-648">7,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-649">7,133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" format="ixt:fixed-zero" scale="3" id="f-650">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:fixed-zero" scale="3" id="f-652">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-653">7,133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-654">154,850</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-655">124,906</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-656">2,472</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-657">11,201</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-658">134</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-659">116,043</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-660">214,969</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-661">185,025</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InterestReceivableAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-662">3,414</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-663">16,397</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:num-dot-decimal" scale="3" id="f-664">3,201</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-665">168,841</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid, and on July 15, 2024, the senior lender on the construction loans associated with the underlying projects provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">During the second quarter of 2024, the Company determined that an allowance for credit loss of $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="f-666">11.2</ix:nonFraction>&#160;million was needed on this mortgage loan. The reserve amount consists of approximately $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-667">10.7</ix:nonFraction>&#160;million of principal and approximately $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossInterest" format="ixt:num-dot-decimal" scale="6" id="f-668">0.5</ix:nonFraction>&#160;million of interest. Additionally, the maturity date on this mortgage loan was extended to December 2, 2024.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Outstanding principal and interest due upon maturity.</span></div></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><ix:continuation id="f-591-4" continuedAt="f-591-5"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326: Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-535-5" continuedAt="f-535-6"><ix:continuation id="f-591-5" continuedAt="f-591-6"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2023, the Company determined that the risk of credit loss on <ix:nonFraction unitRef="loan" contextRef="c-107" decimals="INF" name="hr:NumberOfMezzanineLoans" format="ixt-sec:numwordsen" scale="0" id="f-669">two</ix:nonFraction> of its mezzanine loans were no longer remote and recorded a credit loss reserve of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="f-670">5.2</ix:nonFraction>&#160;million.   During the three and six months ended June 30, 2024, the Company determined that the risk of credit loss on <ix:nonFraction unitRef="loan" contextRef="c-1" decimals="INF" name="hr:NumberOfMortgageLoans" format="ixt-sec:numwordsen" scale="0" id="f-671"><ix:nonFraction unitRef="loan" contextRef="c-5" decimals="INF" name="hr:NumberOfMortgageLoans" format="ixt-sec:numwordsen" scale="0" id="f-672">one</ix:nonFraction></ix:nonFraction> of its mortgage note receivables was no longer remote and recorded a credit loss reserve of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="f-673"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="f-674">11.2</ix:nonFraction></ix:nonFraction>&#160;million.  The Company utilized the level 3 fair value hierarchy, which included a brokerage estimate on the underlying collateral of the loan, to determine the amount of credit loss reserve.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="f-675" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.061%"><tr><td style="width:1.0%"/><td style="width:59.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.426%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-676">5,196</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-677">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-678">11,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-679">5,196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-680">16,397</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-681">5,196</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-591-6"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from <ix:nonFraction unitRef="financing_receivable" contextRef="c-3" decimals="INF" name="hr:NumberOfRecognizedLeaseFinancialReceivables" format="ixt-sec:numwordsen" scale="0" id="f-682">two</ix:nonFraction> financing receivables totaling $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" scale="6" id="f-683">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" scale="6" id="f-684">4.2</ix:nonFraction> million, respectively, for the three and six months ended June&#160;30, 2024, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" scale="6" id="f-685">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" scale="6" id="f-686">4.2</ix:nonFraction> million, respectively, for the three and six months ended June&#160;30, 2023, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized interest income related to real estate notes receivable of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:InterestIncomeOperating" scale="6" id="f-687">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:InterestIncomeOperating" scale="6" id="f-688">4.2</ix:nonFraction> million, respectively, for the three and six months ended June&#160;30, 2024, and $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:InterestIncomeOperating" scale="6" id="f-689">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:InterestIncomeOperating" scale="6" id="f-690">4.3</ix:nonFraction> million, respectively, for the three and six months ended  June&#160;30, 2023. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  In 2023, the Company placed <ix:nonFraction unitRef="financing_receivable" contextRef="c-4" decimals="INF" name="hr:NumberOfRealEstateNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-691">two</ix:nonFraction> of its real estate notes receivable with principal balances, net of credit loss, of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual" format="ixt:num-dot-decimal" scale="6" id="f-692">48.9</ix:nonFraction>&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and six month periods ended June&#160;30, 2024.  In 2024, the Company placed <ix:nonFraction unitRef="financing_receivable" contextRef="c-3" decimals="INF" name="hr:NumberOfRealEstateNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-693">one</ix:nonFraction> of its real estate notes receivable with a principal balance, net of credit loss, of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual" format="ixt:num-dot-decimal" scale="6" id="f-694">20.5</ix:nonFraction>&#160;million on non-accrual status.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-695" continuedAt="f-695-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of ASC Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of ASC Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-535-6" continuedAt="f-535-7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-695-1" continuedAt="f-695-2">Revenue that is accounted for under ASC Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-696" continuedAt="f-696-1" escape="true">Below is a detail of the amounts by category:</ix:nonNumeric></span></div><ix:continuation id="f-696-1" continuedAt="f-696-2"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.960%"><tr><td style="width:1.0%"/><td style="width:37.259%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.755%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-697">2,463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-698">2,370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-699">5,009</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-700">4,761</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income/other</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-701">1,859</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-702">1,860</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-703">3,504</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-704">4,086</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-705">4,322</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-706">4,230</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-707">8,513</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-708">8,847</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div></ix:continuation><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="f-696-2">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</ix:continuation>           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><ix:continuation id="f-695-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-709" continuedAt="f-709-1" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">New Accounting Pronouncements </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">Topic 280)</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">. Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-709-1"><ix:continuation id="f-535-7">The update is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. At this time, the Company does not expect that the adoption of this ASU will have a material impact on its consolidated financial statements other than compliance with these new disclosure requirements, which will begin with the Company's Annual Report on Form 10-K for the year ending December 31, 2024.</ix:continuation></ix:continuation> </span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="hr:AcquisitionsAndDispositionsTextBlock" id="f-710" continuedAt="f-710-1" escape="true">Real Estate Investments</ix:nonNumeric></span></div><ix:continuation id="f-710-1" continuedAt="f-710-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2024 Acquisition Activity</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had no real estate acquisition activity for the six months ended June&#160;30, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsTextBlock" id="f-711" continuedAt="f-711-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and six months ended June&#160;30, 2024 and 2023 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"/><td style="width:55.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-712">309,754</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-713">327,746</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-714">311,511</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-715">327,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-716">66,547</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:fixed-zero" scale="3" id="f-717">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-718">66,547</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-719">3,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-720">146</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-721">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-722">568</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-723">797</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="3" id="f-724">1,314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" scale="3" id="f-725">484</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="3" id="f-726">2,649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="3" id="f-727">3,030</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-728">374,841</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-729">327,245</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-730">374,841</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-731">327,245</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-711-1" continuedAt="f-711-2"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span></ix:continuation><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"><ix:continuation id="f-711-2">In the second quarter of 2024, the Company contributed 11 properties into a new joint venture in which it retained a <ix:nonFraction unitRef="number" contextRef="c-131" decimals="2" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-732">20</ix:nonFraction>% ownership interest.  See 2024 "Real Estate Asset Dispositions" below for additional information. In 2023, there was an additional investment in an existing joint venture in which the Company retained a <ix:nonFraction unitRef="number" contextRef="c-132" decimals="2" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-733">40</ix:nonFraction>% ownership interest. The investment consisted of the Company's contribution of a property in Dallas, Texas to the joint venture.</ix:continuation> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-710-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2024 Real Estate Asset Dispositions </span></div><ix:nonNumeric contextRef="c-1" name="hr:AssetDispositionsTableTextBlock" id="f-734" continuedAt="f-734-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions and joint venture contributions for the six months ended June&#160;30, 2024.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/1/24</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="hr:DispositionSalesPrice" scale="3" id="f-735">725</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-736">60</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="f-737">665</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" scale="3" id="f-738">765</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-739">82</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-740">18</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-133" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-741">14,800</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">San Angelo, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/12/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-742">5,085</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-743">128</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-744">4,957</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-745">4,917</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-746">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-747">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-135" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-748">24,580</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/20/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="hr:DispositionSalesPrice" scale="3" id="f-749">250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-750">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="f-751">241</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" scale="3" id="f-752">713</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-753">520</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-754">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-137" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-755">37,040</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Multiple </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/23/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-756">284,348</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-757">14,270</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-758">270,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-759">254,176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="f-760">25,836</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-761">9,934</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-139" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-762">556,274</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Denver, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/30/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-763">19,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-764">628</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-765">18,372</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-766">18,522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-767">165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-768">315</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-141" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-769">37,130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Austin, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/6/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-770">54,858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-771">1,575</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-772">53,283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-773">27,964</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-774">623</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-775">24,696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-143" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-776">129,879</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Minneapolis, MN</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/21/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-777">1,082</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-778">144</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="f-779">938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" scale="3" id="f-780">303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-781">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-782">592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-145" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-783">50,291</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Greensboro/Raleigh, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2, 3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/28/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-784">99,518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-785">2,835</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-786">96,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-787">86,810</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-788">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-789">8,967</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-147" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-790">309,424</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-791">464,866</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-792">19,649</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-793">445,217</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-794">394,170</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="f-795">27,037</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-796">24,010</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-149" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-797">1,159,418</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt">The Company contributed the following medical outpatient properties to a joint venture in which the Company retained <ix:nonFraction unitRef="number" contextRef="c-151" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-798"><ix:nonFraction unitRef="number" contextRef="c-152" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-799"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-800"><ix:nonFraction unitRef="number" contextRef="c-154" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-801"><ix:nonFraction unitRef="number" contextRef="c-155" decimals="INF" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-802">20</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% ownership: <ix:nonFraction unitRef="property" contextRef="c-156" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-803"><ix:nonFraction unitRef="property" contextRef="c-157" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-804"><ix:nonFraction unitRef="property" contextRef="c-158" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-805"><ix:nonFraction unitRef="property" contextRef="c-159" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-806"><ix:nonFraction unitRef="property" contextRef="c-160" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-807">one</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; <ix:nonFraction unitRef="property" contextRef="c-161" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-808">two</ix:nonFraction> medical outpatient properties in Los Angeles and <ix:nonFraction unitRef="property" contextRef="c-162" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-809">four</ix:nonFraction> in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="6" id="f-810">256.8</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt">The Company sold <ix:nonFraction unitRef="property" contextRef="c-164" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-811">seven</ix:nonFraction> medical outpatient properties in Greensboro, NC and <ix:nonFraction unitRef="property" contextRef="c-165" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-812">two</ix:nonFraction> medical outpatient properties in Raleigh, NC to a single buyer in a single transaction.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-734-1" continuedAt="f-734-2"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">3</span></ix:continuation><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.33pt"><ix:continuation id="f-734-2">The amount in the net proceeds column for this portfolio disposition includes the receivable for the cash held in escrow that closed on June 28, 2024 and was received by the Company on July 1, 2024.  These proceeds were recorded as a receivable in other assets, net as of June 30, 2024.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="f-813">three</ix:nonFraction> properties classified as assets held for sale as of June&#160;30, 2024 and <ix:nonFraction unitRef="property" contextRef="c-4" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="f-814">one</ix:nonFraction> property classified as assets held for sale as of December&#160;31, 2023.  <ix:nonNumeric contextRef="c-1" name="hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" id="f-815" continuedAt="f-815-1" escape="true">The table below reflects the assets and liabilities classified as held for sale as of June&#160;30, 2024 and December&#160;31, 2023:</ix:nonNumeric></span></div><ix:continuation id="f-815-1"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"/><td style="width:41.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-816">2,330</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-817">1,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-818">43,342</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-819">6,779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-820">1,017</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-821">1,017</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-822">46,689</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-823">9,646</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-824">13,600</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" scale="3" id="f-825">913</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-826">33,089</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-827">8,733</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-828">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-830">850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-831">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="f-832">591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="f-833">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-834">34,530</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-835">8,834</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" scale="3" id="f-836">531</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" scale="3" id="f-837">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-838">589</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-839">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="f-840">685</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="f-841">272</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-842">1,805</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="f-843">295</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-845" continuedAt="f-845-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-844" continuedAt="f-844-1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-845-1" continuedAt="f-845-2"><ix:continuation id="f-844-1" continuedAt="f-844-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-845-2" continuedAt="f-845-3"><ix:continuation id="f-844-2" continuedAt="f-844-3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the Consumer Price Index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="f-846">308.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="f-847">626.2</ix:nonFraction> million, respectively.  Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="f-848">329.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="f-849">653.8</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="f-850" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"/><td style="width:42.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-851">441,170</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-852">827,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" format="ixt:num-dot-decimal" scale="3" id="f-853">734,851</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" format="ixt:num-dot-decimal" scale="3" id="f-854">614,428</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" format="ixt:num-dot-decimal" scale="3" id="f-855">500,591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-856">1,629,794</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="f-857">4,748,784</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of June&#160;30, 2024, the Company had <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfPropertiesSubjectToGroundLeases" scale="0" id="f-858">221</ix:nonFraction> properties totaling <ix:nonFraction unitRef="sqft" contextRef="c-1" decimals="-5" name="hr:SquareFeetSubjecttoGroundLeases" scale="6" id="f-859">16.5</ix:nonFraction> million square feet that were held under ground leases. Some of the Company's ground lease renewal terms are based on fixed rent renewal terms, and others have market rent renewal terms. These ground leases typically have initial terms of <ix:nonNumeric contextRef="c-168" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-860">40</ix:nonNumeric> to <ix:nonNumeric contextRef="c-169" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-861">99</ix:nonNumeric> years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally stated in the lease or based on CPI. The Company had <ix:nonFraction unitRef="lease" contextRef="c-1" decimals="INF" name="hr:NumberofGroundLeasesPrepaid" scale="0" id="f-862">73</ix:nonFraction> prepaid ground leases as of June&#160;30, 2024. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-863">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-864">0.3</ix:nonFraction>&#160;million of the Company's rental expense for the three months ended June 30, 2024 and 2023, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="hr:AmortizationofPrepaidRent" scale="6" id="f-865">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-866">0.7</ix:nonFraction>&#160;million for the six months ended June&#160;30, 2024 and 2023, respectively.  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-868" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-867" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its <ix:nonFraction unitRef="lease" contextRef="c-3" decimals="INF" name="hr:NumberofGroundLeasesExcludingPrepaidLeases" scale="0" id="f-869">148</ix:nonFraction> non-prepaid ground leases) as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-870">5,912</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-871">1,013</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-872">12,644</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-873">2,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-874">12,739</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-875">2,255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-876">12,934</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-877">2,294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-878">13,061</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-879">2,326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-880">693,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:FinanceLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-881">394,072</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-882">750,846</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-883">404,178</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-884">520,245</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-885">328,979</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-886">230,601</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-887">75,199</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-888" escape="true"><ix:continuation id="f-845-3"><ix:continuation id="f-844-3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-889">4,599</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-890">5,329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-891">9,065</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-892">10,436</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-893">1,315</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-894">2,235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-895">2,542</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-896">4,371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-897">392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-898">387</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-899">779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-900">774</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-901">942</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-902">923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-903">1,880</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-904">1,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-905">7,248</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-906">8,874</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-907">14,266</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-908">17,422</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-909">4,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-910">5,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-911">8,929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-912">11,190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-913">591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-914">541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="f-915">1,154</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="f-916">1,094</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-917">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-918">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-919">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-920">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-921">2,561</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-922">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-923">2,561</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-924">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-925">45.9</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-51" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-926">47.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-927">57.4</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-51" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-928">58.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-929">5.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-51" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-930">5.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-931">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-51" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-932">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:continuation></ix:continuation></ix:nonNumeric><div style="margin-bottom:6pt"><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_58"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-933" continuedAt="f-933-1" escape="true">Notes and Bonds Payable</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-934" continuedAt="f-934-1" escape="true"><ix:continuation id="f-933-1" continuedAt="f-933-2"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of June&#160;30, 2024 and December 31, 2023.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"/><td style="width:39.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATE </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 6/30/2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">6/30/2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="f-935">1.5</ix:nonFraction> billion Unsecured Credit Facility </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-936">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-170" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-938">6.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-939">200</ix:nonFraction> million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-940">199,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-941">199,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-942">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-943">250</ix:nonFraction> million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-944">249,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-945">349,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-174" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-946">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-947">300</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-948">299,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-949">299,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-950">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-951">150</ix:nonFraction> million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-952">149,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-953">149,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-954">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-955">200</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-956">199,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-957">199,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-958">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-959">300</ix:nonFraction> million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-960">298,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-961">298,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-182" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-962">6.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-963">249,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-964">249,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-184" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-965">4.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-966">582,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-967">579,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-968">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-969">485,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-970">483,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-188" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-971">4.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-972">297,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-973">297,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-190" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-974">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-975">580,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-976">575,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-977">5.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-978">296,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-979">296,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-194" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-980">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-981">296,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-982">295,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-983">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-984">658,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-985">649,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-986">5.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/24-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-987">52,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-988">70,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-989">3.57</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-203" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-990">6.88</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-991">5,148,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-992">4,994,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.      </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">As of June&#160;30, 2024, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-8" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="9" id="f-993">1.3</ix:nonFraction> billion available to be drawn on its $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="f-994">1.5</ix:nonFraction>&#160;billion Unsecured Credit Facility.</span></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-933-2"><ix:continuation id="f-934-1" continuedAt="f-934-2"><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">In April 2024, the Company exercised its option to extend the maturity date for <ix:nonNumeric contextRef="c-204" name="hr:DebtInstrumentExtensionPeriodForMaturityDate" format="ixt-sec:durwordsen" id="f-995">one year</ix:nonNumeric> to May 2025 for a fee of approximately $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-996">0.3</ix:nonFraction>&#160;million.   </span></div></ix:continuation><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-934-2" continuedAt="f-934-3"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span></ix:continuation><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"><ix:continuation id="f-934-3">In June 2024, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="us-gaap:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-997">100</ix:nonFraction>&#160;million of the initial $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-998">350</ix:nonFraction>&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for <ix:nonNumeric contextRef="c-208" name="hr:DebtInstrumentExtensionPeriodForMaturityDate" format="ixt-sec:durwordsen" id="f-999">one year</ix:nonNumeric> to July 2025 for a fee of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1000">0.3</ix:nonFraction>&#160;million.</ix:continuation>   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Changes in Debt Structure</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 6, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1001">4.77</ix:nonFraction>% per annum with an outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="f-1002">11.3</ix:nonFraction>&#160;million.</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> The mortgage note encumbered a <ix:nonFraction unitRef="sqft" contextRef="c-211" decimals="0" name="hr:ExtinguishmentOfDebtEncumberedSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-1003">63,012</ix:nonFraction> square foot property in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">California</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On February 1, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-212" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1004">4.12</ix:nonFraction>%</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> per annum with an outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="f-1005">5.6</ix:nonFraction>&#160;million. T</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">he mortgage note encumbered a <ix:nonFraction unitRef="sqft" contextRef="c-214" decimals="0" name="hr:ExtinguishmentOfDebtEncumberedSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-1006">40,324</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> squ</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">are foot property in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Georgia</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">.</span></div></ix:continuation><div id="i82b2eb8af02545bbaeb7c706ae9573fb_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-1007" continuedAt="f-1007-1" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-1007-1" continuedAt="f-1007-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-1008" continuedAt="f-1008-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had <ix:nonFraction unitRef="derivative" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="f-1009">15</ix:nonFraction> outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"/><td style="width:41.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2026</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1010">275,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1011">3.74</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1012">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-216" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1013">3.83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1014">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-217" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1015">3.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1016">200,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1017">4.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1018">300,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1019">3.93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1020">1,075,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-220" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1021">3.92</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-1007-2"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-1022" continuedAt="f-1022-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the fair value of the Company's derivative financial instruments and their classification on the Condensed Consolidated Balance Sheet as of June&#160;30, 2024.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="f-1022-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.859%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="f-1023">1,839</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="f-1024">11,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="f-1025">9,699</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><ix:continuation id="f-1008-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June&#160;30, 2024 and 2023 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"/><td style="width:24.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.940%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1026">5,891</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1027">21,523</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1028">3,811</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1029">3,568</ix:nonFraction>)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1030">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1031">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1032">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1033">107</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1034">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1035">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1036">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1037">42</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1038">5,891</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1039">21,523</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1040">3,662</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1041">3,419</ix:nonFraction>)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"/><td style="width:24.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.940%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>six months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>six months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1042">25,501</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1043">12,981</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1044">7,825</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1045">6,000</ix:nonFraction>)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1046">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1047">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1048">213</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1049">213</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1050">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1051">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1052">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1053">84</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1054">25,501</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1055">12,981</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1056">7,528</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1057">5,703</ix:nonFraction>)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="f-1058">10.5</ix:nonFraction> million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="f-1059">0.6</ix:nonFraction>&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender should the Company&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DerivativeNetLiabilityPositionAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1060">0.3</ix:nonFraction>&#160;million. As of June&#160;30, 2024, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.</span></div></ix:continuation><div id="i82b2eb8af02545bbaeb7c706ae9573fb_67"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1061" continuedAt="f-1061-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1061-1" continuedAt="f-1061-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">From time to time, the Company is involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-1061-2"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the six months ended June&#160;30, 2024, the Company invested $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" scale="6" id="f-1062">35.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" scale="6" id="f-1063">8.5</ix:nonFraction> million toward active development and redevelopment of properties, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" scale="6" id="f-1064">22.3</ix:nonFraction> million toward recently completed development and redevelopment projects.</span></div></ix:continuation><div id="i82b2eb8af02545bbaeb7c706ae9573fb_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1065" continuedAt="f-1065-1" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-1065-1" continuedAt="f-1065-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="f-1066" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June&#160;30, 2024 and the twelve months ended December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1067">380,964,433</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1068">380,589,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1069">8,623</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-257" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1070">8,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Conversion of OP units to common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-1071">194,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-257" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-1072">190,544</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares Repurchased</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-1073">17,242,237</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-108" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-1074">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares and forfeitures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1075">401,648</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-257" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1076">175,368</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1077">364,327,234</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1078">380,964,433</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company declared and paid common stock dividends totaling $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-1079">0.62</ix:nonFraction> per share.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On Jul</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 30, 2024, the Company declared a quarterly common stock dividend in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-258" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1080">0.31</ix:nonFraction> per share payable on August 28, 2024 to stockholders of record on August 12, 2024.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Repurchases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On May 31, 2023, the Company&#8217;s Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-1081">500.0</ix:nonFraction> million of outstanding shares of the Company&#8217;s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. In April 2024, </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">the Company repurch</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ased <ix:nonFraction unitRef="shares" contextRef="c-204" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-1082">2,966,764</ix:nonFraction> shares of its common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-204" decimals="INF" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-1083">14.07</ix:nonFraction> for a total of $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions" format="ixt:num-dot-decimal" scale="6" id="f-1084">41.7</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">under this authorization.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On April 30, 2024, the Company's Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-1085">500.0</ix:nonFraction> million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. The stock repurchase authorization expires on April 29, 2025, and the Company may suspend or terminate repurchases at any time without prior notice. Under the Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In May and June 2024, the Company repurchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-260" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-1086">14,275,473</ix:nonFraction> shares of its common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-260" decimals="INF" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-1087">16.18</ix:nonFraction> for a total of $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions" format="ixt:num-dot-decimal" scale="6" id="f-1088">231.0</ix:nonFraction>&#160;million under this authorization. As of June&#160;30, 2024, the Company was authorized to repurchase an additional $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:StockRepurchaseProgramAuthorizedAdditionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1089">269.0</ix:nonFraction>&#160;million of the Company's common stock. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Subsequent to June 30, 2024, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-261" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-1090">1,296,985</ix:nonFraction> shares of its common stock for a total of $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions" format="ixt:num-dot-decimal" scale="6" id="f-1091">21.8</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="f-1065-2" continuedAt="f-1065-3"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1092" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June&#160;30, 2024 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1093">374,498,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1094">380,829,011</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1095">377,916,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1096">380,812,981</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1097">2,021,471</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1098">1,932,334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1099">1,954,956</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1100">1,952,350</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1101">372,477,299</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1102">378,896,677</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1103">375,962,033</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1104">378,860,631</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1105">372,477,299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1106">378,896,677</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1107">375,962,033</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1108">378,860,631</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1109">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1110">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1111">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1112">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1113">372,477,299</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1114">378,896,677</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1115">375,962,033</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1116">378,860,631</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1117">145,938</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1118">83,726</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1119">461,157</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1120">171,804</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="f-1121">917</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="f-1122">606</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="f-1123">1,819</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="f-1124">1,830</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1125">2,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-1126">967</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1127">6,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1128">1,920</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" scale="3" id="f-1129">717</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" scale="3" id="f-1130">77</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:num-dot-decimal" scale="3" id="f-1131">2,047</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:num-dot-decimal" scale="3" id="f-1132">1,154</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss applicable to common stockholders - basic</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1133">145,414</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1134">83,442</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1135">458,482</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1136">170,560</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1137">0.39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1138">0.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1139">1.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1140">0.45</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1141">0.39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1142">0.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1143">1.22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1144">0.45</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP Units redeemable for <ix:nonFraction unitRef="shares" contextRef="c-262" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1145">3,657,682</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-263" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1146">3,669,454</ix:nonFraction> shares for the three and six months ended June&#160;30, 2024, respectively, were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during those periods.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Stock Incentive Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's stock incentive plan ("Incentive Plan") permits the grant of incentive awards to its employees and directors in any of the following forms: options, stock appreciation rights, restricted stock, restricted or deferred stock units, performance awards, dividend equivalents, or other stock-based awards, including units in the OP.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company made the following equity awards:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">Restricted Stock </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the first quarter of 2024, the Company granted non-vested stock awards to its named executive officers and other members of senior management with an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1147">5.6</ix:nonFraction>&#160;million, which consisted of an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-264" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1148">361,712</ix:nonFraction> non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:f-1149">three</span> to <ix:nonNumeric contextRef="c-266" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1150">eight years</ix:nonNumeric>.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the second quarter of 2024, the Company granted to independent directors an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-267" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1151">58,910</ix:nonFraction> shares of non-vested stock awards with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1152">0.9</ix:nonFraction>&#160;million, and an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1153">45,982</ix:nonFraction> LTIP Series D units with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1154">0.7</ix:nonFraction>&#160;million. The Company also granted </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">non-vested stock awards to other members of senior management with an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1155">0.1</ix:nonFraction>&#160;million, which consisted of an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1156">9,350</ix:nonFraction> non-vested shares.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">Restricted Stock Units ("RSUs")</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">On February 13, 2024, the Company granted an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-270" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1157">208,055</ix:nonFraction> RSUs to members of senior management, with an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" scale="6" id="f-1158">3.5</ix:nonFraction> million and a <ix:nonNumeric contextRef="c-271" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1159">five-year</ix:nonNumeric> vesting period. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="f-1065-3" continuedAt="f-1065-4"><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">On April 30, 2024, the Company granted an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-272" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1160">21,816</ix:nonFraction> RSUs to members of senior management, with an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1161">0.3</ix:nonFraction>&#160;million and a <ix:nonNumeric contextRef="c-273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1162">five-year</ix:nonNumeric> vesting period.</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="c-271" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1163">36</ix:nonFraction>% of the RSUs vest based on relative total shareholder return ("TSR") and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-274" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1164">19.10</ix:nonFraction> for the relative TSR component for the February 2024 grant using the following assumptions:</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1165" continuedAt="f-1165-1" escape="true"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1166">28.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-275" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1167">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1168">4.44</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-275" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="f-1169">15.22</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="c-276" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1170">64</ix:nonFraction>% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-276" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1171">15.22</ix:nonFraction> based on the Company's share price on the date of grant. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">LTIP Series C Units</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On February 13, 2024, the Company granted an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-277" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1172">906,044</ix:nonFraction> LTIP Series C units ("LTIP-C units) in the OP to its named executive officers with <ix:nonNumeric contextRef="c-278" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:durwordsen" id="f-1173">three-year</ix:nonNumeric> forward-looking performance targets, a five-year vesting period and an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="f-1174">7.5</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="c-280" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1175">36</ix:nonFraction>% of the LTIP-C units vest based on relative TSR and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1176">9.62</ix:nonFraction> for the relative TSR component for the February 2024 grant using the following assumptions:</span></div><ix:continuation id="f-1165-1"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"/><td style="width:56.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:41.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-282" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1177">28.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-282" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1178">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-282" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1179">4.44</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="f-1180">15.22</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="c-283" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1181">64</ix:nonFraction>% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1182">15.22</ix:nonFraction> based on the Company's share price on the date of grant. The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-1183" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"/><td style="width:47.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1184">4,043,154</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-285" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1185">2,946,242</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1186">2,615,562</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1187">2,090,060</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-288" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1188">135,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1189">43,276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-290" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1190">1,611,578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-291" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1191">1,118,537</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-288" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1192">46,660</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1193">74,304</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-290" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1194">75,074</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-291" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1195">188,070</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Change in awards based on performance assessment</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-288" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-1196">47,202</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-1197">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-290" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-1198">47,202</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-291" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-1199">79,250</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-288" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-1200">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1201">3,860</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-290" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1202">19,805</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-291" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1203">29,923</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1204">4,085,059</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-293" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1205">2,911,354</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1206">4,085,059</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-293" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1207">2,911,354</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-right:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="f-1208" escape="true"><ix:continuation id="f-1065-4"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested awards issued as of June&#160;30, 2024:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"/><td style="width:48.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" scale="6" id="f-1209">8.0</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" scale="6" id="f-1210">13.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" scale="6" id="f-1211">10.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" scale="6" id="f-1212">5.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" scale="6" id="f-1213">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-1214">39.9</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i82b2eb8af02545bbaeb7c706ae9573fb_73"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-1215" continuedAt="f-1215-1" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-1215-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The carrying amount approximates fair value (level 1 inputs) due to the short-term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements using level 2 inputs in the hierarchy.  However, the fair value of one note receivable was determined utilizing the fair value of the receivables' collateral, as the receivables are collateral-dependent, and were classified as level 3 inputs in the hierarchy.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, which consider forward yield curves and discount rates. See Note 5 for additional information.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="f-1216" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June&#160;30, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.532%"><tr><td style="width:1.0%"/><td style="width:27.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1217">5,148.2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1218">4,984.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1219">4,994.9</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1220">4,872.7</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1221">168.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1222">163.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1223">173.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1224">172.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_79"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_82"></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">The following discussion and analysis should be read together with the Consolidated Financial Statements and related Notes thereto included in Item 1 of this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2023, including factors identified under the headings &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">Unless stated otherwise or the context otherwise requires, references to the "Company," "we," "us," and "our" are to Healthcare Realty Trust and, unless the context requires otherwise, its consolidated subsidiaries, including the OP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, disclosures that are &#8220;forward-looking statements.&#8221; Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;should,&#8221; &#8220;could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company&#8217;s expected results may not be achieved; failure to realize the expected benefits of the Merger; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company&#8217;s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption &#8220;Risk Factors&#8221; and elsewhere in the Company&#8217;s filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2023. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company&#8217;s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">For a detailed discussion of the Company&#8217;s risk factors, please refer to the Company's filings with the SEC, including this report and the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023.</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_85"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Sources and Uses of Cash</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s primary sources of cash include rent receipts from its real estate portfolio based on contractual arrangements with its tenants, proceeds from the sales of real estate properties, joint ventures, and proceeds from public or private debt or equity offerings.  As of June&#160;30, 2024, the Company had $1.3 billion available to be drawn on its unsecured credit facility ("Unsecured Credit Facility") and available cash.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects to continue to meet its liquidity needs, including funding additional investments, paying dividends, and funding debt service, through cash flows from operations and liquidity sources, including the Unsecured Credit Facility. Management believes that the Company's liquidity and sources of capital are adequate to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by investing activities for the six months ended June&#160;30, 2024 were approximately $151.4 million. Below is a summary of the investing activities. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Dispositions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company disposed of or contributed to a joint venture 25 properties during the six months ended June&#160;30, 2024 for a total sales price of $464.9 million, generating cash proceeds of $378.7 million, net of joint venture contributions, including $96.0 million of proceeds that were held in escrow at June 30, 2024.  The following table details these dispositions for the six months ended June&#160;30, 2024:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.009%"><tr><td style="width:1.0%"/><td style="width:31.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.220%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Date Disposed</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Sale Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Square Footage</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/1/24</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,800&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">San Angelo, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/12/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,085&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/20/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Multiple </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/23/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">284,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">556,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Denver, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/30/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Austin, TX </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/6/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">54,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129,879&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Minneapolis, MN</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/21/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Greensboro/Raleigh, NC </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/28/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99,518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309,424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">464,866&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,159,418&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt">The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; two medical outpatient properties in Los Angeles and four in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt">The Company sold seven MOB properties in Greensboro, NC and two MOB properties in Raleigh, NC to a single buyer in a single transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Investment in Unconsolidated Joint Venture</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company's investment in an unconsolidated joint venture in which it holds a 20% interest increased by $66.5 million relating to the retained ownership from the MOB properties contributed to the joint venture.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Capital Expenditures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company incurred capital costs totaling $140.7 million for the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$44.1 million toward active development and redevelopment of properties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$22.3 million toward completed development and redevelopment of properties;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$24.4 million toward first generation tenant improvements and planned capital expenditures for acquisitions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$32.0 million toward second generation tenant improvements; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$17.9 million toward building capital.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On June 24, 2024, the Company's mezzanine loans totaling $54.1&#160;million in Texas matured.  As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid. On July 15, 2024, the senior lender on the construction loan associated with the underlying project provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender.  The Company expects to extend the maturity of the mezzanine loans concurrent with this arrangement</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Additionally, during the three months ended June 30, 2024, the Company placed one of its real estate notes receivable with a principal balance of $20.5&#160;million on non-accrual status. The Company determined that the risk of credit loss was no longer remote and recorded a credit loss reserve of $11.2&#160;million. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Financing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows used in financing activities for the six months ended June&#160;30, 2024 were approximately $379.6 million.  See Notes 4 and 7 to the Condensed Consolidated Financial Statements accompanying this report for more information about capital markets and financing activities. </span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Debt Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had outstanding interest rate derivatives totaling $1.1 billion to hedge the one-month term Secured Overnight Financing Rate ("SOFR"). The following details the amount and rate of each swap (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.672%"><tr><td style="width:1.0%"/><td style="width:42.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2026</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,075,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Changes in Debt Structure</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.77% per annum with an outstanding principal balance of $11.3&#160;million. The mortgage note encumbered a 63,012 square foot property in California. Additionally, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.12% per annum with an outstanding principal balance of $5.6&#160;million. The mortgage note encumbered a 40,324 </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">squ</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">are foot property in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Georgia</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">.  </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In June 2024, the Company repaid $100&#160;million of the $350&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for one year to July 2025 for a fee of approximately $0.3&#160;million.   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Supplemental Guarantor Information</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The OP has issued unsecured notes described in Note 4 to the Company's Condensed Consolidated Financial Statements included in this report. All unsecured notes are fully and unconditionally guaranteed by the Company, and the OP is 98.6% owned by the Company. Effective January 4, 2021, the Securities and Exchange Commission (the &#8220;SEC&#8221;) adopted amendments to the financial disclosure requirements which permit subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Accordingly, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, the Company has excluded the summarized financial information for the OP because the assets, liabilities, and results of operations of the OP are not materially different than the corresponding amounts in the Company's consolidated financial statements and management believes such summarized financial information would be repetitive and would not provide incremental value to investors.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by operating activities decreased from $254.3 million for the six months ended June&#160;30, 2023 to $244.3 million for the six months ended June&#160;30, 2024. Items impacting cash flows from operations include, but are not limited to, cash generated from property operations, interest payments and the timing of the payment of invoices and other expenses.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may, from time to time, sell properties and redeploy cash from property sales into new investments or to repay indebtedness. The income from the new investments or reduction in interest expense could be less than the income from properties sold which would adversely affect the Company's results of operations and cash flows.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_88"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Trends and Matters Impacting Operating Results</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management monitors factors and trends important to the Company and the REIT industry to gauge the potential impact on Company operations. In addition to the matters discussed in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, some of the factors and trends that management believes may impact future operations of the Company are outlined below.  </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Economic and Market Conditions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rising interest rates and increased volatility in the capital markets have increased the Company&#8217;s cost and availability of debt and equity capital. Limited availability and increases in the cost of capital could adversely impact the Company&#8217;s ability to finance operations and acquire and develop properties. To the extent the Company&#8217;s tenants experience increased costs or financing difficulties due to the economic and market conditions, they may be unable or unwilling to make payments or perform their obligations when due. Additionally, increased interest rates may also result in less liquid property markets, limiting the Company&#8217;s ability to sell existing assets or obtain joint venture capital. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expiring Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects that approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> 15% o</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">f its leases will expire each year in the ordinary course of business. There are 793 multi-tenant leases totaling 2.5 million square feet that will expire during the remainder of 2024.  Approximately 70.1% of the leases expiring during the remainder of 2024 are for space in buildings located on or adjacent to hospital campuses, are distributed throughout the portfolio, and are not concentrated with any one tenant, health system or market area. The Company typically expects to retain 75% to 90% of tenants upon expiration, and the retention ratio for the first six months of the year was within this range. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company historically has experienced increases in property taxes throughout its portfolio as a result of increasing assessments and tax rates levied across the country. The Company continues its efforts to appeal property tax increases and manage the impact of the increases. In addition, the Company historically has incurred variability in portfolio utilities expense based on seasonality, with the first and third quarters usually reflecting greater amounts. The effects of these operating expense increases are mitigated in leases that have provisions for operating expense reimbursement. As of June&#160;30, 2024, leases for approximately 92% o</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">f the Company's total leased square footage allow for some recovery of operating expenses, with approxima</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 28% ha</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ving modified gross lease structures and approxima</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 64% hav</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ing</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> net lease structures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Purchase Options</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Information about the Company's unexercised purchase options and the amount and basis for determination of the purchase price is detailed in the table below (dollars in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.024%"><tr><td style="width:1.0%"/><td style="width:36.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">YEAR EXERCISABLE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS REAL ESTATE INVESTMENT AS OF </span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">JUNE 30, 2024 </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">111,223&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">79,839&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">173,636&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">110,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">135,435&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">81,835&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2031</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">106,063&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">23,417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2033</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2034 and thereafter </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">342,681&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,164,727&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes three properties totaling $45.4 million with stated purchase prices or prices based on fixed capitalization rates. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">These purchase options have been exercisable for an average of 14.4 years.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes two medical office buildings that are recorded in the line item Investment in financing receivable, net on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures and Key Performance Indicators</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management considers certain non-GAAP financial measures and key performance indicators to be useful supplemental measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors, as well as reconciliations of these measures to the most directly comparable GAAP financial measures.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The non-GAAP financial measures and key performance indicators presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Condensed Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Funds from Operations ("FFO"), Normalized FFO and Funds Available for Distribution ("FAD")</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts (&#8220;NAREIT&#8221;). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT&#8217;s operating performance equal to &#8220;net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization, impairment, and after adjustments for unconsolidated partnerships and joint ventures.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to FFO, the Company presents Normalized FFO and FAD. Normalized FFO is presented by adding to FFO acquisition-related costs, acceleration of debt issuance costs, debt extinguishment costs and other Company-defined normalizing items to evaluate operating performance. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, non-cash financing receivable amortization, loan origination cost amortization, deferred financing fees amortization, stock-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD should not be considered as an alternative to net income as an indicator of the Company's financial performance or to cash flow from operating activities as an indicator of the Company's liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management believes FFO, Normalized FFO, FFO per common share, Normalized FFO per share and FAD ("Non-GAAP Measures") provide an understanding of the operating performance of the Company&#8217;s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, impairments and gains or losses from sales of real estate, all of which are based on historical costs, and which may be of limited relevance in evaluating current performance, Non-GAAP Measures can facilitate comparisons of operating performance between periods. The Company reports Non-GAAP Measures because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these Non-GAAP Measures. However, none of these measures represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. Further, these measures should not be considered as an alternative to net income as an indicator of the Company&#8217;s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below reconciles net income to FFO, Normalized FFO and FAD for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Amounts in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net loss attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(143,780)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(82,759)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(454,616)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(169,884)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Net loss attributable to common stockholders per diluted share </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(0.39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(0.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">(0.45)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(33,431)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,156)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(33,453)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,162)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">120,917&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">136,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">81,442&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">177,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">185,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">358,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">371,112&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling loss from operating partnership units</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,077)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,355)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,094)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proportionate share of unconsolidated joint ventures</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,412&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,386&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,253&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">FFO adjustments</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">267,577&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">236,447&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">464,943&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">451,551&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">FFO adjustments per common share - diluted </span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.18&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">123,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">153,688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">281,667&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">FFO attributable to common stockholders per common share - diluted </span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.73&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Transaction costs </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(15,670)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,815)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Merger-related fair value of debt instruments</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,064&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,418&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-routine legal costs/forfeited earnest money received </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Credit losses and gains on other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,599&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,530&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV normalizing items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Normalized FFO adjustments</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,703&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,839)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">280,995&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21,029&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">Normalized FFO adjustments per common share - diluted </span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(0.01)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.05&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">143,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">291,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">302,696&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Normalized FFO attributable to common stockholders per common share - diluted </span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.79&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest amortization </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rent reserves, net</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent, net</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,799)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,005)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,432)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(16,251)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock-based compensation </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,669&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV non-cash items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(148)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(316)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(598)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO adjusted for non-cash items</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">142,777&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,818&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">288,015&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,539&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2nd generation TI</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,287)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,236)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(32,491)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(26,118)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Leasing commissions paid</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,012)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,493)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,227)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,506)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building capital</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,835)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,649)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18,198)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,595)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FAD</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107,643&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">116,440&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">212,099&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">242,320&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO weighted average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 6</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">376,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">383,409&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">379,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">383,372&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Potential common shares are not included in diluted earnings per share when a loss exists as the effect would be antidilutive.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">For the three and six months ended June 30, 2024, includes a $4.9 million gain on sale of corporate assets included in "Gains on sales of real estate and other assets" on the Statement of Operations, a $2.2 million straight line rent reversed included in "Rental income" on the Statement of Operations, and a $11.2 million credit loss reserve on a note receivable included in "Impairment of real estate properties and credit loss reserves" on the Statement of Operations. For the six months ended June 30, 2023, includes a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate properties and credit loss reserves" on the Statement of Operations and $3.4 million reserve included in &#8220;Rental Income&#8221; on the Statement of Operations for previously deferred rent and straight line rent for three skilled nursing facilities.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes the Company's proportionate share of lease intangible amortization related to unconsolidated joint ventures.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">Includes the Company's proportionate share of straight-line rent, net related to unconsolidated joint ventures.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">6</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.96pt">The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 420,687 and 442,263, respectively, for the three months ended June 30, 2024 and 2023, and the dilutive impact of 3,657,682 and 3,669,454 OP units outstanding for the three and six months ended June 30, 2024, respectively. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Cash Net Operating Income ("NOI") and Same Store Cash NOI</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income, interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, financing receivable amortization, tenant improvement amortization and leasing commission amortization. The Company also excludes cash lease termination fees. Cash NOI is historical and not necessarily indicative of future results. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale or intended for sale, properties undergoing redevelopment, and newly-redeveloped or developed properties. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.  </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any recently acquired property will be included in the same store pool once the Company has owned the property for five full quarters. Newly-developed or redeveloped properties will be included in the same store pool five full quarters after substantial completion. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table reflects the Company's Same Store Cash NOI for the six months ended June&#160;30, 2024 and 2023: </span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.486%"><tr><td style="width:1.0%"/><td style="width:37.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.272%"/><td style="width:0.1%"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT<br/>at June 30, 2024</span></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SAME STORE CASH NOI for the six months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store properties</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,932,206&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">365,569&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">356,489&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture same store properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">353,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following tables reconcile net loss to Same Store NOI and the same store property metrics to the total owned real estate portfolio for the six months ended June&#160;30, 2024 and 2023:</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Reconciliation of Same Store Cash NOI  </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.926%"><tr><td style="width:1.0%"/><td style="width:57.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.642%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">SAME STORE RECONCILIATION</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss </span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(461,157)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(171,804)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expense </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">484,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">207,225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">351,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">367,671&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expenses</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,953&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,029)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(16,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other revenue</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,439)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,725)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash NOI</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">399,280&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">417,214&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash NOI not included in same store</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,025)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(51,448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Same store cash NOI</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,255&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">365,766&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,686)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,277)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Same store cash NOI (excluding JVs)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">365,569&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">356,489&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1.</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.25pt">Includes transaction costs, Merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization and ground lease straight-line rent expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2.</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:12.74pt">Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease terminations and tenant improvement overage amortization.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Reconciliation of Same Store Properties</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"/><td style="width:45.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">AS OF JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars and square feet in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PROPERTY COUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE <br/>FEET</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OCCUPANCY</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store properties </span></div></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,932,206&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">34,906&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture same store properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">353,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">86.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Wholly owned and joint venture acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">114,104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development completions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">97,968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redevelopments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">445,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">53.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Planned dispositions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">60,076&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total </span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,003,835&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39,730&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.8&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">424,284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total owned real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,579,551&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,094&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Excludes assets held for sale, construction in progress, land held for development, corporate property and financing lease right-of-use assets unrelated to an imputed lease arrangement as a result of a sale leaseback transaction.</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Three Months Ended June&#160;30, 2024 Compared to Three Months Ended June&#160;30, 2023 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s results of operations for the three months ended June&#160;30, 2024 compared to the same period in 2023 were impacted by acquisitions, developments, dispositions, gains on sale, and capital markets transactions. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenues</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rental income decreased $21.5 million, or 6.5%, for the three months ended June&#160;30, 2024 compared to the prior year period. This decrease is primarily comprised of the following:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $18.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 contributed $0.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Leasing activity, including contractual rent increases, contributed $2.5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Reversed revenue related to the Steward Health Care System LLC ("Steward") bankruptcy resulted in a decrease of $5.5 million, including $2.6 million of straight-line rent.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Property operating expenses decreased $7.7 million, or 6.1%, for the three months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $8.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 resulted in an increase of $0.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Administrative, leasing commissions, and other legal expense of $2.3 million; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Janitorial expense of $0.2 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decreases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Utilities expense of $0.8 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Maintenance and repair expense of $1.0 million; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Property taxes of $0.2 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">General and administrative expenses decreased approximately $1.5 million, or 9.5%, for the three months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in payroll and payroll related expenses of approximately $0.5 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in non-cash compensation incentive expense of $0.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in travel expense of $0.5 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increase in cash compensation incentive expense of $0.5 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Other decreases including legal and other administrative costs of $0.6 million.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger-related costs for the three months ended June 30, 2023 included a net reduction in legal and consulting fees as a result of a refund related to state transfer taxes.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Depreciation and amortization expense decreased $9.7 million, or 5.3%, for the three months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 resulted in an increase of $0.2 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Various building and tenant improvement expenditures resulted in an increase of $11.6 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $11.5 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Assets that became fully depreciated resulted in a decrease of $10.0 million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Income (Expense)</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Gains on sale of real estate properties and other assets</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the second quarter of 2024, the Company recognized gains on sale of real estate properties and other assets of approximately $38.3 million. In the second quarter of 2023, the Company recognized gains on sale of real estate properties of approximately $7.2 million.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Interest expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest expense decreased $2.9 million, or 4.4%, for the three months ended June&#160;30, 2024 compared to the prior year period. The components of interest expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"/><td style="width:45.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">CHANGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,956&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,766&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net discount/premium accretion</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,198&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(376)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of interest rate swap settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of treasury hedge settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair value derivative</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(997)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest cost capitalization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(974)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(712)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(262)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">62,457&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">65,334&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,877)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Contractual interest expense decreased $1.8 million, or 3.4%, for the three months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Term Loans accounted for an increase of approximately $1.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Credit Facility accounted for a decrease of approximately $3.3 million as a result of a decreased weighted average balance outstanding.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Active interest rate derivatives accounted for a decrease of $1.2 million, while expired interest rate derivatives accounted for an increase of $1.9 million. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Mortgage note repayments, net of assumptions, accounted for a decrease of approximately $0.3 million.</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">  </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of real estate properties and credit loss reserves</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the second quarter of 2024, the Company recognized impairments totaling $10.2 million on 15 properties sold and $110.7 million on 17 properties with changes in the expected holding periods.  In addition, the Company recorded $11.2 million in credit loss reserves relates to notes receivables.  In the second quarter of 2023, the Company recognized impairments totaling $55.2 million primarily as a result of four properties with changes in the expected holding periods.  </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Equity loss from unconsolidated joint ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized its proportionate share of losses from its unconsolidated joint ventures. These losses are primarily attributable to non-cash depreciation expense.  See Note 2 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's unconsolidated joint ventures.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Six Months Ended June&#160;30, 2024 Compared to Six Months Ended June&#160;30, 2023 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s results of operations for the six months ended June&#160;30, 2024 compared to the same period in 2023 were impacted by acquisitions, developments, dispositions, gains on sale, and capital markets transactions. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenues</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rental income decreased $27.6 million, or 4.2%, for the six months ended June&#160;30, 2024 compared to the prior year period. This decrease is primarily comprised of the following:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $34.0 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 contributed $1.4 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Leasing activity, including contractual rent increases, contributed $11.2 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Reversed revenue related to the Steward bankruptcy resulted in a decrease of $6.2 million, including straight-line rent of $2.7 million.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Property operating expenses decreased $8.6 million, or 3.5%, for the six months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $16.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 resulted in an increase of $0.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Administrative, leasing commissions, and other legal expense of $2.6 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Maintenance and repair expense of $1.1 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Utilities expense of $1.0 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Compensation expense of $1.0 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Janitorial expense of $0.9 million; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Security expense of $0.2 million.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">General and administrative expenses decreased approximately $1.6 million, or 5.3%, for the six months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in payroll and payroll related expenses of approximately $1.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increase in non-cash compensation incentive expense of $1.2 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Other decreases including legal and other administrative costs of $1.1 million.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger-related costs for the six months ended June 30, 2023 included a net reduction in legal and consulting fees as a result of a refund related to state transfer taxes.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Depreciation and amortization expense decreased $16.1 million, or 4.4%, for the six months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2023 and 2024 resulted in a decrease of $23.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2023 resulted in an increase of $0.9 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Various building and tenant improvement expenditures resulted in an increase of $24.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Assets that became fully depreciated resulted in a decrease of $18.0 million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Income (Expense)</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Gains on sale of real estate properties and other assets</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Gains on the sale of real estate properties and other assets for the six months ended June 30, 2024 and 2023 totaled $38.4 million and $8.2 million, respectively.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Interest expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest expense decreased $5.6 million, or 4.3%, for the six months ended June&#160;30, 2024 compared to the prior year period. The components of interest expense are as follows:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"/><td style="width:45.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">CHANGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,414&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">103,533&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,119)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net discount/premium accretion</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(645)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of interest rate swap settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of treasury hedge settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair value derivative</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(92.7)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest cost capitalization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,916)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,282)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(634)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">123,510&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129,092&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,582)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Contractual interest expense decreased $3.1 million, or 3.0%, for the six months ended June&#160;30, 2024 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Term Loans accounted for an increase of approximately $4.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Credit Facility accounted for a decrease of approximately $7.3 million as a result of a decreased weighted average balance outstanding.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Active interest rate derivatives accounted for a decrease of $3.5 million, while expired interest rate derivatives accounted for an increase of $4.0 million. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Mortgage note repayments, net of assumptions, accounted for a decrease of approximately $0.7 million.</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">  </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of real estate properties and credit loss reserves</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company recognized impairments totaling $136.9&#160;million on 15 properties sold and 18 properties with changes in the expected holding periods, including one property reclassified to held for sale.  In addition, the Company recorded $11.2&#160;million in credit loss reserves relates to notes receivables.  During the six months ended June&#160;30, 2023, the Company recognized impairments totaling $86.6 million relating to five properties that were sold, one land parcel that was sold, three properties reclassified to held for sale and four additional properties with changes in the expected holding periods.  In addition, the Company recorded $5.2&#160;million in credit loss reserves related to notes receivables.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of Goodwill</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended March 31, 2024, the Company determined that the carrying value of its single reporting unit exceeded estimated fair value and therefore recorded a $250.5 million full impairment of its goodwill, which is recorded as a non-cash charge in &#8220;Impairment of goodwill&#8221; in the consolidated statements of operations.  See Note 1 to the Condensed Consolidated Financial Statements accompanying this report for more details. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Equity loss from unconsolidated joint ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized its proportionate share of losses from its unconsolidated joint ventures. These losses are primarily attributable to non-cash depreciation expense.  See Note 2 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's unconsolidated joint ventures.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_94"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;3.  Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to market risk in the form of changing interest rates on its debt and mortgage notes. Management uses regular monitoring of market conditions and analysis techniques to manage this risk. During the six months ended June&#160;30, 2024, there were no material changes in the quantitative and qualitative disclosures about market risks presented in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_97"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;4.  Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), as of the end of the period covered by this report. Based on this evaluation, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company&#8217;s disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports it files or submits under the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">There have not been any changes in the Company&#8217;s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_100"></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_103"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1A.  Risk Factors</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to the other information set forth in this report and the risk factor discussed below, an investor should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, which could materially affect the Company&#8217;s business, financial condition or future results. The risks, as described in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, are not the only risks facing the Company. Additional risks and uncertainties not currently known to management or that management currently deems immaterial also may materially adversely affect the Company&#8217;s business, financial condition, operating results or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Risk Factors Relating to the Company</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Operational Risks</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">The Company's revenues depend on the ability of its tenants under its leases to generate sufficient income from their operations to make rental payments to the Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s revenues are subject to the financial strength of its tenants and associated health systems. The Company has no operational control over the business of these tenants and associated health systems that face a wide range of economic, competitive, government reimbursement and regulatory pressures and constraints, including the loss of licensure or certification. Any slowdown in the economy, decline in the availability of financing from the capital markets, or changes in healthcare regulations may adversely affect the businesses of the Company&#8217;s tenants to varying degrees. Such conditions may further impact such tenants&#8217; abilities to meet their obligations to the Company and, in certain cases, could lead to restructurings, disruptions, or bankruptcies of such tenants. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company leases to government tenants from time to time that may be subject to annual budget appropriations. If a government tenant fails to receive its annual budget appropriation, it might not be able to make its lease payments to the Company. In addition, defaults under leases with federal government tenants are governed by federal statute and not by state eviction or rent deficiency laws. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The conditions described above could adversely affect the Company&#8217;s revenues and could increase allowances for losses and result in impairment charges, which could decrease net income attributable to common stockholders and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">equity and reduce cash flows from operations. For example, Steward leases approximately 580,000 square feet of space from the Company, accounting for approximately 1.6% of the Company&#8217;s total in-place annualized base rent. On May 6, 2024, Steward announced that it had filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. The bankruptcy filing by Steward has delayed the Company&#8217;s efforts to collect past due balances under its leases with Steward and may ultimately preclude collection of these amounts. Further, two of the leases have been rejected in bankruptcy and additional leases could be rejected. Steward owes the Company approximately $3.0 million in prepetition rent. There can be no assurance that Steward will meet its financial obligations to the Company or that the Company will be able to timely re-let spaces for which leases have been rejected.</span></div><div><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_109"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, the Company repurchased shares of its common stock as follows:&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.085%"><tr><td style="width:1.0%"/><td style="width:30.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.776%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">PERIOD</span></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES PURCHASED </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">AVERAGE PRICE PAID per share </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">MAXIMUM NUMBER (or Approximate DOLLAR VALUE) OF SHARES that may yet be purchased under the plans or programs </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">May 31, 2023 Authorized Shares</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">500,000,000&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1 - January 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">500,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">February 1 - February 29</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">500,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">March 1 - March 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">500,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">April 1 - April 30 </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,966,764&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,966,764&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">458,191,783&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">April 30, 2024 Authorized Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">500,000,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1 - May 31 </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,536,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,536,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">379,829,237&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1 - June 30 </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,738,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,738,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">269,040,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">17,250,465&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15.81&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">17,242,237&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">269,040,536&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Share purchases in February 2024 represent shares of Company common stock withheld and cancelled to satisfy employee tax withholding obligations payable upon the vesting of non-vested shares.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">On May 31, 2023, the Company's Board of Directors authorized the repurchase of up to $500 million of outstanding shares of the Company's common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions.  On April&#160;30, 2024, the Company's Board of Directors authorized the repurchase of up to $500 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. The stock repurchase authorization expires on April 29, 2025. The Company may suspend or terminate at any time without prior notice.   The Company is not obligated under this authorization to repurchase any specific number of shares.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Repurchases of common stock in April 2024 were made under the $500 million stock repurchase authorization on May&#160;31, 2023. All repurchases of common stock made after April 30, 2024 were repurchased under the $500 million stock repurchase authorization on April&#160;30, 2024.  As of June&#160;30, 2024, the Company was authorized to repurchase an additional $269 million of the Company's common stock.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_112"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;5. Other Information</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, no director or officer of the Company <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1225"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1226">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1227"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1228">terminated</ix:nonNumeric></ix:nonNumeric> a "Rule 10b5-1 trading agreement" or "non-Rule 10b5-1 trading agreement," as each term is defined in Item 408(a) of Regulation S-K.</span></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_115"></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;6. Exhibits  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.017%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXHIBIT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.1</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1360604/000136060423000083/hr-2023630xex31.htm">Fifth Articles of Amendment and Restatement of the Company, as amended.</a></span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1360604/000136060420000037/ex31.htm">Fourth Amended and Restated Bylaws of the Company.</a></span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001360604/000119312522202185/d384978d8k.htm">Certificate of Limited Partnership of Healthcare Realty Holdings, L.P.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001360604/000119312522202185/d384978d8k.htm">Second Amended and Restated Agreement of Limited Partnership of Healthcare Realty Holdings, L.P.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;text-decoration:none;top:-2.62pt;vertical-align:baseline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001360604/000119312522202185/d384978d8k.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.017%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex22.htm">Exhibit 22</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex22.htm">Subsidiary Issuers of Guaranteed Securities (filed herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex311.htm">Exhibit 31.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex311.htm">Certification of the Chief Executive Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex312.htm">Exhibit&#160;31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex312.htm">Certification of the Chief Financial Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex32.htm">Exhibit&#160;32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2024630xex32.htm">Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Schema Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Calculation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Labels Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Definition Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.PRE</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Presentation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"> 1   Filed as an exhibit to the Company's (File No. 001-35568) Quarterly Report on Form 10-Q filed with the SEC on August 8, 2023 and hereby incorporated by reference.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"> 2  Filed as an exhibit to Legacy HTA's (File No. 001-35568) Current Report on Form 8-K filed with the SEC on April 29, 2020 and hereby incorporated by reference.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"> 3  Filed as an exhibit to the Company's (File No. 001-35568) Current Report on Form 8-K filed with the SEC on July 26, 2022 and hereby incorporated by reference.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="i82b2eb8af02545bbaeb7c706ae9573fb_118"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#i82b2eb8af02545bbaeb7c706ae9573fb_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"/><td style="width:40.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.427%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">HEALTHCARE REALTY TRUST INCORPORATED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">/s/ J. CHRISTOPHER DOUGLAS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">J. Christopher Douglas</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">August 2, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>2
<FILENAME>hr-2024630xex22.htm
<DESCRIPTION>EX-22
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3c0f13f78dab4815b1f59acb45442c2e_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 22</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">LIST OF SUBSIDIARY ISSUERS OF GUARANTEED SECURITIES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">As of June 30, 2024, Healthcare Realty Trust Incorporated is the guarantor of the outstanding debt securities of its subsidiaries, as listed below.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Debt Instrument</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Issuer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.88% Senior Notes due 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.50% Senior Notes due 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.75% Senior Notes due 2027</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.63% Senior Notes due 2028</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.10% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.40% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.05% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.00% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>hr-2024630xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i6af0697561de42aeb458efe461931dcf_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Todd J. Meredith, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2, 2024</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>hr-2024630xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ief979b25ff554f42af5b1ee30e4645f8_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, J. Christopher Douglas, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2, 2024</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>hr-2024630xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="icfa901ed0edc43e3b30f85560a8dcbcb_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 SECTION 906</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. Section&#160;1350,</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">as Adopted Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Quarterly Report of Healthcare Realty Trust Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended June&#160;30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Todd J. Meredith, President and Chief Executive Officer of the Company, and I, J. Christopher Douglas, Executive Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2, 2024</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hr-20240630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hr="http://healthcarerealty.com/20240630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthcarerealty.com/20240630">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthcarerealty.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952157 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestments" roleURI="http://healthcarerealty.com/role/RealEstateInvestments">
        <link:definition>9952159 - Disclosure - Real Estate Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://healthcarerealty.com/role/Leases">
        <link:definition>9952160 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayable" roleURI="http://healthcarerealty.com/role/NotesandBondsPayable">
        <link:definition>9952161 - Disclosure - Notes and Bonds Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments">
        <link:definition>9952162 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies">
        <link:definition>9952163 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://healthcarerealty.com/role/StockholdersEquity">
        <link:definition>9952164 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments">
        <link:definition>9952165 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsTables" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables">
        <link:definition>9954473 - Disclosure - Real Estate Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://healthcarerealty.com/role/LeasesTables">
        <link:definition>9954474 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableTables" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables">
        <link:definition>9954475 - Disclosure - Notes and Bonds Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>9954476 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://healthcarerealty.com/role/StockholdersEquityTables">
        <link:definition>9954477 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>9954478 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954479 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails">
        <link:definition>9954480 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails">
        <link:definition>9954481 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails">
        <link:definition>9954482 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails">
        <link:definition>9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>9954484 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails">
        <link:definition>9954485 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsDispositionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails">
        <link:definition>9954486 - Disclosure - Real Estate Investments - Dispositions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsNarrativeDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails">
        <link:definition>9954487 - Disclosure - Real Estate Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsAssetsHeldforSaleDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails">
        <link:definition>9954488 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseIncomeDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails">
        <link:definition>9954489 - Disclosure - Leases - Lease Income - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLessorAccountingDetails" roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails">
        <link:definition>9954490 - Disclosure - Leases - Lessor Accounting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesGroundLeasesDetails" roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails">
        <link:definition>9954491 - Disclosure - Leases - Ground Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>9954492 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>9954492 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails">
        <link:definition>9954493 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableDetails" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails">
        <link:definition>9954494 - Disclosure - Notes and Bonds Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableNarrativeDetails" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails">
        <link:definition>9954495 - Disclosure - Notes and Bonds Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails">
        <link:definition>9954496 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails">
        <link:definition>9954497 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails">
        <link:definition>9954498 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>9954499 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>9954500 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails">
        <link:definition>9954501 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockTransactionsNarrativeDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails">
        <link:definition>9954502 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails">
        <link:definition>9954503 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails">
        <link:definition>9954504 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails">
        <link:definition>9954505 - Disclosure - Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails">
        <link:definition>9954506 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsDetails" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails">
        <link:definition>9954507 - Disclosure - Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hr_InterestRateSwapExpiringDecember12027Member" abstract="true" name="InterestRateSwapExpiringDecember12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_TermLoandue2026Member" abstract="true" name="TermLoandue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_StraightLineRentReceivable" abstract="false" name="StraightLineRentReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_GreensboroNCMember" abstract="true" name="GreensboroNCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" abstract="false" name="ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDueMay2025Member" abstract="true" name="TermLoanDueMay2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfPropertiesClassifiedAsHeldForSale" abstract="false" name="NumberOfPropertiesClassifiedAsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_PaymentsForRepurchasesOfCommonStock" abstract="false" name="PaymentsForRepurchasesOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MultipleMember" abstract="true" name="MultipleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InvestmentInRealEstatePropertiesAndMortgageNotes" abstract="false" name="InvestmentInRealEstatePropertiesAndMortgageNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_StockIncentivePlanMember" abstract="true" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SeniorNotesdue2025Member" abstract="true" name="SeniorNotesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_PerformanceConditionsMember" abstract="true" name="PerformanceConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EquityMethodInvestmentsRollForward" abstract="true" name="EquityMethodInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_CumulativeDividendsMember" abstract="true" name="CumulativeDividendsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstatePropertiesHeldInJointVenturesMember" abstract="true" name="RealEstatePropertiesHeldInJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstateDispositionsLineItems" abstract="true" name="RealEstateDispositionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_NotesReceivableCarryingAmount" abstract="false" name="NotesReceivableCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PhiladelphiaPAMember" abstract="true" name="PhiladelphiaPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_AmortizationofPrepaidRent" abstract="false" name="AmortizationofPrepaidRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDue2028Member" abstract="true" name="TermLoanDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfRealEstateNotesReceivable" abstract="false" name="NumberOfRealEstateNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_OneMember" abstract="true" name="OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" abstract="false" name="AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_StockIssuanceProgramDomain" abstract="true" name="StockIssuanceProgramDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_HoustonTexasMember" abstract="true" name="HoustonTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfNotesReceivable" abstract="false" name="NumberOfNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_NotesReceivableInterestRate" abstract="false" name="NotesReceivableInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_SanAngeloTXMember" abstract="true" name="SanAngeloTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InterestIncomeFinancingReceivableNoncash" abstract="false" name="InterestIncomeFinancingReceivableNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" abstract="true" name="CompletedDevelpomentAndRedevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateDispositionsMember" abstract="true" name="RealEstateDispositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfMezzanineLoans" abstract="false" name="NumberOfMezzanineLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_AustinTXMember" abstract="true" name="AustinTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringDecember12026Member" abstract="true" name="InterestRateSwapExpiringDecember12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" abstract="false" name="NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EquityOwnershipForConsolidationPercent" abstract="false" name="EquityOwnershipForConsolidationPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" abstract="false" name="LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_HoustonTXMember" abstract="true" name="HoustonTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StockIssuanceProgramAxis" abstract="true" name="StockIssuanceProgramAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_ReportingUnitCarryingValue" abstract="false" name="ReportingUnitCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PropertyEntitiesNotDeterminedToBeVIEsMember" abstract="true" name="PropertyEntitiesNotDeterminedToBeVIEsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LeaseIntangibles" abstract="false" name="LeaseIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SquareFeetSubjecttoGroundLeases" abstract="false" name="SquareFeetSubjecttoGroundLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_ProceedsFromDispositionsHeldInEscrow" abstract="false" name="ProceedsFromDispositionsHeldInEscrow" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PercentageOfRestrictedStockUnits" abstract="false" name="PercentageOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_MarketCondition2Member" abstract="true" name="MarketCondition2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LTIPSeriesCUnitsMember" abstract="true" name="LTIPSeriesCUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2026Member" abstract="true" name="SeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ActiveDevelopmentPropertiesMember" abstract="true" name="ActiveDevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_AlbanyNYMember" abstract="true" name="AlbanyNYMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MergerRelatedCosts" abstract="false" name="MergerRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_HealthCareRealtyTrustIncorporatedMember" abstract="true" name="HealthCareRealtyTrustIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_TermLoanDueJuly2024Member" abstract="true" name="TermLoanDueJuly2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfRealEstateInvestments" abstract="false" name="NumberOfRealEstateInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_NumberofGroundLeasesExcludingPrepaidLeases" abstract="false" name="NumberofGroundLeasesExcludingPrepaidLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" abstract="false" name="TreasuryStockValueAcquiredCostMethodExcludingCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_FinanceLeasePrincipalOnlyPayments" abstract="false" name="FinanceLeasePrincipalOnlyPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" abstract="false" name="ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_RaleighNCMember" abstract="true" name="RaleighNCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SettledInterestRateSwapsMember" abstract="true" name="SettledInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_DirectorsMember" abstract="true" name="DirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstateNotesReceivableNet" abstract="false" name="RealEstateNotesReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="hr_ClosingAdjustmentsDisposedEntity" abstract="false" name="ClosingAdjustmentsDisposedEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberofGroundLeasesPrepaid" abstract="false" name="NumberofGroundLeasesPrepaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_StockRepurchaseProgramAuthorizedAdditionalAmount" abstract="false" name="StockRepurchaseProgramAuthorizedAdditionalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" abstract="false" name="LessorOperatingLeasePaymenttobeReceivedafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ColumbusOHMember" abstract="true" name="ColumbusOHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RedevelopmentPropertiesMember" abstract="true" name="RedevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateOther" abstract="false" name="RealEstateOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_HealthcareTrustofAmericaHoldingsLPMember" abstract="true" name="HealthcareTrustofAmericaHoldingsLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NotesReceivableMaximumLoanCommitment" abstract="false" name="NotesReceivableMaximumLoanCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DenverCOMember" abstract="true" name="DenverCOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ReceivablesAndOtherAssets" abstract="false" name="ReceivablesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ExecutiveIncentiveProgramMember" abstract="true" name="ExecutiveIncentiveProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_CumulativeNetIncomeMember" abstract="true" name="CumulativeNetIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12027Member" abstract="true" name="InterestRateSwapExpiringJune12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NonControllingInterestHoldersMember" abstract="true" name="NonControllingInterestHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NumberOfRecognizedLeaseFinancialReceivables" abstract="false" name="NumberOfRecognizedLeaseFinancialReceivables" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_ScheduleOfRealEstateDispositionsTable" abstract="true" name="ScheduleOfRealEstateDispositionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" abstract="false" name="ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DebtInstrumentExtensionPeriodForMaturityDate" abstract="false" name="DebtInstrumentExtensionPeriodForMaturityDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_SeniorNotesdue2030Member" abstract="true" name="SeniorNotesdue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_JointVentureCarryingAmount" abstract="false" name="JointVentureCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfJointVentures" abstract="false" name="NumberOfJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_FinancingReceivableAllowanceForCreditLossReserves" abstract="false" name="FinancingReceivableAllowanceForCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ImpairmentOfRealEstateAndCreditLossReserves" abstract="false" name="ImpairmentOfRealEstateAndCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SeattleWAMember" abstract="true" name="SeattleWAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringMay12026Member" abstract="true" name="InterestRateSwapExpiringMay12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" abstract="false" name="RealEstateInvestmentsPropertyOwnedInNumberOfStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_LTIPSeriesDUnitsMember" abstract="true" name="LTIPSeriesDUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" abstract="false" name="AssetsHeldForSaleAndDiscontinuedOperationsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PersonalProperty" abstract="false" name="PersonalProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfMortgageLoans" abstract="false" name="NumberOfMortgageLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_ConstructionActivityTotalFundingDuringthePeriod" abstract="false" name="ConstructionActivityTotalFundingDuringthePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_Florida1Member" abstract="true" name="Florida1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_OtherInvestorsMember" abstract="true" name="OtherInvestorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessOverviewAbstract" abstract="true" name="BusinessOverviewAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_MortgageLoanMember" abstract="true" name="MortgageLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_OperatingExpensesandCostofGoodsSold" abstract="false" name="OperatingExpensesandCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_UnsecuredCreditFacilityOneMember" abstract="true" name="UnsecuredCreditFacilityOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LosAngelesCaliforniaMember" abstract="true" name="LosAngelesCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NewYorkNYMember" abstract="true" name="NewYorkNYMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_CumulativeNetIncomeAttributableToCommonStockholders" abstract="false" name="CumulativeNetIncomeAttributableToCommonStockholders" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NatureOfOperationsPolicyTextBlock" abstract="false" name="NatureOfOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_SeniorNotesdue2028Member" abstract="true" name="SeniorNotesdue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" abstract="false" name="ProceedsFromContributionsFromRedeemableNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AssetDispositionsTableTextBlock" abstract="false" name="AssetDispositionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_ExtinguishmentOfDebtEncumberedSquareFootage" abstract="false" name="ExtinguishmentOfDebtEncumberedSquareFootage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_TermLoanDue2025Member" abstract="true" name="TermLoanDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_MinneapolisMNMember" abstract="true" name="MinneapolisMNMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateInvestmentNetDisposedOfDuringPeriod" abstract="false" name="RealEstateInvestmentNetDisposedOfDuringPeriod" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDue2027Member" abstract="true" name="TermLoanDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" abstract="false" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_LimitedLiabilityCompanyOneMember" abstract="true" name="LimitedLiabilityCompanyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" abstract="false" name="NumberOfPropertiesHeldInUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_CumulativeNetLossAttributableToCommonStockholders" abstract="false" name="CumulativeNetLossAttributableToCommonStockholders" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ManagementFeeIncomeMember" abstract="true" name="ManagementFeeIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ParkingIncomeMember" abstract="true" name="ParkingIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" abstract="true" name="ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12026Member" abstract="true" name="InterestRateSwapExpiringJune12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_OperatingPartnershipPerformanceUnitsMember" abstract="true" name="OperatingPartnershipPerformanceUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_FinancingReceivableAllowanceForCreditLossInterest" abstract="false" name="FinancingReceivableAllowanceForCreditLossInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AtlantaGAMember" abstract="true" name="AtlantaGAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ActiveInterestRateSwapsMember" abstract="true" name="ActiveInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NonVestedStockAwardMember" abstract="true" name="NonVestedStockAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_VariableInterestEntityMember" abstract="true" name="VariableInterestEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ApproximateSquareFeetInvestedInByCompany" abstract="false" name="ApproximateSquareFeetInvestedInByCompany" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_StraightlineRentLiability" abstract="false" name="StraightlineRentLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfVariableInterestEntities" abstract="false" name="NumberOfVariableInterestEntities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_SeniorNotesDue2031Member" abstract="true" name="SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_AcquisitionsAndDispositionsTextBlock" abstract="false" name="AcquisitionsAndDispositionsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_NumberOfPropertiesMeasuredAtFairValue" abstract="false" name="NumberOfPropertiesMeasuredAtFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_OtherMembersOfSeniorManagementMember" abstract="true" name="OtherMembersOfSeniorManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MezzanineLoanMember" abstract="true" name="MezzanineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_PowayCAMember" abstract="true" name="PowayCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_JointVentureOwnershipPercentage" abstract="false" name="JointVentureOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageNotesPayableNetMember" abstract="true" name="MortgageNotesPayableNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_GreensboroRaleighNCMember" abstract="true" name="GreensboroRaleighNCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2027Member" abstract="true" name="SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_DispositionSalesPrice" abstract="false" name="DispositionSalesPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hr-20240630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab6b885c-fbfc-4433-b05b-6ba5bb65efa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_LongTermDebt_ab6b885c-fbfc-4433-b05b-6ba5bb65efa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_d257b6c4-ee84-4b0b-a24b-29883fec83cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_d257b6c4-ee84-4b0b-a24b-29883fec83cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eda6f5fb-6d94-49e4-b738-792da77b029c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eda6f5fb-6d94-49e4-b738-792da77b029c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d2ada8cd-a3e2-42e4-9825-1152d6c8267c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_OperatingLeaseLiability_d2ada8cd-a3e2-42e4-9825-1152d6c8267c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_88afad00-a90c-4a04-b387-c54f2dc6125c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_FinanceLeaseLiability_88afad00-a90c-4a04-b387-c54f2dc6125c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_45bebc41-fd2b-438c-a996-1b90555e1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c0b6459e-720f-4f1b-9180-24f467ef8379" xlink:to="loc_us-gaap_OtherLiabilities_45bebc41-fd2b-438c-a996-1b90555e1dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_8e983f84-a96f-4c89-8ad3-9f3edfa247dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_8e983f84-a96f-4c89-8ad3-9f3edfa247dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42f4f58c-eea9-4598-82cb-0872c1a02e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42f4f58c-eea9-4598-82cb-0872c1a02e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_47bdfee3-39ea-4189-83b2-d56809f842a8" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_47bdfee3-39ea-4189-83b2-d56809f842a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dffaf082-e4c7-42b9-b70a-376970ccb3db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dffaf082-e4c7-42b9-b70a-376970ccb3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6810aeef-6828-450e-bc2f-0807d6d4b1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6810aeef-6828-450e-bc2f-0807d6d4b1e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e9867ba8-3d07-4c79-b1fc-70cff2c04c82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_Goodwill_e9867ba8-3d07-4c79-b1fc-70cff2c04c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_60e8a797-4880-40ac-9157-2b76a95ffd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bffafad-d93d-4387-ad63-47d6cf691361" xlink:to="loc_us-gaap_OtherAssets_60e8a797-4880-40ac-9157-2b76a95ffd0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_fcd0afce-809b-4ffc-b67a-aece949608e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_Land_fcd0afce-809b-4ffc-b67a-aece949608e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4f607ab7-15fc-465e-b7eb-e23856f911ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4f607ab7-15fc-465e-b7eb-e23856f911ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_b3cf6873-a801-4e49-b2cc-d4cf614332d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_b3cf6873-a801-4e49-b2cc-d4cf614332d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_92c303b4-d4c4-443c-aff1-601369b2d7b3" xlink:href="hr-20240630.xsd#hr_PersonalProperty"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_hr_PersonalProperty_92c303b4-d4c4-443c-aff1-601369b2d7b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d2d296dd-a556-4b00-bac4-6a64a40df55e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d2d296dd-a556-4b00-bac4-6a64a40df55e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2c781ad2-f144-4df5-9f65-6fe31cbee671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2c781ad2-f144-4df5-9f65-6fe31cbee671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_83f98ec9-b75a-4972-ae92-c6ac5ba722a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopmentInProcess"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_DevelopmentInProcess_83f98ec9-b75a-4972-ae92-c6ac5ba722a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_56329d8d-8b13-444b-887d-dcf3063fbe63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_d3503455-9d64-4574-93a3-ae0e2890fc89" xlink:to="loc_us-gaap_LandAvailableForDevelopment_56329d8d-8b13-444b-887d-dcf3063fbe63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_c6b46e03-6a88-48bb-96bd-3737f9765c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_debb57a3-b3fb-44f8-b6ce-28794014d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_c6b46e03-6a88-48bb-96bd-3737f9765c4d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_debb57a3-b3fb-44f8-b6ce-28794014d1e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_d44ef3eb-0f75-4cb3-bffc-a8e71ce4a939" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_c6b46e03-6a88-48bb-96bd-3737f9765c4d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_d44ef3eb-0f75-4cb3-bffc-a8e71ce4a939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_bc57be7b-45ef-45c6-821f-3e0c1f7c89ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CumulativeDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_us-gaap_CumulativeDividends_bc57be7b-45ef-45c6-821f-3e0c1f7c89ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_9ad2bd42-df2b-4f59-a8f9-6d20ab88bb99" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_9ad2bd42-df2b-4f59-a8f9-6d20ab88bb99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_57c02081-3545-49dc-b173-0506ae8ca730" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_57c02081-3545-49dc-b173-0506ae8ca730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_150e9c92-8015-40ce-bfd5-9ee631e3601a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_150e9c92-8015-40ce-bfd5-9ee631e3601a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8f1f12c0-bf33-4191-84c9-e4fad4481782" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_us-gaap_CommonStockValue_8f1f12c0-bf33-4191-84c9-e4fad4481782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_256b6acf-96dc-49cb-9433-5e16642a3150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f0e5b55e-8a5b-486e-b2ee-414682fc779f" xlink:to="loc_us-gaap_PreferredStockValue_256b6acf-96dc-49cb-9433-5e16642a3150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8c89dd1-0e4c-40a5-bdba-b937515ff590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fc24b08c-8ef2-4579-94a5-bdf3856d0ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8c89dd1-0e4c-40a5-bdba-b937515ff590" xlink:to="loc_us-gaap_Liabilities_fc24b08c-8ef2-4579-94a5-bdf3856d0ed2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_61196c98-d81a-4af0-a640-bc7f79d36c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8c89dd1-0e4c-40a5-bdba-b937515ff590" xlink:to="loc_us-gaap_CommitmentsAndContingencies_61196c98-d81a-4af0-a640-bc7f79d36c1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_faa1a087-ce70-4fb6-871b-3270d16c7697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8c89dd1-0e4c-40a5-bdba-b937515ff590" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_faa1a087-ce70-4fb6-871b-3270d16c7697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4fce455c-ffe9-4444-817b-deb7c973717b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8c89dd1-0e4c-40a5-bdba-b937515ff590" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4fce455c-ffe9-4444-817b-deb7c973717b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7ec7f45f-aca4-4e24-abe3-081af469c392" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84200dfe-6ca0-4b54-9112-4aa650285197" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7ec7f45f-aca4-4e24-abe3-081af469c392" xlink:to="loc_us-gaap_StockholdersEquity_84200dfe-6ca0-4b54-9112-4aa650285197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d14a0945-5524-48d7-93e2-74623aea879a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7ec7f45f-aca4-4e24-abe3-081af469c392" xlink:to="loc_us-gaap_MinorityInterest_d14a0945-5524-48d7-93e2-74623aea879a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:href="hr-20240630.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_022c65bd-4180-4dff-b125-0b5c87929cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_022c65bd-4180-4dff-b125-0b5c87929cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_62550e8c-3a09-4117-a80e-47d60752da97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_62550e8c-3a09-4117-a80e-47d60752da97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_ca56bde6-dc9b-42c7-a74d-f9e3de9072be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:to="loc_us-gaap_AcquisitionCosts_ca56bde6-dc9b-42c7-a74d-f9e3de9072be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_9c01253b-dfd5-47b1-a980-6f6ef84711ae" xlink:href="hr-20240630.xsd#hr_MergerRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:to="loc_hr_MergerRelatedCosts_9c01253b-dfd5-47b1-a980-6f6ef84711ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c974f084-b574-46b1-a137-e805aca5240a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_2cf3d9b8-17eb-4576-9431-9ffe0b491a29" xlink:to="loc_us-gaap_DepreciationAndAmortization_c974f084-b574-46b1-a137-e805aca5240a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_737bea18-5b2d-4b48-a50a-49c9ead7cc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fb2f9edc-7378-4082-9ea1-bffc61b9585a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_737bea18-5b2d-4b48-a50a-49c9ead7cc8b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fb2f9edc-7378-4082-9ea1-bffc61b9585a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_11b6f475-9067-4f4c-b56f-b6b030cd90d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_737bea18-5b2d-4b48-a50a-49c9ead7cc8b" xlink:to="loc_us-gaap_ProfitLoss_11b6f475-9067-4f4c-b56f-b6b030cd90d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_75309ed5-f556-43d1-94b8-20175c126f07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_c619d6ab-ab18-4044-878e-be48a591a335" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_75309ed5-f556-43d1-94b8-20175c126f07" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_c619d6ab-ab18-4044-878e-be48a591a335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_083a0e04-8bd8-486a-b82b-b8e44fab5e66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_75309ed5-f556-43d1-94b8-20175c126f07" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_083a0e04-8bd8-486a-b82b-b8e44fab5e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5ab78ff3-a870-4070-a32a-cf414aa07355" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_75309ed5-f556-43d1-94b8-20175c126f07" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5ab78ff3-a870-4070-a32a-cf414aa07355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_3491399b-d71d-4ddb-a1a8-07134855ab72" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_3491399b-d71d-4ddb-a1a8-07134855ab72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_81f00bf7-8575-4fb4-ada9-27ad913fc87f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_81f00bf7-8575-4fb4-ada9-27ad913fc87f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b8a7d39-bff0-41e4-8506-0a010aebe185" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b8a7d39-bff0-41e4-8506-0a010aebe185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_555b9f32-ca7b-4439-b342-7b7334a04eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_us-gaap_InterestExpenseNonoperating_555b9f32-ca7b-4439-b342-7b7334a04eaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9c2b1abb-4caf-4600-9af7-9b904952c874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9c2b1abb-4caf-4600-9af7-9b904952c874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2ee3f372-88fa-43dc-a395-922cbb475a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a9d43bce-274d-44f5-90aa-09d4d37bac65" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2ee3f372-88fa-43dc-a395-922cbb475a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_24f80b11-d620-40e9-8337-2015b5ca4032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_27138608-3d03-4cc3-9efc-5c0d52acae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_24f80b11-d620-40e9-8337-2015b5ca4032" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_27138608-3d03-4cc3-9efc-5c0d52acae9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_07d8967a-250a-40ae-a2de-524ec3d3b236" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_24f80b11-d620-40e9-8337-2015b5ca4032" xlink:to="loc_us-gaap_Revenues_07d8967a-250a-40ae-a2de-524ec3d3b236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_ed8c4da6-e6af-43aa-8032-3a12243f5539" xlink:href="hr-20240630.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_24f80b11-d620-40e9-8337-2015b5ca4032" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_ed8c4da6-e6af-43aa-8032-3a12243f5539" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_99279b1e-1c80-488d-a79e-617d8796388e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0278358b-eab2-45f4-a8a8-561075d6ef18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_99279b1e-1c80-488d-a79e-617d8796388e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0278358b-eab2-45f4-a8a8-561075d6ef18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4af985b1-b812-482b-b92c-e114a4c67358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_99279b1e-1c80-488d-a79e-617d8796388e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4af985b1-b812-482b-b92c-e114a4c67358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eea53031-8203-4609-8871-906a20589002" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d1efe18-d5cb-41b2-8436-7344ca782bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eea53031-8203-4609-8871-906a20589002" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d1efe18-d5cb-41b2-8436-7344ca782bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dccbcb72-44c4-4353-b44c-366c7c2d406f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eea53031-8203-4609-8871-906a20589002" xlink:to="loc_us-gaap_ProfitLoss_dccbcb72-44c4-4353-b44c-366c7c2d406f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbd15971-2caa-4094-a57d-1406fe517ace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_283213a8-8e59-4364-9db6-aa44580a88a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbd15971-2caa-4094-a57d-1406fe517ace" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_283213a8-8e59-4364-9db6-aa44580a88a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ad92144e-714f-4287-87d2-3b6216c11ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbd15971-2caa-4094-a57d-1406fe517ace" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ad92144e-714f-4287-87d2-3b6216c11ce9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_d1af909d-46cd-4a8c-9a26-e47f1f8abb19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_d1af909d-46cd-4a8c-9a26-e47f1f8abb19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_148e1cae-22cd-45cf-af44-30003c93e271" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_148e1cae-22cd-45cf-af44-30003c93e271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_6e2d5789-daaa-4a68-b234-0587fb25e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_6e2d5789-daaa-4a68-b234-0587fb25e7f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_1b2a2d83-cd7c-46bd-9d9f-6174e8253e00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_1b2a2d83-cd7c-46bd-9d9f-6174e8253e00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_aaa9eb87-fed5-4f00-849d-ee121a5129b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_aaa9eb87-fed5-4f00-849d-ee121a5129b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_c40f2d86-9757-4af4-a302-59f40c71356b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_c40f2d86-9757-4af4-a302-59f40c71356b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_cf2e7ded-51b3-4394-81eb-311ccd90953f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_cf2e7ded-51b3-4394-81eb-311ccd90953f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_91e244dd-6d32-4fad-9abe-00ea0ae65bd1" xlink:href="hr-20240630.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_91e244dd-6d32-4fad-9abe-00ea0ae65bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6c998ae8-381c-4feb-8c6d-bd801cd2536d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6c998ae8-381c-4feb-8c6d-bd801cd2536d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_51f4967e-c166-460b-8732-38d23c42db0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94ac9e9e-ea08-4c4c-989e-5f9886a38b71" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_51f4967e-c166-460b-8732-38d23c42db0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_990d832f-6a54-4432-8104-53b43377ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_ProfitLoss_990d832f-6a54-4432-8104-53b43377ce05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3e278fb5-8ea5-4e90-8325-f65a1b525cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3e278fb5-8ea5-4e90-8325-f65a1b525cfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_6050dd37-897e-4e0c-9405-0ad0d62afdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_6050dd37-897e-4e0c-9405-0ad0d62afdeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f2cad30f-99ba-4614-9ec5-c195b9b717ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_ShareBasedCompensation_f2cad30f-99ba-4614-9ec5-c195b9b717ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_83b3a0e9-6857-480e-ae33-ec3e596347e6" xlink:href="hr-20240630.xsd#hr_StraightLineRentReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_hr_StraightLineRentReceivable_83b3a0e9-6857-480e-ae33-ec3e596347e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_3430c8a7-3128-4aaf-ad12-a7859ee9cf1d" xlink:href="hr-20240630.xsd#hr_StraightlineRentLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_hr_StraightlineRentLiability_3430c8a7-3128-4aaf-ad12-a7859ee9cf1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_d4c3cacb-434d-41a7-b00c-1ed429d73b33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_d4c3cacb-434d-41a7-b00c-1ed429d73b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_2f6222b8-b19b-4265-b044-43e2ced3fdd8" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_2f6222b8-b19b-4265-b044-43e2ced3fdd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_34412f0b-2c72-46f9-85d5-932fbbdf7846" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_34412f0b-2c72-46f9-85d5-932fbbdf7846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3e13b9e3-2d45-40f0-9415-630cfe72fcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3e13b9e3-2d45-40f0-9415-630cfe72fcaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_839d2470-d865-4ef7-a7da-fed0493fdd3b" xlink:href="hr-20240630.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_839d2470-d865-4ef7-a7da-fed0493fdd3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a652ebe-d5ee-47e2-8d89-2d452cbb7023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0a652ebe-d5ee-47e2-8d89-2d452cbb7023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_26cfbffe-808d-4426-a224-6fa7675218f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_26cfbffe-808d-4426-a224-6fa7675218f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6cd5e76a-0f55-4b46-8a31-8207b74bf0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6cd5e76a-0f55-4b46-8a31-8207b74bf0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ba0cf9d1-7f47-4162-85dc-32246e7140b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f47ab1bc-fa2c-4253-ab85-6c965fc27748" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ba0cf9d1-7f47-4162-85dc-32246e7140b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_214ef228-d6e8-4208-8773-43673b2c07d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0158df11-fb6f-4473-b4a4-96d8011fe219" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_214ef228-d6e8-4208-8773-43673b2c07d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0158df11-fb6f-4473-b4a4-96d8011fe219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b68aa77-ab26-40cd-9211-c7fc74a7f144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_214ef228-d6e8-4208-8773-43673b2c07d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b68aa77-ab26-40cd-9211-c7fc74a7f144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc45660d-f72e-4837-a1ff-4491454b1974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_214ef228-d6e8-4208-8773-43673b2c07d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc45660d-f72e-4837-a1ff-4491454b1974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_b9a4b54a-d572-4471-aec4-dc920a38830e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_b9a4b54a-d572-4471-aec4-dc920a38830e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_cdb727a8-d3bf-4eab-a7e0-e0aa10832097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_cdb727a8-d3bf-4eab-a7e0-e0aa10832097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_0ccfae6d-618e-493b-9e7c-3c08aed1035f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_RepaymentsOfDebt_0ccfae6d-618e-493b-9e7c-3c08aed1035f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_e3799210-883c-464a-8424-54d6697525ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_e3799210-883c-464a-8424-54d6697525ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b2fd3013-1352-4b41-8cbd-307f2b71d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b2fd3013-1352-4b41-8cbd-307f2b71d33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e609b77f-f1e5-4724-a5de-7d018300709f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e609b77f-f1e5-4724-a5de-7d018300709f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentsForRepurchasesOfCommonStock_ea62035d-9bc3-4272-852c-16291cdf9d9a" xlink:href="hr-20240630.xsd#hr_PaymentsForRepurchasesOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_hr_PaymentsForRepurchasesOfCommonStock_ea62035d-9bc3-4272-852c-16291cdf9d9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_c950aad6-d9ec-4bfe-8946-3a5f81924cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_c950aad6-d9ec-4bfe-8946-3a5f81924cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6c557284-31b0-42c7-bde4-223e2df0716c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6c557284-31b0-42c7-bde4-223e2df0716c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_13cb0f3a-3187-422a-a572-e07112670783" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c2d0f05-fbbd-4aa5-8ceb-0a5de16c10ed" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_13cb0f3a-3187-422a-a572-e07112670783" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2787b9bd-e366-476f-86e2-c2c104816b66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_fa5e14c9-3f4b-4f4e-a906-ba140d3c64a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2787b9bd-e366-476f-86e2-c2c104816b66" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_fa5e14c9-3f4b-4f4e-a906-ba140d3c64a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b5b59d95-3066-4391-ae5f-dcb0f88ca9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2787b9bd-e366-476f-86e2-c2c104816b66" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b5b59d95-3066-4391-ae5f-dcb0f88ca9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_4ee192c7-196e-4bcf-9459-9b517da83896" xlink:href="hr-20240630.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2787b9bd-e366-476f-86e2-c2c104816b66" xlink:to="loc_hr_ReceivablesAndOtherAssets_4ee192c7-196e-4bcf-9459-9b517da83896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d299b24b-eb00-4947-9a5b-ce0a6880e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_16172122-843d-4d17-8202-0bf8c7cbf784" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d299b24b-eb00-4947-9a5b-ce0a6880e78a" xlink:to="loc_us-gaap_Liabilities_16172122-843d-4d17-8202-0bf8c7cbf784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d0b6a712-34ff-4965-b915-88ac723f7087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d299b24b-eb00-4947-9a5b-ce0a6880e78a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d0b6a712-34ff-4965-b915-88ac723f7087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_439a26af-dbe5-4a01-bb19-dd2e61963b39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d299b24b-eb00-4947-9a5b-ce0a6880e78a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_439a26af-dbe5-4a01-bb19-dd2e61963b39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_cca9f15a-ff92-40a2-b113-27484e626648" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_52c1978b-694a-446e-90d3-7ee957459152" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_cca9f15a-ff92-40a2-b113-27484e626648" xlink:to="loc_us-gaap_Land_52c1978b-694a-446e-90d3-7ee957459152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_25b1495b-5ac2-4f04-962d-dc6e8da8de2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_cca9f15a-ff92-40a2-b113-27484e626648" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_25b1495b-5ac2-4f04-962d-dc6e8da8de2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_afa8375a-3879-41b7-863c-0b7a88b9f403" xlink:href="hr-20240630.xsd#hr_LeaseIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_cca9f15a-ff92-40a2-b113-27484e626648" xlink:to="loc_hr_LeaseIntangibles_afa8375a-3879-41b7-863c-0b7a88b9f403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1448ccc9-6887-4e09-bbc2-1a986d7036ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_53c6e1db-0b88-4f83-a4f1-897532240f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1448ccc9-6887-4e09-bbc2-1a986d7036ea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_53c6e1db-0b88-4f83-a4f1-897532240f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b4313468-7033-4cde-b78b-d0d734ab0c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1448ccc9-6887-4e09-bbc2-1a986d7036ea" xlink:to="loc_us-gaap_OperatingLeaseLiability_b4313468-7033-4cde-b78b-d0d734ab0c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_b953d60e-ae6f-4c62-9076-2ab786304539" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1448ccc9-6887-4e09-bbc2-1a986d7036ea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_b953d60e-ae6f-4c62-9076-2ab786304539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_c3e7e321-fb42-4d7a-9437-68d9ca1a9289" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_bc7f50cf-d57c-4412-acbc-5bf681e021c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_c3e7e321-fb42-4d7a-9437-68d9ca1a9289" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_bc7f50cf-d57c-4412-acbc-5bf681e021c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80bff0a4-d8f8-46a4-afee-d0036482e6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_c3e7e321-fb42-4d7a-9437-68d9ca1a9289" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80bff0a4-d8f8-46a4-afee-d0036482e6ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0734f175-068c-43f3-94e4-5f4820cc020c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_c3e7e321-fb42-4d7a-9437-68d9ca1a9289" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0734f175-068c-43f3-94e4-5f4820cc020c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_a238f9de-038d-464e-a5d5-31e0a38938ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_c3e7e321-fb42-4d7a-9437-68d9ca1a9289" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_a238f9de-038d-464e-a5d5-31e0a38938ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesLessorAccountingDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_e108a130-2d71-4ccf-b2ec-eb5a7bc82837" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_e108a130-2d71-4ccf-b2ec-eb5a7bc82837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_4fe77beb-e827-4c09-939e-4e658888f00d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_4fe77beb-e827-4c09-939e-4e658888f00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_7cf27789-1575-4934-9cdb-ea1da5e4b4da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_7cf27789-1575-4934-9cdb-ea1da5e4b4da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_19ad65b0-2f0c-4c00-b7d7-743b2192bf40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_19ad65b0-2f0c-4c00-b7d7-743b2192bf40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_f688eaed-27e2-4d72-91ff-9d3f94cf3670" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_f688eaed-27e2-4d72-91ff-9d3f94cf3670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_1522a530-5709-4548-9840-38f19401b23e" xlink:href="hr-20240630.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d3330950-bc34-407b-b455-227ba4198ca5" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_1522a530-5709-4548-9840-38f19401b23e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac422be7-654f-4d34-9e60-0e0722abbbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3cef12cf-79e4-4608-8815-686e418b5f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac422be7-654f-4d34-9e60-0e0722abbbd2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3cef12cf-79e4-4608-8815-686e418b5f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cff23649-64f1-4cbe-956b-8e3fbab2afc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac422be7-654f-4d34-9e60-0e0722abbbd2" xlink:to="loc_us-gaap_OperatingLeaseLiability_cff23649-64f1-4cbe-956b-8e3fbab2afc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bb303e7b-01f2-4105-a776-f5668ae5bf19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ac58b5c-4773-48d5-a2e4-ae717b3cad72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bb303e7b-01f2-4105-a776-f5668ae5bf19" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ac58b5c-4773-48d5-a2e4-ae717b3cad72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fd926605-22b0-4aba-8ba8-8777e44e7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bb303e7b-01f2-4105-a776-f5668ae5bf19" xlink:to="loc_us-gaap_FinanceLeaseLiability_fd926605-22b0-4aba-8ba8-8777e44e7b62" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c8689398-4b61-49e0-bc4a-6f3d515016a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c8689398-4b61-49e0-bc4a-6f3d515016a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_76d735ca-e18b-4cd6-8a29-d6a26e3f4bda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_76d735ca-e18b-4cd6-8a29-d6a26e3f4bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f7c05a1d-471d-4326-b3ce-140bc71c792d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f7c05a1d-471d-4326-b3ce-140bc71c792d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d342e3b6-5123-4c9a-a764-3f4b2a548980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d342e3b6-5123-4c9a-a764-3f4b2a548980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_85df2fa4-eed2-4eb0-94a3-2d6acfe886ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_85df2fa4-eed2-4eb0-94a3-2d6acfe886ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_341f086b-6ae2-41f7-97e7-4b8355ccb317" xlink:href="hr-20240630.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11760405-844e-4075-b8d2-6b47873411f9" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_341f086b-6ae2-41f7-97e7-4b8355ccb317" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_71729cff-b3c9-459e-8c3e-4ba27370f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_71729cff-b3c9-459e-8c3e-4ba27370f6fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_8ecc329a-b8b7-45f3-a34e-43489d6cb710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_8ecc329a-b8b7-45f3-a34e-43489d6cb710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cabe0bc8-6b58-46e0-a574-f82e25c31424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cabe0bc8-6b58-46e0-a574-f82e25c31424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3ccae681-f82c-4a01-a83b-bec28410fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3ccae681-f82c-4a01-a83b-bec28410fb4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2b1f5163-99c5-4181-9f36-220970af2a32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2b1f5163-99c5-4181-9f36-220970af2a32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_21b23880-af9d-41e8-916e-b98ec739f8f6" xlink:href="hr-20240630.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c1798408-bea8-47aa-a041-a34319f81e21" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_21b23880-af9d-41e8-916e-b98ec739f8f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f81c432c-c9d2-4117-b394-81717e378caa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dcd9cd40-d7be-4d67-9fe3-d14883b0e851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f81c432c-c9d2-4117-b394-81717e378caa" xlink:to="loc_us-gaap_OperatingLeaseCost_dcd9cd40-d7be-4d67-9fe3-d14883b0e851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a1b20179-a269-48b1-a05e-3d7d7c2c44c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f81c432c-c9d2-4117-b394-81717e378caa" xlink:to="loc_us-gaap_VariableLeaseCost_a1b20179-a269-48b1-a05e-3d7d7c2c44c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0d3109c1-27d3-4005-946d-25f694844991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f81c432c-c9d2-4117-b394-81717e378caa" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0d3109c1-27d3-4005-946d-25f694844991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_40b56f12-488b-4e61-a9df-9c04faddb662" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f81c432c-c9d2-4117-b394-81717e378caa" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_40b56f12-488b-4e61-a9df-9c04faddb662" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_1b8ae65f-96e1-41bb-afb2-ba51635e5878" xlink:href="hr-20240630.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b5759ed4-10bd-4f6f-9a5a-6d525222ca47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_1b8ae65f-96e1-41bb-afb2-ba51635e5878" xlink:to="loc_us-gaap_ProfitLoss_b5759ed4-10bd-4f6f-9a5a-6d525222ca47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_b5547649-0c8a-4d62-8073-8815ee27bc16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_1b8ae65f-96e1-41bb-afb2-ba51635e5878" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_b5547649-0c8a-4d62-8073-8815ee27bc16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c4eacafa-2f2f-4a37-ad7b-543b974e3c24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_1b8ae65f-96e1-41bb-afb2-ba51635e5878" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c4eacafa-2f2f-4a37-ad7b-543b974e3c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_3103dae0-a9ef-4d21-93ee-f823f249b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_1b8ae65f-96e1-41bb-afb2-ba51635e5878" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_3103dae0-a9ef-4d21-93ee-f823f249b79e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_361eaa88-fe7f-4b82-bdd3-a1df1af7c425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01fd6d4d-6fc8-4be3-aff5-9cbcc267f4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_361eaa88-fe7f-4b82-bdd3-a1df1af7c425" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01fd6d4d-6fc8-4be3-aff5-9cbcc267f4d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_c0ff297d-88aa-43df-9cee-e9032d450dfc" xlink:href="hr-20240630.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_361eaa88-fe7f-4b82-bdd3-a1df1af7c425" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_c0ff297d-88aa-43df-9cee-e9032d450dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3210b020-fb14-43b2-9182-6594c271eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_9424134e-7449-4b53-b05e-50fa36dd2a98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3210b020-fb14-43b2-9182-6594c271eaba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_9424134e-7449-4b53-b05e-50fa36dd2a98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_49106a4d-be97-4cea-8a58-9910b13c4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3210b020-fb14-43b2-9182-6594c271eaba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_49106a4d-be97-4cea-8a58-9910b13c4b08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_53d6330c-3749-47d5-a7ba-ef51e8673220" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_53d6330c-3749-47d5-a7ba-ef51e8673220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_7ea57050-4820-422d-8f35-30a1cb7788a4" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_7ea57050-4820-422d-8f35-30a1cb7788a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_c67b9a05-2aac-4329-810c-386b89442f95" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_c67b9a05-2aac-4329-810c-386b89442f95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_3693194c-a458-4c2b-98ad-b0eee8fd7156" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_3693194c-a458-4c2b-98ad-b0eee8fd7156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_f357c00a-4bdc-42a2-9488-67d4953271bd" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2beea1a6-524f-403a-b5c1-4b37982b38fb" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_f357c00a-4bdc-42a2-9488-67d4953271bd" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hr-20240630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:to="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aab4f9a4-6593-4740-a076-a7b2f147c849_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:to="loc_us-gaap_EquityComponentDomain_aab4f9a4-6593-4740-a076-a7b2f147c849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:to="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:to="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_455b56aa-4b55-497c-9e3d-ee6deb31161f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_CommonStockMember_455b56aa-4b55-497c-9e3d-ee6deb31161f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a30de692-28ad-4439-b474-27595a7d1143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a30de692-28ad-4439-b474-27595a7d1143" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a2c80805-33f2-458b-ad4f-348f014f71f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a2c80805-33f2-458b-ad4f-348f014f71f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_17893b52-9e3b-45d6-8fdc-3704e7abb14a" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_hr_CumulativeNetIncomeMember_17893b52-9e3b-45d6-8fdc-3704e7abb14a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_249c2e6c-49c5-4ea4-910d-11c1f3031f2c" xlink:href="hr-20240630.xsd#hr_CumulativeDividendsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_hr_CumulativeDividendsMember_249c2e6c-49c5-4ea4-910d-11c1f3031f2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_02b3f9e8-0586-4c1a-892e-82026a604b43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_02b3f9e8-0586-4c1a-892e-82026a604b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff9540c8-bc20-47fa-b9f3-34e18d150906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff9540c8-bc20-47fa-b9f3-34e18d150906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bcdc44a1-f8ef-401c-bb9e-394f20398898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bcdc44a1-f8ef-401c-bb9e-394f20398898" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c63660f5-16c9-4137-a758-044e7225642b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c63660f5-16c9-4137-a758-044e7225642b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_480d7b27-05b2-4d6b-8223-b4b7a03e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_480d7b27-05b2-4d6b-8223-b4b7a03e2184" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bf110f21-1069-4a93-980f-ad16d33d3872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bf110f21-1069-4a93-980f-ad16d33d3872" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_09b52238-15c1-4b9b-8f1e-c65f12b1a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_09b52238-15c1-4b9b-8f1e-c65f12b1a49d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_41831220-b74e-462f-92bf-052ef855a165" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_ProfitLoss_41831220-b74e-462f-92bf-052ef855a165" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ef117793-99a1-4f6c-b9e9-b59817221dca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ef117793-99a1-4f6c-b9e9-b59817221dca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_72f71138-108f-44a5-a8f7-22acaee5b545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_72f71138-108f-44a5-a8f7-22acaee5b545" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f7de7e9c-435a-4245-b8fb-ad93ba5965c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_DividendsCommonStockCash_f7de7e9c-435a-4245-b8fb-ad93ba5965c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e9d0421-4c9e-4ecd-b2c0-1d5ea527108c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_74b43637-f91f-4ced-9422-975654b53a51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_74b43637-f91f-4ced-9422-975654b53a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_859e711e-c347-4913-a0c0-68cbe7f3d85b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_859e711e-c347-4913-a0c0-68cbe7f3d85b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1c1b077f-6add-4ff3-bf93-74b81a51733b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1c1b077f-6add-4ff3-bf93-74b81a51733b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b5524dd0-ebd5-4a78-ac57-953ab5d46561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4ac7cf83-0974-40fa-b79b-00b7215b8b20_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4ac7cf83-0974-40fa-b79b-00b7215b8b20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b8f0defe-d8cf-44b4-9176-437bd3d972a6" xlink:href="hr-20240630.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b8f0defe-d8cf-44b4-9176-437bd3d972a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1927342-91f8-410c-bd61-e4db3c770594_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1927342-91f8-410c-bd61-e4db3c770594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_516f0ca5-3d7e-4be5-bf25-fbc0cac4cc8a" xlink:href="hr-20240630.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_516f0ca5-3d7e-4be5-bf25-fbc0cac4cc8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e0ced55a-adc3-420a-8e63-fa9832e0bf48" xlink:href="hr-20240630.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e0ced55a-adc3-420a-8e63-fa9832e0bf48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9e35547d-89b1-4eab-81f2-680c82f5d957_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:to="loc_srt_OwnershipDomain_9e35547d-89b1-4eab-81f2-680c82f5d957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:to="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_79b10ad8-6247-45c6-9858-9a12aa94ef33" xlink:href="hr-20240630.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_79b10ad8-6247-45c6-9858-9a12aa94ef33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_527e7157-330d-457b-8a81-0bc1740bb2f2" xlink:href="hr-20240630.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:to="loc_hr_NonControllingInterestHoldersMember_527e7157-330d-457b-8a81-0bc1740bb2f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d0652643-020c-42e3-85fa-d294346dc8af_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:to="loc_dei_EntityDomain_d0652643-020c-42e3-85fa-d294346dc8af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:to="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_80a75702-8a79-404e-8bf9-1f529aeff8fe" xlink:href="hr-20240630.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_80a75702-8a79-404e-8bf9-1f529aeff8fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e8d7422f-b42c-4402-9ef4-bdb26ac9a2f3" xlink:href="hr-20240630.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e8d7422f-b42c-4402-9ef4-bdb26ac9a2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherInvestorsMember_03db33dc-4f70-485c-95c9-92e5ead4ca4d" xlink:href="hr-20240630.xsd#hr_OtherInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_OtherInvestorsMember_03db33dc-4f70-485c-95c9-92e5ead4ca4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_87f38bb4-a32b-4f9a-9882-a3c67344352a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_87f38bb4-a32b-4f9a-9882-a3c67344352a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_5bee1a3e-ad85-4e52-b96f-b27932e08088" xlink:href="hr-20240630.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:to="loc_hr_VariableInterestEntityMember_5bee1a3e-ad85-4e52-b96f-b27932e08088" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f04c0097-5a9b-4036-8066-bc538bca84bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f04c0097-5a9b-4036-8066-bc538bca84bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_12b6765a-3a31-4e2e-97d6-a202e40d649e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:to="loc_us-gaap_NotesReceivableMember_12b6765a-3a31-4e2e-97d6-a202e40d649e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5636ce53-f94a-4124-abc2-197e06f4712b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:to="loc_us-gaap_ReportingUnitDomain_5636ce53-f94a-4124-abc2-197e06f4712b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:to="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OneMember_ed2b6a7a-9075-4300-b5b5-53997647565a" xlink:href="hr-20240630.xsd#hr_OneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:to="loc_hr_OneMember_ed2b6a7a-9075-4300-b5b5-53997647565a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_668581bf-a6bf-4296-95b1-24530a6334a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_668581bf-a6bf-4296-95b1-24530a6334a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4e5c13cb-b1ed-44e9-b96f-0f7b8d1b769a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4e5c13cb-b1ed-44e9-b96f-0f7b8d1b769a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:href="hr-20240630.xsd#hr_BusinessOverviewAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_b27a348b-3506-4609-a37d-114cfd8d9174" xlink:href="hr-20240630.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_b27a348b-3506-4609-a37d-114cfd8d9174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_93017492-6241-488a-a523-4f33f3ec3a94" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_NumberOfRealEstateInvestments_93017492-6241-488a-a523-4f33f3ec3a94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_affdef41-a836-4816-a190-c0035e78863b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_affdef41-a836-4816-a190-c0035e78863b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_16bfa080-99f4-40c4-ab92-c3d78e03864f" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_16bfa080-99f4-40c4-ab92-c3d78e03864f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_39e39ce3-f11e-4713-b307-50535940ec11" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_39e39ce3-f11e-4713-b307-50535940ec11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_3ee1496e-342a-4f84-9470-21374351740e" xlink:href="hr-20240630.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_3ee1496e-342a-4f84-9470-21374351740e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_6b3b6766-fc08-4743-a7a1-c0da9a5ef8f9" xlink:href="hr-20240630.xsd#hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_6b3b6766-fc08-4743-a7a1-c0da9a5ef8f9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1dd1ae68-7d32-498e-b747-d55107e1b421" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1dd1ae68-7d32-498e-b747-d55107e1b421" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a65f790f-d16d-4e83-81f7-e7880582c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a65f790f-d16d-4e83-81f7-e7880582c2b8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6c6889b0-c7fb-41b6-9275-bfc9833ce489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6c6889b0-c7fb-41b6-9275-bfc9833ce489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_64f06ae2-361a-49b9-b20b-ff82bd14dcea" xlink:href="hr-20240630.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_64f06ae2-361a-49b9-b20b-ff82bd14dcea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_42788dbe-4d12-4af4-981e-745cf6039867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_42788dbe-4d12-4af4-981e-745cf6039867" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_4b5e0621-ccc6-4cb3-a10e-fb14310d1b42" xlink:href="hr-20240630.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfVariableInterestEntities_4b5e0621-ccc6-4cb3-a10e-fb14310d1b42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_08c08aa8-59d8-4b05-837c-ce92e0555747" xlink:href="hr-20240630.xsd#hr_NumberOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfNotesReceivable_08c08aa8-59d8-4b05-837c-ce92e0555747" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_a3779f62-db43-4236-a93f-0d6b95ec8fc7" xlink:href="hr-20240630.xsd#hr_NumberOfJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfJointVentures_a3779f62-db43-4236-a93f-0d6b95ec8fc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c19252f-b226-4111-9000-e1bd9c8ccb33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c19252f-b226-4111-9000-e1bd9c8ccb33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_b75b8ad5-aa52-4bcf-bb4b-aa071f15ebe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_b75b8ad5-aa52-4bcf-bb4b-aa071f15ebe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesMeasuredAtFairValue_91ae3d06-3a23-4181-957f-42855caf33f1" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesMeasuredAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_hr_NumberOfPropertiesMeasuredAtFairValue_91ae3d06-3a23-4181-957f-42855caf33f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_9dbac6a5-d4e2-4ea0-9c67-10d5842e2625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_9dbac6a5-d4e2-4ea0-9c67-10d5842e2625" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReportingUnitCarryingValue_9d75f78b-a872-4360-9b81-64a934666059" xlink:href="hr-20240630.xsd#hr_ReportingUnitCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:to="loc_hr_ReportingUnitCarryingValue_9d75f78b-a872-4360-9b81-64a934666059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b782b46f-fef4-48e1-939e-4922da1925d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b782b46f-fef4-48e1-939e-4922da1925d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_75611dc6-4b13-4bf1-92e2-9f64e3e05e27" xlink:href="hr-20240630.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:to="loc_hr_RealEstateNotesReceivableNet_75611dc6-4b13-4bf1-92e2-9f64e3e05e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMezzanineLoans_33be4765-e01d-4920-886c-d5c57182c261" xlink:href="hr-20240630.xsd#hr_NumberOfMezzanineLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfMezzanineLoans_33be4765-e01d-4920-886c-d5c57182c261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMortgageLoans_3ea7e3f1-9c5e-4c91-a61f-9d18cdd42278" xlink:href="hr-20240630.xsd#hr_NumberOfMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfMortgageLoans_3ea7e3f1-9c5e-4c91-a61f-9d18cdd42278" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_64bda9ec-f287-4d81-a7ea-14801ca5a841" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_64bda9ec-f287-4d81-a7ea-14801ca5a841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_5622ff93-8d38-4661-b3d7-d5ca742ceab8" xlink:href="hr-20240630.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_5622ff93-8d38-4661-b3d7-d5ca742ceab8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_3d13ef4f-4ce1-4865-b14a-42cdd5d0acf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_3d13ef4f-4ce1-4865-b14a-42cdd5d0acf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_81fca982-d503-4041-858c-4655a864abe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_InterestIncomeOperating_81fca982-d503-4041-858c-4655a864abe6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_0831b7e4-5ee5-4401-99a4-bacfae5935b9" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_0831b7e4-5ee5-4401-99a4-bacfae5935b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_4524bfc7-4a20-45f7-9331-0c4a8603fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_4524bfc7-4a20-45f7-9331-0c4a8603fa39" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8e7542c1-babe-47dd-b036-4729539d3637_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8e7542c1-babe-47dd-b036-4729539d3637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_8f1d678f-302b-4188-832e-1af83cc05d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_8f1d678f-302b-4188-832e-1af83cc05d0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:to="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_e5905953-edd6-4c8d-9627-0621e812400f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_e5905953-edd6-4c8d-9627-0621e812400f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f35c0def-9de8-4ebc-a3d0-12c8484f83b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f35c0def-9de8-4ebc-a3d0-12c8484f83b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_eac5d190-b8ca-410d-b4ff-7b7285ce314b" xlink:href="hr-20240630.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_hr_ReceivablesAndOtherAssets_eac5d190-b8ca-410d-b4ff-7b7285ce314b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5e9c5d3b-83bc-4b86-a6c5-cbf32a737b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_Assets_5e9c5d3b-83bc-4b86-a6c5-cbf32a737b3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_20e3212d-d563-4081-9149-83cc1bc5396f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_20e3212d-d563-4081-9149-83cc1bc5396f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dd2d8195-68b2-4ad5-969b-7d0a53de0e01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_Liabilities_dd2d8195-68b2-4ad5-969b-7d0a53de0e01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34f985c2-9549-4aea-824d-315fc2e9f1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34f985c2-9549-4aea-824d-315fc2e9f1d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13acceb5-fbcc-4e8b-9def-6a0698ae504d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_StockholdersEquity_13acceb5-fbcc-4e8b-9def-6a0698ae504d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetLossAttributableToCommonStockholders_aa63ecab-31e6-4c25-a916-20cd5c8e5af2" xlink:href="hr-20240630.xsd#hr_CumulativeNetLossAttributableToCommonStockholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_hr_CumulativeNetLossAttributableToCommonStockholders_aa63ecab-31e6-4c25-a916-20cd5c8e5af2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_abf40c1f-0d81-429d-8f52-3aaef333b7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_abf40c1f-0d81-429d-8f52-3aaef333b7ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fe015c56-76dd-4a1e-ba1e-6a70b62d033c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fe015c56-76dd-4a1e-ba1e-6a70b62d033c" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:to="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_25ea7917-4bb4-44f1-be14-0607cf4223e6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:to="loc_srt_SegmentGeographicalDomain_25ea7917-4bb4-44f1-be14-0607cf4223e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:to="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_d0671ec5-d783-4f67-b133-6257b1614e45" xlink:href="hr-20240630.xsd#hr_HoustonTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_hr_HoustonTexasMember_d0671ec5-d783-4f67-b133-6257b1614e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_895b55e6-d65d-49c7-9dc4-625e61281fc1" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_stpr_NC_895b55e6-d65d-49c7-9dc4-625e61281fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_d32ec452-4123-4ac0-ac82-fe182511d59e" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_stpr_TX_d32ec452-4123-4ac0-ac82-fe182511d59e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_49e22d71-8de4-4d46-8d75-92249c3be785_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:to="loc_srt_ConsolidatedEntitiesDomain_49e22d71-8de4-4d46-8d75-92249c3be785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_56ac111b-f5c7-4f05-925f-5e3bc8fe8001" xlink:href="hr-20240630.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:to="loc_hr_VariableInterestEntityMember_56ac111b-f5c7-4f05-925f-5e3bc8fe8001" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4f75c91e-beb2-42dc-9bff-82906376aac9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4f75c91e-beb2-42dc-9bff-82906376aac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_4ab5c303-8a5b-4f8a-a04c-b3e41c6803b2" xlink:href="hr-20240630.xsd#hr_NumberOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_NumberOfNotesReceivable_4ab5c303-8a5b-4f8a-a04c-b3e41c6803b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_c6188972-bb89-4928-8f1c-0c12400cb0bf" xlink:href="hr-20240630.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_NotesReceivableCarryingAmount_c6188972-bb89-4928-8f1c-0c12400cb0bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_1b03eb69-9806-4dd9-9e18-4ce84fd865af" xlink:href="hr-20240630.xsd#hr_JointVentureCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_JointVentureCarryingAmount_1b03eb69-9806-4dd9-9e18-4ce84fd865af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_aed8be09-0a42-4490-9306-00603f50bc45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_aed8be09-0a42-4490-9306-00603f50bc45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_6cea8e65-6a4b-447e-8e54-7214615cface" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_6cea8e65-6a4b-447e-8e54-7214615cface" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:to="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_182b75fe-23dd-42bb-9617-1dc70cc1c8ca_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:to="loc_srt_SegmentGeographicalDomain_182b75fe-23dd-42bb-9617-1dc70cc1c8ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:to="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember_99581f67-6153-4756-a427-8cb00e5d62e9" xlink:href="hr-20240630.xsd#hr_PowayCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_PowayCAMember_99581f67-6153-4756-a427-8cb00e5d62e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember_5cadd470-23a0-44df-b143-eb692000f93d" xlink:href="hr-20240630.xsd#hr_ColumbusOHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_ColumbusOHMember_5cadd470-23a0-44df-b143-eb692000f93d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_4033757d-a94c-439f-a05a-59336184c4c4" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_TX_4033757d-a94c-439f-a05a-59336184c4c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ_3c0a7c16-2acb-4246-abe1-a9f676f99ec1" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_AZ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_AZ_3c0a7c16-2acb-4246-abe1-a9f676f99ec1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_b3557267-c8f9-401e-a89d-d005d52a36f3" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_NC_b3557267-c8f9-401e-a89d-d005d52a36f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_a3d1b71f-0a31-4480-b525-2e37ccfb0f58" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_FL_a3d1b71f-0a31-4480-b525-2e37ccfb0f58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_fcf7be12-73f9-46c6-8dd9-c9fad8920fd6" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_CA_fcf7be12-73f9-46c6-8dd9-c9fad8920fd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_Florida1Member_b358d6df-4d07-4f0e-abab-9285e46b9150" xlink:href="hr-20240630.xsd#hr_Florida1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_Florida1Member_b358d6df-4d07-4f0e-abab-9285e46b9150" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ab74caba-88f4-482b-9468-87ae81979b29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ab74caba-88f4-482b-9468-87ae81979b29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember_9bd9cff2-f08a-4788-b9d0-4bbb9895ccfb" xlink:href="hr-20240630.xsd#hr_MezzanineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:to="loc_hr_MezzanineLoanMember_9bd9cff2-f08a-4788-b9d0-4bbb9895ccfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_ae3cbd3b-fe2e-41ba-aa55-307120b9b7c0" xlink:href="hr-20240630.xsd#hr_MortgageLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:to="loc_hr_MortgageLoanMember_ae3cbd3b-fe2e-41ba-aa55-307120b9b7c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_206a1f23-ef0e-43aa-8ab4-2cffdd15b2ed" xlink:href="hr-20240630.xsd#hr_NotesReceivableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_NotesReceivableInterestRate_206a1f23-ef0e-43aa-8ab4-2cffdd15b2ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue_6979b7d4-7c56-4946-9341-9f56ee8ba85d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_SaleLeasebackTransactionNetBookValue_6979b7d4-7c56-4946-9341-9f56ee8ba85d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_eafb1c28-5b45-4a82-b9ab-092cbe4aa08a" xlink:href="hr-20240630.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_eafb1c28-5b45-4a82-b9ab-092cbe4aa08a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_150c54b8-aaa9-44de-b0e3-381bc7cd446e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_150c54b8-aaa9-44de-b0e3-381bc7cd446e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableAndOtherAssets_c9884427-1811-4a3c-8f7c-410bb961d08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_InterestReceivableAndOtherAssets_c9884427-1811-4a3c-8f7c-410bb961d08a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_36948605-e01c-4ef6-b71d-67eb78ab045c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_36948605-e01c-4ef6-b71d-67eb78ab045c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_37e46209-abfc-4573-9692-3e270a3c17e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_37e46209-abfc-4573-9692-3e270a3c17e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_c2b3c219-d438-4312-9de1-4b28554e9208" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_c2b3c219-d438-4312-9de1-4b28554e9208" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_86f8024a-0008-4787-a8f1-f24221a3f4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_InterestIncomeOperating_86f8024a-0008-4787-a8f1-f24221a3f4cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9a5edabf-a3bd-4152-8590-6ca76b0a88d8" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9a5edabf-a3bd-4152-8590-6ca76b0a88d8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_7b1e5ab6-d023-4bf2-a859-31e0522eb3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_7b1e5ab6-d023-4bf2-a859-31e0522eb3fe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossInterest_f9dfcd8f-e66e-4bfc-a732-aa38d0ed39c0" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossInterest_f9dfcd8f-e66e-4bfc-a732-aa38d0ed39c0" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:to="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_07327563-538e-4da1-9139-8b4d9ab44fc8_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:to="loc_srt_ProductsAndServicesDomain_07327563-538e-4da1-9139-8b4d9ab44fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:to="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_7a2d36fa-8df5-48b4-a204-bb24d0bd141d" xlink:href="hr-20240630.xsd#hr_ParkingIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:to="loc_hr_ParkingIncomeMember_7a2d36fa-8df5-48b4-a204-bb24d0bd141d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_5cc7411a-7beb-4612-8e8c-f187b9988c82" xlink:href="hr-20240630.xsd#hr_ManagementFeeIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:to="loc_hr_ManagementFeeIncomeMember_5cc7411a-7beb-4612-8e8c-f187b9988c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0fb209-7efd-4467-97dc-f349a87b0b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0fb209-7efd-4467-97dc-f349a87b0b02" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:to="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_344c280a-1cc5-4482-81a5-74b97d52ab3a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:to="loc_srt_OtherPropertyMember_344c280a-1cc5-4482-81a5-74b97d52ab3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6eb14231-e513-42f2-a174-b1ebf7229f5f_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:to="loc_srt_SegmentGeographicalDomain_6eb14231-e513-42f2-a174-b1ebf7229f5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:to="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_3547c2c5-2847-42ab-b66b-188c8c212404" xlink:href="hr-20240630.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:to="loc_hr_LosAngelesCaliforniaMember_3547c2c5-2847-42ab-b66b-188c8c212404" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_34a4316f-fedf-4e4e-a597-d750326e1100_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:to="loc_srt_OwnershipDomain_34a4316f-fedf-4e4e-a597-d750326e1100_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:to="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_f1da0ec8-24c0-4f3e-a399-7ef915675889" xlink:href="hr-20240630.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_f1da0ec8-24c0-4f3e-a399-7ef915675889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:href="hr-20240630.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7753d4e5-b1bc-4173-982f-474fd87d4144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7753d4e5-b1bc-4173-982f-474fd87d4144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_9a4783ce-a333-47fc-a7e4-60c9c65b627f" xlink:href="hr-20240630.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_9a4783ce-a333-47fc-a7e4-60c9c65b627f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c98e5631-1f3a-4bd5-819f-1bd16b17ff13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c98e5631-1f3a-4bd5-819f-1bd16b17ff13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_1511e093-0dee-4fe1-aafe-c455500321bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_1511e093-0dee-4fe1-aafe-c455500321bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b433b47a-ddb3-4569-bf06-aa8bb50af551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_01dcc8ec-a0ce-4b8a-a4d6-f95d5227f7c4" xlink:href="hr-20240630.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:to="loc_hr_JointVentureOwnershipPercentage_01dcc8ec-a0ce-4b8a-a4d6-f95d5227f7c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:href="hr-20240630.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_efdac11b-b318-49fe-ac8f-42aae91605a5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:to="loc_srt_SegmentGeographicalDomain_efdac11b-b318-49fe-ac8f-42aae91605a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:to="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember_d018a2cc-ea1d-49a7-9360-0a42eba0bdca" xlink:href="hr-20240630.xsd#hr_AlbanyNYMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AlbanyNYMember_d018a2cc-ea1d-49a7-9360-0a42eba0bdca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SanAngeloTXMember_86ef5f15-292c-4a81-9221-d10709547272" xlink:href="hr-20240630.xsd#hr_SanAngeloTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_SanAngeloTXMember_86ef5f15-292c-4a81-9221-d10709547272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember_82c7a26a-3d94-4145-b8c5-2c44df7e548b" xlink:href="hr-20240630.xsd#hr_HoustonTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_HoustonTXMember_82c7a26a-3d94-4145-b8c5-2c44df7e548b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MultipleMember_4616404f-f345-4c2e-8d26-b1fecb7ab1e4" xlink:href="hr-20240630.xsd#hr_MultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_MultipleMember_4616404f-f345-4c2e-8d26-b1fecb7ab1e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DenverCOMember_15d28b99-f92c-49a2-a184-7a499e346c12" xlink:href="hr-20240630.xsd#hr_DenverCOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_DenverCOMember_15d28b99-f92c-49a2-a184-7a499e346c12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AustinTXMember_19996b6b-cf3f-4292-a88e-3d5b92bbab42" xlink:href="hr-20240630.xsd#hr_AustinTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AustinTXMember_19996b6b-cf3f-4292-a88e-3d5b92bbab42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MinneapolisMNMember_555115e7-177b-4a7b-872f-e95538755377" xlink:href="hr-20240630.xsd#hr_MinneapolisMNMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_MinneapolisMNMember_555115e7-177b-4a7b-872f-e95538755377" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroRaleighNCMember_5af99902-5d1f-46a0-8068-4c7f8b8adb69" xlink:href="hr-20240630.xsd#hr_GreensboroRaleighNCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_GreensboroRaleighNCMember_5af99902-5d1f-46a0-8068-4c7f8b8adb69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_4ac3a560-1a16-4558-b8eb-47d25ee6231f" xlink:href="hr-20240630.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_LosAngelesCaliforniaMember_4ac3a560-1a16-4558-b8eb-47d25ee6231f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeattleWAMember_abf60f97-7520-4e20-b22b-b0a035d68926" xlink:href="hr-20240630.xsd#hr_SeattleWAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_SeattleWAMember_abf60f97-7520-4e20-b22b-b0a035d68926" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroNCMember_13f3e4f7-c1a8-4833-a051-363413fe613e" xlink:href="hr-20240630.xsd#hr_GreensboroNCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_GreensboroNCMember_13f3e4f7-c1a8-4833-a051-363413fe613e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RaleighNCMember_cee157a3-f2df-429f-929e-ef0c70f1506c" xlink:href="hr-20240630.xsd#hr_RaleighNCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_RaleighNCMember_cee157a3-f2df-429f-929e-ef0c70f1506c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember_883d1e9c-212e-4140-be6d-b093a4c7157d" xlink:href="hr-20240630.xsd#hr_AtlantaGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AtlantaGAMember_883d1e9c-212e-4140-be6d-b093a4c7157d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PhiladelphiaPAMember_3396d323-e2f5-4373-b2ba-33298b34e861" xlink:href="hr-20240630.xsd#hr_PhiladelphiaPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_PhiladelphiaPAMember_3396d323-e2f5-4373-b2ba-33298b34e861" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewYorkNYMember_92ed7681-a81a-4ca8-ab2d-4aa97c49e53c" xlink:href="hr-20240630.xsd#hr_NewYorkNYMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_NewYorkNYMember_92ed7681-a81a-4ca8-ab2d-4aa97c49e53c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_aeafb826-6739-47f1-a9db-91003cf0da65_default" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_aeafb826-6739-47f1-a9db-91003cf0da65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_bc86ae33-a197-4592-8b0d-f40407edbf59" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:to="loc_hr_RealEstateDispositionsMember_bc86ae33-a197-4592-8b0d-f40407edbf59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:to="loc_us-gaap_RelatedPartyDomain_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:to="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_b0fb7679-aa56-49fa-a42d-c94eb793b7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:to="loc_us-gaap_CorporateJointVentureMember_b0fb7679-aa56-49fa-a42d-c94eb793b7b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_64cd71e0-a736-40e4-8f15-caf68b3fa13b" xlink:href="hr-20240630.xsd#hr_DispositionSalesPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_DispositionSalesPrice_64cd71e0-a736-40e4-8f15-caf68b3fa13b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_c44532d5-c28f-4973-96d7-f21f93e01e82" xlink:href="hr-20240630.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_c44532d5-c28f-4973-96d7-f21f93e01e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_d22df1ba-4e35-417a-862e-ab8fe486ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_d22df1ba-4e35-417a-862e-ab8fe486ab61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_e1da0c28-d57a-48c4-9b0b-e4bd658061d8" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_e1da0c28-d57a-48c4-9b0b-e4bd658061d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_73fef696-4ac5-48b3-b0ac-623b778d5f43" xlink:href="hr-20240630.xsd#hr_RealEstateOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_RealEstateOther_73fef696-4ac5-48b3-b0ac-623b778d5f43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_9562a04d-5d8c-4862-8ce1-958add6d1f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_9562a04d-5d8c-4862-8ce1-958add6d1f95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_408bc137-0d07-48ab-b64f-24af59da3cdc" xlink:href="hr-20240630.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_408bc137-0d07-48ab-b64f-24af59da3cdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_5e3fc9de-cfca-4ecc-ad04-ded24614412b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_5e3fc9de-cfca-4ecc-ad04-ded24614412b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_a27b69f2-0709-4ed4-884b-4e4c8587f212" xlink:href="hr-20240630.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_JointVentureOwnershipPercentage_a27b69f2-0709-4ed4-884b-4e4c8587f212" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8b21e848-c412-40a5-a48e-3409247f50ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8b21e848-c412-40a5-a48e-3409247f50ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7c3bacb4-7f32-48ee-86f2-13cb74cf47c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7c3bacb4-7f32-48ee-86f2-13cb74cf47c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_64fd5807-be1f-481b-8a57-6beded68398c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_Land_64fd5807-be1f-481b-8a57-6beded68398c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_747448a1-f046-4824-8532-f3cc1b42f2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_747448a1-f046-4824-8532-f3cc1b42f2f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_097b6b55-60ee-45e9-a876-f7be16374425" xlink:href="hr-20240630.xsd#hr_LeaseIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_hr_LeaseIntangibles_097b6b55-60ee-45e9-a876-f7be16374425" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_a14944bd-a512-4b27-a402-727db8e8bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_a14944bd-a512-4b27-a402-727db8e8bca4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ca3bebb-1cd3-4d7f-a556-cec0a50435b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ca3bebb-1cd3-4d7f-a556-cec0a50435b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_3907c9e3-6253-4054-8597-c027553dc73a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_3907c9e3-6253-4054-8597-c027553dc73a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a4c3dedc-176c-4ce5-a145-105d0ae4115d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a4c3dedc-176c-4ce5-a145-105d0ae4115d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a490240-a6f6-43e2-8eda-5fc10a451c46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a490240-a6f6-43e2-8eda-5fc10a451c46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_978fcbd5-8860-4299-a069-fb07b518b5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_978fcbd5-8860-4299-a069-fb07b518b5b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_0fec2091-2197-495e-940b-b8b28bb0a21b" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_0fec2091-2197-495e-940b-b8b28bb0a21b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_cea606b0-7f8c-4907-ac91-7a4314c95394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_cea606b0-7f8c-4907-ac91-7a4314c95394" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d4e42f1d-5f6e-414a-b29c-4841a571bf86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_OperatingLeaseLiability_d4e42f1d-5f6e-414a-b29c-4841a571bf86" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f8cbb0a0-2374-40c2-b8db-2246f4f6f0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f8cbb0a0-2374-40c2-b8db-2246f4f6f0ec" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6d10708b-5b58-4591-b56e-3c85ed43effb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6d10708b-5b58-4591-b56e-3c85ed43effb" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesGroundLeasesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:to="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87a69154-aa23-41be-9ada-df676f62fb9c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:to="loc_srt_RangeMember_87a69154-aa23-41be-9ada-df676f62fb9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:to="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bca5f0a2-43c9-46b8-8463-5884a7ea8c7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:to="loc_srt_MinimumMember_bca5f0a2-43c9-46b8-8463-5884a7ea8c7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26b8215f-54e7-49e4-a52b-345466dabb2c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:to="loc_srt_MaximumMember_26b8215f-54e7-49e4-a52b-345466dabb2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_6ac63194-073f-48ce-af74-c06ba7c9409a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_6ac63194-073f-48ce-af74-c06ba7c9409a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_a17fb90f-3690-4136-aa3c-c4b543b9f046" xlink:href="hr-20240630.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_a17fb90f-3690-4136-aa3c-c4b543b9f046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0371a1ec-c9af-4bbe-8ed7-6ef187f6b918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0371a1ec-c9af-4bbe-8ed7-6ef187f6b918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_4211696f-0f21-4d22-b089-ce2fe6397f68" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_4211696f-0f21-4d22-b089-ce2fe6397f68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_168ba543-9676-4a75-ade8-5bfec63e4f62" xlink:href="hr-20240630.xsd#hr_AmortizationofPrepaidRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_AmortizationofPrepaidRent_168ba543-9676-4a75-ade8-5bfec63e4f62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_1df3f817-4927-45ee-8e1e-5a3357d0e47e" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_1df3f817-4927-45ee-8e1e-5a3357d0e47e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9c4e0a11-ef1f-423b-b332-9952aa4da753_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9c4e0a11-ef1f-423b-b332-9952aa4da753_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3142dab5-79c8-43e6-a96b-a904cafffa45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_LineOfCreditMember_3142dab5-79c8-43e6-a96b-a904cafffa45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_0fc278f0-8a11-43f1-93e1-82356116134a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_MediumTermNotesMember_0fc278f0-8a11-43f1-93e1-82356116134a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5a3dda40-795b-436e-9377-5ee5a64d119d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_SeniorNotesMember_5a3dda40-795b-436e-9377-5ee5a64d119d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_f6d587bd-4023-4eea-aec9-a1fe1e834439" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_MortgagesMember_f6d587bd-4023-4eea-aec9-a1fe1e834439" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_1dcf003f-dbf8-4a92-89b3-3118abaf23c7" xlink:href="hr-20240630.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_1dcf003f-dbf8-4a92-89b3-3118abaf23c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2025Member_76bb84ed-621e-4980-bd4d-eeb600d9794e" xlink:href="hr-20240630.xsd#hr_TermLoanDueMay2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDueMay2025Member_76bb84ed-621e-4980-bd4d-eeb600d9794e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member_f2b68aa1-411b-497a-8887-ea6d5a989438" xlink:href="hr-20240630.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDueJuly2024Member_f2b68aa1-411b-497a-8887-ea6d5a989438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_df637a19-6ad6-403c-87de-c38b830e4d72" xlink:href="hr-20240630.xsd#hr_TermLoanDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2025Member_df637a19-6ad6-403c-87de-c38b830e4d72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_1e57c05a-80d9-45fa-9b97-fd0ca329fe19" xlink:href="hr-20240630.xsd#hr_TermLoandue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoandue2026Member_1e57c05a-80d9-45fa-9b97-fd0ca329fe19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_3bfb7dc9-2897-4715-bbbb-f990432ef8bb" xlink:href="hr-20240630.xsd#hr_TermLoanDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2027Member_3bfb7dc9-2897-4715-bbbb-f990432ef8bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_8a624e09-71d3-427b-a618-4366f1d03c33" xlink:href="hr-20240630.xsd#hr_TermLoanDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2028Member_8a624e09-71d3-427b-a618-4366f1d03c33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_a9ba5561-4bcb-4a14-a2e3-a1fb916c6641" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2025Member_a9ba5561-4bcb-4a14-a2e3-a1fb916c6641" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_5ea98b10-2a0d-42ad-9dbd-d92d487c6ac0" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2026Member_5ea98b10-2a0d-42ad-9dbd-d92d487c6ac0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_f9123a7b-48db-4ddc-b391-62ea4d4c8aea" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2027Member_f9123a7b-48db-4ddc-b391-62ea4d4c8aea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_44f49ee8-c121-4b9f-b861-0032fe427dfc" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2028Member_44f49ee8-c121-4b9f-b861-0032fe427dfc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_901d9e14-b1a9-4e79-8e9f-93aa843432e8" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_901d9e14-b1a9-4e79-8e9f-93aa843432e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_89c37493-d36c-457f-9f57-a4d0a72255eb" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2030Member_89c37493-d36c-457f-9f57-a4d0a72255eb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_1cdebb22-e9f4-4718-8881-83637d1f5b52" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2031Member_1cdebb22-e9f4-4718-8881-83637d1f5b52" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_0c5f3a21-c8c1-4956-b739-0f6d79571744" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_0c5f3a21-c8c1-4956-b739-0f6d79571744" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_65607421-3a88-42ee-9862-5453a5fe2f34" xlink:href="hr-20240630.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_MortgageNotesPayableNetMember_65607421-3a88-42ee-9862-5453a5fe2f34" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_3dde298e-4abc-42c4-8e0d-b9c77b4276d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_us-gaap_UnsecuredDebtMember_3dde298e-4abc-42c4-8e0d-b9c77b4276d9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2170e61-4948-4264-b51a-48de9626b869_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:to="loc_srt_RangeMember_a2170e61-4948-4264-b51a-48de9626b869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:to="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e2622fe4-2ab4-42ae-8204-e693e6ec0e6b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:to="loc_srt_MinimumMember_e2622fe4-2ab4-42ae-8204-e693e6ec0e6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af8e63c7-a47e-443d-8860-a95c6ef00e18" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:to="loc_srt_MaximumMember_af8e63c7-a47e-443d-8860-a95c6ef00e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dd988b1f-fda0-4c62-8a32-276dec18aeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LongTermDebt_dd988b1f-fda0-4c62-8a32-276dec18aeb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_88232104-afa7-4bea-a658-f0749400fee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_88232104-afa7-4bea-a658-f0749400fee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_86d687cb-2820-48d1-a1c2-e790a21be2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_86d687cb-2820-48d1-a1c2-e790a21be2e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7ae6c765-913e-446d-81bf-571911b20cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7ae6c765-913e-446d-81bf-571911b20cfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5ae9b23c-1980-487a-9e9c-825a36672931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5ae9b23c-1980-487a-9e9c-825a36672931" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_3a856c34-bc47-4508-aad0-ef916beb5bbe" xlink:href="hr-20240630.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_3a856c34-bc47-4508-aad0-ef916beb5bbe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_d609f68a-140c-4c95-9f78-b13bec7ba940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_d609f68a-140c-4c95-9f78-b13bec7ba940" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepaidPrincipal_03815d8a-b163-489e-b489-15d2f098bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentRepaidPrincipal_03815d8a-b163-489e-b489-15d2f098bf16" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9baf17d4-1706-44a5-b880-d3085015789c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9baf17d4-1706-44a5-b880-d3085015789c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_59f4fbc7-8d8d-41d2-aeda-784f5f336b22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:to="loc_us-gaap_MortgagesMember_59f4fbc7-8d8d-41d2-aeda-784f5f336b22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d3027001-4c7c-4b52-b9e1-aff18bc9d42c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:to="loc_srt_SegmentGeographicalDomain_d3027001-4c7c-4b52-b9e1-aff18bc9d42c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:to="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a66ebc66-57f0-418d-8ac3-6d8fd597ec3b" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:to="loc_stpr_CA_a66ebc66-57f0-418d-8ac3-6d8fd597ec3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_c6d083cf-2ac7-4462-9cc2-4a70a0bbaa24" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_GA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:to="loc_stpr_GA_c6d083cf-2ac7-4462-9cc2-4a70a0bbaa24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_568f5282-96d8-4c19-b7a6-98962a7f1516_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_568f5282-96d8-4c19-b7a6-98962a7f1516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_25fd6e23-8fed-4ee2-ba0f-ff4f2179f396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:to="loc_us-gaap_MortgagesMember_25fd6e23-8fed-4ee2-ba0f-ff4f2179f396" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b71f237-a254-4cf4-9655-781dbfe981c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b71f237-a254-4cf4-9655-781dbfe981c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6849d501-79d2-4c8b-8a49-6f9af531e528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6849d501-79d2-4c8b-8a49-6f9af531e528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_b4395b24-c7f2-42a0-a722-1b7115ce0100" xlink:href="hr-20240630.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_b4395b24-c7f2-42a0-a722-1b7115ce0100" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_891ac685-0096-4805-90cd-cf463468100f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_891ac685-0096-4805-90cd-cf463468100f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:to="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_d7d0e121-84da-4af8-b658-18b0de3c8dc5" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_d7d0e121-84da-4af8-b658-18b0de3c8dc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_c0faf100-8327-4928-82db-591eca3dc1a5" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_c0faf100-8327-4928-82db-591eca3dc1a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_70f3f5f4-7371-468b-8a25-0a267fc68e27" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_70f3f5f4-7371-468b-8a25-0a267fc68e27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_a5f3be7b-f742-41cc-bd61-a518c1423016" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_a5f3be7b-f742-41cc-bd61-a518c1423016" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_ec917cc4-55d1-4785-8a2b-52a48e9d2e70" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_ec917cc4-55d1-4785-8a2b-52a48e9d2e70" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_409136dc-8a43-4a60-abd0-b0a6acae7f0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_409136dc-8a43-4a60-abd0-b0a6acae7f0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dbcd7cf0-9698-4c54-a997-96da051295de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:to="loc_us-gaap_CashFlowHedgingMember_dbcd7cf0-9698-4c54-a997-96da051295de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_20bb8667-f83c-4341-9f19-ac3d25a06fb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:to="loc_us-gaap_HedgingDesignationDomain_20bb8667-f83c-4341-9f19-ac3d25a06fb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:to="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ddfa39c6-cca0-47ad-8b74-3789b3154655" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ddfa39c6-cca0-47ad-8b74-3789b3154655" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e08bbbca-806f-4a0b-8ad5-c0ce32c96c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e08bbbca-806f-4a0b-8ad5-c0ce32c96c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_367f42c7-a9e6-426c-8a9d-262458de4bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_DerivativeNotionalAmount_367f42c7-a9e6-426c-8a9d-262458de4bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_da1f5fca-d347-47f6-a146-60ee0cdfedf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_da1f5fca-d347-47f6-a146-60ee0cdfedf3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:to="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4170a7e3-ce26-4381-83d8-256796ae7a84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4170a7e3-ce26-4381-83d8-256796ae7a84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_529f584c-4111-40cd-b171-bc697d5abeff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:to="loc_us-gaap_OtherLiabilitiesMember_529f584c-4111-40cd-b171-bc697d5abeff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_fdbb06cd-5fa1-4536-8447-22f1c483b4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:to="loc_us-gaap_OtherAssetsMember_fdbb06cd-5fa1-4536-8447-22f1c483b4ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5beaba52-e41e-4990-905c-68b9cef1668b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:to="loc_us-gaap_HedgingDesignationDomain_5beaba52-e41e-4990-905c-68b9cef1668b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:to="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4725b44-415c-4170-a3a7-24216394a9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4725b44-415c-4170-a3a7-24216394a9dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_713f1d78-723a-4563-a07a-04c49475b311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_713f1d78-723a-4563-a07a-04c49475b311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a52e4bf4-c815-41d4-a55b-43ae8e6aad78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:to="loc_us-gaap_InterestRateSwapMember_a52e4bf4-c815-41d4-a55b-43ae8e6aad78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_52a53744-9647-4b83-863b-fa41d9d10e15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_52a53744-9647-4b83-863b-fa41d9d10e15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:to="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40ea416e-7803-4cde-ab40-ca7128b0b255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40ea416e-7803-4cde-ab40-ca7128b0b255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_1ac414d1-7980-46fa-b92b-c124b2e03f03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_InterestRateContractMember_1ac414d1-7980-46fa-b92b-c124b2e03f03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_353a02e7-e27b-413d-b674-e447f650769c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_TreasuryLockMember_353a02e7-e27b-413d-b674-e447f650769c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ccb3c09d-cd8c-4af0-a71f-fc98b845f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_InterestRateSwapMember_ccb3c09d-cd8c-4af0-a71f-fc98b845f34c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d376b929-cfa4-44be-bf13-2ff071248479_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d376b929-cfa4-44be-bf13-2ff071248479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_5e2724e7-6361-4a4b-bbfa-af663ed904eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:to="loc_us-gaap_InterestExpenseMember_5e2724e7-6361-4a4b-bbfa-af663ed904eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2b8aa5f9-f4ef-4436-98b8-49200641092f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2b8aa5f9-f4ef-4436-98b8-49200641092f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e265660b-79b6-4ed5-b8bd-020c513a1a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e265660b-79b6-4ed5-b8bd-020c513a1a7c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:to="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_376258f5-857e-4e39-96fb-2e623e4e614f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_376258f5-857e-4e39-96fb-2e623e4e614f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_d4102991-ffc7-4717-9ad7-72f342616631" xlink:href="hr-20240630.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:to="loc_hr_ActiveInterestRateSwapsMember_d4102991-ffc7-4717-9ad7-72f342616631" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_25a947d6-a382-4676-bda5-f4814da23a60" xlink:href="hr-20240630.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:to="loc_hr_SettledInterestRateSwapsMember_25a947d6-a382-4676-bda5-f4814da23a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0640848a-f335-44aa-a4fd-bf6cc8d145a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0640848a-f335-44aa-a4fd-bf6cc8d145a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_d84c98e1-9457-45b7-b749-abe12ccc538b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_d84c98e1-9457-45b7-b749-abe12ccc538b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:to="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:to="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_bebc7a47-508d-4f5f-b386-18632df3bd29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:to="loc_us-gaap_OtherCommitmentsDomain_bebc7a47-508d-4f5f-b386-18632df3bd29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:to="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember_0b4dff0b-d28f-487c-be55-1a21800c81c5" xlink:href="hr-20240630.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_ActiveDevelopmentPropertiesMember_0b4dff0b-d28f-487c-be55-1a21800c81c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember_3f7cb756-2027-40b5-b136-a2d81fe612a8" xlink:href="hr-20240630.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_RedevelopmentPropertiesMember_3f7cb756-2027-40b5-b136-a2d81fe612a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_aec863d7-13eb-4ca6-b664-8c9d9d09a64e" xlink:href="hr-20240630.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_aec863d7-13eb-4ca6-b664-8c9d9d09a64e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_6dae4f80-3df3-48ee-8036-1c4ad7f5bab0" xlink:href="hr-20240630.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:to="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_6dae4f80-3df3-48ee-8036-1c4ad7f5bab0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_211e85c4-92c8-452e-8675-4fffaf69db47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:to="loc_us-gaap_EquityComponentDomain_211e85c4-92c8-452e-8675-4fffaf69db47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:to="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eb4e69e7-bd67-420c-94b8-5c98b5363f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:to="loc_us-gaap_CommonStockMember_eb4e69e7-bd67-420c-94b8-5c98b5363f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:href="hr-20240630.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e0405a6f-0043-43f6-b814-c7a3bd3420dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e0405a6f-0043-43f6-b814-c7a3bd3420dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6f556bff-e8c6-4797-8dfa-95ac78ee7951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6f556bff-e8c6-4797-8dfa-95ac78ee7951" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_dcce3847-f02c-4b5e-889e-2f9d6470ce39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_dcce3847-f02c-4b5e-889e-2f9d6470ce39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_fb50f76c-7739-4dbd-835d-1cf76b672c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_fb50f76c-7739-4dbd-835d-1cf76b672c3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_468cf121-1986-4535-b7d7-63c39bc736fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_468cf121-1986-4535-b7d7-63c39bc736fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6a55e47e-319d-424d-90fb-9d2cca370c85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_034b60e2-146d-41f2-a70e-6d4e14c3b6ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:to="loc_us-gaap_EquityComponentDomain_034b60e2-146d-41f2-a70e-6d4e14c3b6ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:to="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b705937f-ef8d-42e9-a547-7d0f20a87eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:to="loc_us-gaap_CommonStockMember_b705937f-ef8d-42e9-a547-7d0f20a87eb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_299cf4b6-3713-432c-9448-8f965ebfd5fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_299cf4b6-3713-432c-9448-8f965ebfd5fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2a9a1bab-4f2e-4116-9c67-7f8b0fda73b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2a9a1bab-4f2e-4116-9c67-7f8b0fda73b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f45be8cd-a73c-4d9b-a16f-daf57193d3f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f45be8cd-a73c-4d9b-a16f-daf57193d3f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_8c3c8f3a-9398-4d8e-99a0-10906bbe7190" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_8c3c8f3a-9398-4d8e-99a0-10906bbe7190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_8173db5e-f42e-48e5-b0da-9fd889803241" xlink:href="hr-20240630.xsd#hr_NonVestedStockAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_hr_NonVestedStockAwardMember_8173db5e-f42e-48e5-b0da-9fd889803241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a09ef02e-c479-4ed2-8918-5c068ee78f85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a09ef02e-c479-4ed2-8918-5c068ee78f85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:to="loc_us-gaap_PlanNameDomain_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:to="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_1cfcd49f-d521-4f15-bf0d-9aa35ec7abb9" xlink:href="hr-20240630.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_1cfcd49f-d521-4f15-bf0d-9aa35ec7abb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesCUnitsMember_cf6aa6e2-b002-42ec-a205-f458b47dc68f" xlink:href="hr-20240630.xsd#hr_LTIPSeriesCUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_LTIPSeriesCUnitsMember_cf6aa6e2-b002-42ec-a205-f458b47dc68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_6216f8b3-bc99-4588-8adb-533a2c83c07c" xlink:href="hr-20240630.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_StockIncentivePlanMember_6216f8b3-bc99-4588-8adb-533a2c83c07c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesDUnitsMember_22b8beaa-1588-4f7b-a198-d5eab7719def" xlink:href="hr-20240630.xsd#hr_LTIPSeriesDUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_LTIPSeriesDUnitsMember_22b8beaa-1588-4f7b-a198-d5eab7719def" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherMembersOfSeniorManagementMember_56f2f2ca-52b0-4a2a-862c-ba0d6b8194d2" xlink:href="hr-20240630.xsd#hr_OtherMembersOfSeniorManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_OtherMembersOfSeniorManagementMember_56f2f2ca-52b0-4a2a-862c-ba0d6b8194d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_492a5a69-5a2c-4f27-b132-18129acbc4f4_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:to="loc_srt_RangeMember_492a5a69-5a2c-4f27-b132-18129acbc4f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:to="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06a261b6-d936-466a-8301-fd3eed2e5b3f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:to="loc_srt_MinimumMember_06a261b6-d936-466a-8301-fd3eed2e5b3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_50673ecb-b678-4642-840b-34045f112a97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:to="loc_srt_MaximumMember_50673ecb-b678-4642-840b-34045f112a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_99caef5a-4ea0-4359-97cb-fffcc20a9596_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_99caef5a-4ea0-4359-97cb-fffcc20a9596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_dcd46c2c-e5bf-46b3-a274-7291d52b42a1" xlink:href="hr-20240630.xsd#hr_DirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:to="loc_hr_DirectorsMember_dcd46c2c-e5bf-46b3-a274-7291d52b42a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_fc6e84eb-29ce-40bc-8ad8-a3457b381986_default" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:to="loc_hr_StockIssuanceProgramDomain_fc6e84eb-29ce-40bc-8ad8-a3457b381986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:to="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:href="hr-20240630.xsd#hr_PerformanceConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:to="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_bd70f3df-9784-4ae4-b501-94a2a2a9d463" xlink:href="hr-20240630.xsd#hr_MarketCondition2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:to="loc_hr_MarketCondition2Member_bd70f3df-9784-4ae4-b501-94a2a2a9d463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_bd2e7abf-7ac7-4154-b008-4bd2100473a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:to="loc_us-gaap_GranteeStatusDomain_bd2e7abf-7ac7-4154-b008-4bd2100473a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:to="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e1f18ef8-5bd3-4fed-8ad0-aefd35aec521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e1f18ef8-5bd3-4fed-8ad0-aefd35aec521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_914321f8-4c4d-4b37-ac95-5059ec77bc39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_914321f8-4c4d-4b37-ac95-5059ec77bc39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_76ca5f70-c7cb-4fa8-b617-62ca4718a7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:to="loc_us-gaap_SubsequentEventMember_76ca5f70-c7cb-4fa8-b617-62ca4718a7c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_87732e26-5e18-4317-b8de-0c8077caae14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_87732e26-5e18-4317-b8de-0c8077caae14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_2f1bc9ed-ec9e-4447-89db-4ac5eaaa2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_2f1bc9ed-ec9e-4447-89db-4ac5eaaa2bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d393398f-9d16-48ee-8ae0-202f05021e41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d393398f-9d16-48ee-8ae0-202f05021e41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f90619af-ca2d-444a-ae55-9cc7c9758144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f90619af-ca2d-444a-ae55-9cc7c9758144" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d625a5c6-7a1b-4605-9d74-1d41b1a52d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d625a5c6-7a1b-4605-9d74-1d41b1a52d12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_5f2e8d84-413a-4564-a438-9bf2ca99e498" xlink:href="hr-20240630.xsd#hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_5f2e8d84-413a-4564-a438-9bf2ca99e498" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_22f630f0-000c-4517-a973-7e71e0cf791b" xlink:href="hr-20240630.xsd#hr_StockRepurchaseProgramAuthorizedAdditionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_22f630f0-000c-4517-a973-7e71e0cf791b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c4e586e-9901-4a21-9af2-5490c54cda27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c4e586e-9901-4a21-9af2-5490c54cda27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_238687aa-79c3-4570-947b-ecf7438dbdac" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_238687aa-79c3-4570-947b-ecf7438dbdac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_68ca33fd-f010-4e11-94e7-e64ae25886e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_68ca33fd-f010-4e11-94e7-e64ae25886e8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a66c52b-e9dd-448d-b7bd-6bfdc59a8f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a66c52b-e9dd-448d-b7bd-6bfdc59a8f04" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_d3f40613-dbfe-4c42-a8fd-bc614e5bcaaa" xlink:href="hr-20240630.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_d3f40613-dbfe-4c42-a8fd-bc614e5bcaaa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_48521a3b-56d4-4660-b75e-a8a7e017e456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_48521a3b-56d4-4660-b75e-a8a7e017e456" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_54b7194e-cb70-4854-bf63-03b01423b064" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_54b7194e-cb70-4854-bf63-03b01423b064" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_8c178e30-acc5-475b-986d-272d0a525daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_8c178e30-acc5-475b-986d-272d0a525daf" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:to="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c24cc5b3-5568-4b4d-93e0-9ad284e400b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c24cc5b3-5568-4b4d-93e0-9ad284e400b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1c555eb-8467-42eb-ad14-93ad3cef6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1c555eb-8467-42eb-ad14-93ad3cef6e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_fcd69714-aef0-45cb-8f93-4f9f1262a1a4" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_fcd69714-aef0-45cb-8f93-4f9f1262a1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fe21a329-78b1-4450-b3a8-dd4aa47344c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fe21a329-78b1-4450-b3a8-dd4aa47344c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_24a7984f-65b0-4f91-b3b7-37157f5ed7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_24a7984f-65b0-4f91-b3b7-37157f5ed7d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92cc716a-5413-41f5-8832-d3f2039a3f48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92cc716a-5413-41f5-8832-d3f2039a3f48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a74bf15b-3bac-4531-8afd-18e99575fcba" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a74bf15b-3bac-4531-8afd-18e99575fcba" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:to="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:to="loc_us-gaap_PlanNameDomain_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:to="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_f4d1cc70-102e-4b8e-9047-b0909d127cb4" xlink:href="hr-20240630.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:to="loc_hr_StockIncentivePlanMember_f4d1cc70-102e-4b8e-9047-b0909d127cb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb5c53d5-5881-4e64-ab3f-ac93bfa25e63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb5c53d5-5881-4e64-ab3f-ac93bfa25e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d58dac17-7cae-4a21-bfad-ce78b3405009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d58dac17-7cae-4a21-bfad-ce78b3405009" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d9ce0292-d2fb-4ca1-ae18-d8d1304ae785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d9ce0292-d2fb-4ca1-ae18-d8d1304ae785" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_5873a337-9f25-42f9-99f1-88b38c8e24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_5873a337-9f25-42f9-99f1-88b38c8e24ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_abcfd844-5f18-45d1-ad11-41c14f793253" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_abcfd844-5f18-45d1-ad11-41c14f793253" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_feb95bb6-2aaf-430a-a533-16a3fd56a3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:to="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_77038a08-704f-4563-956c-6b95353cdfa0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_77038a08-704f-4563-956c-6b95353cdfa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_47e9122f-62cf-4ef1-a24f-25ea25005861" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_47e9122f-62cf-4ef1-a24f-25ea25005861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9eb92784-c877-4a09-914a-743173bc171f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9eb92784-c877-4a09-914a-743173bc171f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_2203f1e7-44e7-421d-8a27-21fbcca36963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:to="loc_us-gaap_DebtInstrumentFairValue_2203f1e7-44e7-421d-8a27-21fbcca36963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_1abfd138-3624-448a-9c07-5684d2ae6951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_1abfd138-3624-448a-9c07-5684d2ae6951" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_7e7139a7-e112-4c1b-82f1-90723041e28a" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_7e7139a7-e112-4c1b-82f1-90723041e28a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_088d92ba-76bc-464a-a96e-a522f9c17d2c" xlink:href="hr-20240630.xsd#hr_NonVestedStockAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_NonVestedStockAwardMember_088d92ba-76bc-464a-a96e-a522f9c17d2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hr-20240630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b89388f8-17d2-43e1-a39b-e0b260fc2c25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPERATING</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_68ee41c6-47e8-4f99-ae62-b17698068840_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_15c718ef-1b49-4bec-8866-fded807c5833_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_932f0934-cb9f-4052-a5e9-ed0e31372d6e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_9e99931c-09a5-451a-9827-04788ccd493c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_85d24dec-e74b-4a96-935a-da4a8047f456_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_b5386b76-8784-4b8a-97f0-5a2e08541b8e_terseLabel_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_label_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_documentation_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets" xlink:href="hr-20240630.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReceivablesAndOtherAssets" xlink:to="lab_hr_ReceivablesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4e0eb9cd-dced-4f6d-9252-517f9a7f004a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeattleWAMember_c07188b5-58a9-476c-9ed7-2ccb7a66b5a6_terseLabel_en-US" xlink:label="lab_hr_SeattleWAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Seattle, WA</link:label>
    <link:label id="lab_hr_SeattleWAMember_label_en-US" xlink:label="lab_hr_SeattleWAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Seattle, WA [Member]</link:label>
    <link:label id="lab_hr_SeattleWAMember_documentation_en-US" xlink:label="lab_hr_SeattleWAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Seattle, WA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeattleWAMember" xlink:href="hr-20240630.xsd#hr_SeattleWAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeattleWAMember" xlink:to="lab_hr_SeattleWAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_a4571d9f-17ab-49c1-aeba-1e06cbd4a3e6_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesPrepaid" xlink:to="lab_hr_NumberofGroundLeasesPrepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_35fad48e-6d3f-492e-afb4-046845bc3076_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest owned (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b4072f5d-c086-44fb-8c5e-6ff9718bbc13_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_46c42279-a355-454f-ad5f-805f281d9390_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_e255b72b-7535-4569-929d-a8750990aa02_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint venture ownership (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0edd2956-3213-41cc-b554-69308ee22400_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DenverCOMember_0b262a2e-97e1-4d9c-8f27-35704f8ad604_terseLabel_en-US" xlink:label="lab_hr_DenverCOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denver, CO</link:label>
    <link:label id="lab_hr_DenverCOMember_label_en-US" xlink:label="lab_hr_DenverCOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Denver, CO [Member]</link:label>
    <link:label id="lab_hr_DenverCOMember_documentation_en-US" xlink:label="lab_hr_DenverCOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Denver, CO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DenverCOMember" xlink:href="hr-20240630.xsd#hr_DenverCOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DenverCOMember" xlink:to="lab_hr_DenverCOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_3e293d6f-0b16-4de3-a6db-7554aba80e16_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e7939d2a-7057-4e24-8caa-90d2dc602b47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b45824d8-8bcb-41f3-a9fb-af8b6814ae4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_141b60b7-76d9-4dbf-8723-fdf0a34c08dc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable interest entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_75c9d7f4-b046-4df4-9210-4b27c601593a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1a3923b4-e819-48da-8c4e-7458582a3df1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_4a9b135a-5c0d-4680-a74d-06286195f077_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_7f44a4a3-cefb-4192-9689-bce9093e9cc5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_a3e5d973-7c11-46ea-bf12-41c5400f4260_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to redemption value of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesAbstract_2f936e58-2264-47c0-919b-e8f23aff706e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Impairment:</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesAbstract_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract" xlink:to="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_3d419344-d8c4-49ca-a3fb-3ba926fa34dd_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NewYorkNYMember_dddae198-3b5a-48ac-8361-b934995609e0_terseLabel_en-US" xlink:label="lab_hr_NewYorkNYMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York, NY</link:label>
    <link:label id="lab_hr_NewYorkNYMember_label_en-US" xlink:label="lab_hr_NewYorkNYMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York, NY [Member]</link:label>
    <link:label id="lab_hr_NewYorkNYMember_documentation_en-US" xlink:label="lab_hr_NewYorkNYMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New York, NY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewYorkNYMember" xlink:href="hr-20240630.xsd#hr_NewYorkNYMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NewYorkNYMember" xlink:to="lab_hr_NewYorkNYMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_dec6c7e7-f2b4-48e2-b769-20576e8ab9b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d8341129-f93b-4f92-a8f0-8ee7c5a910eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-vested share-based awards, net of withheld shares and forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_ba9b35a4-9a96-4c99-849c-65cc06643c87_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_3774707a-0e58-4041-a539-69c7141c05c2_verboseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_eada911f-5c8e-4da7-a0bd-43b8db14272d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_80862f2c-c2c6-41cc-9089-dc530b204020_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_9f001e77-92a6-42ef-bd2c-80063aeaa65b_verboseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">NET REAL ESTATE INVESTMENT</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_label_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investment Net Disposed of During Period</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real estate investment net disposed of during the Period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:to="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_1b89501b-b1c1-4427-96cf-f68bf4c073ca_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions from redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:to="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_5247c008-fa0c-4879-9268-56a6a1a29a9c_terseLabel_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redevelopment Properties</link:label>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redevelopment Properties [Member]</link:label>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redevelopment Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember" xlink:href="hr-20240630.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RedevelopmentPropertiesMember" xlink:to="lab_hr_RedevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_bcc2f24f-de99-42a6-a488-4209f921d233_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_23ebd10d-5c65-433a-9684-60114aab5cf7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Company's Allowance For Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_99f072b4-5e68-47a7-9ed4-bbada1dee039_terseLabel_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 and thereafter</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20240630.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_71de4c90-6280-40ed-a071-4d9bbf504651_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_7062bccc-cb37-488e-b6ca-eb69b6d9aaa3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4d6e45d4-c64d-42cd-905d-82150f36d379_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_490c1613-4a11-4e4b-9a9c-9428566ded09_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_74e9b523-9b81-49da-b4b4-849ea2a8a3a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_0e587fca-dc00-48c5-8b11-0e5a51d64fad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_5ed53200-aeab-4bed-b9a8-a5bf1e652c26_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_e656059c-c83c-44df-8b6b-a99302fc08cd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_bddd4b0b-14fe-49c3-a6b6-265be57bd077_verboseLabel_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contributions from redeemable non-controlling interests</link:label>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_label_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Contributions from Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_documentation_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Contributions from Redeemable Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:href="hr-20240630.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:to="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_903df008-91cf-40da-a44f-0ba0f594d079_netLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">GAIN/(IMPAIRMENT)</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_c78aafdf-af2d-41cd-8842-c0762c59adde_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_8d7376fc-e849-4f9e-bc80-47def1981d7a_terseLabel_en-US" xlink:label="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nationwide portfolio (percent)</link:label>
    <link:label id="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_label_en-US" xlink:label="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasing and Property Management Services Provided as Percentage of Nationwide Portfolio</link:label>
    <link:label id="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_documentation_en-US" xlink:label="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leasing and Property Management Services Provided as Percentage of Nationwide Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:href="hr-20240630.xsd#hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:to="lab_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_fe074371-c15e-4f12-a451-01b9aa8e2e7a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_860f4800-5f04-4bf7-b24c-ae7b364af436_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_6b85dfb9-9259-4d84-b88e-ef4658423cd5_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:to="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AustinTXMember_c3f26cc6-299c-42fe-9ecc-b6d3c0d20595_terseLabel_en-US" xlink:label="lab_hr_AustinTXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Austin, TX</link:label>
    <link:label id="lab_hr_AustinTXMember_label_en-US" xlink:label="lab_hr_AustinTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Austin, TX [Member]</link:label>
    <link:label id="lab_hr_AustinTXMember_documentation_en-US" xlink:label="lab_hr_AustinTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Austin, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AustinTXMember" xlink:href="hr-20240630.xsd#hr_AustinTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AustinTXMember" xlink:to="lab_hr_AustinTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2028Member_bcf01a40-ab25-4617-b721-9378a687ea2f_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2028</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2028Member" xlink:to="lab_hr_SeniorNotesdue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_VariableInterestEntityMember_f4015d82-5289-46b3-8a2e-894225a048c7_terseLabel_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_label_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Member]</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_documentation_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember" xlink:href="hr-20240630.xsd#hr_VariableInterestEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_VariableInterestEntityMember" xlink:to="lab_hr_VariableInterestEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_66d1153b-b1e6-489a-83ab-9f756f541f6a_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of owned real estate properties</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_label_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_documentation_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:to="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_b7679a97-f8ba-4b0c-999a-84c62ffac426_terseLabel_en-US" xlink:label="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchases, excluding commissions</link:label>
    <link:label id="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_label_en-US" xlink:label="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Excluding Commissions</link:label>
    <link:label id="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_documentation_en-US" xlink:label="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Excluding Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:href="hr-20240630.xsd#hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:to="lab_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_87c45bbd-e431-425b-ad3a-154e61b67af5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_762b3a43-a9a3-4de9-9476-5763995cbbb8_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b3238140-ce9f-4b14-a4a8-5e2ca3a43cf2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares, acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_f3c720f5-3f2b-4d21-a710-0a9934e0db10_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_055d4f49-6a06-43d2-a7e8-6d891eb7b615_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investment Property, at Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_6fb83e91-223f-4601-9cc5-bd0d3af271aa_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock price (in dollar per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_96b8e2e4-f8a9-4ed8-adc2-e0e70a01d3ed_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_78332f5c-967b-4288-9db0-2ae57754c5a4_terseLabel_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land held for development</link:label>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_label_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land Available for Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAvailableForDevelopment" xlink:to="lab_us-gaap_LandAvailableForDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1de98e56-0057-42d7-af55-40eef4862b44_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_ad4bbd25-b0be-42f5-b6e9-2773ff568943_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3c145300-246c-4fe1-866f-6638661c29c1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d562d47-9996-41c2-a160-592b05409fb7_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_61c5b12b-d54c-478e-b853-488aba25c16d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dbe251a9-1c7c-4a82-9192-e914469b44e3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_525f2cb4-5d14-40c0-bd81-18dcc32e0126_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_9276f549-3847-4753-b188-69dd1f7a596c_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Redeemable Non-controlling Interests, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_bc04ed59-16d8-47c7-a43a-aa9c6df661ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Redeemable Non-controlling Interests, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8061bd30-6fbc-4731-b06e-ba006c0f82ea_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates in the Condensed Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PaymentsForRepurchasesOfCommonStock_3e4d6eda-36de-4143-b752-3a7a7da9bd5b_negatedTerseLabel_en-US" xlink:label="lab_hr_PaymentsForRepurchasesOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_hr_PaymentsForRepurchasesOfCommonStock_label_en-US" xlink:label="lab_hr_PaymentsForRepurchasesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Repurchases Of Common Stock</link:label>
    <link:label id="lab_hr_PaymentsForRepurchasesOfCommonStock_documentation_en-US" xlink:label="lab_hr_PaymentsForRepurchasesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Repurchases Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentsForRepurchasesOfCommonStock" xlink:href="hr-20240630.xsd#hr_PaymentsForRepurchasesOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PaymentsForRepurchasesOfCommonStock" xlink:to="lab_hr_PaymentsForRepurchasesOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_dfd43ab4-55be-4fc7-9435-52b443661909_verboseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cumulative net income attributable to common stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Net Income Attributable to Common Stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative net income attributable to common stockholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:to="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_68ae9afe-898c-4523-9386-eff1cac2860b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e333e103-9dc1-4c36-8310-ba08374ffcbc_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_d7a2921b-c6c8-42d3-acde-e2c473506649_terseLabel_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Encumbered square footage</link:label>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_label_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt, Encumbered Square Footage</link:label>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_documentation_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt, Encumbered Square Footage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:href="hr-20240630.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:to="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_7e9e46ba-9156-4ea7-a6a7-9980b416e809_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_247422d5-3b0f-48e2-9fff-096ee9c41202_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5fac2f73-0495-49a3-afcc-3731334b32fe_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f19650a3-52d2-4757-a0fe-6dcf8cd8fcb9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_720c80fd-716b-42d5-a6a1-7320ffc20a7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_7114c4a8-e0e1-4253-beea-49e2b3d06b88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance and assumption costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f6e8dc88-fa3e-4a0f-8a6f-5325b7cbb763_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af384f37-cfb9-4611-993a-89d07bd00545_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_289dff4b-a1bc-453a-8e03-1732e122ec49_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_7aef6173-9e75-4a44-8a50-ae806b971a6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_9d71589b-e292-4a79-aafb-f4b8625bc4b4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8ba0440d-0980-4e26-b32a-a234fdd4ce40_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average incremental shares of common stock excluded from the computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_7f4941c4-33c6-435b-9a82-32fd0a81d954_totalLabel_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss applicable to common stockholders - basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_label_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_documentation_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:href="hr-20240630.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:to="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_35d3ce5d-3d22-4c96-b7db-e0346a4ad7ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_d90fe9f7-fce4-4a47-8e53-44bf6ccb6baf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE DISCOUNT AND FEES</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Covered and Not Covered, after Allowance for Credit Loss, Fee, Premium, and Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:to="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b923898b-52f5-4aac-a127-7f83ec77325f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_11a87286-e9c7-488f-abcc-b2874fcf734f_verboseLabel_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Investments</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_label_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions and Dispositions [Text Block]</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_documentation_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisitions and dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:href="hr-20240630.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:to="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad3c290a-a02a-4531-9990-c715c93766ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_09de755b-77f5-48cd-ad71-e6c7a12947a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9e48304b-8495-4ad0-97f6-03c828b6737f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_5c07262c-9f34-4367-a388-aa20ecd3174b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_97853dfd-a0e2-4ae7-9121-7e35089dbb3b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b9e9ade4-3dc2-4a09-b068-1ec8192f3d2e_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_f0e43854-0aaa-401a-88f1-35f79eab79b6_terseLabel_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Settled Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember" xlink:href="hr-20240630.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SettledInterestRateSwapsMember" xlink:to="lab_hr_SettledInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_2e859d55-144e-415e-99c7-c3fa42f6e584_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_e930ef21-14e5-4371-8aa4-4182fbac7422_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of real estate assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfRealEstate" xlink:to="lab_us-gaap_ImpairmentOfRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47c05e2d-fd5f-4df0-84eb-27268260385b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_7cc38fe8-a48d-4040-8e5c-f2b5ae5a830a_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_ecd8d9b7-234e-46aa-b119-975044756dd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Medium-Term Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_8127e60d-941b-4b14-a69d-909a037c7351_negatedTerseLabel_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest from financing and notes receivable</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_label_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_documentation_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:href="hr-20240630.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:to="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AmortizationofPrepaidRent_14274892-81d9-4302-91e3-71d6624d93d8_terseLabel_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of prepaid rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_label_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_documentation_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent" xlink:href="hr-20240630.xsd#hr_AmortizationofPrepaidRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AmortizationofPrepaidRent" xlink:to="lab_hr_AmortizationofPrepaidRent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f3db6892-cc12-4713-a20c-696ea46b46d3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4d03ee41-7c47-4202-841b-98f2c5e40dd8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options under the Employee Stock Option Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_673109ad-6499-4f23-8be9-00d477f76bb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_ed52f2ef-0d1d-4fd9-8cde-0a79b702a180_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_299f1847-40d2-400b-8d43-f74c0f94e4e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_98b01f0c-d463-4de9-8a01-e03948ef2a47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_cf1c6796-b42d-4cd5-b08c-a71517dfeb46_negatedLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_38bdda54-7cea-4264-b76d-2f5422095a00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investment Property, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c796fde8-b3b1-4302-aae6-a5abe3db32d6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepaidPrincipal_d13a1505-f90f-404d-a01c-137010c41f1a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepaidPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repaid amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepaidPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepaidPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Repaid, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepaidPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="lab_us-gaap_DebtInstrumentRepaidPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b0050ea3-1f90-441b-a510-231a130128f0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightlineRentLiability_9e4c1c08-d268-42fc-8aae-6de51079ad88_terseLabel_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of straight-line rent on operating leases (lessee)</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_label_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Straight-line Rent Liability</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_documentation_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Straight-line rent liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability" xlink:href="hr-20240630.xsd#hr_StraightlineRentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightlineRentLiability" xlink:to="lab_hr_StraightlineRentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9693d684-a61d-453e-be1c-61d39ad2be1b_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightLineRentReceivable_17c1b8b9-f72e-4904-aa98-a6f39a29cb4e_negatedLabel_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amortization of straight-line rent receivable (lessor)</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_label_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Straight-line Rent Receivable</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_documentation_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Straight-line rent receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable" xlink:href="hr-20240630.xsd#hr_StraightLineRentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightLineRentReceivable" xlink:to="lab_hr_StraightLineRentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_85139083-01c1-4ae2-bdc4-a4fae004e8b1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_993c3b0d-8641-4ea6-adba-4fa096d0b904_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_da3994fe-3d6a-4abb-a9bc-21c92651e1bf_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReportingUnitCarryingValue_480c9dc3-9b83-4e8e-84e9-92e1ed347e5c_terseLabel_en-US" xlink:label="lab_hr_ReportingUnitCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting unit, carrying value</link:label>
    <link:label id="lab_hr_ReportingUnitCarryingValue_label_en-US" xlink:label="lab_hr_ReportingUnitCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Carrying Value</link:label>
    <link:label id="lab_hr_ReportingUnitCarryingValue_documentation_en-US" xlink:label="lab_hr_ReportingUnitCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reporting Unit, Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReportingUnitCarryingValue" xlink:href="hr-20240630.xsd#hr_ReportingUnitCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReportingUnitCarryingValue" xlink:to="lab_hr_ReportingUnitCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_e5f208c8-c044-42ae-925d-902ad4e6adb1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_2272d1e8-c33f-4843-8a71-86bad1ecbf2e_terseLabel_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_label_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Entities Not Determined to be VIEs [Member]</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_documentation_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:href="hr-20240630.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:to="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_ffc98883-bee4-4081-ae2a-a93e155defe3_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_54f9d91a-9744-4fe3-b1c2-886edda4b000_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of the activity under the incentive plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_56ca9fdc-acfe-49cd-9494-325e594757b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments of notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_4fd549f6-466f-47c1-b924-e7a9f9efba46_terseLabel_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_label_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Partnership Performance Units [Member]</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_documentation_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:to="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3661a163-0c3e-460b-8ff1-4f7de5dc3974_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_a6e4da81-78f8-4a12-96d1-24f5c9bc7ca8_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e27b8c0f-571c-41d7-8308-323dc10a56f6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_057e4f86-28e2-4a59-9d32-e174dda602c8_terseLabel_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of dispositions</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_label_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Dispositions [Table Text Block]</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_documentation_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock" xlink:href="hr-20240630.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetDispositionsTableTextBlock" xlink:to="lab_hr_AssetDispositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_2ebd676a-5aa9-4987-94d6-d861894484e5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_4f204b57-edb6-45ba-ab7e-079d00d54a41_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HoustonTexasMember_1a722f18-ed61-4c7a-bfa3-5060e189ba8d_terseLabel_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Houston, TX</link:label>
    <link:label id="lab_hr_HoustonTexasMember_label_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:label id="lab_hr_HoustonTexasMember_documentation_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember" xlink:href="hr-20240630.xsd#hr_HoustonTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HoustonTexasMember" xlink:to="lab_hr_HoustonTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6de5ad0d-efe0-45fb-ad59-5bd78e576a88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_df9dc5e2-549d-4a5b-9fa4-63f6e1c8f7e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_31a9344b-dd25-4aed-924b-8c49e5917d63_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_594f2171-b1f2-4ef9-99a3-6e2452759189_negatedLabel_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_label_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Real Estate and Credit Loss Reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_documentation_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment of Real Estate and Credit Loss Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:to="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_21ab50fd-dba7-4eea-a491-49e5675b7f42_terseLabel_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_label_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HealthCare Realty Trust Incorporated [Member]</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_documentation_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:href="hr-20240630.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:to="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_9af9aa20-570c-4a8e-94bd-1e5b8e4d19c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c6b4ac86-7e5e-4e23-a0e6-fb6dad272800_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_c2767c3a-cac5-4e00-8b3e-c22091fd0c65_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d23e6074-f63c-471b-b7cb-7a781cbd59d5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_f8cf1801-251c-4eaf-b2b3-06f564d4a58b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6e38ac88-e643-422a-9723-4ec994e9ffce_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_81a71db3-40d7-4983-97e7-cb15418dc426_terseLabel_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoandue2026Member_aa9aa345-713a-4310-b2c2-ee785ba2af9f_terseLabel_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$150 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_label_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_documentation_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member" xlink:href="hr-20240630.xsd#hr_TermLoandue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoandue2026Member" xlink:to="lab_hr_TermLoandue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeDividendsMember_4e3d1f52-ee08-4249-ac5f-654431d96a70_terseLabel_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_label_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Dividends [Member]</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_documentation_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative Dividends [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember" xlink:href="hr-20240630.xsd#hr_CumulativeDividendsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeDividendsMember" xlink:to="lab_hr_CumulativeDividendsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9b86e051-9938-4913-9192-c0074685aac7_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SanAngeloTXMember_048a81ce-3c8d-4caa-846a-0f1d81c68883_terseLabel_en-US" xlink:label="lab_hr_SanAngeloTXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">San Angelo, TX</link:label>
    <link:label id="lab_hr_SanAngeloTXMember_label_en-US" xlink:label="lab_hr_SanAngeloTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">San Angelo, TX [Member]</link:label>
    <link:label id="lab_hr_SanAngeloTXMember_documentation_en-US" xlink:label="lab_hr_SanAngeloTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">San Angelo, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SanAngeloTXMember" xlink:href="hr-20240630.xsd#hr_SanAngeloTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SanAngeloTXMember" xlink:to="lab_hr_SanAngeloTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f656290c-5084-42cc-85c2-28316fb49968_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">(Gain)/loss recognized in AOCI on derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_09d55e62-899a-4013-8dd7-44e8522fa9c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetLossAttributableToCommonStockholders_c61c7295-06b8-43b3-b6cc-1052e1855c42_negatedTerseLabel_en-US" xlink:label="lab_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cumulative net loss</link:label>
    <link:label id="lab_hr_CumulativeNetLossAttributableToCommonStockholders_label_en-US" xlink:label="lab_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Net loss Attributable to Common Stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetLossAttributableToCommonStockholders_documentation_en-US" xlink:label="lab_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative Net loss Attributable to Common Stockholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:href="hr-20240630.xsd#hr_CumulativeNetLossAttributableToCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:to="lab_hr_CumulativeNetLossAttributableToCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_afa26fa0-aa79-41c0-9c07-10b838908478_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9c72aaf4-af5c-4567-b163-7b1f68f9c02a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_f8d92cea-e0e3-403f-a9db-1ddf4a0d9641_terseLabel_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$350 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_label_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due July 2024 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_documentation_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due July 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member" xlink:href="hr-20240630.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDueJuly2024Member" xlink:to="lab_hr_TermLoanDueJuly2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_1fb32269-792d-4a86-b52c-f9c6c041b9b0_terseLabel_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Los Angeles, California</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_label_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_documentation_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember" xlink:href="hr-20240630.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LosAngelesCaliforniaMember" xlink:to="lab_hr_LosAngelesCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8e8e3236-be6e-406a-a0b8-0ead387e94c8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9450e375-83ed-402e-baec-f6b5a65d9abd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_798fe749-7f9d-4947-ac83-09ba28e7115f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MinneapolisMNMember_44d1fe86-e4bb-4e87-91cb-db886dcf23aa_terseLabel_en-US" xlink:label="lab_hr_MinneapolisMNMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minneapolis, MN</link:label>
    <link:label id="lab_hr_MinneapolisMNMember_label_en-US" xlink:label="lab_hr_MinneapolisMNMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minneapolis, MN [Member]</link:label>
    <link:label id="lab_hr_MinneapolisMNMember_documentation_en-US" xlink:label="lab_hr_MinneapolisMNMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minneapolis, MN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MinneapolisMNMember" xlink:href="hr-20240630.xsd#hr_MinneapolisMNMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MinneapolisMNMember" xlink:to="lab_hr_MinneapolisMNMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_2bd9137e-aec7-4149-ab7b-e0fb193bbfb6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_d21e1848-fc2b-4567-9019-f7156363b6b9_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgage note receivables taken in connection with sale of real estate</link:label>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_label_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage Loan Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:to="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_7e7654ae-9144-455b-ac83-429c30c50c36_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_472995bb-0328-4608-8e42-0a361f42d7eb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b4ae6a31-9dd5-4b4b-aa7f-8517d20beb9d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Partners' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_c9c11ab9-d112-4996-a28c-101b16152d28_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total real estate properties, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_72eacb42-134e-49e1-8ef1-f169f6ff8717_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total real estate properties, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_1b0dbd49-dda3-4994-8f88-483e2c09f219_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real estate assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investment Property, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_abfda49b-65b1-4201-bc05-2d11f22bf82d_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_1bb016b3-f970-410c-80e7-3694d04e572e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5c878fcc-379e-471d-b36b-d87236254d2b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_9a563447-17af-4e21-b8d9-9eb85e7b3e9c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_38fca98e-f95f-4071-9bb0-39afa1c74fe1_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sales of real estate properties and other assets</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_f17119fa-219a-40b3-8ba4-944e7497df10_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on sales of real estate properties and other assets</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:to="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_61e1ab7e-bf4f-4afe-b44b-38b95799d031_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MAXIMUM LOAN COMMITMENT</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_label_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_documentation_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:href="hr-20240630.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:to="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MezzanineLoanMember_cd7cef4c-73bb-4ec7-96d4-91139bdc6cc0_terseLabel_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mezzanine loans</link:label>
    <link:label id="lab_hr_MezzanineLoanMember_label_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mezzanine Loan [Member]</link:label>
    <link:label id="lab_hr_MezzanineLoanMember_documentation_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mezzanine Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember" xlink:href="hr-20240630.xsd#hr_MezzanineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MezzanineLoanMember" xlink:to="lab_hr_MezzanineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_d4cadf12-a162-4e17-9259-94c445758a0a_terseLabel_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New investments during the period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_label_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_documentation_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:href="hr-20240630.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:to="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b2522e0d-3b94-4a7e-b6cf-defe4ffc4d72_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_602caea2-c39c-4b45-b4bd-5f65d08ddabc_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_3644d2d2-5aab-49f6-a19e-86adfea23e78_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_232f5aab-cef3-4054-828c-82c4da087810_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_9b89f394-7806-443c-9e5c-a7c0a81c6e8f_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes receivable, carrying amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_label_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_documentation_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount" xlink:href="hr-20240630.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableCarryingAmount" xlink:to="lab_hr_NotesReceivableCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_5d333d79-017b-4157-bec9-1b7e2bd4cd26_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_cadd4985-fdca-44ff-a93b-fcc71277aa2c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">REAL ESTATE NOTES RECEIVABLE, GROSS</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_8b7a012e-c136-473d-910f-f3e0a1992b61_terseLabel_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active Development Properties</link:label>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Active Development Properties [Member]</link:label>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Active Development Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember" xlink:href="hr-20240630.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ActiveDevelopmentPropertiesMember" xlink:to="lab_hr_ActiveDevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1b618672-c138-463f-8347-6135d7713b12_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_8cea05a5-ddfc-4a39-a37f-30965b757c3d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9d4d1a43-ccb3-4887-836d-617484917fc3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7ba3bbf8-c5a3-48f1-b1c3-8684fcd89cef_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_3f5ab459-84d1-4434-b6a8-1e518b9e3e16_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_044c2c38-6364-456f-9182-e9214192e32e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_be419ded-84cf-441a-9043-b8a3a03a7e9b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares acquired, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_ca33f768-c9e6-4b16-a5ad-ba2cadbd9b06_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d6979cea-3c15-4b4e-90ae-e8cdea867665_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-vested shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_714a3cd4-36cd-4a8f-a6ec-bb8e31298570_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d8fac970-1c12-41a2-a16e-df09947ba849_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Investments in unconsolidated joint ventures, beginning of period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a3e08bf9-2af0-4bfb-8f25-3415af6c3aa1_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Investments in unconsolidated joint ventures, end of period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_80df1dd0-aa51-4f42-b033-4c41803b336d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_ac0afa6c-11da-4d2c-9bf6-1bd608ebb939_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real estate notes receivable</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_acbd380e-c34c-4664-bbd4-78d5c0739e9d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested/Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_13907e1a-9ea4-41c2-a3a0-a20bb19d5702_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Condensed Balance Sheet</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_d7019e5d-6ef6-44ef-acc6-242419ca1210_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_46c50c0c-c8fd-409c-ad08-b3484a3c4aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d58123f9-60ab-4bf2-805c-67ebdca7bd4c_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_f704476e-94f7-4776-b72a-74df67b31bfd_terseLabel_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Healthcare Trust of America Holdings L P</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_label_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Healthcare Trustof America Holdings L P [Member]</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_documentation_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Healthcare Trustof America Holdings L P</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:href="hr-20240630.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:to="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65ac950e-0101-4fc8-9d4a-e7e6d64d2e35_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1ccf09ac-dcb7-4a55-8f9a-b4563c21b559_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_84699da0-28b2-49f4-9549-9d3b08890d1e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_a38c81dd-563d-4711-9da8-cad4437218f1_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2027Member_0242020f-dab5-4937-9f21-f0ed928a5b6f_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$200 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_label_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due 2027 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member" xlink:href="hr-20240630.xsd#hr_TermLoanDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2027Member" xlink:to="lab_hr_TermLoanDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_a2543c28-32f7-47c1-87d2-09fc5db60577_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_7d845467-0352-4935-82c2-cf4d8b034270_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of real estate notes receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateNotesReceivable" xlink:to="lab_hr_NumberOfRealEstateNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_c3f4a250-105c-4fc8-b029-5128caf2992e_verboseLabel_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property operating</link:label>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_label_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Direct Costs of Leased and Rented Property or Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:to="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2b6edaf5-3814-42cf-9abb-d791cd3f956b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_95e63c7b-3b65-4cc6-8408-2a6a82a7bb62_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1833c04b-03cc-453a-8875-9b4061c9c1d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_9ce4d736-2b40-417b-bfb4-d7dac453f916_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_cee0640f-3732-4a66-8b1b-62d0ef1fa16e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_6ff78798-8a97-44b5-9abd-c90f7cb50ef9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_02314880-ced5-4b4c-84a4-7dd7ff1c9bf8_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3f8d8c8-92cc-4c07-8aac-83cda5772bcd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_b5f2f5de-24cf-4b9a-a2a9-51d8f7696e5b_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_99dc2a16-e1e9-4548-a428-f39657e56e36_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_5a035c53-0198-440e-bd12-5b163e49f9b1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_2ab19a27-010b-4e48-a359-0973c9a87855_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of OP Units to common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_b9864447-2fff-4a07-9711-e0e62bf5449a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ced9dc81-bb9a-430a-a745-8b191456f1bc_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a5a3f91a-a558-41bb-a51f-3ade18b9f51e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_ce670d37-6f9e-468c-8de8-21efa475d170_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Compensation Cost, Nonvested Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_de9aa810-cb60-4093-bf1d-0208a5f91e6b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_33272a77-86fd-4717-9aea-57477fd036b9_terseLabel_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of OP Units (in shares)</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_label_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of OP Units</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_documentation_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of OP Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:href="hr-20240630.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:to="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c510004e-365d-498d-999d-a6bd4d3b2903_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_2ee7894e-5d0e-4a62-a7c8-7ef33813753a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oil and Gas, Full Cost Method, Capitalized Cost Excluded from Amortization, Acquisition Cost, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4c3fbf99-4484-47d8-b3e4-77af936b9620_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_23d6a24c-8bf3-49c8-ba0e-2515c4ea038b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ec966a78-f54f-429b-92f3-3fde3e6dbc04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_80f25369-c670-4514-8078-1b9a376a6bd8_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPERATING</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_7fccd2a4-a8d2-41fa-88e1-525907affc82_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_3183eda8-ab0f-4934-9e60-0c7549aacdd0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_6c29bcc3-e00d-4efd-bd54-ecf465645f18_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_dee2031c-c634-47fa-90ae-5e36404edbf8_negatedLabel_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">CLOSING ADJUSTMENTS</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_label_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Closing Adjustments Disposed Entity</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_documentation_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:href="hr-20240630.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:to="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f9bb9df-9cbc-4c94-898a-edb2985bd762_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_56e4d5cd-e040-40d2-9c33-c2bf1a7bb263_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b04978b9-cc2c-4fa4-9627-904ba339da4e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5c6502b1-5487-4bd2-afbf-0fdc6fb3fc9b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per common share- net loss (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_329531e2-355f-4038-8d2c-07170dd50a6c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonVestedStockAwardMember_803a50a4-1fdf-4d8e-8f85-db478e096dbf_terseLabel_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-vested Stock Award</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_label_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Vested Stock Award [Member]</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_documentation_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Vested Stock Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember" xlink:href="hr-20240630.xsd#hr_NonVestedStockAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonVestedStockAwardMember" xlink:to="lab_hr_NonVestedStockAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2cc30dfe-5b25-45c8-996d-6d51b0be42fb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_793888d5-f840-4c7a-88fe-7600d0f31081_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contracts with Customers (ASC Topic 606)</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_eacaf566-2ad2-47c1-a01c-c0f6afb09d95_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeMember_61bb3159-780b-43aa-ac8c-c9170a73450c_terseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Net Income</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Net Income [Member]</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative Net Income [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeMember" xlink:to="lab_hr_CumulativeNetIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2025Member_f2a3740e-5a5e-432a-a96f-60d5de98fea9_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$300 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_label_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due 2025 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member" xlink:href="hr-20240630.xsd#hr_TermLoanDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2025Member" xlink:to="lab_hr_TermLoanDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_ca040e42-e45e-4dcf-9dd5-dc308480e1d5_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OtherPropertyMember_95e1c672-d767-4b9c-a272-6ee5cbc3839b_terseLabel_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Parking Garages</link:label>
    <link:label id="lab_srt_OtherPropertyMember_label_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OtherPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OtherPropertyMember" xlink:to="lab_srt_OtherPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_61ffd6b7-12a2-4349-8fd3-d03014d47693_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_e30c839c-7f4e-4e97-951d-3156bd9b6db8_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_393475af-8a21-46cd-b4f6-ecda72b05953_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_91971b8e-b6ee-4bbc-a249-19bb6b4f2631_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_10b0610b-ad33-4324-b43b-b6da74a176f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DirectorsMember_f7e9c31d-cb1b-44de-8101-0e1794026251_terseLabel_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_hr_DirectorsMember_label_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Directors [Member]</link:label>
    <link:label id="lab_hr_DirectorsMember_documentation_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember" xlink:href="hr-20240630.xsd#hr_DirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DirectorsMember" xlink:to="lab_hr_DirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_dda1f8a1-2c63-4a61-b708-fc655c06b530_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c8e3ddca-5d23-4afb-ab1b-33a67628728c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e88a458d-ee2e-4d4a-bfe6-a4b99e3c714c_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b31666e1-c84d-42fe-b8c9-d1194d5a791c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5c0a214a-4311-49e6-bd69-1c98be9765cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIncentivePlanMember_5e8bd7fe-d7eb-4407-b458-9c617321aff3_terseLabel_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock incentive plan</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_label_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_documentation_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember" xlink:href="hr-20240630.xsd#hr_StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIncentivePlanMember" xlink:to="lab_hr_StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LeaseIntangibles_85b78ccc-d2b3-4abf-804f-df2e8d63ff34_terseLabel_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_label_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_documentation_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles" xlink:href="hr-20240630.xsd#hr_LeaseIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LeaseIntangibles" xlink:to="lab_hr_LeaseIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1e7bef8b-01e1-4fed-9786-0a76ea40911c_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_967d1120-c69b-4250-9d70-bc83ebda1951_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AMOUNT</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_63c402a2-3dc3-4a31-9a10-a296ea99afe2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_11110e63-58a4-4eda-83a4-ae9b150fe743_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb0023ef-7452-4f21-977e-b055f9ebe9cd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other operating</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_156d6e29-8fb4-4fb2-ab09-846311128188_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PerformanceConditionsMember_7de62626-58e7-4298-a91f-cda69d99e10a_terseLabel_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance conditions</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_label_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Conditions [Member]</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_documentation_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember" xlink:href="hr-20240630.xsd#hr_PerformanceConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PerformanceConditionsMember" xlink:to="lab_hr_PerformanceConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_090e98a8-4fb5-4ac3-9716-d8de383e4523_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031Member_d84c25af-2ea2-4574-b17e-b97ea1522d53_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031Member" xlink:to="lab_hr_SeniorNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_593f2972-8e9c-45d9-b6c0-7f76e1af14c2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivable, nonaccrual</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Nonaccrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_74193fbd-ad64-4b24-b47d-950cf8961548_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AlbanyNYMember_07a92165-1e8b-4121-8ddb-fcf6ae286ce9_terseLabel_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Albany, NY</link:label>
    <link:label id="lab_hr_AlbanyNYMember_label_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Albany, NY [Member]</link:label>
    <link:label id="lab_hr_AlbanyNYMember_documentation_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Albany, NY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember" xlink:href="hr-20240630.xsd#hr_AlbanyNYMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AlbanyNYMember" xlink:to="lab_hr_AlbanyNYMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6d6041ab-0af9-4210-9578-5ae63dcf62e5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HoustonTXMember_2fcab868-45c6-4ba0-9b4d-d72e6e831adc_verboseLabel_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Houston, TX</link:label>
    <link:label id="lab_hr_HoustonTXMember_label_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Houston, TX [Member]</link:label>
    <link:label id="lab_hr_HoustonTXMember_documentation_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Houston, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember" xlink:href="hr-20240630.xsd#hr_HoustonTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HoustonTXMember" xlink:to="lab_hr_HoustonTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_a07cb45f-36f9-4de7-b376-4de0189d127b_terseLabel_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_label_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_documentation_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:to="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fb96c807-0e40-4091-84fe-a4731be3a921_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2026Member_330f9c7b-2ce6-4bde-b098-2e8f8246fd3d_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2026</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2026 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2026Member" xlink:to="lab_hr_SeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_f419e3f6-bacd-4d9c-99a2-c24948db73da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_a0367306-79c8-48cf-bded-7510259355b9_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Non-Controlling Interests:</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e0ebb68a-0e25-419b-973e-1004bc760fd8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_42e119d4-1032-4b65-b059-7af35c1bdca5_terseLabel_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extension period for maturity date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_label_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_documentation_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:href="hr-20240630.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:to="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53b66ba-62b1-4322-96ee-5395ae7c9724_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_75032213-c10c-432d-890a-ec13112c5de5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_2dd815b1-3dec-425b-b3c3-df02da9164af_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b2f86fc6-f007-41c3-b159-37c3edd9f09e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c9bd477d-65d2-4182-9599-a4cb2fd28150_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_1187b9f4-1f0c-4048-871c-5d6e3fca7e2a_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f81389d-6b9e-437e-9807-34e20f4e37d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_0ee4eddf-a0dc-40ad-a4f3-179ea766cc3c_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDueMay2025Member_5d8ad313-fc6c-4070-8c1a-e81aa2f709a1_terseLabel_en-US" xlink:label="lab_hr_TermLoanDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$200 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDueMay2025Member_label_en-US" xlink:label="lab_hr_TermLoanDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due May 2025 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDueMay2025Member_documentation_en-US" xlink:label="lab_hr_TermLoanDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2025Member" xlink:href="hr-20240630.xsd#hr_TermLoanDueMay2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDueMay2025Member" xlink:to="lab_hr_TermLoanDueMay2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GreensboroNCMember_364650ae-b501-459f-9b1f-dc5c95610fa3_terseLabel_en-US" xlink:label="lab_hr_GreensboroNCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Greensboro, NC</link:label>
    <link:label id="lab_hr_GreensboroNCMember_label_en-US" xlink:label="lab_hr_GreensboroNCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Greensboro, NC [Member]</link:label>
    <link:label id="lab_hr_GreensboroNCMember_documentation_en-US" xlink:label="lab_hr_GreensboroNCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Greensboro, NC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroNCMember" xlink:href="hr-20240630.xsd#hr_GreensboroNCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GreensboroNCMember" xlink:to="lab_hr_GreensboroNCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_089adc95-ad18-42cd-ac8c-e597baa7a16e_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_432722c1-7f29-429d-9c6e-f41898f8a4e7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_label_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Building and Building Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:to="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_b0b3e1cb-753a-4c2d-b9d4-1e87f3fc35a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long Lived Assets Held-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Held-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:to="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_860abe5f-f467-4a3d-a979-679d250be8d7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2025Member_94cec5f2-ff51-4201-a3da-6b7b5a41a1e2_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2025</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2025Member" xlink:to="lab_hr_SeniorNotesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_d445e705-af0a-4984-bddd-7e36c3cca585_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_4698973c-9967-4aa3-a6a1-075ec2b8aa84_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Development of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Develop Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:to="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93179b0d-743b-4705-9c33-82720c04ffaa_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_4580c540-c9f4-4e19-9ca1-d3a0dd4bb7bd_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanMember_639db8f7-82fd-442f-89a6-a929b40bc42c_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_hr_MortgageLoanMember_label_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage Loan [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember" xlink:href="hr-20240630.xsd#hr_MortgageLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanMember" xlink:to="lab_hr_MortgageLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_422c1152-55e7-4d5c-a057-68673a43a564_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2030Member_708bba8f-0950-4bee-b1b0-2b4976de0cbb_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2030Member" xlink:to="lab_hr_SeniorNotesdue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_93a2c76b-13ab-42bd-902a-283d07ec795b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CARRYING VALUE</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a945dc0a-7980-41c6-9070-5ae1115f4e7d_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a8e753a-4a2e-466a-bb67-8d02512d9de8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_03c75da2-2bd0-47d2-be33-2440d5768feb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a69e1f0e-fba4-4da9-acf7-a009fe9a63b2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cfb03b2c-9e98-4d92-8028-b54cfd1a3437_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c6175dbb-1f12-41f2-8954-29a71111bd13_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c8443f03-9b1a-4534-9bb8-9cf8c3efe5a1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2027Member_794bcce0-d7c3-4e9b-8859-a3e22506b157_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2027</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2027 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2027Member" xlink:to="lab_hr_SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2ddcba85-80b5-4d1e-b813-7af6b4b56af0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_1b8a8d0a-eb44-4d20-848f-9d4b23dfbdfa_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_62fae90e-1ef0-402e-ac53-a952c9218169_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MarketCondition2Member_1e7fc73b-0e02-47fd-898f-baf6392bd9d0_terseLabel_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Relative TSR Component</link:label>
    <link:label id="lab_hr_MarketCondition2Member_label_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition 2 [Member]</link:label>
    <link:label id="lab_hr_MarketCondition2Member_documentation_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member" xlink:href="hr-20240630.xsd#hr_MarketCondition2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MarketCondition2Member" xlink:to="lab_hr_MarketCondition2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_5a6fed5e-108c-4d8c-bc9b-7775340911ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44649c31-059a-45ed-9a24-5de4704fd82a_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ca21c904-8b23-4b2f-a415-06eacc8df70a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_f75e66ff-f698-448d-8f94-7c1ef3c586ee_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_c746a914-1032-42e9-8cc9-013bed05b415_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_f4983b5f-697b-474c-93cd-d732e580f566_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4b995169-c889-4509-99b3-30ac24ae02d3_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d8bfb3b8-54d1-4f0c-9f2e-f7c474adb274_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_dcf6f68c-9483-4740-88fb-67948182272e_verboseLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_65d14d3e-0731-4230-a36f-eb626f9a3b6e_totalLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_label_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Held-for-sale and Discontinued Operations Net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_documentation_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets held for sale and discontinued operations, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:to="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_be835663-ac59-40d4-a540-b8aa02528310_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_79658028-e076-4bfa-86f0-f74a2f81d221_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5587e7f7-7acc-4855-bd89-ee541e654aab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4dd856a2-823e-453c-97c0-dc0573e4354d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_23f20063-d5ff-4bc9-895d-e8a1a849715a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_d0ae2ff7-9665-492f-916a-d3d8d04bdff1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of the Activity Under the Incentive Plan and RSU Activity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8a0864f1-a6dc-4dcf-a81a-9d66181e4dd1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNetBookValue_14246133-e63c-4f90-a227-7f9617364c0a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivable, carrying value</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNetBookValue_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Leaseback Transaction, Net Book Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:to="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PersonalProperty_c3498270-d062-4fde-b7b7-9f999f92574a_terseLabel_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personal property</link:label>
    <link:label id="lab_hr_PersonalProperty_label_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Personal Property</link:label>
    <link:label id="lab_hr_PersonalProperty_documentation_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Personal property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty" xlink:href="hr-20240630.xsd#hr_PersonalProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PersonalProperty" xlink:to="lab_hr_PersonalProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_07d789cd-abe7-4001-bf3b-63e92e3097e4_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_7c871a62-c44a-4909-a4d2-c6ff011a8211_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems" xlink:to="lab_us-gaap_RealEstatePropertiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8065bc1f-a589-4e72-8fa7-66992676ee49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5f7c7eeb-83a7-4e06-9ebb-29ed13b4122a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_57b7fddd-e8a0-408a-b4f2-6fedda4f7abf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_5cff9381-9d3d-4847-a0d4-8b505c2ed549_terseLabel_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross investment amount, total</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_label_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment in Real Estate Properties and Mortgage Notes</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_documentation_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment in real estate properties and mortgage notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:href="hr-20240630.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:to="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_baa73343-cd61-4011-ae0f-51e8cb2fc4bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramAxis_7607e042-9df4-41d3-afaa-1bf49f20619f_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_label_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramAxis" xlink:to="lab_hr_StockIssuanceProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_83c058fa-20de-45ce-a69e-354b94b98b7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gains arising during the period on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_c21397fc-187e-4f07-9d1b-2b115c80fe92_totalLabel_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_label_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_documentation_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:href="hr-20240630.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:to="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_04017773-1d6c-42e0-9045-dab61af875ef_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Financing Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_967421cb-723a-411d-a69f-c25e7715ad34_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Properties measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Held-for-Sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:to="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_7d9348d8-ada1-419c-822b-2c2596e195f7_terseLabel_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity ownership for consolidation (percent)</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_label_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_documentation_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent" xlink:href="hr-20240630.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityOwnershipForConsolidationPercent" xlink:to="lab_hr_EquityOwnershipForConsolidationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d2519dea-a335-441e-9967-faabf9fe1636_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_83e57e06-2776-445b-8e0b-c0b673122420_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_3367f3af-b08a-4e0c-9162-7d8879f88f45_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_eac5bcc2-c1e7-472d-bdb0-dbb6bd001e94_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLineItems_732ce813-2907-4302-b3a1-5ea35b815cf2_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstateLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLineItems" xlink:to="lab_us-gaap_RealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9414f219-7747-42c0-bd06-4b2a3b02fe18_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AZ_f270d45d-e58a-4df1-89a8-182837eafeab_terseLabel_en-US" xlink:label="lab_stpr_AZ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arizona</link:label>
    <link:label id="lab_stpr_AZ_label_en-US" xlink:label="lab_stpr_AZ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARIZONA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_AZ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AZ" xlink:to="lab_stpr_AZ" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9baf6798-269d-4388-b283-ad6bc1cac1bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_50f13111-a03d-45e9-8918-405c0e8a19ab_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment in financing receivable, net</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fffc321b-aee3-433e-a59e-9e34c0fe4351_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_36d55c4b-33c8-4814-a97f-fcb1cb6996eb_terseLabel_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_label_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Properties Held in Joint Ventures [Member]</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_documentation_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:href="hr-20240630.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:to="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessOverviewAbstract_f36f1920-6a42-4fc0-81a2-4b5ff56f16b2_terseLabel_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Overview:</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_label_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_documentation_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract" xlink:href="hr-20240630.xsd#hr_BusinessOverviewAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessOverviewAbstract" xlink:to="lab_hr_BusinessOverviewAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_70dd8032-885d-49b9-85d8-4c6cc4f93d63_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b99b9f23-200a-464f-95f8-1c3210c26833_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_3bb1406c-e485-4534-b014-cc9333fd1ffc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_be566e93-bac1-4968-bf61-7769ed5498f0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity loss recognized during the period</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableAndOtherAssets_13d87338-f114-4e3c-ba55-6655936d6a70_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INTEREST RECEIVABLE (OTHER ASSETS)</link:label>
    <link:label id="lab_us-gaap_InterestReceivableAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_InterestReceivableAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Receivable and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableAndOtherAssets" xlink:to="lab_us-gaap_InterestReceivableAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DispositionSalesPrice_6bf0f5f0-0b39-48a8-aeee-178d650cff2f_terseLabel_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SALE PRICE</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_label_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_documentation_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice" xlink:href="hr-20240630.xsd#hr_DispositionSalesPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DispositionSalesPrice" xlink:to="lab_hr_DispositionSalesPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7e4af131-2bd1-4402-a1f7-a679bd89c37d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_c2b268ca-a075-4c9e-ad9d-0a4750079261_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GreensboroRaleighNCMember_8c85527e-f936-4199-addc-f6e1c38d4323_terseLabel_en-US" xlink:label="lab_hr_GreensboroRaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Greensboro/Raleigh, NC</link:label>
    <link:label id="lab_hr_GreensboroRaleighNCMember_label_en-US" xlink:label="lab_hr_GreensboroRaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Greensboro/Raleigh, NC [Member]</link:label>
    <link:label id="lab_hr_GreensboroRaleighNCMember_documentation_en-US" xlink:label="lab_hr_GreensboroRaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Greensboro/Raleigh, NC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroRaleighNCMember" xlink:href="hr-20240630.xsd#hr_GreensboroRaleighNCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GreensboroRaleighNCMember" xlink:to="lab_hr_GreensboroRaleighNCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_d74bf77b-f5f1-4f34-8d06-4220ea36646a_terseLabel_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Completed Develpoment and Redevelopment Properties</link:label>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Completed Develpoment and Redevelopment Properties [Member]</link:label>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Completed Develpoment and Redevelopment Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:href="hr-20240630.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:to="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_1a05ecf4-c088-4855-823b-723e5dd8b5e6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_b4bcfef6-558d-41d2-8532-b4d749b09037_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_Florida1Member_c9eb1831-3ded-4269-9023-55749b829705_terseLabel_en-US" xlink:label="lab_hr_Florida1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Florida 1</link:label>
    <link:label id="lab_hr_Florida1Member_label_en-US" xlink:label="lab_hr_Florida1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Florida 1 [Member]</link:label>
    <link:label id="lab_hr_Florida1Member_documentation_en-US" xlink:label="lab_hr_Florida1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Florida 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_Florida1Member" xlink:href="hr-20240630.xsd#hr_Florida1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_Florida1Member" xlink:to="lab_hr_Florida1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4c9a86da-16f9-40b3-9b2b-c08c12414828_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_ed7c62e6-f444-41a6-a4f9-96b9d0dd97cb_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from financing receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales-type Lease, Interest Income, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_d23a8979-f2a5-4373-a8f9-5169c9f801c8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net borrowings (repayments) on unsecured credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ManagementFeeIncomeMember_8e99b44f-4eac-4758-973a-f0dc9fc671e3_terseLabel_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management fee income/other</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_label_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_documentation_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember" xlink:href="hr-20240630.xsd#hr_ManagementFeeIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ManagementFeeIncomeMember" xlink:to="lab_hr_ManagementFeeIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OtherInvestorsMember_08e24239-b03b-458e-81c5-1c81b3c7641d_terseLabel_en-US" xlink:label="lab_hr_OtherInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Investors</link:label>
    <link:label id="lab_hr_OtherInvestorsMember_label_en-US" xlink:label="lab_hr_OtherInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Investors [Member]</link:label>
    <link:label id="lab_hr_OtherInvestorsMember_documentation_en-US" xlink:label="lab_hr_OtherInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Investors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherInvestorsMember" xlink:href="hr-20240630.xsd#hr_OtherInvestorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OtherInvestorsMember" xlink:to="lab_hr_OtherInvestorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesMember_815ec82d-9315-4417-aa11-749872a9c607_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgages</link:label>
    <link:label id="lab_us-gaap_MortgagesMember_label_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgages [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesMember" xlink:to="lab_us-gaap_MortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f9c455ae-c46d-430f-8d8d-5a5ddf78bbb4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_ca710eba-cd7d-46be-a13a-5062fe6fdff3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives in net liability position</link:label>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Net Liability Position, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:to="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_2e39cd86-3d6a-45fe-ab87-6e8809ccc470_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_d9c424fc-45aa-46ef-ab72-e3e96379319a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares Repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_f5e2b9be-d258-4880-9dd1-a1b8966c0a1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, shares, conversion of units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_9d732b12-3834-4c81-81ae-a87cffaaa07e_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:to="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8be9155e-8f17-40e7-81b1-d653545fe295_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other assets, including right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_634b0be7-4861-4447-bd46-e53880e48944_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_cdc052fc-b327-4c1d-9087-61303cef5160_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f61091ec-6337-4fa4-86ae-d0fdc47d4826_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_53bdcc04-6a73-41b7-9516-bbfe258e9f5c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ProceedsFromDispositionsHeldInEscrow_7c5bc190-44e0-4762-89c2-b636de7a94f1_terseLabel_en-US" xlink:label="lab_hr_ProceedsFromDispositionsHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from dispositions held in escrow</link:label>
    <link:label id="lab_hr_ProceedsFromDispositionsHeldInEscrow_label_en-US" xlink:label="lab_hr_ProceedsFromDispositionsHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Dispositions Held In Escrow</link:label>
    <link:label id="lab_hr_ProceedsFromDispositionsHeldInEscrow_documentation_en-US" xlink:label="lab_hr_ProceedsFromDispositionsHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Dispositions Held In Escrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromDispositionsHeldInEscrow" xlink:href="hr-20240630.xsd#hr_ProceedsFromDispositionsHeldInEscrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ProceedsFromDispositionsHeldInEscrow" xlink:to="lab_hr_ProceedsFromDispositionsHeldInEscrow" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfMortgageLoans_c8166eda-6101-4cf9-829a-3b999d773470_terseLabel_en-US" xlink:label="lab_hr_NumberOfMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of mortgage loans</link:label>
    <link:label id="lab_hr_NumberOfMortgageLoans_label_en-US" xlink:label="lab_hr_NumberOfMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Mortgage Loans</link:label>
    <link:label id="lab_hr_NumberOfMortgageLoans_documentation_en-US" xlink:label="lab_hr_NumberOfMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Mortgage Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMortgageLoans" xlink:href="hr-20240630.xsd#hr_NumberOfMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfMortgageLoans" xlink:to="lab_hr_NumberOfMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ea1fa19d-60c4-4928-aef0-3bc221ee0324_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a3d68652-ef94-42c3-8979-2bbbc252bdb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_06c16fc4-e683-4e5a-9348-084a51ae68f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertiesMeasuredAtFairValue_23276eda-6df7-4ee9-8d90-acf0c14b28fd_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of properties measured at fair value</link:label>
    <link:label id="lab_hr_NumberOfPropertiesMeasuredAtFairValue_label_en-US" xlink:label="lab_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Properties Measured at Fair Value</link:label>
    <link:label id="lab_hr_NumberOfPropertiesMeasuredAtFairValue_documentation_en-US" xlink:label="lab_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Properties Measured at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesMeasuredAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:to="lab_hr_NumberOfPropertiesMeasuredAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_a3ff0c06-16b8-435c-95dd-5a95ce7c1edc_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill Impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2f5e277e-cb34-4f75-986b-cf8c7652a164_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_b81c4753-c5a1-450e-8faa-bac2bce07755_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2400aad3-69a5-4e7e-8578-610c51515e46_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_2a1c90bf-a8a0-45e4-b857-59a989f8fc50_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1ec82f80-5dc7-4bb2-9607-3282da9ad0be_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MergerRelatedCosts_381f9248-a728-4d21-b6a4-62a61d942311_terseLabel_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Merger-related costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_label_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Merger Related Costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_documentation_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Merger Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts" xlink:href="hr-20240630.xsd#hr_MergerRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MergerRelatedCosts" xlink:to="lab_hr_MergerRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2028Member_1b6fe379-988f-4f24-b122-f0be40f99968_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$300 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_label_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan due 2028 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member" xlink:href="hr-20240630.xsd#hr_TermLoanDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2028Member" xlink:to="lab_hr_TermLoanDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_39d230a7-f730-4d42-b82e-be063f4d8475_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_180c4a64-f7e8-4acb-b58d-7160e9c03813_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Limited partner's capital, units outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_label_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limited Partners' Capital Account, Units Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:to="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_4dd7b8e1-b5c3-4f9b-bfaf-abe315b1787b_terseLabel_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction activity and development properties</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_label_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_documentation_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:href="hr-20240630.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:to="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1be8dc04-77f5-45a9-83fb-a48314447550_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_5a6a4aa2-c7fe-445e-be0e-3844d6e3b483_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableInterestRate_271a252f-8131-48c3-8408-4b26731fe0b6_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INTEREST RATE</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_label_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_documentation_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate" xlink:href="hr-20240630.xsd#hr_NotesReceivableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableInterestRate" xlink:to="lab_hr_NotesReceivableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_26fcce35-25d7-4c13-8730-683266ae7aa8_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_b1437706-b9f0-4515-a376-7f7dcc63b8e2_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6afa10dc-aa77-4652-8e22-79d09f530d2c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_67e9f4df-44f6-4c27-904c-35fb369ad302_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e263d024-a892-4f5b-9ce8-a39c2bc39308_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9eccce62-82ad-4358-9fc6-d3756328814d_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_37a6763c-7475-40d4-b2bb-aac74eee5b2c_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investment Property, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_bffdb224-20a6-4244-820d-68eccc2339c0_terseLabel_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_label_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_documentation_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward" xlink:href="hr-20240630.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityMethodInvestmentsRollForward" xlink:to="lab_hr_EquityMethodInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a72c04c9-fe1d-4945-b94e-4ab8a9d7547f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_8fd9a96f-4eba-49af-9c76-942a51099417_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_95c11a86-9f69-4af8-af4d-a4f323569ddd_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_95c55b89-3c7c-4a9b-98e7-ef7096205cfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4a933994-d4cb-4db6-8037-0d26546aa083_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfMezzanineLoans_f69e5fca-12e4-4cb5-9860-170800212179_terseLabel_en-US" xlink:label="lab_hr_NumberOfMezzanineLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of mezzanine loans</link:label>
    <link:label id="lab_hr_NumberOfMezzanineLoans_label_en-US" xlink:label="lab_hr_NumberOfMezzanineLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Mezzanine Loans</link:label>
    <link:label id="lab_hr_NumberOfMezzanineLoans_documentation_en-US" xlink:label="lab_hr_NumberOfMezzanineLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Mezzanine Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMezzanineLoans" xlink:href="hr-20240630.xsd#hr_NumberOfMezzanineLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfMezzanineLoans" xlink:to="lab_hr_NumberOfMezzanineLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PowayCAMember_31d40170-0332-4eb8-a31c-1d068a9a2347_terseLabel_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Poway, CA</link:label>
    <link:label id="lab_hr_PowayCAMember_label_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Poway, CA [Member]</link:label>
    <link:label id="lab_hr_PowayCAMember_documentation_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Poway, CA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember" xlink:href="hr-20240630.xsd#hr_PowayCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PowayCAMember" xlink:to="lab_hr_PowayCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_cbe6adbc-1e80-44ed-bdb4-8f613a097c76_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_b4c10e4f-1757-463a-91ff-7924b70f14be_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_6ba8b127-8653-4c67-9299-6bb385e4930d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_59937108-1f88-41ce-8743-926444783dd6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_60715edc-1302-4f5c-9206-6f03a7f8bad3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of real estate properties and additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale, Property, Held-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_34777c73-e5e2-479a-8ff8-5e02ff999f2b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_71b2c0d7-d2cd-4daa-86e6-11300f5f163e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossInterest_e53d213e-5fbb-49b2-b702-33ac4a54ba34_terseLabel_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit loss, interest</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossInterest_label_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Interest</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossInterest_documentation_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:to="lab_hr_FinancingReceivableAllowanceForCreditLossInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_8d824b23-71a6-4f14-bb21-df363afec179_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_df2f8814-c645-438b-ab7d-ec4b6909ba9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: comprehensive loss attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_36bef31d-b9cd-4645-af8d-e0266906ad54_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_15bd9ac0-6b01-4a0a-b982-9d59b4839d1f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_733e7983-764c-467d-9628-c0d9772c6d49_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of properties held in unconsolidated joint ventures</link:label>
    <link:label id="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_label_en-US" xlink:label="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Properties Held in Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Properties Held in Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:to="lab_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopmentInProcess_08d374b0-f59d-43a4-a225-05b0b18bd447_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopmentInProcess" xlink:to="lab_us-gaap_DevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_713acb13-f58c-40fc-b22b-62c880d8c2bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_150ccf17-3a61-4969-b923-0e8a7ae69c23_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ColumbusOHMember_3430f619-07c0-4f6d-9c82-20ace097bae3_terseLabel_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Columbus, OH</link:label>
    <link:label id="lab_hr_ColumbusOHMember_label_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Columbus, OH [Member]</link:label>
    <link:label id="lab_hr_ColumbusOHMember_documentation_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Columbus, OH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember" xlink:href="hr-20240630.xsd#hr_ColumbusOHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ColumbusOHMember" xlink:to="lab_hr_ColumbusOHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_9245c886-b62f-4e2e-a37f-73c7785f1b65_terseLabel_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Incentive Program</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_label_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_documentation_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember" xlink:href="hr-20240630.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ExecutiveIncentiveProgramMember" xlink:to="lab_hr_ExecutiveIncentiveProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_faf4ae21-3b70-4bce-9732-10c27cac8e6f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_GA_8a0aa264-86c9-4340-9079-799612f36bf8_verboseLabel_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Georgia</link:label>
    <link:label id="lab_stpr_GA_label_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GEORGIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_GA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_GA" xlink:to="lab_stpr_GA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_00364aa3-9f6e-43b6-89b9-c85f13263da8_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_77ac2fdd-15f9-4293-b36b-e2ff6adf2059_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of non-prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:to="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fdf8c6ca-bd4f-4bef-b78a-304159feb498_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available to be drawn debt amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_62c2a005-fe21-45c0-951b-2f498287f8e2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture_24226dd1-4daa-4271-9cfc-d2eed5e59f56_terseLabel_en-US" xlink:label="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution of real estate properties into unconsolidated joint venture</link:label>
    <link:label id="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture_label_en-US" xlink:label="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contribution of Real Estate Properties into Unconsolidated Joint Venture</link:label>
    <link:label id="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture_documentation_en-US" xlink:label="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contribution of Real Estate Properties into Unconsolidated Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:href="hr-20240630.xsd#hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:to="lab_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_570394e1-9153-44e7-b49e-f4ba4fe02d0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_d8efa3de-3d24-486d-9abd-2758547aa533_terseLabel_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows outflows related to financing leases</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_label_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_documentation_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:href="hr-20240630.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:to="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_970f82a5-ab2a-4a07-87ce-c090739102be_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ParkingIncomeMember_90861143-1f44-43d3-8e9b-2503df1a561c_terseLabel_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Parking income</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_label_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_documentation_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember" xlink:href="hr-20240630.xsd#hr_ParkingIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ParkingIncomeMember" xlink:to="lab_hr_ParkingIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_277ff034-b1f4-4a42-8495-0d0f15297b44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_30714220-44d5-4dd2-874e-7dc33707045e_terseLabel_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 and thereafter</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_label_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_documentation_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:href="hr-20240630.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:to="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bdec1402-0582-4c67-bb83-98b534f1d868_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_a1a7930f-54d1-4e7c-941f-e4cc200f257f_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Florida</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_09c34255-77be-45b7-bc42-6c64eced179a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_159a1e6c-3ac7-4f51-b74a-e6d370f1559f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_113f8fdf-b161-4912-9e15-ede0c463a8e2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_cff1469a-fa1f-4b03-97a6-d322afa9bcb3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfJointVentures_5182d062-d270-48b4-a4bb-ee1c40c59871_terseLabel_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of joint ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_label_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_documentation_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures" xlink:href="hr-20240630.xsd#hr_NumberOfJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfJointVentures" xlink:to="lab_hr_NumberOfJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_5be1239a-48c4-4c48-ae1e-da8d046a049a_terseLabel_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_label_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limited Liability Company One [Member]</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_documentation_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember" xlink:href="hr-20240630.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LimitedLiabilityCompanyOneMember" xlink:to="lab_hr_LimitedLiabilityCompanyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_43991992-ede3-4e05-8776-8d1721305d55_terseLabel_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of restricted stock units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_label_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_documentation_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits" xlink:href="hr-20240630.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PercentageOfRestrictedStockUnits" xlink:to="lab_hr_PercentageOfRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MultipleMember_940c86fc-f6d0-4e42-8be8-282bfe694944_terseLabel_en-US" xlink:label="lab_hr_MultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Multiple</link:label>
    <link:label id="lab_hr_MultipleMember_label_en-US" xlink:label="lab_hr_MultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Multiple [Member]</link:label>
    <link:label id="lab_hr_MultipleMember_documentation_en-US" xlink:label="lab_hr_MultipleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MultipleMember" xlink:href="hr-20240630.xsd#hr_MultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MultipleMember" xlink:to="lab_hr_MultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_2351665a-4e00-412e-9bd5-700e87837eea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_60abcc88-d9ac-4b87-a0c0-0e4b00cb026b_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_22a36ca5-4634-4f02-b7eb-3199254a81e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23a00aef-f6c9-49f5-a4d2-97b5db7cc879_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation:</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_af6df241-31b3-4ba2-912e-6b862bc36fdb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0f36daf8-9f60-4b2b-83af-d4d54f01af09_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7f2a6fcb-1316-4bcd-ad42-84169232acec_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_5d3aa4f4-cc5b-42dc-b53b-e9fc62587044_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ff31085a-ce4e-4e9b-ab37-9da8dd1b36cf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_5a02a824-84e6-42c9-832b-42b824e9254f_terseLabel_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$1.5 billion Unsecured Credit Facility 2</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_label_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Credit Facility One [Member]</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_documentation_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unsecured Credit Facility One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember" xlink:href="hr-20240630.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_UnsecuredCreditFacilityOneMember" xlink:to="lab_hr_UnsecuredCreditFacilityOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_863f92ff-9a9f-4982-bad7-47980b57b8d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends to common stockholders and distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LTIPSeriesDUnitsMember_e2e9da39-ebb7-47ed-8740-815c51f41ecf_terseLabel_en-US" xlink:label="lab_hr_LTIPSeriesDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LTIP Series D Units</link:label>
    <link:label id="lab_hr_LTIPSeriesDUnitsMember_label_en-US" xlink:label="lab_hr_LTIPSeriesDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LTIP Series D Units [Member]</link:label>
    <link:label id="lab_hr_LTIPSeriesDUnitsMember_documentation_en-US" xlink:label="lab_hr_LTIPSeriesDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">LTIP Series D Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesDUnitsMember" xlink:href="hr-20240630.xsd#hr_LTIPSeriesDUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LTIPSeriesDUnitsMember" xlink:to="lab_hr_LTIPSeriesDUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_973123e8-2884-4906-8a73-628f4baa154d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_409e294f-c71b-4e6d-80a7-a4fbed78dae4_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CARRYING VALUE</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_05398f41-64a7-4fb7-871b-d706c2257770_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_2f2ac6b4-a159-4d58-b338-20ab79598d75_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_label_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_documentation_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:href="hr-20240630.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:to="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_12e3b882-961e-4e71-beed-8eda05cc4417_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6ac7b481-fb4f-4919-b62f-95a65a45ed06_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_0ae17537-49b8-41b7-a9e8-27a8dbfb36c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_497131e7-ec12-4cf7-a5b3-4fcca80cd67c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_95d1f18f-bacd-4767-b12c-342ef558704c_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long Lived Assets Held-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets Held-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:to="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_79d35e20-0438-4722-904c-f67ea21f01b0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes and Bonds Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_901a2b2d-b8b4-40be-8e3c-e4cd33093889_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_57f3650c-63c2-4769-a7f4-21d854a11757_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b6713292-f074-4281-9548-8f43fd8527b0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_783d4012-fb03-409d-96f2-def7eea736a4_terseLabel_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 and thereafter</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20240630.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a1318e9d-78c2-47e9-94a0-fcd9d0f4706c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_bbeaa397-c329-4e51-97d8-358d031c64df_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_86b747e4-15ac-4433-af18-58f168544cb9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_30448c3b-601b-4259-b7c0-9b672a68b8d0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a26a6fe7-63af-4b71-b673-642341404e71_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_d8b85efe-2702-4368-896d-747c1bfec5be_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_45985b77-b42d-462c-b778-0e2de7fdeba6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settled interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_b32da766-72da-4310-a42c-fc581f4f8d55_terseLabel_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment in financing receivable, net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_label_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_documentation_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet" xlink:href="hr-20240630.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateNotesReceivableNet" xlink:to="lab_hr_RealEstateNotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6549593a-b2ad-4ecb-b83d-96de8324c3f5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0179dc60-9480-42b7-a2ac-37526406a3a8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 364,327 and 380,964 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_1ab7551a-86b5-45b6-abb5-a16c9960ba86_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows outflows related to financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_70f1024a-3443-4f68-acd1-a1a438b9a8c0_verboseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_b85f0f02-9d7c-4750-a38d-84213ff42a97_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_817c766c-406f-48cf-af47-c298866b4b73_terseLabel_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of variable interest entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_label_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_documentation_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities" xlink:href="hr-20240630.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfVariableInterestEntities" xlink:to="lab_hr_NumberOfVariableInterestEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_74528591-f8c0-4b13-b737-53460c66e28c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_72cd5a0a-84b5-41db-97d9-59b05ce8dc95_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_2887132c-76f1-43a5-af04-fe75d6f3f3e0_terseLabel_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_label_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Controlling Interest Holders [Member]</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_documentation_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember" xlink:href="hr-20240630.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonControllingInterestHoldersMember" xlink:to="lab_hr_NonControllingInterestHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_1ab73970-5468-403d-8153-2b48c3fb2012_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsMember_3f20b3aa-c9d0-4501-9e04-3142936e7d82_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_label_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsMember" xlink:to="lab_hr_RealEstateDispositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateOther_dfb89b8d-ac6d-4625-8d40-e95d1e1c5cf2_terseLabel_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OTHER (INCLUDING RECEIVABLES)</link:label>
    <link:label id="lab_hr_RealEstateOther_label_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Other</link:label>
    <link:label id="lab_hr_RealEstateOther_documentation_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real estate other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther" xlink:href="hr-20240630.xsd#hr_RealEstateOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateOther" xlink:to="lab_hr_RealEstateOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_7b143ed3-3749-4f37-b045-e9cf107d31c5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_9c67f460-8342-437d-b7d7-95c5cdd045db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_aeb8c616-9905-48eb-9c6e-ef7055e1efb0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Common Stock Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OtherMembersOfSeniorManagementMember_71191671-f7e3-4207-a88c-b68ce697fd6e_terseLabel_en-US" xlink:label="lab_hr_OtherMembersOfSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Members Of Senior Management</link:label>
    <link:label id="lab_hr_OtherMembersOfSeniorManagementMember_label_en-US" xlink:label="lab_hr_OtherMembersOfSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Members Of Senior Management [Member]</link:label>
    <link:label id="lab_hr_OtherMembersOfSeniorManagementMember_documentation_en-US" xlink:label="lab_hr_OtherMembersOfSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Members Of Senior Management</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherMembersOfSeniorManagementMember" xlink:href="hr-20240630.xsd#hr_OtherMembersOfSeniorManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OtherMembersOfSeniorManagementMember" xlink:to="lab_hr_OtherMembersOfSeniorManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7e62dd35-d929-4a99-bb5f-11f0b72e2745_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_33993805-df6b-42a0-a070-889b4aa29d84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Funding of mortgages and notes receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_e71cc65c-79f8-4099-b60c-480227696b82_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_23256520-6981-419b-b0f0-97c946a19e75_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_d9725f88-4525-4dd8-bcde-eee55fc83158_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_d6f9ec31-6668-4bdf-b5f1-bf70189a0e12_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_c7d8e7e3-6e5f-438c-98c6-0dd121f1bfc2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_941d5e20-c195-422d-8810-07da810d2db7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_beced10d-747b-4552-85eb-4d5cf942e1d5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per common share - net loss (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_335d8d2a-edfc-4036-8fc0-8d5bf6b809a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NET PROCEEDS</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale, Real Estate, Held-for-Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_654c4620-6513-4125-a669-44d4f327713d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_13ca919f-d554-4b14-a947-5724fe6a489a_terseLabel_en-US" xlink:label="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional authorized amount for share repurchase program</link:label>
    <link:label id="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_label_en-US" xlink:label="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized, Additional Amount</link:label>
    <link:label id="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_documentation_en-US" xlink:label="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized, Additional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:href="hr-20240630.xsd#hr_StockRepurchaseProgramAuthorizedAdditionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:to="lab_hr_StockRepurchaseProgramAuthorizedAdditionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_2b8327f6-451b-486a-8e11-e48045b10cc9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows outflows related to operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_ba5a6b77-a202-43f0-a8bb-163c451761ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from notes receivable repayments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_4127fc7e-a36d-40aa-b193-cee8a11f7d33_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_5e9fa8ee-9eac-4b7d-942b-a603b8b8b206_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments made on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_fcf9144c-5609-4044-85a5-4559b25b7ece_verboseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Invoices accrued for construction, tenant improvements and other capitalized costs</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c9a56f7b-c2e7-431a-81c3-8859b5f96447_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4c0bd5e5-fb98-469c-9d54-637b3fb738ac_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_887024d4-b6b7-48e3-b773-b3bcd6593e30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5bb286f7-c700-45f7-9819-fbe7a390c89c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c65b41e5-c39b-4627-a0f3-87ad55593d96_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_0507c0a9-52f6-4f78-a400-4641ab0beab5_terseLabel_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Square feet subject to ground leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_label_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_documentation_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:href="hr-20240630.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:to="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_a1984e02-dfcb-4b98-b6fc-19be9693950c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributions from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fb3b4e4-9588-4f55-829b-eb8d38730e06_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ecb4cfc5-f23a-4bba-aebe-5c08f5797bd9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_3e9948f4-3837-4904-a1f2-5864d9ee10dc_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of owned real estate properties</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OneMember_42b450b0-8341-44ba-9504-67223c10039c_terseLabel_en-US" xlink:label="lab_hr_OneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One</link:label>
    <link:label id="lab_hr_OneMember_label_en-US" xlink:label="lab_hr_OneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One [Member]</link:label>
    <link:label id="lab_hr_OneMember_documentation_en-US" xlink:label="lab_hr_OneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OneMember" xlink:href="hr-20240630.xsd#hr_OneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OneMember" xlink:to="lab_hr_OneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_be9db4f3-b269-4454-a98c-7e2c9e86ea24_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other amortization</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_2044d427-e9f7-4074-a7bd-094fa2c12552_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_017d5b13-6244-40de-8798-62e3a7b02b8a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_29c3362f-a9ce-482d-842f-be225324d614_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e6c83a78-52f8-40e8-a6a6-e59eec916244_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeDividends_bf1ecdde-50d6-4a59-8715-e0ac7f663b9f_negatedLabel_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cumulative dividends</link:label>
    <link:label id="lab_us-gaap_CumulativeDividends_label_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CumulativeDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeDividends" xlink:to="lab_us-gaap_CumulativeDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1ef883c8-8ee3-4599-93a8-e17840714fbe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_41d966e0-36dc-4a06-aa85-1c3d3751d0c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">ALLOWANCE FOR CREDIT LOSSES</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_553fe642-1317-42c6-879c-d9c8d7fd3781_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses, beginning of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_aa7c8498-3b15-4c68-bd32-bcd75055ebbb_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses, end of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2ef8d328-724c-4e44-a6d4-289bfc7cfa11_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_afc0b3c2-b531-43ce-a552-db634620d7f8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramDomain_ddf42084-ad51-40f8-88ff-240a931ba50a_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_label_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramDomain" xlink:to="lab_hr_StockIssuanceProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8514fadc-c095-4786-9819-6940a854790a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_9cad92ea-2210-4210-9a05-998b7e8ee641_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_label_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsLineItems" xlink:to="lab_hr_RealEstateDispositionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_8bd6d513-a85f-4909-b837-e9f1e51f3ac2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8837e67c-c47c-47c0-9045-849c669a50ae_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_67f01642-0c81-4eb6-9139-60c165fd1ba1_verboseLabel_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_label_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_documentation_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:href="hr-20240630.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:to="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_cbedfce8-4a4d-4acd-a6fd-ed5565178882_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of real estate properties</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_label_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Real Estate Investments</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of real estate investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateInvestments" xlink:to="lab_hr_NumberOfRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_0a0d062d-e87e-4a66-b076-09b27c975912_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RaleighNCMember_f556644b-bc38-441a-8c35-1718abca206e_terseLabel_en-US" xlink:label="lab_hr_RaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raleigh, NC</link:label>
    <link:label id="lab_hr_RaleighNCMember_label_en-US" xlink:label="lab_hr_RaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Raleigh, NC [Member]</link:label>
    <link:label id="lab_hr_RaleighNCMember_documentation_en-US" xlink:label="lab_hr_RaleighNCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Raleigh, NC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RaleighNCMember" xlink:href="hr-20240630.xsd#hr_RaleighNCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RaleighNCMember" xlink:to="lab_hr_RaleighNCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_a0068853-58e1-4cfe-920e-ebc4fb28ca20_terseLabel_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint venture, ownership (in percentage)</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_label_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_documentation_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage" xlink:href="hr-20240630.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureOwnershipPercentage" xlink:to="lab_hr_JointVentureOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5bd26a10-99e6-4e76-bdfe-8667ee3997b6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAbstract_5239adcc-7954-4984-b0f8-94457f1ec1bf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAbstract" xlink:to="lab_us-gaap_GoodwillImpairedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_a8df061a-ed56-4345-a2de-d7b1886d9949_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FINANCING</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_08762b0c-27a9-4733-a8ec-a4759bb97a6c_terseLabel_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SQUARE FOOTAGE</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_label_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area Covered Under Real Estate Investment Sold in Measurement Units</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_documentation_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Area covered under real estate investment sold in measurement units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:href="hr-20240630.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:to="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_90ce24b1-8d1e-4d50-8c58-98c4bfd42d4b_verboseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of states that the company owns real estate in, whole units</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_label_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Investments Property Owned in Number of States</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real estate investments property owned in number of states.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:to="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_b022664d-9ca0-4a3a-b446-354435114610_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1a14ec57-b265-4949-9be2-ecb8ae0f0163_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_db24645d-b605-4a8c-8c40-97df2088db1c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b63117d4-addd-4382-a849-ebd1ccd59c76_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dc7e76af-2971-4445-9b69-db3c80d46f69_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_d74dd019-7e66-46df-bd30-c27a7f429f0c_terseLabel_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of recognized lease financial receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_label_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_documentation_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:href="hr-20240630.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:to="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_343873df-fd3f-448f-8d80-596b0a268b8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Property, Ownership [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:to="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_926d9e9b-d0bc-47de-bf3f-7c18062a11b0_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding principal repaid</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_209be149-d9ef-4869-b345-4cdf3d4d7249_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_dcd908da-6a5c-4d8e-b3a4-8ed0076e754f_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_8124b332-d5d8-44f5-948d-883065b1bf52_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_661dde81-a36b-4569-8841-b8e79d7ec063_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_8d119c13-89fc-45b9-87fd-33ca702908cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ground lease, initial term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_455d870d-4de9-4219-95e7-c708b47d50be_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfNotesReceivable_0681d860-f23d-4648-a4b6-a6c1acc17127_terseLabel_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of notes receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable" xlink:href="hr-20240630.xsd#hr_NumberOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfNotesReceivable" xlink:to="lab_hr_NumberOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_34d4e307-98c9-4604-820c-a2828be32e5e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fbc57629-2716-4d01-8187-7c01d99d6877_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e2d6e2d-d43b-47b2-86cf-e55ff7d69ee8_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4c6778d7-f8f3-46bd-91ae-b41540cf85e7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Share-based awards, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9a1f509d-72f2-4d48-bd18-9eacce483049_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Share-based awards, ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_6ec24db2-64c8-4f51-8865-d6fb13ab9611_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_d657307c-c9a2-4011-b166-6242356f8c9f_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_d50103a6-4dc1-4f42-a01a-f163b1fd5a25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in awards based on performance assessment (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateAbstract_e2b207cc-68b8-4eca-a751-ede51a9e26e6_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Notes Receivable:</link:label>
    <link:label id="lab_us-gaap_RealEstateAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateAbstract" xlink:to="lab_us-gaap_RealEstateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LTIPSeriesCUnitsMember_b9f66bcc-3d3c-469e-ac52-8d976fadc3a3_terseLabel_en-US" xlink:label="lab_hr_LTIPSeriesCUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LTIP Series C Units</link:label>
    <link:label id="lab_hr_LTIPSeriesCUnitsMember_label_en-US" xlink:label="lab_hr_LTIPSeriesCUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LTIP Series C Units [Member]</link:label>
    <link:label id="lab_hr_LTIPSeriesCUnitsMember_documentation_en-US" xlink:label="lab_hr_LTIPSeriesCUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">LTIP Series C Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesCUnitsMember" xlink:href="hr-20240630.xsd#hr_LTIPSeriesCUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LTIPSeriesCUnitsMember" xlink:to="lab_hr_LTIPSeriesCUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NC_f0258452-0ee3-43bc-9f8e-ce28b8b27754_terseLabel_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">North Carolina</link:label>
    <link:label id="lab_stpr_NC_label_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NORTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NC" xlink:to="lab_stpr_NC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4f62a810-af0f-464f-ac1a-a35c7b23b644_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_cddc2853-b296-41f2-b58e-a0c21cf7195e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a5c78398-24db-4ec9-904a-e0e0421aa197_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_28b1108d-3549-40e8-89d2-e35153d55dc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_72e34679-13af-4f4c-b656-c219dd242b7d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MAXIMUM EXPOSURE TO LOSS</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a57e6722-866e-41eb-a399-2ca51e43a7c5_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5112a900-5875-4c6b-810f-a9034146f107_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_d94961b9-0d59-40c4-9452-b1f4bb4a6764_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reclassification adjustments for gains included in interest expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_5cc7242e-2baa-4400-9f99-305e510f1cc8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification adjustments for gains included in net income (interest expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05a02504-5db3-4b02-b435-080883a93daa_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">(Gain) Loss, Reclassified from AOCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_c015fda8-d859-4199-976e-c55114798eef_terseLabel_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active Interest Rate Swap</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember" xlink:href="hr-20240630.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ActiveInterestRateSwapsMember" xlink:to="lab_hr_ActiveInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6d83ea3d-65e7-448f-991b-f4760d9a00d0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_5f2addc6-4f27-4027-a353-7061824ef84b_terseLabel_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Overview</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_label_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Policy Text Block]</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_documentation_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nature Of Operations Policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:href="hr-20240630.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:to="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_a6b5a2a8-ef59-4da6-85c8-b8dc8b902bb1_terseLabel_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit loss reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_label_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_documentation_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:to="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_4db46b46-8a78-4766-8718-742eb9de1493_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, ownership percentage, noncontrolling owner</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Ownership Percentage, Noncontrolling Owner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_5dc0844c-3a61-4cc1-9608-0ab47d085654_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_244078c8-6844-4d3e-99e2-3b30c3e79124_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of properties subject to ground leases</link:label>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_label_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Properties Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:to="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1b496536-c195-453d-9927-8f6afc0a20c7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6eb500a-39da-45cc-b561-d26dde6e695a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_157abd03-85a5-4fd4-88b3-d61a887135a8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PhiladelphiaPAMember_0b39cacf-e930-41a0-af16-b32ab5387655_terseLabel_en-US" xlink:label="lab_hr_PhiladelphiaPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Philadelphia, PA</link:label>
    <link:label id="lab_hr_PhiladelphiaPAMember_label_en-US" xlink:label="lab_hr_PhiladelphiaPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Philadelphia, PA [Member]</link:label>
    <link:label id="lab_hr_PhiladelphiaPAMember_documentation_en-US" xlink:label="lab_hr_PhiladelphiaPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Philadelphia, PA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PhiladelphiaPAMember" xlink:href="hr-20240630.xsd#hr_PhiladelphiaPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PhiladelphiaPAMember" xlink:to="lab_hr_PhiladelphiaPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_bb2059f0-06cd-4305-b263-12c9ad1e03c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Owner distributions</link:label>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_label_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:to="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8fc9c169-301c-4903-98fa-2c14d8439806_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureCarryingAmount_bcea2320-efae-437d-918d-e273a384b1a8_terseLabel_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint venture, carrying amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_label_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_documentation_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount" xlink:href="hr-20240630.xsd#hr_JointVentureCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureCarryingAmount" xlink:to="lab_hr_JointVentureCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a455e429-8974-42b2-b8b0-1d1372ce194f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64bb2bfe-d18b-4747-a462-077d39570478_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d15e51f0-b59f-4af5-9374-8b6f9fa31523_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3ad1edd-def0-4511-b37c-9bb8413acfde_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_bb62f254-19de-40c9-bfe7-5e10a99663dd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AtlantaGAMember_2612b0a6-d8d6-4bc7-92bb-2e0850362040_terseLabel_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Atlanta, GA</link:label>
    <link:label id="lab_hr_AtlantaGAMember_label_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Atlanta, GA [Member]</link:label>
    <link:label id="lab_hr_AtlantaGAMember_documentation_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Atlanta, GA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember" xlink:href="hr-20240630.xsd#hr_AtlantaGAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AtlantaGAMember" xlink:to="lab_hr_AtlantaGAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateTable_242b1fe2-f9d0-4bd6-9d57-42a14de9fa40_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:label id="lab_us-gaap_RealEstateTable_label_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateTable" xlink:to="lab_us-gaap_RealEstateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_23951864-4f8a-424a-b15b-0221a73800e8_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Non-Controlling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_066fb186-a77e-49c7-96a6-c4f0ec483243_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_99a00812-a5b1-4c6f-9296-404eb9d0fb68_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medium-term notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medium-Term Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_6806024a-a868-449b-b7f3-6c1bbf662472_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Settled treasury hedges</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_3803cf68-bf4d-4951-a3eb-d60804d96960_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_label_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale [Table Text Block]</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_documentation_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:href="hr-20240630.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:to="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_09bace28-005f-4526-aee4-3c78b9ffc478_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_fe5fd2a8-09b4-4395-93c2-698d43cca2a5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d17d9539-d60a-48f0-a24d-260f8f9ec1fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_07ad787f-7333-45d8-8d71-17514ca4cd1e_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments Receivable</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_c4bf0ead-8734-4640-b304-537848e2e20b_terseLabel_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgage notes payable</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_label_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_documentation_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember" xlink:href="hr-20240630.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageNotesPayableNetMember" xlink:to="lab_hr_MortgageNotesPayableNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_a27b2734-74c8-45c2-b0e0-0c03a31196c7_terseLabel_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Approximate square feet invested in by company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_label_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_documentation_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:href="hr-20240630.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:to="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hr-20240630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:627f5e76-d6fd-48cf-8a56-b8300ae13e07,g:0f86b207-cf59-4fc7-8877-ae78a64d425e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/CoverPage" xlink:type="simple" xlink:href="hr-20240630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b98c2648-b77e-4fe4-9eeb-fd2d47d2142a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentType_b98c2648-b77e-4fe4-9eeb-fd2d47d2142a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_012c4943-aadd-4f15-9f46-01075e376488" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentQuarterlyReport_012c4943-aadd-4f15-9f46-01075e376488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a210bbc6-854f-4d01-a32e-8e682a44e89c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentPeriodEndDate_a210bbc6-854f-4d01-a32e-8e682a44e89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9d6b3310-f008-4710-b7cc-fc5cc464ba9a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentTransitionReport_9d6b3310-f008-4710-b7cc-fc5cc464ba9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_485f6dfd-f4c3-4f34-8fcb-a4727c9cc7ae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityFileNumber_485f6dfd-f4c3-4f34-8fcb-a4727c9cc7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_648a24ac-a3b1-46a8-bb4c-87c1e02ff3fe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityRegistrantName_648a24ac-a3b1-46a8-bb4c-87c1e02ff3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9998cdc7-745c-4da6-b4c5-1ab7c99cafa4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9998cdc7-745c-4da6-b4c5-1ab7c99cafa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_399a5e9b-1bcb-4407-805b-a198ac97159f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityTaxIdentificationNumber_399a5e9b-1bcb-4407-805b-a198ac97159f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dffe4cd7-2548-440d-a98b-c96f469a4703" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityAddressAddressLine1_dffe4cd7-2548-440d-a98b-c96f469a4703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_751a07b9-f564-48fd-8d12-8848b67d9f95" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityAddressAddressLine2_751a07b9-f564-48fd-8d12-8848b67d9f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d7a98116-a7e0-40f9-b742-2d568c65f6c3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityAddressCityOrTown_d7a98116-a7e0-40f9-b742-2d568c65f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_821f6eca-f172-498c-9174-bb42aa3f2ca5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityAddressStateOrProvince_821f6eca-f172-498c-9174-bb42aa3f2ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0653d6f4-765d-4f7b-ab91-5770cc3614f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityAddressPostalZipCode_0653d6f4-765d-4f7b-ab91-5770cc3614f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7332fefb-4ee7-4e1a-919d-2868c4f3bdf2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_CityAreaCode_7332fefb-4ee7-4e1a-919d-2868c4f3bdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4f874e7c-453b-47c7-b9dd-faf31932a337" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_LocalPhoneNumber_4f874e7c-453b-47c7-b9dd-faf31932a337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a5d815e9-7661-4fa9-96af-f5f7d8922826" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_Security12bTitle_a5d815e9-7661-4fa9-96af-f5f7d8922826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a64c973d-5612-42e1-9542-e0a975b4b2d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_TradingSymbol_a64c973d-5612-42e1-9542-e0a975b4b2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4e71d099-5c22-454e-98d4-b609cedf2b1e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_SecurityExchangeName_4e71d099-5c22-454e-98d4-b609cedf2b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8cd0b073-0da2-4899-ab75-9b976f4bb5c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityCurrentReportingStatus_8cd0b073-0da2-4899-ab75-9b976f4bb5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_334f6285-f349-40ea-b6d5-d27cb241b9d1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityInteractiveDataCurrent_334f6285-f349-40ea-b6d5-d27cb241b9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6bde5bcc-73b4-487e-804d-e6afe12787ba" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityFilerCategory_6bde5bcc-73b4-487e-804d-e6afe12787ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d748ff50-5beb-4a3a-a39e-0b8474c22c8a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntitySmallBusiness_d748ff50-5beb-4a3a-a39e-0b8474c22c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e846ee76-0ca5-4f15-88d6-a516b84a04e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityEmergingGrowthCompany_e846ee76-0ca5-4f15-88d6-a516b84a04e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ec24a6dd-5731-4853-923c-4abc9142c74f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityShellCompany_ec24a6dd-5731-4853-923c-4abc9142c74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1b7d14ee-1c82-45ca-8a8e-dd816e7836f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1b7d14ee-1c82-45ca-8a8e-dd816e7836f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_708230f5-649c-427e-9609-c8c17fad6b9b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_EntityCentralIndexKey_708230f5-649c-427e-9609-c8c17fad6b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dbf5c15a-7953-4666-a6b3-67d62df3a8ac" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_CurrentFiscalYearEndDate_dbf5c15a-7953-4666-a6b3-67d62df3a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_22e1c988-a69e-4ea6-89f9-366a72da02b4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentFiscalYearFocus_22e1c988-a69e-4ea6-89f9-366a72da02b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12945134-aac0-4db9-9f80-06fed3808bd2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12945134-aac0-4db9-9f80-06fed3808bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_96e69c34-575d-4ad9-bf3d-8e3125930fc3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8ea142ea-31d9-4931-ac12-60198c77a39c" xlink:to="loc_dei_AmendmentFlag_96e69c34-575d-4ad9-bf3d-8e3125930fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_13eec663-cbb3-4afc-808f-d42a25b203c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_13eec663-cbb3-4afc-808f-d42a25b203c7" xlink:to="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_eca61853-b9c9-48bc-840c-5086fcc45145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_Land_eca61853-b9c9-48bc-840c-5086fcc45145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_32dc89a9-5a33-4219-b3e9-4658dfdd12e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_32dc89a9-5a33-4219-b3e9-4658dfdd12e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_195d1836-e96a-475d-b600-c468cdb27e67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_195d1836-e96a-475d-b600-c468cdb27e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_1c0115f2-0a09-4624-a17a-67aac2d8679b" xlink:href="hr-20240630.xsd#hr_PersonalProperty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_hr_PersonalProperty_1c0115f2-0a09-4624-a17a-67aac2d8679b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_12444def-f4d8-424a-af60-1884fdcd40f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_12444def-f4d8-424a-af60-1884fdcd40f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_e2be92bd-3e38-473a-be51-19e0c44f744b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_e2be92bd-3e38-473a-be51-19e0c44f744b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_5f02b678-8a97-4191-b160-be9085183da3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_DevelopmentInProcess_5f02b678-8a97-4191-b160-be9085183da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_798199d5-b159-4e25-8cff-bf35132e9082" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_LandAvailableForDevelopment_798199d5-b159-4e25-8cff-bf35132e9082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_5560ba06-09ca-473a-ab20-b5df2b6485cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_5560ba06-09ca-473a-ab20-b5df2b6485cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_12e07ed8-4dc1-4efb-80a9-6c68a0d3cdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_12e07ed8-4dc1-4efb-80a9-6c68a0d3cdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_50297aab-52ed-4022-907b-05c90ae313b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_7bd0bab0-4c82-45df-839c-f4a59c576a0d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_50297aab-52ed-4022-907b-05c90ae313b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_376faff8-23ac-4731-9cac-7389a5cda0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_376faff8-23ac-4731-9cac-7389a5cda0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_a444654f-6962-40af-9f7a-848dd55b068c" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_a444654f-6962-40af-9f7a-848dd55b068c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6734e5ba-ea05-4e89-9321-be11c502eb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6734e5ba-ea05-4e89-9321-be11c502eb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0d4a8a3d-ba33-4602-96b2-6d16adb28522" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0d4a8a3d-ba33-4602-96b2-6d16adb28522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_96d5947f-b24f-4d42-86f9-b283e2640053" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_Goodwill_96d5947f-b24f-4d42-86f9-b283e2640053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_2dd35683-4986-4210-b2c8-89cf58afd41a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_OtherAssets_2dd35683-4986-4210-b2c8-89cf58afd41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d8fd83dc-a2cd-4f0a-9e29-0ccdb889aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d69c0ad3-e0ff-4e27-b157-2291e6418400" xlink:to="loc_us-gaap_Assets_d8fd83dc-a2cd-4f0a-9e29-0ccdb889aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_13eec663-cbb3-4afc-808f-d42a25b203c7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:to="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_732ea48b-70df-4c80-bb0e-1c89a8786279" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_LongTermDebt_732ea48b-70df-4c80-bb0e-1c89a8786279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_ca14ae13-bc71-4a3e-8256-8a3e9981b451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_ca14ae13-bc71-4a3e-8256-8a3e9981b451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a91c968b-535b-4e5b-a43f-f4f41bee11f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a91c968b-535b-4e5b-a43f-f4f41bee11f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2050c87b-552d-4010-927c-fb4744f820ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_OperatingLeaseLiability_2050c87b-552d-4010-927c-fb4744f820ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3cf1f739-a350-4ddd-b166-d7e2722fb301" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_FinanceLeaseLiability_3cf1f739-a350-4ddd-b166-d7e2722fb301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_5ca8ecf2-41c0-4438-9839-6b71285ca870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_OtherLiabilities_5ca8ecf2-41c0-4438-9839-6b71285ca870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8b66b113-3f8a-4335-9635-d2c520d35a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6571f09f-ace1-4d65-8af5-2da7cad28e28" xlink:to="loc_us-gaap_Liabilities_8b66b113-3f8a-4335-9635-d2c520d35a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a8e9a473-64e9-4cf5-beee-f19142477f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a8e9a473-64e9-4cf5-beee-f19142477f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cedf8a2e-cc4e-49f6-b25d-f38ccf9b4af5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_cedf8a2e-cc4e-49f6-b25d-f38ccf9b4af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c8d0f6bc-b047-41e1-ad98-b7999f4f2fae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_PreferredStockValue_c8d0f6bc-b047-41e1-ad98-b7999f4f2fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_63c7d8d8-1bea-4c68-b84f-f3c6a33e2473" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_CommonStockValue_63c7d8d8-1bea-4c68-b84f-f3c6a33e2473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f2c20c9-f27a-484f-ad87-fcd47e9c5735" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f2c20c9-f27a-484f-ad87-fcd47e9c5735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4ddcd657-e231-440a-b607-943cd37a12fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4ddcd657-e231-440a-b607-943cd37a12fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_3088f98f-8d07-4ca7-b11e-2a6f892a2a25" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_3088f98f-8d07-4ca7-b11e-2a6f892a2a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_8cee31cd-c782-43f0-affc-bd605b6f348d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CumulativeDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_CumulativeDividends_8cee31cd-c782-43f0-affc-bd605b6f348d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f7221ed7-b854-40c8-b3d5-3f017767f0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_StockholdersEquity_f7221ed7-b854-40c8-b3d5-3f017767f0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9b5c184b-7b87-4a22-b44a-3bd61fad6d38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_MinorityInterest_9b5c184b-7b87-4a22-b44a-3bd61fad6d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_912bb305-d7c0-4dd3-a251-d7d6321ab4c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db949201-7fb5-409a-9f94-e538a94af004" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_912bb305-d7c0-4dd3-a251-d7d6321ab4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f09d5930-4e9a-44f6-85de-1b011fc07ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f621dd40-b472-4bd1-baea-7c7626e5fe7b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f09d5930-4e9a-44f6-85de-1b011fc07ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c011b3dc-9427-4da1-b784-bb06b2571faa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c011b3dc-9427-4da1-b784-bb06b2571faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_25c9bfa1-169b-423a-85cb-392d8a115b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_25c9bfa1-169b-423a-85cb-392d8a115b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_add1193e-f06b-4be3-9d7e-496353959477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_PreferredStockSharesIssued_add1193e-f06b-4be3-9d7e-496353959477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_83c3fabb-190e-4ff6-a3a4-8a0e87f44c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_83c3fabb-190e-4ff6-a3a4-8a0e87f44c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5062a242-9cca-4a25-927f-58113eca2d94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5062a242-9cca-4a25-927f-58113eca2d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cea67033-8c78-41a2-965a-7e8b3b764e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cea67033-8c78-41a2-965a-7e8b3b764e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_78cd76c2-c27c-42a8-9033-f3a36862da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_CommonStockSharesIssued_78cd76c2-c27c-42a8-9033-f3a36862da5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e5c59c44-6446-40b3-9437-9f5e8271d61f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9873e668-77da-47eb-8668-edd917f47584" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e5c59c44-6446-40b3-9437-9f5e8271d61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_6e62d45d-f5fe-4d11-a952-f1fa850e184b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_6e62d45d-f5fe-4d11-a952-f1fa850e184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_be395ba0-6b3e-453d-8cb1-b8573caad1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_be395ba0-6b3e-453d-8cb1-b8573caad1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a42f47d7-0a94-4e38-b2ea-574d315b8992" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a42f47d7-0a94-4e38-b2ea-574d315b8992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8fa03e74-a1e6-4fda-a8f9-1c06a547f65a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9d5c0d65-e994-43da-be85-e6e043378c39" xlink:to="loc_us-gaap_Revenues_8fa03e74-a1e6-4fda-a8f9-1c06a547f65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_34d9f5d7-7978-4ef4-9858-71c146ed80c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_34d9f5d7-7978-4ef4-9858-71c146ed80c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c2e804a0-38cd-4cb0-90d3-8ec649c7685d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c2e804a0-38cd-4cb0-90d3-8ec649c7685d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_9dfde2e5-d198-4f97-a5d8-473e680f0be0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_us-gaap_AcquisitionCosts_9dfde2e5-d198-4f97-a5d8-473e680f0be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_56c65881-e644-432d-8eae-ac0cdd7d87e8" xlink:href="hr-20240630.xsd#hr_MergerRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_hr_MergerRelatedCosts_56c65881-e644-432d-8eae-ac0cdd7d87e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_f8b39cfa-e3a8-4ebe-b6a9-eb61827f7fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_us-gaap_DepreciationAndAmortization_f8b39cfa-e3a8-4ebe-b6a9-eb61827f7fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_12a3ad36-737f-429e-96d5-fa4a6ec72de8" xlink:href="hr-20240630.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_31f0b35d-00e5-4ad5-95ee-45e07bcbec3a" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_12a3ad36-737f-429e-96d5-fa4a6ec72de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b40dd601-d597-4302-b2cf-4a4e08ca892a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b40dd601-d597-4302-b2cf-4a4e08ca892a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_e27a51dd-0a40-4288-9316-ef7302816029" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_InterestExpenseNonoperating_e27a51dd-0a40-4288-9316-ef7302816029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_eb06635f-ff7f-43a2-8946-35b951a51bce" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_eb06635f-ff7f-43a2-8946-35b951a51bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3c2ba3bb-de03-4815-8b39-172faaf6dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3c2ba3bb-de03-4815-8b39-172faaf6dd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7ea4170e-f4a7-4aef-8248-f1bc5b3c6faf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7ea4170e-f4a7-4aef-8248-f1bc5b3c6faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dc1cb082-448d-4f58-99ac-cc9dc03f34d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dc1cb082-448d-4f58-99ac-cc9dc03f34d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f8a9937f-bdd9-4125-bd52-128a4ead6e98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f8a9937f-bdd9-4125-bd52-128a4ead6e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ff26974d-47b6-403c-b687-f3056fa2cb17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_ProfitLoss_ff26974d-47b6-403c-b687-f3056fa2cb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e7b3cacc-3f18-47df-94fe-d7010d1fb630" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e7b3cacc-3f18-47df-94fe-d7010d1fb630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ab23dde7-506a-496d-8f0e-fbe08e39af81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b947c1ee-b3dd-416b-91ae-9ed4992c0e34" xlink:to="loc_us-gaap_NetIncomeLoss_ab23dde7-506a-496d-8f0e-fbe08e39af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0feda29c-cd27-4868-8038-072614e09a29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_EarningsPerShareBasic_0feda29c-cd27-4868-8038-072614e09a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_197ffeb9-d3d0-410d-9b5d-1abbf8b092ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_197ffeb9-d3d0-410d-9b5d-1abbf8b092ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a3f409e5-5463-4a29-aa1c-23e204a21dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a3f409e5-5463-4a29-aa1c-23e204a21dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3412914d-cb39-4711-9e94-5c3f7b3de5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3412914d-cb39-4711-9e94-5c3f7b3de5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_92e80329-7759-435b-86f1-64e5012b448c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c39da701-fa51-4884-8113-02852b9b35b9" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_92e80329-7759-435b-86f1-64e5012b448c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5bf60ba3-db71-486e-a9c6-ddb16a877aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_ProfitLoss_5bf60ba3-db71-486e-a9c6-ddb16a877aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6d52aa6b-03c6-4c45-9bd0-b418925deec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6d52aa6b-03c6-4c45-9bd0-b418925deec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c43ff9d8-c509-4291-a7d4-6c3647cc466b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6d52aa6b-03c6-4c45-9bd0-b418925deec7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c43ff9d8-c509-4291-a7d4-6c3647cc466b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_50b9c2d2-1da5-4885-a186-c3ab168fb5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c43ff9d8-c509-4291-a7d4-6c3647cc466b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_50b9c2d2-1da5-4885-a186-c3ab168fb5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_01a4c5a4-69ad-4139-a76b-9b5b5bd94495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c43ff9d8-c509-4291-a7d4-6c3647cc466b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_01a4c5a4-69ad-4139-a76b-9b5b5bd94495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_973d1195-d9bf-42e6-b0a0-12a7a1ed3c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_973d1195-d9bf-42e6-b0a0-12a7a1ed3c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e2cef289-fbca-4464-b8ac-c614c3b153af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e2cef289-fbca-4464-b8ac-c614c3b153af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_54eb9f5e-40f7-4439-af32-7010eb00e0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_54eb9f5e-40f7-4439-af32-7010eb00e0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b76ddf92-16a5-488e-a10f-f2ac52848e43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea495f3a-c44f-420d-93be-db2097a57726" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b76ddf92-16a5-488e-a10f-f2ac52848e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e1220311-22d7-4a04-ab42-166d78c3765a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e1220311-22d7-4a04-ab42-166d78c3765a" xlink:to="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab4f9a4-6593-4740-a076-a7b2f147c849" xlink:to="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:to="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_455b56aa-4b55-497c-9e3d-ee6deb31161f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_CommonStockMember_455b56aa-4b55-497c-9e3d-ee6deb31161f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a30de692-28ad-4439-b474-27595a7d1143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a30de692-28ad-4439-b474-27595a7d1143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a2c80805-33f2-458b-ad4f-348f014f71f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a2c80805-33f2-458b-ad4f-348f014f71f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_17893b52-9e3b-45d6-8fdc-3704e7abb14a" xlink:href="hr-20240630.xsd#hr_CumulativeNetIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_hr_CumulativeNetIncomeMember_17893b52-9e3b-45d6-8fdc-3704e7abb14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_249c2e6c-49c5-4ea4-910d-11c1f3031f2c" xlink:href="hr-20240630.xsd#hr_CumulativeDividendsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_01328d08-a12d-4c66-9a7c-47046e418b2e" xlink:to="loc_hr_CumulativeDividendsMember_249c2e6c-49c5-4ea4-910d-11c1f3031f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_02b3f9e8-0586-4c1a-892e-82026a604b43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7435a5d3-61fa-42f2-97a2-1b16b292375f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_02b3f9e8-0586-4c1a-892e-82026a604b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_818eba2c-80bc-4496-b636-23eebd6a6203" xlink:to="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff9540c8-bc20-47fa-b9f3-34e18d150906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff9540c8-bc20-47fa-b9f3-34e18d150906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bcdc44a1-f8ef-401c-bb9e-394f20398898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bcdc44a1-f8ef-401c-bb9e-394f20398898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c63660f5-16c9-4137-a758-044e7225642b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c63660f5-16c9-4137-a758-044e7225642b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_480d7b27-05b2-4d6b-8223-b4b7a03e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_480d7b27-05b2-4d6b-8223-b4b7a03e2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bf110f21-1069-4a93-980f-ad16d33d3872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bf110f21-1069-4a93-980f-ad16d33d3872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_09b52238-15c1-4b9b-8f1e-c65f12b1a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_09b52238-15c1-4b9b-8f1e-c65f12b1a49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_41831220-b74e-462f-92bf-052ef855a165" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_ProfitLoss_41831220-b74e-462f-92bf-052ef855a165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ef117793-99a1-4f6c-b9e9-b59817221dca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ef117793-99a1-4f6c-b9e9-b59817221dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_72f71138-108f-44a5-a8f7-22acaee5b545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_72f71138-108f-44a5-a8f7-22acaee5b545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f7de7e9c-435a-4245-b8fb-ad93ba5965c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_DividendsCommonStockCash_f7de7e9c-435a-4245-b8fb-ad93ba5965c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e9d0421-4c9e-4ecd-b2c0-1d5ea527108c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_88d7978b-b75f-4f36-ba3c-360f0317e9d5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e9d0421-4c9e-4ecd-b2c0-1d5ea527108c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e78527b3-0203-4d04-890b-3cd94c715145" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_74b43637-f91f-4ced-9422-975654b53a51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_74b43637-f91f-4ced-9422-975654b53a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_859e711e-c347-4913-a0c0-68cbe7f3d85b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_859e711e-c347-4913-a0c0-68cbe7f3d85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1c1b077f-6add-4ff3-bf93-74b81a51733b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1c1b077f-6add-4ff3-bf93-74b81a51733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b5524dd0-ebd5-4a78-ac57-953ab5d46561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_15cf0c68-bd29-43ee-ac84-2fb07255e187" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b5524dd0-ebd5-4a78-ac57-953ab5d46561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_15cdb315-8add-4a4b-bfea-73db1ee310d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c4893bd8-22fb-422b-ab22-e496e53845ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_15cdb315-8add-4a4b-bfea-73db1ee310d5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_c4893bd8-22fb-422b-ab22-e496e53845ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20240630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b34aeb-1c69-4fc7-b675-8b29bff9b557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b34aeb-1c69-4fc7-b675-8b29bff9b557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c784f69e-64e4-4e51-abc6-b7618a18f9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b34aeb-1c69-4fc7-b675-8b29bff9b557" xlink:to="loc_us-gaap_ProfitLoss_c784f69e-64e4-4e51-abc6-b7618a18f9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b34aeb-1c69-4fc7-b675-8b29bff9b557" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dcc2fd60-f3db-42f5-ab42-10ab91a69a13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dcc2fd60-f3db-42f5-ab42-10ab91a69a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_6d3d0a6f-b1ed-4915-985c-cd926bbdb0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_6d3d0a6f-b1ed-4915-985c-cd926bbdb0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_41dc7e11-5531-4b4f-bf15-305a7d73858e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_ShareBasedCompensation_41dc7e11-5531-4b4f-bf15-305a7d73858e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_6d8cac3c-6c53-43cd-b2ff-36c1bcb30c12" xlink:href="hr-20240630.xsd#hr_StraightLineRentReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_hr_StraightLineRentReceivable_6d8cac3c-6c53-43cd-b2ff-36c1bcb30c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_9310ab26-5e83-4581-9b8c-15747948a972" xlink:href="hr-20240630.xsd#hr_StraightlineRentLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_hr_StraightlineRentLiability_9310ab26-5e83-4581-9b8c-15747948a972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_ac6165d2-ab48-49d0-900b-97237aa6de67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_ac6165d2-ab48-49d0-900b-97237aa6de67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_d7a5bd04-f4b4-4f36-ada0-683de309b6ba" xlink:href="hr-20240630.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_d7a5bd04-f4b4-4f36-ada0-683de309b6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2c8641dd-04fb-4e83-9a4e-7bc4c4fa3119" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2c8641dd-04fb-4e83-9a4e-7bc4c4fa3119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2fc0ce26-a7a5-42a3-ac1f-19a6f1816355" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2fc0ce26-a7a5-42a3-ac1f-19a6f1816355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_12337db5-aa6b-4416-aa22-6446bb0894cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_12337db5-aa6b-4416-aa22-6446bb0894cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_3665084e-9d86-41b8-bd66-af6b9473a540" xlink:href="hr-20240630.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_3665084e-9d86-41b8-bd66-af6b9473a540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7516f9a-7795-40aa-aac2-505f070649a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_61dca3bf-e85c-450e-aba8-0670aa42d514" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7516f9a-7795-40aa-aac2-505f070649a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b11fe6f9-5fd4-4086-bbff-60c2b81a8fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7516f9a-7795-40aa-aac2-505f070649a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b11fe6f9-5fd4-4086-bbff-60c2b81a8fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a00e8b54-e212-4f25-b707-3d5c4b3a8c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7516f9a-7795-40aa-aac2-505f070649a8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a00e8b54-e212-4f25-b707-3d5c4b3a8c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_237ec7b6-ef31-433a-92c7-65a2ffee6080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d7516f9a-7795-40aa-aac2-505f070649a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_237ec7b6-ef31-433a-92c7-65a2ffee6080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_355700da-09d4-4eef-a1ae-e2583fd96495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b34aeb-1c69-4fc7-b675-8b29bff9b557" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_355700da-09d4-4eef-a1ae-e2583fd96495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_0c916bb9-16c6-479c-9e27-f6880609ca10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_0c916bb9-16c6-479c-9e27-f6880609ca10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_3296009b-fadb-4971-a05c-4e7638706744" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_3296009b-fadb-4971-a05c-4e7638706744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_9d060af5-8afa-48cf-9e32-75c66a3977b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_9d060af5-8afa-48cf-9e32-75c66a3977b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_12df9f62-faec-42d8-b96e-f01f7d6b278a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_12df9f62-faec-42d8-b96e-f01f7d6b278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_c56607fd-5d71-4bdd-bea9-21c042066e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_c56607fd-5d71-4bdd-bea9-21c042066e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_a85dd4bd-d9ee-4853-9e11-f6198f9912c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_a85dd4bd-d9ee-4853-9e11-f6198f9912c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_b5993652-7fd6-4fa4-b2a3-8f6f3d75497b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_b5993652-7fd6-4fa4-b2a3-8f6f3d75497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_a17d712a-dafb-4d8c-a83a-5c2b12e0c4b9" xlink:href="hr-20240630.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_a17d712a-dafb-4d8c-a83a-5c2b12e0c4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6092b53e-ab40-4d70-8092-a6519598e1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6092b53e-ab40-4d70-8092-a6519598e1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_0bd3b294-c450-4443-b5c3-250086ca6f70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_0bd3b294-c450-4443-b5c3-250086ca6f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_017a6e0f-31ca-4ba7-b02d-93324120930a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6132d071-4249-4f61-b73c-ac1cc57c6381" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_017a6e0f-31ca-4ba7-b02d-93324120930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_6360135e-9b19-47ce-b0aa-7f1a42756589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_6360135e-9b19-47ce-b0aa-7f1a42756589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_f9678cb0-cf12-4e8b-a7d7-d143eda90da3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_f9678cb0-cf12-4e8b-a7d7-d143eda90da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2cb752b4-0f6a-45d1-aff0-a494a9eb31ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_RepaymentsOfDebt_2cb752b4-0f6a-45d1-aff0-a494a9eb31ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_3c348da9-bf7c-49fd-8756-fc6fb1664220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_3c348da9-bf7c-49fd-8756-fc6fb1664220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f34d1431-ac7e-4e1c-9ecd-42e5395d67c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f34d1431-ac7e-4e1c-9ecd-42e5395d67c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c6d66c19-0f27-476a-a8fa-de8085afb842" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c6d66c19-0f27-476a-a8fa-de8085afb842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentsForRepurchasesOfCommonStock_63acde62-536b-44e4-97a2-c813e00d4af0" xlink:href="hr-20240630.xsd#hr_PaymentsForRepurchasesOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_hr_PaymentsForRepurchasesOfCommonStock_63acde62-536b-44e4-97a2-c813e00d4af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_0aae637f-3702-4234-b4d7-08a8e7fe23b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_0aae637f-3702-4234-b4d7-08a8e7fe23b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_9e80dd91-07d4-4322-904a-7659b7351110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_9e80dd91-07d4-4322-904a-7659b7351110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_37c97026-3c48-49a7-a55b-b21431c538ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_37c97026-3c48-49a7-a55b-b21431c538ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc452fc-5196-42a8-ba0c-23cb2b0c5ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_51b5c0f1-810a-41fa-abd6-18010ae93eb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc452fc-5196-42a8-ba0c-23cb2b0c5ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc4008f7-0d93-412e-8952-ef3df269de76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dc4008f7-0d93-412e-8952-ef3df269de76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ce2725d-98ff-4596-9298-be92d5217380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ce2725d-98ff-4596-9298-be92d5217380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d5bdec08-ab85-4e26-8c35-d39f6fc8ea25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d5bdec08-ab85-4e26-8c35-d39f6fc8ea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3e753bd1-ca11-4984-aa7d-c8a55a199b82" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2acc1d96-c1cc-4aaa-b9d6-86b1dbf3321f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_us-gaap_InterestPaidNet_2acc1d96-c1cc-4aaa-b9d6-86b1dbf3321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1_0de4f77a-1736-437a-aa80-8ed62bc78532" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_us-gaap_MortgageLoanRelatedToPropertySales1_0de4f77a-1736-437a-aa80-8ed62bc78532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9328d212-71a9-42c4-883e-baba6322ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9328d212-71a9-42c4-883e-baba6322ce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_8ac30a19-bea3-429e-8585-a2535bd50837" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_us-gaap_InterestPaidCapitalized_8ac30a19-bea3-429e-8585-a2535bd50837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromDispositionsHeldInEscrow_15fc4c30-aae7-432c-a2c9-041ed625ab72" xlink:href="hr-20240630.xsd#hr_ProceedsFromDispositionsHeldInEscrow"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_hr_ProceedsFromDispositionsHeldInEscrow_15fc4c30-aae7-432c-a2c9-041ed625ab72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture_1f4904f3-5d6b-469f-ae72-d56b2d3c595a" xlink:href="hr-20240630.xsd#hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5b3aa30-076a-4762-a2fe-e7afec33752e" xlink:to="loc_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture_1f4904f3-5d6b-469f-ae72-d56b2d3c595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fef6ed98-67e6-4eb4-8156-265082ef1da7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9995fdfa-dd70-4b24-a0df-6d40f406dcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fef6ed98-67e6-4eb4-8156-265082ef1da7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9995fdfa-dd70-4b24-a0df-6d40f406dcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_64eba50c-6783-4c7e-95bc-174c6bbef3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock_2a0a3d98-af48-4ed9-b471-88e395cf6ded" xlink:href="hr-20240630.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_64eba50c-6783-4c7e-95bc-174c6bbef3d6" xlink:to="loc_hr_AcquisitionsAndDispositionsTextBlock_2a0a3d98-af48-4ed9-b471-88e395cf6ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/Leases" xlink:type="simple" xlink:href="hr-20240630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_942ce3db-c690-4277-bf53-70367d7a3d83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_4af3c7a7-289e-41ea-b385-3ddc1337255b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_942ce3db-c690-4277-bf53-70367d7a3d83" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_4af3c7a7-289e-41ea-b385-3ddc1337255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2b30dd81-6b57-4050-bf2d-488cb2c38d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_942ce3db-c690-4277-bf53-70367d7a3d83" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2b30dd81-6b57-4050-bf2d-488cb2c38d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayable"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_153a92c5-b98c-4881-8305-eac6d50c763e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e331ece0-f775-476a-92b0-e2e87d70b534" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_153a92c5-b98c-4881-8305-eac6d50c763e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e331ece0-f775-476a-92b0-e2e87d70b534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbb694bd-3546-4e5a-8996-b6822db15f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2645b53b-69ec-4844-94b3-046454b2f99d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbb694bd-3546-4e5a-8996-b6822db15f2f" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2645b53b-69ec-4844-94b3-046454b2f99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="hr-20240630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea47edfc-d041-439c-bb7b-ae2053d4758e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c0d118d0-d905-4d66-b421-f457eb358d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea47edfc-d041-439c-bb7b-ae2053d4758e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c0d118d0-d905-4d66-b421-f457eb358d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_723d9feb-ffc3-455d-b79d-45b8adfea1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bad19e67-c52d-420c-8dc2-8a149c05b70f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_723d9feb-ffc3-455d-b79d-45b8adfea1c7" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bad19e67-c52d-420c-8dc2-8a149c05b70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="hr-20240630.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a38c2cde-5d79-419f-992f-9bb1213825f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_6df3be9e-cced-44ee-b43e-4cbc15be13e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a38c2cde-5d79-419f-992f-9bb1213825f1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_6df3be9e-cced-44ee-b43e-4cbc15be13e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock_a752e176-7355-4e22-a5c7-fd34361ec2c1" xlink:href="hr-20240630.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_hr_NatureOfOperationsPolicyTextBlock_a752e176-7355-4e22-a5c7-fd34361ec2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ce8dd83a-11f7-4338-a3bd-b8813850b240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ce8dd83a-11f7-4338-a3bd-b8813850b240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_f611ccad-f16d-4af9-a7b3-b7d76835444f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_f611ccad-f16d-4af9-a7b3-b7d76835444f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_9f11a0f3-5879-45b8-a7d8-bfb9b0bc5d87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_9f11a0f3-5879-45b8-a7d8-bfb9b0bc5d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f8c683d2-95fc-49ac-b291-730158a3be9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_UseOfEstimates_f8c683d2-95fc-49ac-b291-730158a3be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_a82e650d-73f0-4060-bad3-7e0e822105a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_a82e650d-73f0-4060-bad3-7e0e822105a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_93addf74-b114-4cc0-8d24-85d88381b160" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_93addf74-b114-4cc0-8d24-85d88381b160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_49c16d4d-5b8a-4f29-b4ad-551146c60431" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_49c16d4d-5b8a-4f29-b4ad-551146c60431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_674710bc-afea-4d75-b00e-ec479519bde1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_674710bc-afea-4d75-b00e-ec479519bde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0cc3c114-38bf-4428-8af4-e255bb68a7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0cc3c114-38bf-4428-8af4-e255bb68a7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c3902125-ce98-4127-93a2-b578880324db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d12b7a17-1560-4512-8203-38dd370381aa" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c3902125-ce98-4127-93a2-b578880324db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_708b841f-0524-44dd-ac0d-f827856c1ff8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_708b841f-0524-44dd-ac0d-f827856c1ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_75d45764-0d91-409a-8740-9f4211af5400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_75d45764-0d91-409a-8740-9f4211af5400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_fef2d6d5-dd3a-4cf3-aa11-762c566ded75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_fef2d6d5-dd3a-4cf3-aa11-762c566ded75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_899b32d4-f849-4cbc-8dd7-c36705a2ea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_899b32d4-f849-4cbc-8dd7-c36705a2ea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da298955-a699-4ae9-85c8-d29a0cc004bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cf8d39d-5cb1-4bf9-86a4-f80292f87062" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da298955-a699-4ae9-85c8-d29a0cc004bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f623fdb-5ad6-46e8-a32b-f253283c6ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_9bc46502-b2c5-4730-9ab5-b0bda0fd3ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f623fdb-5ad6-46e8-a32b-f253283c6ee3" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_9bc46502-b2c5-4730-9ab5-b0bda0fd3ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock_62e13b74-fd66-4702-944b-6302dc7dec85" xlink:href="hr-20240630.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f623fdb-5ad6-46e8-a32b-f253283c6ee3" xlink:to="loc_hr_AssetDispositionsTableTextBlock_62e13b74-fd66-4702-944b-6302dc7dec85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_2f20b8ea-d947-4ed4-b259-6cec0a4d5ab8" xlink:href="hr-20240630.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0f623fdb-5ad6-46e8-a32b-f253283c6ee3" xlink:to="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_2f20b8ea-d947-4ed4-b259-6cec0a4d5ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesTables" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5de2fc8e-d277-4e5c-8c38-377ba74abfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_29684042-c72f-4ce8-a9f8-9a5f7796184e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5de2fc8e-d277-4e5c-8c38-377ba74abfc6" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_29684042-c72f-4ce8-a9f8-9a5f7796184e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7e0e09ba-5e2a-46a8-95bc-318290c15217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5de2fc8e-d277-4e5c-8c38-377ba74abfc6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7e0e09ba-5e2a-46a8-95bc-318290c15217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9d4de872-ac4c-44fc-bc85-2ac2be6b1cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5de2fc8e-d277-4e5c-8c38-377ba74abfc6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9d4de872-ac4c-44fc-bc85-2ac2be6b1cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_355d3f94-bc44-46f4-b196-91a4208b6cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5de2fc8e-d277-4e5c-8c38-377ba74abfc6" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_355d3f94-bc44-46f4-b196-91a4208b6cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayableTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_06f18d80-eb79-4578-9abe-e55b23d308a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_7a8ea2c5-7403-46ad-a7eb-6061b3a373fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_06f18d80-eb79-4578-9abe-e55b23d308a8" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_7a8ea2c5-7403-46ad-a7eb-6061b3a373fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3b4e827e-75d9-453d-8e08-2629e926fcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36baffa0-d76d-43fc-933e-6ad74192f96e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3b4e827e-75d9-453d-8e08-2629e926fcdc" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36baffa0-d76d-43fc-933e-6ad74192f96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_98320650-a708-47f1-8167-0d590eb366fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3b4e827e-75d9-453d-8e08-2629e926fcdc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_98320650-a708-47f1-8167-0d590eb366fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_c27bf59a-e7ff-478b-bde5-3a1e135a4c97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_c27bf59a-e7ff-478b-bde5-3a1e135a4c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4837c3eb-aa88-43da-9a7c-b9710f52c4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4837c3eb-aa88-43da-9a7c-b9710f52c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_54350451-952d-4e0c-8114-5d57fd7dbfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_54350451-952d-4e0c-8114-5d57fd7dbfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_89607f32-28d4-490c-b298-471cdcf5a773" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_89607f32-28d4-490c-b298-471cdcf5a773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_c153ec0c-f1b5-4074-8992-707b62494d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69e6eee5-d210-4058-bbf9-513146e7d11b" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_c153ec0c-f1b5-4074-8992-707b62494d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20240630.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0a663a91-1cc8-4c93-b621-d131d2b60b28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_f63543d9-46a3-4a75-9e9f-ae580193e6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0a663a91-1cc8-4c93-b621-d131d2b60b28" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_f63543d9-46a3-4a75-9e9f-ae580193e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_80aa87dd-6605-411e-9785-54ff04d2911d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_80aa87dd-6605-411e-9785-54ff04d2911d" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4ac7cf83-0974-40fa-b79b-00b7215b8b20" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b8f0defe-d8cf-44b4-9176-437bd3d972a6" xlink:href="hr-20240630.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3f35f455-480d-4508-9734-39c283a22eea" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_b8f0defe-d8cf-44b4-9176-437bd3d972a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1927342-91f8-410c-bd61-e4db3c770594" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_516f0ca5-3d7e-4be5-bf25-fbc0cac4cc8a" xlink:href="hr-20240630.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_516f0ca5-3d7e-4be5-bf25-fbc0cac4cc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e0ced55a-adc3-420a-8e63-fa9832e0bf48" xlink:href="hr-20240630.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7efe12e1-4304-421a-b272-996e15d8ac75" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e0ced55a-adc3-420a-8e63-fa9832e0bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_9e35547d-89b1-4eab-81f2-680c82f5d957" xlink:to="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_79b10ad8-6247-45c6-9858-9a12aa94ef33" xlink:href="hr-20240630.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_79b10ad8-6247-45c6-9858-9a12aa94ef33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_527e7157-330d-457b-8a81-0bc1740bb2f2" xlink:href="hr-20240630.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_91e78f03-9d26-4c9d-b335-b5558fb6e848" xlink:to="loc_hr_NonControllingInterestHoldersMember_527e7157-330d-457b-8a81-0bc1740bb2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d0652643-020c-42e3-85fa-d294346dc8af" xlink:to="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_80a75702-8a79-404e-8bf9-1f529aeff8fe" xlink:href="hr-20240630.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_80a75702-8a79-404e-8bf9-1f529aeff8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e8d7422f-b42c-4402-9ef4-bdb26ac9a2f3" xlink:href="hr-20240630.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_e8d7422f-b42c-4402-9ef4-bdb26ac9a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherInvestorsMember_03db33dc-4f70-485c-95c9-92e5ead4ca4d" xlink:href="hr-20240630.xsd#hr_OtherInvestorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4368950f-f7fd-4d4e-a7a2-134845f0f2f6" xlink:to="loc_hr_OtherInvestorsMember_03db33dc-4f70-485c-95c9-92e5ead4ca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_87f38bb4-a32b-4f9a-9882-a3c67344352a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_5bee1a3e-ad85-4e52-b96f-b27932e08088" xlink:href="hr-20240630.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e9244074-5143-4047-86c0-f7f824c8528f" xlink:to="loc_hr_VariableInterestEntityMember_5bee1a3e-ad85-4e52-b96f-b27932e08088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_f04c0097-5a9b-4036-8066-bc538bca84bc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_12b6765a-3a31-4e2e-97d6-a202e40d649e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0479a142-3470-494b-8abd-7b95d258d6ec" xlink:to="loc_us-gaap_NotesReceivableMember_12b6765a-3a31-4e2e-97d6-a202e40d649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_5636ce53-f94a-4124-abc2-197e06f4712b" xlink:to="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OneMember_ed2b6a7a-9075-4300-b5b5-53997647565a" xlink:href="hr-20240630.xsd#hr_OneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_0994ecd5-cf4f-4e26-80c0-1e0c94f0f538" xlink:to="loc_hr_OneMember_ed2b6a7a-9075-4300-b5b5-53997647565a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_668581bf-a6bf-4296-95b1-24530a6334a7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4e5c13cb-b1ed-44e9-b96f-0f7b8d1b769a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6b43f47-4d30-49d8-a80e-8c0dcc1d5f5d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4e5c13cb-b1ed-44e9-b96f-0f7b8d1b769a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_ed7f4a71-a72f-4129-b5c6-f8492ce0cb51" xlink:to="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:href="hr-20240630.xsd#hr_BusinessOverviewAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_b27a348b-3506-4609-a37d-114cfd8d9174" xlink:href="hr-20240630.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_b27a348b-3506-4609-a37d-114cfd8d9174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_93017492-6241-488a-a523-4f33f3ec3a94" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_NumberOfRealEstateInvestments_93017492-6241-488a-a523-4f33f3ec3a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_affdef41-a836-4816-a190-c0035e78863b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_affdef41-a836-4816-a190-c0035e78863b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_16bfa080-99f4-40c4-ab92-c3d78e03864f" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures_16bfa080-99f4-40c4-ab92-c3d78e03864f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_39e39ce3-f11e-4713-b307-50535940ec11" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_39e39ce3-f11e-4713-b307-50535940ec11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_3ee1496e-342a-4f84-9470-21374351740e" xlink:href="hr-20240630.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_3ee1496e-342a-4f84-9470-21374351740e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_6b3b6766-fc08-4743-a7a1-c0da9a5ef8f9" xlink:href="hr-20240630.xsd#hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio_6b3b6766-fc08-4743-a7a1-c0da9a5ef8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1dd1ae68-7d32-498e-b747-d55107e1b421" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1dd1ae68-7d32-498e-b747-d55107e1b421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a65f790f-d16d-4e83-81f7-e7880582c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_39ab32c8-65ed-4b4f-873c-189595825468" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a65f790f-d16d-4e83-81f7-e7880582c2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6c6889b0-c7fb-41b6-9275-bfc9833ce489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6c6889b0-c7fb-41b6-9275-bfc9833ce489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_64f06ae2-361a-49b9-b20b-ff82bd14dcea" xlink:href="hr-20240630.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_64f06ae2-361a-49b9-b20b-ff82bd14dcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_42788dbe-4d12-4af4-981e-745cf6039867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_42788dbe-4d12-4af4-981e-745cf6039867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_4b5e0621-ccc6-4cb3-a10e-fb14310d1b42" xlink:href="hr-20240630.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfVariableInterestEntities_4b5e0621-ccc6-4cb3-a10e-fb14310d1b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_08c08aa8-59d8-4b05-837c-ce92e0555747" xlink:href="hr-20240630.xsd#hr_NumberOfNotesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfNotesReceivable_08c08aa8-59d8-4b05-837c-ce92e0555747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_a3779f62-db43-4236-a93f-0d6b95ec8fc7" xlink:href="hr-20240630.xsd#hr_NumberOfJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_537346ec-3e18-47db-a1ba-e2aa86d406d5" xlink:to="loc_hr_NumberOfJointVentures_a3779f62-db43-4236-a93f-0d6b95ec8fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c19252f-b226-4111-9000-e1bd9c8ccb33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_b62ab029-24bf-4c91-8a39-ef27fabe59ba" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c19252f-b226-4111-9000-e1bd9c8ccb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_b75b8ad5-aa52-4bcf-bb4b-aa071f15ebe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_b75b8ad5-aa52-4bcf-bb4b-aa071f15ebe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesMeasuredAtFairValue_91ae3d06-3a23-4181-957f-42855caf33f1" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesMeasuredAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_hr_NumberOfPropertiesMeasuredAtFairValue_91ae3d06-3a23-4181-957f-42855caf33f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_9dbac6a5-d4e2-4ea0-9c67-10d5842e2625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_264ab8dd-57f7-4f5a-b1d1-b2c3998485f6" xlink:to="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_9dbac6a5-d4e2-4ea0-9c67-10d5842e2625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReportingUnitCarryingValue_9d75f78b-a872-4360-9b81-64a934666059" xlink:href="hr-20240630.xsd#hr_ReportingUnitCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:to="loc_hr_ReportingUnitCarryingValue_9d75f78b-a872-4360-9b81-64a934666059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b782b46f-fef4-48e1-939e-4922da1925d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillImpairedAbstract_bdf75b06-afa4-42b4-9248-67fa73b2cdac" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b782b46f-fef4-48e1-939e-4922da1925d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_75611dc6-4b13-4bf1-92e2-9f64e3e05e27" xlink:href="hr-20240630.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_9eea1af4-5a23-4784-a634-80f0a9481b08" xlink:to="loc_hr_RealEstateNotesReceivableNet_75611dc6-4b13-4bf1-92e2-9f64e3e05e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2bebd3d4-91b8-4092-8523-d5c8b1f177c7" xlink:to="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMezzanineLoans_33be4765-e01d-4920-886c-d5c57182c261" xlink:href="hr-20240630.xsd#hr_NumberOfMezzanineLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfMezzanineLoans_33be4765-e01d-4920-886c-d5c57182c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfMortgageLoans_3ea7e3f1-9c5e-4c91-a61f-9d18cdd42278" xlink:href="hr-20240630.xsd#hr_NumberOfMortgageLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfMortgageLoans_3ea7e3f1-9c5e-4c91-a61f-9d18cdd42278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_64bda9ec-f287-4d81-a7ea-14801ca5a841" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_64bda9ec-f287-4d81-a7ea-14801ca5a841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_5622ff93-8d38-4661-b3d7-d5ca742ceab8" xlink:href="hr-20240630.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_5622ff93-8d38-4661-b3d7-d5ca742ceab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_3d13ef4f-4ce1-4865-b14a-42cdd5d0acf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_3d13ef4f-4ce1-4865-b14a-42cdd5d0acf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_81fca982-d503-4041-858c-4655a864abe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_InterestIncomeOperating_81fca982-d503-4041-858c-4655a864abe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_0831b7e4-5ee5-4401-99a4-bacfae5935b9" xlink:href="hr-20240630.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_0831b7e4-5ee5-4401-99a4-bacfae5935b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_4524bfc7-4a20-45f7-9331-0c4a8603fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_33669546-cc45-4146-96a4-c22e4a1c8d4c" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_4524bfc7-4a20-45f7-9331-0c4a8603fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ce18f83a-e2a3-438b-93ce-bd11d3373033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ce18f83a-e2a3-438b-93ce-bd11d3373033" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8e7542c1-babe-47dd-b036-4729539d3637" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_8f1d678f-302b-4188-832e-1af83cc05d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dafe0b12-f3ae-4cd8-a6c3-ae6f4e4317fd" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_8f1d678f-302b-4188-832e-1af83cc05d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_70852c98-13fe-4854-ab6c-e3f70dd38f6b" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:to="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_e5905953-edd6-4c8d-9627-0621e812400f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_e5905953-edd6-4c8d-9627-0621e812400f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f35c0def-9de8-4ebc-a3d0-12c8484f83b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f35c0def-9de8-4ebc-a3d0-12c8484f83b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_eac5d190-b8ca-410d-b4ff-7b7285ce314b" xlink:href="hr-20240630.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_hr_ReceivablesAndOtherAssets_eac5d190-b8ca-410d-b4ff-7b7285ce314b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5e9c5d3b-83bc-4b86-a6c5-cbf32a737b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77d6b730-0f9c-471f-afe5-ceea61fde4fb" xlink:to="loc_us-gaap_Assets_5e9c5d3b-83bc-4b86-a6c5-cbf32a737b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_343db73a-255f-489c-a2ad-f54a51e2500b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_20e3212d-d563-4081-9149-83cc1bc5396f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_20e3212d-d563-4081-9149-83cc1bc5396f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dd2d8195-68b2-4ad5-969b-7d0a53de0e01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_Liabilities_dd2d8195-68b2-4ad5-969b-7d0a53de0e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34f985c2-9549-4aea-824d-315fc2e9f1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_34f985c2-9549-4aea-824d-315fc2e9f1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13acceb5-fbcc-4e8b-9def-6a0698ae504d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_StockholdersEquity_13acceb5-fbcc-4e8b-9def-6a0698ae504d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetLossAttributableToCommonStockholders_aa63ecab-31e6-4c25-a916-20cd5c8e5af2" xlink:href="hr-20240630.xsd#hr_CumulativeNetLossAttributableToCommonStockholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_hr_CumulativeNetLossAttributableToCommonStockholders_aa63ecab-31e6-4c25-a916-20cd5c8e5af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_abf40c1f-0d81-429d-8f52-3aaef333b7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_abf40c1f-0d81-429d-8f52-3aaef333b7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fe015c56-76dd-4a1e-ba1e-6a70b62d033c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d858a46d-2514-46ca-be9a-2e60fcfd097f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fe015c56-76dd-4a1e-ba1e-6a70b62d033c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_04912a97-614d-47aa-80eb-3c4b6d94ad47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_04912a97-614d-47aa-80eb-3c4b6d94ad47" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:to="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_25ea7917-4bb4-44f1-be14-0607cf4223e6" xlink:to="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_d0671ec5-d783-4f67-b133-6257b1614e45" xlink:href="hr-20240630.xsd#hr_HoustonTexasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_hr_HoustonTexasMember_d0671ec5-d783-4f67-b133-6257b1614e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_895b55e6-d65d-49c7-9dc4-625e61281fc1" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_stpr_NC_895b55e6-d65d-49c7-9dc4-625e61281fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_d32ec452-4123-4ac0-ac82-fe182511d59e" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d54ffd8d-161c-4308-8709-aa01605d8655" xlink:to="loc_stpr_TX_d32ec452-4123-4ac0-ac82-fe182511d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_49e22d71-8de4-4d46-8d75-92249c3be785" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_56ac111b-f5c7-4f05-925f-5e3bc8fe8001" xlink:href="hr-20240630.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:to="loc_hr_VariableInterestEntityMember_56ac111b-f5c7-4f05-925f-5e3bc8fe8001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4f75c91e-beb2-42dc-9bff-82906376aac9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8657857e-815e-4b08-b09f-6a4a2245893b" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4f75c91e-beb2-42dc-9bff-82906376aac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_19a44010-7b4a-4e71-81fe-d3da51c9106b" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_4ab5c303-8a5b-4f8a-a04c-b3e41c6803b2" xlink:href="hr-20240630.xsd#hr_NumberOfNotesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_NumberOfNotesReceivable_4ab5c303-8a5b-4f8a-a04c-b3e41c6803b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_c6188972-bb89-4928-8f1c-0c12400cb0bf" xlink:href="hr-20240630.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_NotesReceivableCarryingAmount_c6188972-bb89-4928-8f1c-0c12400cb0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_1b03eb69-9806-4dd9-9e18-4ce84fd865af" xlink:href="hr-20240630.xsd#hr_JointVentureCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_hr_JointVentureCarryingAmount_1b03eb69-9806-4dd9-9e18-4ce84fd865af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_aed8be09-0a42-4490-9306-00603f50bc45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_aed8be09-0a42-4490-9306-00603f50bc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_6cea8e65-6a4b-447e-8e54-7214615cface" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7e1a8286-b189-464f-8e28-00a6ddab61ad" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_6cea8e65-6a4b-447e-8e54-7214615cface" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_be90e628-1465-42cd-9ae1-d62251ee0d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_be90e628-1465-42cd-9ae1-d62251ee0d8a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:to="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_182b75fe-23dd-42bb-9617-1dc70cc1c8ca" xlink:to="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember_99581f67-6153-4756-a427-8cb00e5d62e9" xlink:href="hr-20240630.xsd#hr_PowayCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_PowayCAMember_99581f67-6153-4756-a427-8cb00e5d62e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember_5cadd470-23a0-44df-b143-eb692000f93d" xlink:href="hr-20240630.xsd#hr_ColumbusOHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_ColumbusOHMember_5cadd470-23a0-44df-b143-eb692000f93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_4033757d-a94c-439f-a05a-59336184c4c4" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_TX_4033757d-a94c-439f-a05a-59336184c4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ_3c0a7c16-2acb-4246-abe1-a9f676f99ec1" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_AZ"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_AZ_3c0a7c16-2acb-4246-abe1-a9f676f99ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_b3557267-c8f9-401e-a89d-d005d52a36f3" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_NC_b3557267-c8f9-401e-a89d-d005d52a36f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_a3d1b71f-0a31-4480-b525-2e37ccfb0f58" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_FL"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_FL_a3d1b71f-0a31-4480-b525-2e37ccfb0f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_fcf7be12-73f9-46c6-8dd9-c9fad8920fd6" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_stpr_CA_fcf7be12-73f9-46c6-8dd9-c9fad8920fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_Florida1Member_b358d6df-4d07-4f0e-abab-9285e46b9150" xlink:href="hr-20240630.xsd#hr_Florida1Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c0dee20-c2d3-4d9b-81ef-d318ed1cb762" xlink:to="loc_hr_Florida1Member_b358d6df-4d07-4f0e-abab-9285e46b9150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ab74caba-88f4-482b-9468-87ae81979b29" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember_9bd9cff2-f08a-4788-b9d0-4bbb9895ccfb" xlink:href="hr-20240630.xsd#hr_MezzanineLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:to="loc_hr_MezzanineLoanMember_9bd9cff2-f08a-4788-b9d0-4bbb9895ccfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_ae3cbd3b-fe2e-41ba-aa55-307120b9b7c0" xlink:href="hr-20240630.xsd#hr_MortgageLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_07bb4308-1c6a-4780-ae1a-fdfc48266d24" xlink:to="loc_hr_MortgageLoanMember_ae3cbd3b-fe2e-41ba-aa55-307120b9b7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_79bbe32e-627b-47af-8ad9-6c633e66ba49" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_206a1f23-ef0e-43aa-8ab4-2cffdd15b2ed" xlink:href="hr-20240630.xsd#hr_NotesReceivableInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_NotesReceivableInterestRate_206a1f23-ef0e-43aa-8ab4-2cffdd15b2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue_6979b7d4-7c56-4946-9341-9f56ee8ba85d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_SaleLeasebackTransactionNetBookValue_6979b7d4-7c56-4946-9341-9f56ee8ba85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_eafb1c28-5b45-4a82-b9ab-092cbe4aa08a" xlink:href="hr-20240630.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_eafb1c28-5b45-4a82-b9ab-092cbe4aa08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_150c54b8-aaa9-44de-b0e3-381bc7cd446e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_150c54b8-aaa9-44de-b0e3-381bc7cd446e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableAndOtherAssets_c9884427-1811-4a3c-8f7c-410bb961d08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_InterestReceivableAndOtherAssets_c9884427-1811-4a3c-8f7c-410bb961d08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_36948605-e01c-4ef6-b71d-67eb78ab045c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_36948605-e01c-4ef6-b71d-67eb78ab045c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_37e46209-abfc-4573-9692-3e270a3c17e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_37e46209-abfc-4573-9692-3e270a3c17e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_c2b3c219-d438-4312-9de1-4b28554e9208" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_c2b3c219-d438-4312-9de1-4b28554e9208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_86f8024a-0008-4787-a8f1-f24221a3f4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_InterestIncomeOperating_86f8024a-0008-4787-a8f1-f24221a3f4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9a5edabf-a3bd-4152-8590-6ca76b0a88d8" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9a5edabf-a3bd-4152-8590-6ca76b0a88d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_7b1e5ab6-d023-4bf2-a859-31e0522eb3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease_7b1e5ab6-d023-4bf2-a859-31e0522eb3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossInterest_f9dfcd8f-e66e-4bfc-a732-aa38d0ed39c0" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d15cba85-1235-4dea-ad96-1b61a2172a07" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossInterest_f9dfcd8f-e66e-4bfc-a732-aa38d0ed39c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_386a7829-ba0f-4e23-9105-763f8eeb8ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4f4b26b9-360a-45e1-a53b-9c8211008bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_386a7829-ba0f-4e23-9105-763f8eeb8ab6" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4f4b26b9-360a-45e1-a53b-9c8211008bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_92f9ddb3-f2bd-448a-b0da-4d57ba1f20cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4f4b26b9-360a-45e1-a53b-9c8211008bf3" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_92f9ddb3-f2bd-448a-b0da-4d57ba1f20cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_a891870e-f910-4861-b41c-cc965636fe8c" xlink:href="hr-20240630.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4f4b26b9-360a-45e1-a53b-9c8211008bf3" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_a891870e-f910-4861-b41c-cc965636fe8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_0eba1cd7-42cb-4cc6-83c4-982cbefc8590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4f4b26b9-360a-45e1-a53b-9c8211008bf3" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_0eba1cd7-42cb-4cc6-83c4-982cbefc8590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee7fdfdc-709f-44fc-81c6-ceadddc4402c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee7fdfdc-709f-44fc-81c6-ceadddc4402c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:to="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_07327563-538e-4da1-9139-8b4d9ab44fc8" xlink:to="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_7a2d36fa-8df5-48b4-a204-bb24d0bd141d" xlink:href="hr-20240630.xsd#hr_ParkingIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:to="loc_hr_ParkingIncomeMember_7a2d36fa-8df5-48b4-a204-bb24d0bd141d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_5cc7411a-7beb-4612-8e8c-f187b9988c82" xlink:href="hr-20240630.xsd#hr_ManagementFeeIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_88da69a6-ab87-4825-a229-891f651b1d51" xlink:to="loc_hr_ManagementFeeIncomeMember_5cc7411a-7beb-4612-8e8c-f187b9988c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_62a92c89-62bc-4c11-99fd-41fd5f63b71c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0fb209-7efd-4467-97dc-f349a87b0b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3c7cd66d-0c95-42fe-a276-b87a8ba17d95" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0fb209-7efd-4467-97dc-f349a87b0b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eaeb1aca-3ff1-46b8-9504-08db9c194fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eaeb1aca-3ff1-46b8-9504-08db9c194fb2" xlink:to="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_83cc2c2d-3b05-45b6-89b1-7fd1d51ee26c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_344c280a-1cc5-4482-81a5-74b97d52ab3a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_bbc9f826-3d29-45b3-93b1-16c0aad133b7" xlink:to="loc_srt_OtherPropertyMember_344c280a-1cc5-4482-81a5-74b97d52ab3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6eb14231-e513-42f2-a174-b1ebf7229f5f" xlink:to="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_3547c2c5-2847-42ab-b66b-188c8c212404" xlink:href="hr-20240630.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_71b87a70-aa56-41ad-a71e-8f7dd384a3cd" xlink:to="loc_hr_LosAngelesCaliforniaMember_3547c2c5-2847-42ab-b66b-188c8c212404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_34a4316f-fedf-4e4e-a597-d750326e1100" xlink:to="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_f1da0ec8-24c0-4f3e-a399-7ef915675889" xlink:href="hr-20240630.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_62ddf766-0e28-4729-8963-4deb562413cc" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_f1da0ec8-24c0-4f3e-a399-7ef915675889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_cad6aed3-7246-4390-9f55-f7a37da258b5" xlink:to="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:href="hr-20240630.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7753d4e5-b1bc-4173-982f-474fd87d4144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7753d4e5-b1bc-4173-982f-474fd87d4144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_9a4783ce-a333-47fc-a7e4-60c9c65b627f" xlink:href="hr-20240630.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_9a4783ce-a333-47fc-a7e4-60c9c65b627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c98e5631-1f3a-4bd5-819f-1bd16b17ff13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c98e5631-1f3a-4bd5-819f-1bd16b17ff13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_1511e093-0dee-4fe1-aafe-c455500321bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_1511e093-0dee-4fe1-aafe-c455500321bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b433b47a-ddb3-4569-bf06-aa8bb50af551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_a671111a-1b1f-404c-be93-305eb833ecfd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b433b47a-ddb3-4569-bf06-aa8bb50af551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_01dcc8ec-a0ce-4b8a-a4d6-f95d5227f7c4" xlink:href="hr-20240630.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_84860d69-8ee6-44b0-9176-98370e085cf9" xlink:to="loc_hr_JointVentureOwnershipPercentage_01dcc8ec-a0ce-4b8a-a4d6-f95d5227f7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a0c175ed-2770-46c7-804f-a53117fcb0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:href="hr-20240630.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a0c175ed-2770-46c7-804f-a53117fcb0fa" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_efdac11b-b318-49fe-ac8f-42aae91605a5" xlink:to="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember_d018a2cc-ea1d-49a7-9360-0a42eba0bdca" xlink:href="hr-20240630.xsd#hr_AlbanyNYMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AlbanyNYMember_d018a2cc-ea1d-49a7-9360-0a42eba0bdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SanAngeloTXMember_86ef5f15-292c-4a81-9221-d10709547272" xlink:href="hr-20240630.xsd#hr_SanAngeloTXMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_SanAngeloTXMember_86ef5f15-292c-4a81-9221-d10709547272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember_82c7a26a-3d94-4145-b8c5-2c44df7e548b" xlink:href="hr-20240630.xsd#hr_HoustonTXMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_HoustonTXMember_82c7a26a-3d94-4145-b8c5-2c44df7e548b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MultipleMember_4616404f-f345-4c2e-8d26-b1fecb7ab1e4" xlink:href="hr-20240630.xsd#hr_MultipleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_MultipleMember_4616404f-f345-4c2e-8d26-b1fecb7ab1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DenverCOMember_15d28b99-f92c-49a2-a184-7a499e346c12" xlink:href="hr-20240630.xsd#hr_DenverCOMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_DenverCOMember_15d28b99-f92c-49a2-a184-7a499e346c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AustinTXMember_19996b6b-cf3f-4292-a88e-3d5b92bbab42" xlink:href="hr-20240630.xsd#hr_AustinTXMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AustinTXMember_19996b6b-cf3f-4292-a88e-3d5b92bbab42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MinneapolisMNMember_555115e7-177b-4a7b-872f-e95538755377" xlink:href="hr-20240630.xsd#hr_MinneapolisMNMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_MinneapolisMNMember_555115e7-177b-4a7b-872f-e95538755377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroRaleighNCMember_5af99902-5d1f-46a0-8068-4c7f8b8adb69" xlink:href="hr-20240630.xsd#hr_GreensboroRaleighNCMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_GreensboroRaleighNCMember_5af99902-5d1f-46a0-8068-4c7f8b8adb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_4ac3a560-1a16-4558-b8eb-47d25ee6231f" xlink:href="hr-20240630.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_LosAngelesCaliforniaMember_4ac3a560-1a16-4558-b8eb-47d25ee6231f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeattleWAMember_abf60f97-7520-4e20-b22b-b0a035d68926" xlink:href="hr-20240630.xsd#hr_SeattleWAMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_SeattleWAMember_abf60f97-7520-4e20-b22b-b0a035d68926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GreensboroNCMember_13f3e4f7-c1a8-4833-a051-363413fe613e" xlink:href="hr-20240630.xsd#hr_GreensboroNCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_GreensboroNCMember_13f3e4f7-c1a8-4833-a051-363413fe613e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RaleighNCMember_cee157a3-f2df-429f-929e-ef0c70f1506c" xlink:href="hr-20240630.xsd#hr_RaleighNCMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_RaleighNCMember_cee157a3-f2df-429f-929e-ef0c70f1506c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember_883d1e9c-212e-4140-be6d-b093a4c7157d" xlink:href="hr-20240630.xsd#hr_AtlantaGAMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_AtlantaGAMember_883d1e9c-212e-4140-be6d-b093a4c7157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PhiladelphiaPAMember_3396d323-e2f5-4373-b2ba-33298b34e861" xlink:href="hr-20240630.xsd#hr_PhiladelphiaPAMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_PhiladelphiaPAMember_3396d323-e2f5-4373-b2ba-33298b34e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewYorkNYMember_92ed7681-a81a-4ca8-ab2d-4aa97c49e53c" xlink:href="hr-20240630.xsd#hr_NewYorkNYMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8dfac63d-7623-4c84-94ba-8adf029fcba0" xlink:to="loc_hr_NewYorkNYMember_92ed7681-a81a-4ca8-ab2d-4aa97c49e53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_aeafb826-6739-47f1-a9db-91003cf0da65" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_bc86ae33-a197-4592-8b0d-f40407edbf59" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_31d9385d-1b9c-4f99-b876-5939890572b5" xlink:to="loc_hr_RealEstateDispositionsMember_bc86ae33-a197-4592-8b0d-f40407edbf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_87c3cdf1-3618-4845-97a6-cdf0bd94a3a9" xlink:to="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_b0fb7679-aa56-49fa-a42d-c94eb793b7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_cfb4a7c7-a130-4464-a9eb-7fb2b04b6c40" xlink:to="loc_us-gaap_CorporateJointVentureMember_b0fb7679-aa56-49fa-a42d-c94eb793b7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:href="hr-20240630.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_72811452-4ea2-48d8-8bed-712518385004" xlink:to="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_64cd71e0-a736-40e4-8f15-caf68b3fa13b" xlink:href="hr-20240630.xsd#hr_DispositionSalesPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_DispositionSalesPrice_64cd71e0-a736-40e4-8f15-caf68b3fa13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_c44532d5-c28f-4973-96d7-f21f93e01e82" xlink:href="hr-20240630.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_c44532d5-c28f-4973-96d7-f21f93e01e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_d22df1ba-4e35-417a-862e-ab8fe486ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_d22df1ba-4e35-417a-862e-ab8fe486ab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_e1da0c28-d57a-48c4-9b0b-e4bd658061d8" xlink:href="hr-20240630.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_e1da0c28-d57a-48c4-9b0b-e4bd658061d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_73fef696-4ac5-48b3-b0ac-623b778d5f43" xlink:href="hr-20240630.xsd#hr_RealEstateOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_RealEstateOther_73fef696-4ac5-48b3-b0ac-623b778d5f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_9562a04d-5d8c-4862-8ce1-958add6d1f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_9562a04d-5d8c-4862-8ce1-958add6d1f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_408bc137-0d07-48ab-b64f-24af59da3cdc" xlink:href="hr-20240630.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_408bc137-0d07-48ab-b64f-24af59da3cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_5e3fc9de-cfca-4ecc-ad04-ded24614412b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_5e3fc9de-cfca-4ecc-ad04-ded24614412b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_a27b69f2-0709-4ed4-884b-4e4c8587f212" xlink:href="hr-20240630.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_1d30c845-e293-44cc-bbdd-d12402311568" xlink:to="loc_hr_JointVentureOwnershipPercentage_a27b69f2-0709-4ed4-884b-4e4c8587f212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac8341d0-a50a-414c-bc85-9e8695eb1ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_db05e388-0fe9-4f74-a4cc-f9527b622326" xlink:href="hr-20240630.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac8341d0-a50a-414c-bc85-9e8695eb1ed1" xlink:to="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_db05e388-0fe9-4f74-a4cc-f9527b622326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_03621bfe-ba9f-476a-8c5f-c2966984178f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_03621bfe-ba9f-476a-8c5f-c2966984178f" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b21e848-c412-40a5-a48e-3409247f50ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7c3bacb4-7f32-48ee-86f2-13cb74cf47c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5f884b9a-1e9f-4625-932e-400103f9251d" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7c3bacb4-7f32-48ee-86f2-13cb74cf47c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_c4348c53-ea75-4af0-a05b-6ac7b31ef620" xlink:to="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_64fd5807-be1f-481b-8a57-6beded68398c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_Land_64fd5807-be1f-481b-8a57-6beded68398c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_747448a1-f046-4824-8532-f3cc1b42f2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_747448a1-f046-4824-8532-f3cc1b42f2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_097b6b55-60ee-45e9-a876-f7be16374425" xlink:href="hr-20240630.xsd#hr_LeaseIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_hr_LeaseIntangibles_097b6b55-60ee-45e9-a876-f7be16374425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_a14944bd-a512-4b27-a402-727db8e8bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_a14944bd-a512-4b27-a402-727db8e8bca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ca3bebb-1cd3-4d7f-a556-cec0a50435b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ca3bebb-1cd3-4d7f-a556-cec0a50435b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_3907c9e3-6253-4054-8597-c027553dc73a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_3907c9e3-6253-4054-8597-c027553dc73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a4c3dedc-176c-4ce5-a145-105d0ae4115d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a4c3dedc-176c-4ce5-a145-105d0ae4115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a490240-a6f6-43e2-8eda-5fc10a451c46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a490240-a6f6-43e2-8eda-5fc10a451c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_978fcbd5-8860-4299-a069-fb07b518b5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_978fcbd5-8860-4299-a069-fb07b518b5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_0fec2091-2197-495e-940b-b8b28bb0a21b" xlink:href="hr-20240630.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_0fec2091-2197-495e-940b-b8b28bb0a21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_cea606b0-7f8c-4907-ac91-7a4314c95394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_cea606b0-7f8c-4907-ac91-7a4314c95394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d4e42f1d-5f6e-414a-b29c-4841a571bf86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_OperatingLeaseLiability_d4e42f1d-5f6e-414a-b29c-4841a571bf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f8cbb0a0-2374-40c2-b8db-2246f4f6f0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_f8cbb0a0-2374-40c2-b8db-2246f4f6f0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6d10708b-5b58-4591-b56e-3c85ed43effb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_9431bea9-8067-449d-9b78-1b9be4f8b015" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6d10708b-5b58-4591-b56e-3c85ed43effb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e13b3c74-8876-48bb-a817-62a0e2f77c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_98926093-cb83-4d10-b145-1e261ca829fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e13b3c74-8876-48bb-a817-62a0e2f77c9a" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_98926093-cb83-4d10-b145-1e261ca829fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesLessorAccountingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_beb23daf-ba63-47fa-aff1-8e05b2e88412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_beb23daf-ba63-47fa-aff1-8e05b2e88412" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_efc9420d-bc8b-4987-9a89-c72affd805b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_efc9420d-bc8b-4987-9a89-c72affd805b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_3ed83a7e-6b35-4e88-b3c0-98025545145f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_3ed83a7e-6b35-4e88-b3c0-98025545145f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_e9510ed2-093a-4c11-a658-a9b61b7eb30b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_e9510ed2-093a-4c11-a658-a9b61b7eb30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_f9521629-1d37-4f63-9a44-5671baf92e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_f9521629-1d37-4f63-9a44-5671baf92e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_3ffc8202-5817-4553-b365-ee5e2a5024cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_3ffc8202-5817-4553-b365-ee5e2a5024cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_0bcdb5db-2b51-4fef-bdaf-8bd42dbd408b" xlink:href="hr-20240630.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_0bcdb5db-2b51-4fef-bdaf-8bd42dbd408b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_018d7050-0a9e-44a8-aa4a-da589afc7fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_b0f95b71-68b2-4ac5-8e46-a900ae06bee5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_018d7050-0a9e-44a8-aa4a-da589afc7fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesGroundLeasesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d0e142a3-9f83-4117-a570-c0f76904d236" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d0e142a3-9f83-4117-a570-c0f76904d236" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:to="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_87a69154-aa23-41be-9ada-df676f62fb9c" xlink:to="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bca5f0a2-43c9-46b8-8463-5884a7ea8c7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:to="loc_srt_MinimumMember_bca5f0a2-43c9-46b8-8463-5884a7ea8c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26b8215f-54e7-49e4-a52b-345466dabb2c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27a76a1f-77ac-4104-8801-bd91a44d29a6" xlink:to="loc_srt_MaximumMember_26b8215f-54e7-49e4-a52b-345466dabb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a320c921-3cf4-4ef1-ba5d-86d1f3505090" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_6ac63194-073f-48ce-af74-c06ba7c9409a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_6ac63194-073f-48ce-af74-c06ba7c9409a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_a17fb90f-3690-4136-aa3c-c4b543b9f046" xlink:href="hr-20240630.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_a17fb90f-3690-4136-aa3c-c4b543b9f046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0371a1ec-c9af-4bbe-8ed7-6ef187f6b918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0371a1ec-c9af-4bbe-8ed7-6ef187f6b918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_4211696f-0f21-4d22-b089-ce2fe6397f68" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_4211696f-0f21-4d22-b089-ce2fe6397f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_168ba543-9676-4a75-ade8-5bfec63e4f62" xlink:href="hr-20240630.xsd#hr_AmortizationofPrepaidRent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_AmortizationofPrepaidRent_168ba543-9676-4a75-ade8-5bfec63e4f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_1df3f817-4927-45ee-8e1e-5a3357d0e47e" xlink:href="hr-20240630.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_db65937e-c56c-4a4d-8b02-8ca8d211dfc1" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_1df3f817-4927-45ee-8e1e-5a3357d0e47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2a68b58e-d156-424b-b102-6c3f2461ee6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2a68b58e-d156-424b-b102-6c3f2461ee6c" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_03b7eef9-f030-4527-a152-485607ca947c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_03b7eef9-f030-4527-a152-485607ca947c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_92292dcf-c896-4902-b66d-c98fb4299a07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_92292dcf-c896-4902-b66d-c98fb4299a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_be8091ed-d68b-4f2f-9303-85793355c282" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_be8091ed-d68b-4f2f-9303-85793355c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4b1a619a-7e53-4565-a49f-e32b3768d317" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4b1a619a-7e53-4565-a49f-e32b3768d317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_028ed211-40db-40cd-a001-3c87d3e074d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_028ed211-40db-40cd-a001-3c87d3e074d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_07c6d03c-081e-4d71-beed-58ada482536c" xlink:href="hr-20240630.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_07c6d03c-081e-4d71-beed-58ada482536c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_63ab5908-5c48-4a5f-be18-4fa1efc2e35d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_63ab5908-5c48-4a5f-be18-4fa1efc2e35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_daebf277-89ff-4027-a69c-6850ed6bff07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_daebf277-89ff-4027-a69c-6850ed6bff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d84c68ca-40e0-426f-a215-1da027220644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cb2bd1b9-0a35-495d-b191-f184aa695199" xlink:to="loc_us-gaap_OperatingLeaseLiability_d84c68ca-40e0-426f-a215-1da027220644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2a68b58e-d156-424b-b102-6c3f2461ee6c" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_80208f73-ffe9-498c-8d91-836b662673a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_80208f73-ffe9-498c-8d91-836b662673a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_312c8448-73da-4138-a19a-b174b998532d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_312c8448-73da-4138-a19a-b174b998532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_afe6b228-106b-4814-abff-175ab98f3cab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_afe6b228-106b-4814-abff-175ab98f3cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5f016411-032a-46b2-b954-88a10774fce9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5f016411-032a-46b2-b954-88a10774fce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_94e15ff4-bbcc-454a-bda7-6939bca39ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_94e15ff4-bbcc-454a-bda7-6939bca39ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_fb21fbf5-4a1f-40db-a80f-1eae882c029d" xlink:href="hr-20240630.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_fb21fbf5-4a1f-40db-a80f-1eae882c029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_31997d36-2eab-452a-a4c0-44386cbded89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_31997d36-2eab-452a-a4c0-44386cbded89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9eb92d4e-8d32-46cc-a4f9-7239117b21ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9eb92d4e-8d32-46cc-a4f9-7239117b21ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_996b6d47-c440-4f5c-b057-5a74e1f72084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_548aaef3-d808-489e-9a10-436ff892988f" xlink:to="loc_us-gaap_FinanceLeaseLiability_996b6d47-c440-4f5c-b057-5a74e1f72084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d3bd4653-a007-4c0e-ba0b-300d19de169d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_4c5b50df-b371-4dad-891d-0f2659c62c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d3bd4653-a007-4c0e-ba0b-300d19de169d" xlink:to="loc_us-gaap_LeaseCostAbstract_4c5b50df-b371-4dad-891d-0f2659c62c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_41017dba-d923-4f77-ae72-0dd5ae9ed85f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_4c5b50df-b371-4dad-891d-0f2659c62c1d" xlink:to="loc_us-gaap_OperatingLeaseCost_41017dba-d923-4f77-ae72-0dd5ae9ed85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_adf620b1-6bdf-4633-aa06-4bf721cb1171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_4c5b50df-b371-4dad-891d-0f2659c62c1d" xlink:to="loc_us-gaap_VariableLeaseCost_adf620b1-6bdf-4633-aa06-4bf721cb1171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f6c6df51-c456-4fd5-a680-3895a89d81d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d3bd4653-a007-4c0e-ba0b-300d19de169d" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f6c6df51-c456-4fd5-a680-3895a89d81d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_27a8e590-4788-4922-b2d7-43ab4cd4e687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f6c6df51-c456-4fd5-a680-3895a89d81d0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_27a8e590-4788-4922-b2d7-43ab4cd4e687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_fc2d3b39-415c-4e45-8487-20b13230351e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f6c6df51-c456-4fd5-a680-3895a89d81d0" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_fc2d3b39-415c-4e45-8487-20b13230351e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_45ea7c7f-0e26-4113-ae6e-a126b7758f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_f6c6df51-c456-4fd5-a680-3895a89d81d0" xlink:to="loc_us-gaap_LeaseCost_45ea7c7f-0e26-4113-ae6e-a126b7758f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d3bd4653-a007-4c0e-ba0b-300d19de169d" xlink:to="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2b938047-bd16-4db2-b91b-c55120d51f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_OperatingLeasePayments_2b938047-bd16-4db2-b91b-c55120d51f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_ad028d02-daa3-4796-b299-c2de4bde8bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_ad028d02-daa3-4796-b299-c2de4bde8bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments_8c7285d1-2e0d-4176-af26-83b9989bd257" xlink:href="hr-20240630.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_hr_FinanceLeasePrincipalOnlyPayments_8c7285d1-2e0d-4176-af26-83b9989bd257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c8ba4691-9888-48c6-8f87-02e75b9bc3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c8ba4691-9888-48c6-8f87-02e75b9bc3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e6b42e4b-a8fb-4b7d-83b1-1b69b7dffac9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e6b42e4b-a8fb-4b7d-83b1-1b69b7dffac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b1687806-95c3-48e3-8374-99ce599cce94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b1687806-95c3-48e3-8374-99ce599cce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_110facec-e808-47b8-9ca9-63948cb80273" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_110facec-e808-47b8-9ca9-63948cb80273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7eb4cd20-196e-451f-88ab-0cebf0e5764d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_38aa8078-81b8-49a9-bee3-2db33ca2e087" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7eb4cd20-196e-451f-88ab-0cebf0e5764d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_57d1648f-629b-4965-a662-9f824bf303bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_57d1648f-629b-4965-a662-9f824bf303bf" xlink:to="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c4e0a11-ef1f-423b-b332-9952aa4da753" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3142dab5-79c8-43e6-a96b-a904cafffa45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_LineOfCreditMember_3142dab5-79c8-43e6-a96b-a904cafffa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_0fc278f0-8a11-43f1-93e1-82356116134a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_MediumTermNotesMember_0fc278f0-8a11-43f1-93e1-82356116134a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5a3dda40-795b-436e-9377-5ee5a64d119d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_SeniorNotesMember_5a3dda40-795b-436e-9377-5ee5a64d119d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_f6d587bd-4023-4eea-aec9-a1fe1e834439" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_631b67bc-09e3-4143-b04b-a84ec98c8b78" xlink:to="loc_us-gaap_MortgagesMember_f6d587bd-4023-4eea-aec9-a1fe1e834439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ebbd83b-d0aa-43e3-82c4-cb17bd4d011e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_1dcf003f-dbf8-4a92-89b3-3118abaf23c7" xlink:href="hr-20240630.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_1dcf003f-dbf8-4a92-89b3-3118abaf23c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2025Member_76bb84ed-621e-4980-bd4d-eeb600d9794e" xlink:href="hr-20240630.xsd#hr_TermLoanDueMay2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDueMay2025Member_76bb84ed-621e-4980-bd4d-eeb600d9794e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member_f2b68aa1-411b-497a-8887-ea6d5a989438" xlink:href="hr-20240630.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDueJuly2024Member_f2b68aa1-411b-497a-8887-ea6d5a989438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_df637a19-6ad6-403c-87de-c38b830e4d72" xlink:href="hr-20240630.xsd#hr_TermLoanDue2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2025Member_df637a19-6ad6-403c-87de-c38b830e4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_1e57c05a-80d9-45fa-9b97-fd0ca329fe19" xlink:href="hr-20240630.xsd#hr_TermLoandue2026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoandue2026Member_1e57c05a-80d9-45fa-9b97-fd0ca329fe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_3bfb7dc9-2897-4715-bbbb-f990432ef8bb" xlink:href="hr-20240630.xsd#hr_TermLoanDue2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2027Member_3bfb7dc9-2897-4715-bbbb-f990432ef8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_8a624e09-71d3-427b-a618-4366f1d03c33" xlink:href="hr-20240630.xsd#hr_TermLoanDue2028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_TermLoanDue2028Member_8a624e09-71d3-427b-a618-4366f1d03c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_a9ba5561-4bcb-4a14-a2e3-a1fb916c6641" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2025Member_a9ba5561-4bcb-4a14-a2e3-a1fb916c6641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_5ea98b10-2a0d-42ad-9dbd-d92d487c6ac0" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2026Member_5ea98b10-2a0d-42ad-9dbd-d92d487c6ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_f9123a7b-48db-4ddc-b391-62ea4d4c8aea" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2027Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2027Member_f9123a7b-48db-4ddc-b391-62ea4d4c8aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_44f49ee8-c121-4b9f-b861-0032fe427dfc" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2028Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2028Member_44f49ee8-c121-4b9f-b861-0032fe427dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_901d9e14-b1a9-4e79-8e9f-93aa843432e8" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_901d9e14-b1a9-4e79-8e9f-93aa843432e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_89c37493-d36c-457f-9f57-a4d0a72255eb" xlink:href="hr-20240630.xsd#hr_SeniorNotesdue2030Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesdue2030Member_89c37493-d36c-457f-9f57-a4d0a72255eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_1cdebb22-e9f4-4718-8881-83637d1f5b52" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2031Member_1cdebb22-e9f4-4718-8881-83637d1f5b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_0c5f3a21-c8c1-4956-b739-0f6d79571744" xlink:href="hr-20240630.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_0c5f3a21-c8c1-4956-b739-0f6d79571744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_65607421-3a88-42ee-9862-5453a5fe2f34" xlink:href="hr-20240630.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_hr_MortgageNotesPayableNetMember_65607421-3a88-42ee-9862-5453a5fe2f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_3dde298e-4abc-42c4-8e0d-b9c77b4276d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_888eadc0-a0a5-4862-9dcb-07fcd6eb17d4" xlink:to="loc_us-gaap_UnsecuredDebtMember_3dde298e-4abc-42c4-8e0d-b9c77b4276d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a2170e61-4948-4264-b51a-48de9626b869" xlink:to="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e2622fe4-2ab4-42ae-8204-e693e6ec0e6b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:to="loc_srt_MinimumMember_e2622fe4-2ab4-42ae-8204-e693e6ec0e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af8e63c7-a47e-443d-8860-a95c6ef00e18" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61133fd2-2f43-4be6-a628-a28b444b9eaa" xlink:to="loc_srt_MaximumMember_af8e63c7-a47e-443d-8860-a95c6ef00e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7aeb5880-2bbe-4800-ac83-3e4dc26eebbe" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_dd988b1f-fda0-4c62-8a32-276dec18aeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LongTermDebt_dd988b1f-fda0-4c62-8a32-276dec18aeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_88232104-afa7-4bea-a658-f0749400fee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_88232104-afa7-4bea-a658-f0749400fee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_86d687cb-2820-48d1-a1c2-e790a21be2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_86d687cb-2820-48d1-a1c2-e790a21be2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7ae6c765-913e-446d-81bf-571911b20cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7ae6c765-913e-446d-81bf-571911b20cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5ae9b23c-1980-487a-9e9c-825a36672931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5ae9b23c-1980-487a-9e9c-825a36672931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_3a856c34-bc47-4508-aad0-ef916beb5bbe" xlink:href="hr-20240630.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_3a856c34-bc47-4508-aad0-ef916beb5bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_d609f68a-140c-4c95-9f78-b13bec7ba940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_d609f68a-140c-4c95-9f78-b13bec7ba940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepaidPrincipal_03815d8a-b163-489e-b489-15d2f098bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4894649-373f-4ef3-9da4-d11766699ba5" xlink:to="loc_us-gaap_DebtInstrumentRepaidPrincipal_03815d8a-b163-489e-b489-15d2f098bf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#NotesandBondsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0d77709a-ad2a-4bf3-a8be-2e4ce467e8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d77709a-ad2a-4bf3-a8be-2e4ce467e8ab" xlink:to="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_9baf17d4-1706-44a5-b880-d3085015789c" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_59f4fbc7-8d8d-41d2-aeda-784f5f336b22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_a84920e5-7144-423d-88e4-6d64f09ceae1" xlink:to="loc_us-gaap_MortgagesMember_59f4fbc7-8d8d-41d2-aeda-784f5f336b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d3027001-4c7c-4b52-b9e1-aff18bc9d42c" xlink:to="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a66ebc66-57f0-418d-8ac3-6d8fd597ec3b" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:to="loc_stpr_CA_a66ebc66-57f0-418d-8ac3-6d8fd597ec3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_c6d083cf-2ac7-4462-9cc2-4a70a0bbaa24" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_GA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c04acecb-baa1-44bc-9a4d-e02e16f4ff16" xlink:to="loc_stpr_GA_c6d083cf-2ac7-4462-9cc2-4a70a0bbaa24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_568f5282-96d8-4c19-b7a6-98962a7f1516" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_25fd6e23-8fed-4ee2-ba0f-ff4f2179f396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf032edf-be67-40e9-9e2c-d524c6bfcfe4" xlink:to="loc_us-gaap_MortgagesMember_25fd6e23-8fed-4ee2-ba0f-ff4f2179f396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eae66e9b-9f6f-4be3-bfe4-f7673d67256a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b71f237-a254-4cf4-9655-781dbfe981c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8b71f237-a254-4cf4-9655-781dbfe981c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6849d501-79d2-4c8b-8a49-6f9af531e528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6849d501-79d2-4c8b-8a49-6f9af531e528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_b4395b24-c7f2-42a0-a722-1b7115ce0100" xlink:href="hr-20240630.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f9b891b-0bac-40f6-bf8d-700dc73651e8" xlink:to="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_b4395b24-c7f2-42a0-a722-1b7115ce0100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_588eb3fa-d641-4698-88d7-216415ae6c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_588eb3fa-d641-4698-88d7-216415ae6c16" xlink:to="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_891ac685-0096-4805-90cd-cf463468100f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e08a5b-e948-41fb-a03f-b20322c5d4f4" xlink:to="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_d7d0e121-84da-4af8-b658-18b0de3c8dc5" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_d7d0e121-84da-4af8-b658-18b0de3c8dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_c0faf100-8327-4928-82db-591eca3dc1a5" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_c0faf100-8327-4928-82db-591eca3dc1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_70f3f5f4-7371-468b-8a25-0a267fc68e27" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_70f3f5f4-7371-468b-8a25-0a267fc68e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_a5f3be7b-f742-41cc-bd61-a518c1423016" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_a5f3be7b-f742-41cc-bd61-a518c1423016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_ec917cc4-55d1-4785-8a2b-52a48e9d2e70" xlink:href="hr-20240630.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_2d24956f-71d9-4798-91cc-d19ba046d146" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_ec917cc4-55d1-4785-8a2b-52a48e9d2e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_409136dc-8a43-4a60-abd0-b0a6acae7f0b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dbcd7cf0-9698-4c54-a997-96da051295de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_96145a78-7717-42ab-957b-25ed6d892d2e" xlink:to="loc_us-gaap_CashFlowHedgingMember_dbcd7cf0-9698-4c54-a997-96da051295de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_20bb8667-f83c-4341-9f19-ac3d25a06fb3" xlink:to="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ddfa39c6-cca0-47ad-8b74-3789b3154655" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9081cc7d-31c6-4c26-b534-e092450298e4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ddfa39c6-cca0-47ad-8b74-3789b3154655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_325cc549-722c-4a7d-91b2-b9a221514b89" xlink:to="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e08bbbca-806f-4a0b-8ad5-c0ce32c96c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e08bbbca-806f-4a0b-8ad5-c0ce32c96c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_367f42c7-a9e6-426c-8a9d-262458de4bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_DerivativeNotionalAmount_367f42c7-a9e6-426c-8a9d-262458de4bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_da1f5fca-d347-47f6-a146-60ee0cdfedf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6d15021a-fd85-49bd-b5cf-8d6989ec8f02" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_da1f5fca-d347-47f6-a146-60ee0cdfedf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a30b172-0924-4c32-8f7c-c1922fd7df24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a30b172-0924-4c32-8f7c-c1922fd7df24" xlink:to="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4170a7e3-ce26-4381-83d8-256796ae7a84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_529f584c-4111-40cd-b171-bc697d5abeff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:to="loc_us-gaap_OtherLiabilitiesMember_529f584c-4111-40cd-b171-bc697d5abeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_fdbb06cd-5fa1-4536-8447-22f1c483b4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_323135fd-9b47-435d-8b75-681f5f7cffeb" xlink:to="loc_us-gaap_OtherAssetsMember_fdbb06cd-5fa1-4536-8447-22f1c483b4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5beaba52-e41e-4990-905c-68b9cef1668b" xlink:to="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4725b44-415c-4170-a3a7-24216394a9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_856d3cef-d62a-43f7-a361-d107c055e67a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4725b44-415c-4170-a3a7-24216394a9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713f1d78-723a-4563-a07a-04c49475b311" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a52e4bf4-c815-41d4-a55b-43ae8e6aad78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9b298795-907d-4134-9627-8833e1d7c373" xlink:to="loc_us-gaap_InterestRateSwapMember_a52e4bf4-c815-41d4-a55b-43ae8e6aad78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f5b82aea-f168-407c-81b3-6546072a5313" xlink:to="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_52a53744-9647-4b83-863b-fa41d9d10e15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6d2903d4-b7d6-4e98-9c56-a7ce5b1a4a4b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_52a53744-9647-4b83-863b-fa41d9d10e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdea6b76-71aa-4a8a-85dc-7edb96d02d48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdea6b76-71aa-4a8a-85dc-7edb96d02d48" xlink:to="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40ea416e-7803-4cde-ab40-ca7128b0b255" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_1ac414d1-7980-46fa-b92b-c124b2e03f03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_InterestRateContractMember_1ac414d1-7980-46fa-b92b-c124b2e03f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_353a02e7-e27b-413d-b674-e447f650769c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_TreasuryLockMember_353a02e7-e27b-413d-b674-e447f650769c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ccb3c09d-cd8c-4af0-a71f-fc98b845f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_756e2540-c4bc-4a73-b538-a3a8f6837af0" xlink:to="loc_us-gaap_InterestRateSwapMember_ccb3c09d-cd8c-4af0-a71f-fc98b845f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d376b929-cfa4-44be-bf13-2ff071248479" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_5e2724e7-6361-4a4b-bbfa-af663ed904eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c85c89-33a6-4e6b-a986-46e444b43e53" xlink:to="loc_us-gaap_InterestExpenseMember_5e2724e7-6361-4a4b-bbfa-af663ed904eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d3fed0b1-ecf1-4a7d-81c9-ad9f8d7a15b3" xlink:to="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2b8aa5f9-f4ef-4436-98b8-49200641092f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2b8aa5f9-f4ef-4436-98b8-49200641092f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e265660b-79b6-4ed5-b8bd-020c513a1a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_568db7ac-021f-4c2e-a619-a6850f81c6c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e265660b-79b6-4ed5-b8bd-020c513a1a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7ff1024-e63e-4aef-9751-3e690d463bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7ff1024-e63e-4aef-9751-3e690d463bcb" xlink:to="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_376258f5-857e-4e39-96fb-2e623e4e614f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_d4102991-ffc7-4717-9ad7-72f342616631" xlink:href="hr-20240630.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:to="loc_hr_ActiveInterestRateSwapsMember_d4102991-ffc7-4717-9ad7-72f342616631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_25a947d6-a382-4676-bda5-f4814da23a60" xlink:href="hr-20240630.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eb6c9065-1f7a-4c2a-a99e-532dcf45a643" xlink:to="loc_hr_SettledInterestRateSwapsMember_25a947d6-a382-4676-bda5-f4814da23a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2221ac27-c5e2-439d-ae91-073beb86a3ce" xlink:to="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0640848a-f335-44aa-a4fd-bf6cc8d145a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0640848a-f335-44aa-a4fd-bf6cc8d145a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_d84c98e1-9457-45b7-b749-abe12ccc538b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d902ca7c-4213-4ff3-a8a7-5a89b0151b2b" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_d84c98e1-9457-45b7-b749-abe12ccc538b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91704b25-0398-4847-95f3-a3c3329dce07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91704b25-0398-4847-95f3-a3c3329dce07" xlink:to="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:to="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_bebc7a47-508d-4f5f-b386-18632df3bd29" xlink:to="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember_0b4dff0b-d28f-487c-be55-1a21800c81c5" xlink:href="hr-20240630.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_ActiveDevelopmentPropertiesMember_0b4dff0b-d28f-487c-be55-1a21800c81c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember_3f7cb756-2027-40b5-b136-a2d81fe612a8" xlink:href="hr-20240630.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_RedevelopmentPropertiesMember_3f7cb756-2027-40b5-b136-a2d81fe612a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_aec863d7-13eb-4ca6-b664-8c9d9d09a64e" xlink:href="hr-20240630.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_fd20ea24-a6de-4687-98c9-265f922059bc" xlink:to="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_aec863d7-13eb-4ca6-b664-8c9d9d09a64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_3e7502b4-adbb-43dc-9454-f47b899d0c7e" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_6dae4f80-3df3-48ee-8036-1c4ad7f5bab0" xlink:href="hr-20240630.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_28dc1eb3-cf8c-4ea0-b0d3-e227cba6ae72" xlink:to="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_6dae4f80-3df3-48ee-8036-1c4ad7f5bab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_99b245c6-234a-4551-a43a-de87c36e4841" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_99b245c6-234a-4551-a43a-de87c36e4841" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_211e85c4-92c8-452e-8675-4fffaf69db47" xlink:to="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_eb4e69e7-bd67-420c-94b8-5c98b5363f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_35dac6ff-c123-43bd-858c-ce33a09251db" xlink:to="loc_us-gaap_CommonStockMember_eb4e69e7-bd67-420c-94b8-5c98b5363f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fcd4e55a-0fd7-4360-a1a5-eeafae1b5242" xlink:to="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:href="hr-20240630.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b9dc4ea-d69b-49fa-9ff8-578fce51d396" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e0405a6f-0043-43f6-b814-c7a3bd3420dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e0405a6f-0043-43f6-b814-c7a3bd3420dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6f556bff-e8c6-4797-8dfa-95ac78ee7951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6f556bff-e8c6-4797-8dfa-95ac78ee7951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_dcce3847-f02c-4b5e-889e-2f9d6470ce39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_dcce3847-f02c-4b5e-889e-2f9d6470ce39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_fb50f76c-7739-4dbd-835d-1cf76b672c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_fb50f76c-7739-4dbd-835d-1cf76b672c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_468cf121-1986-4535-b7d7-63c39bc736fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_468cf121-1986-4535-b7d7-63c39bc736fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6a55e47e-319d-424d-90fb-9d2cca370c85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_e39ba80a-2425-430e-be59-0451f1fc1d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6a55e47e-319d-424d-90fb-9d2cca370c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_22026477-159e-4236-8dc6-92eda2395ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_22026477-159e-4236-8dc6-92eda2395ebd" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034b60e2-146d-41f2-a70e-6d4e14c3b6ef" xlink:to="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b705937f-ef8d-42e9-a547-7d0f20a87eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68f4cef6-65a1-4ffe-ab6a-bccd487bd0ad" xlink:to="loc_us-gaap_CommonStockMember_b705937f-ef8d-42e9-a547-7d0f20a87eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_299cf4b6-3713-432c-9448-8f965ebfd5fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2a9a1bab-4f2e-4116-9c67-7f8b0fda73b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e55fffb6-fca3-4b14-80e4-c1d22691205b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2a9a1bab-4f2e-4116-9c67-7f8b0fda73b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f45be8cd-a73c-4d9b-a16f-daf57193d3f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_8c3c8f3a-9398-4d8e-99a0-10906bbe7190" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_8c3c8f3a-9398-4d8e-99a0-10906bbe7190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_8173db5e-f42e-48e5-b0da-9fd889803241" xlink:href="hr-20240630.xsd#hr_NonVestedStockAwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_hr_NonVestedStockAwardMember_8173db5e-f42e-48e5-b0da-9fd889803241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a09ef02e-c479-4ed2-8918-5c068ee78f85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dded330-73f5-40b1-8392-a14821a24857" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a09ef02e-c479-4ed2-8918-5c068ee78f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f7e9a2e5-f105-44d1-bf74-2fae3b4402c1" xlink:to="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_1cfcd49f-d521-4f15-bf0d-9aa35ec7abb9" xlink:href="hr-20240630.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_1cfcd49f-d521-4f15-bf0d-9aa35ec7abb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesCUnitsMember_cf6aa6e2-b002-42ec-a205-f458b47dc68f" xlink:href="hr-20240630.xsd#hr_LTIPSeriesCUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_LTIPSeriesCUnitsMember_cf6aa6e2-b002-42ec-a205-f458b47dc68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_6216f8b3-bc99-4588-8adb-533a2c83c07c" xlink:href="hr-20240630.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_StockIncentivePlanMember_6216f8b3-bc99-4588-8adb-533a2c83c07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LTIPSeriesDUnitsMember_22b8beaa-1588-4f7b-a198-d5eab7719def" xlink:href="hr-20240630.xsd#hr_LTIPSeriesDUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_LTIPSeriesDUnitsMember_22b8beaa-1588-4f7b-a198-d5eab7719def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OtherMembersOfSeniorManagementMember_56f2f2ca-52b0-4a2a-862c-ba0d6b8194d2" xlink:href="hr-20240630.xsd#hr_OtherMembersOfSeniorManagementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_18671bb0-4904-4dc7-bdc8-5172aa8d0f99" xlink:to="loc_hr_OtherMembersOfSeniorManagementMember_56f2f2ca-52b0-4a2a-862c-ba0d6b8194d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_492a5a69-5a2c-4f27-b132-18129acbc4f4" xlink:to="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06a261b6-d936-466a-8301-fd3eed2e5b3f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:to="loc_srt_MinimumMember_06a261b6-d936-466a-8301-fd3eed2e5b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_50673ecb-b678-4642-840b-34045f112a97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf0b413f-f7ad-4d48-803d-6a32ba37caf6" xlink:to="loc_srt_MaximumMember_50673ecb-b678-4642-840b-34045f112a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_99caef5a-4ea0-4359-97cb-fffcc20a9596" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_dcd46c2c-e5bf-46b3-a274-7291d52b42a1" xlink:href="hr-20240630.xsd#hr_DirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_35f7b3f6-a6e5-4f27-b8cb-222f13d1e0fe" xlink:to="loc_hr_DirectorsMember_dcd46c2c-e5bf-46b3-a274-7291d52b42a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:href="hr-20240630.xsd#hr_StockIssuanceProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramAxis_fc6e84eb-29ce-40bc-8ad8-a3457b381986" xlink:to="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:href="hr-20240630.xsd#hr_PerformanceConditionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramDomain_713c7bf0-1e6c-4ef6-9d63-7c75e5bc984c" xlink:to="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_bd70f3df-9784-4ae4-b501-94a2a2a9d463" xlink:href="hr-20240630.xsd#hr_MarketCondition2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_PerformanceConditionsMember_fedd6a2d-96d4-4dcc-ab1b-022437452e7a" xlink:to="loc_hr_MarketCondition2Member_bd70f3df-9784-4ae4-b501-94a2a2a9d463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_bd2e7abf-7ac7-4154-b008-4bd2100473a5" xlink:to="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e1f18ef8-5bd3-4fed-8ad0-aefd35aec521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_479731c3-bef0-4289-bcb7-63698fb6ac20" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e1f18ef8-5bd3-4fed-8ad0-aefd35aec521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_914321f8-4c4d-4b37-ac95-5059ec77bc39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_76ca5f70-c7cb-4fa8-b617-62ca4718a7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b7aa73f8-91d7-481a-a346-09e65fb55712" xlink:to="loc_us-gaap_SubsequentEventMember_76ca5f70-c7cb-4fa8-b617-62ca4718a7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_614d7dc5-08f4-4a62-b82c-d9964da068bc" xlink:to="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_87732e26-5e18-4317-b8de-0c8077caae14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_87732e26-5e18-4317-b8de-0c8077caae14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_2f1bc9ed-ec9e-4447-89db-4ac5eaaa2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_2f1bc9ed-ec9e-4447-89db-4ac5eaaa2bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d393398f-9d16-48ee-8ae0-202f05021e41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d393398f-9d16-48ee-8ae0-202f05021e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_f90619af-ca2d-444a-ae55-9cc7c9758144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_f90619af-ca2d-444a-ae55-9cc7c9758144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d625a5c6-7a1b-4605-9d74-1d41b1a52d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d625a5c6-7a1b-4605-9d74-1d41b1a52d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_5f2e8d84-413a-4564-a438-9bf2ca99e498" xlink:href="hr-20240630.xsd#hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions_5f2e8d84-413a-4564-a438-9bf2ca99e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_22f630f0-000c-4517-a973-7e71e0cf791b" xlink:href="hr-20240630.xsd#hr_StockRepurchaseProgramAuthorizedAdditionalAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_StockRepurchaseProgramAuthorizedAdditionalAmount_22f630f0-000c-4517-a973-7e71e0cf791b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c4e586e-9901-4a21-9af2-5490c54cda27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7c4e586e-9901-4a21-9af2-5490c54cda27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_238687aa-79c3-4570-947b-ecf7438dbdac" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_238687aa-79c3-4570-947b-ecf7438dbdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_68ca33fd-f010-4e11-94e7-e64ae25886e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_68ca33fd-f010-4e11-94e7-e64ae25886e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a66c52b-e9dd-448d-b7bd-6bfdc59a8f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a66c52b-e9dd-448d-b7bd-6bfdc59a8f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_d3f40613-dbfe-4c42-a8fd-bc614e5bcaaa" xlink:href="hr-20240630.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_d3f40613-dbfe-4c42-a8fd-bc614e5bcaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_48521a3b-56d4-4660-b75e-a8a7e017e456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_48521a3b-56d4-4660-b75e-a8a7e017e456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_54b7194e-cb70-4854-bf63-03b01423b064" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_54b7194e-cb70-4854-bf63-03b01423b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_8c178e30-acc5-475b-986d-272d0a525daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a00f1ffa-b36b-4cf2-a8f7-4daa98e8e904" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_8c178e30-acc5-475b-986d-272d0a525daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_c58b0339-864b-4648-ba04-5356d2dc5064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_c58b0339-864b-4648-ba04-5356d2dc5064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d3acaaa1-e4b3-4f73-b8e9-90d73ac367cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d3acaaa1-e4b3-4f73-b8e9-90d73ac367cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5eee2e38-24b3-4773-a7e7-c278ee76e09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5eee2e38-24b3-4773-a7e7-c278ee76e09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_993f059b-19b0-43fd-8975-e1d1266a9c0b" xlink:href="hr-20240630.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_993f059b-19b0-43fd-8975-e1d1266a9c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1af0c6c-8549-4bf5-9236-023fe812df12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_275e5517-16fd-4338-90f4-05fbfb51905f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1af0c6c-8549-4bf5-9236-023fe812df12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cb087df3-05c8-4ed8-b1b5-a12d91fbbed2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_ProfitLoss_cb087df3-05c8-4ed8-b1b5-a12d91fbbed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07eaeb51-2cc1-4d80-9b84-a9594f9ba891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_07eaeb51-2cc1-4d80-9b84-a9594f9ba891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f9a7c84-16f7-4b74-9852-2b722c9f834b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f9a7c84-16f7-4b74-9852-2b722c9f834b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_4bd81f45-3373-4fde-8be3-1b43bfe007d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_4bd81f45-3373-4fde-8be3-1b43bfe007d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_6753cce8-1b64-437c-83ae-e753f81eabd9" xlink:href="hr-20240630.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_6753cce8-1b64-437c-83ae-e753f81eabd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c4d72097-3859-4896-af26-24b6e3e1af95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_EarningsPerShareBasic_c4d72097-3859-4896-af26-24b6e3e1af95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6a62f835-c7ba-45f0-88e8-2c74870bd1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df877c3d-e224-4f15-a539-8e676492d1c0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6a62f835-c7ba-45f0-88e8-2c74870bd1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bead210b-6318-4df0-89e5-b5a153c01f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bead210b-6318-4df0-89e5-b5a153c01f7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:to="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c24cc5b3-5568-4b4d-93e0-9ad284e400b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1c555eb-8467-42eb-ad14-93ad3cef6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1c555eb-8467-42eb-ad14-93ad3cef6e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_fcd69714-aef0-45cb-8f93-4f9f1262a1a4" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a9ff593-2a37-4213-baad-7fbfed487399" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_fcd69714-aef0-45cb-8f93-4f9f1262a1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939dec8-6f0c-4a87-bbfd-b6cb96ec3ef4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e76053cc-ea2c-40de-9a7e-38f0a6ad2dc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fe21a329-78b1-4450-b3a8-dd4aa47344c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fe21a329-78b1-4450-b3a8-dd4aa47344c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_24a7984f-65b0-4f91-b3b7-37157f5ed7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_24a7984f-65b0-4f91-b3b7-37157f5ed7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92cc716a-5413-41f5-8832-d3f2039a3f48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_92cc716a-5413-41f5-8832-d3f2039a3f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a74bf15b-3bac-4531-8afd-18e99575fcba" xlink:href="hr-20240630.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c893919b-af57-4cd6-a0da-7b8e29657b15" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_a74bf15b-3bac-4531-8afd-18e99575fcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c5b74030-3496-4acb-b67b-0d817754be72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c5b74030-3496-4acb-b67b-0d817754be72" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:to="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7e7bb624-7316-4c63-9ebe-5e40c9ee53b4" xlink:to="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_f4d1cc70-102e-4b8e-9047-b0909d127cb4" xlink:href="hr-20240630.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_87d1e225-04e2-4cd7-8978-f5c562106385" xlink:to="loc_hr_StockIncentivePlanMember_f4d1cc70-102e-4b8e-9047-b0909d127cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d2cccd7-513b-457f-a2b1-23494832649a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb99a2e2-eaff-464f-b5c2-31e5e6877a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb5c53d5-5881-4e64-ab3f-ac93bfa25e63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb5c53d5-5881-4e64-ab3f-ac93bfa25e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d58dac17-7cae-4a21-bfad-ce78b3405009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d58dac17-7cae-4a21-bfad-ce78b3405009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d9ce0292-d2fb-4ca1-ae18-d8d1304ae785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d9ce0292-d2fb-4ca1-ae18-d8d1304ae785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_5873a337-9f25-42f9-99f1-88b38c8e24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_5873a337-9f25-42f9-99f1-88b38c8e24ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_abcfd844-5f18-45d1-ad11-41c14f793253" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_abcfd844-5f18-45d1-ad11-41c14f793253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_feb95bb6-2aaf-430a-a533-16a3fd56a3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_070ded49-316f-401f-8022-4f8f054f5361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_feb95bb6-2aaf-430a-a533-16a3fd56a3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e27198e7-7b0a-4618-8ede-bba8cbcbfeb0" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_e27198e7-7b0a-4618-8ede-bba8cbcbfeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_b1e78647-30e7-4a1c-a5ff-7ac4f9dca595" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_b1e78647-30e7-4a1c-a5ff-7ac4f9dca595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_2d72f3c0-bafe-4202-ab1d-78d90a6979e9" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_2d72f3c0-bafe-4202-ab1d-78d90a6979e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_bee406af-d668-48da-a00b-aba0e0e327f6" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_bee406af-d668-48da-a00b-aba0e0e327f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_79a66049-653b-4e28-9041-95c9919ea5ce" xlink:href="hr-20240630.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_79a66049-653b-4e28-9041-95c9919ea5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4a731be3-9a99-4723-943a-ac0b4e272f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2f34069-1c63-43aa-ab1f-2dab4a1354b5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4a731be3-9a99-4723-943a-ac0b4e272f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20240630.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_be26b0f6-8202-44da-a773-3464f1c798ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be26b0f6-8202-44da-a773-3464f1c798ec" xlink:to="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_77038a08-704f-4563-956c-6b95353cdfa0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6fc92e2d-9cac-41e6-aa6a-8e21f51b2019" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_47e9122f-62cf-4ef1-a24f-25ea25005861" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_47e9122f-62cf-4ef1-a24f-25ea25005861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9eb92784-c877-4a09-914a-743173bc171f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ea8478c-dd94-4199-a170-683358838f5d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9eb92784-c877-4a09-914a-743173bc171f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5305b9c4-0786-4393-aaeb-00bca0759895" xlink:to="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_2203f1e7-44e7-421d-8a27-21fbcca36963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:to="loc_us-gaap_DebtInstrumentFairValue_2203f1e7-44e7-421d-8a27-21fbcca36963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_1abfd138-3624-448a-9c07-5684d2ae6951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0332858c-7e58-495f-84d7-a3fe10a66483" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_1abfd138-3624-448a-9c07-5684d2ae6951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:href="hr-20240630.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember" xlink:href="hr-20240630.xsd#hr_NonVestedStockAwardMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_NonVestedStockAwardMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550096288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jul. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHCARE REALTY TRUST INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-4738467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3310 West End Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269-8175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,030,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001360604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547701248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNetAbstract', window );"><strong>Real estate properties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,287,532<span></span>
</td>
<td class="nump">$ 1,343,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">10,436,218<span></span>
</td>
<td class="nump">10,881,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Lease intangibles</a></td>
<td class="nump">764,730<span></span>
</td>
<td class="nump">836,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PersonalProperty', window );">Personal property</a></td>
<td class="nump">12,501<span></span>
</td>
<td class="nump">12,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Investment in financing receivable, net</a></td>
<td class="nump">122,413<span></span>
</td>
<td class="nump">122,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Financing lease right-of-use assets</a></td>
<td class="nump">81,401<span></span>
</td>
<td class="nump">82,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Construction in progress</a></td>
<td class="nump">97,732<span></span>
</td>
<td class="nump">60,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAvailableForDevelopment', window );">Land held for development</a></td>
<td class="nump">59,871<span></span>
</td>
<td class="nump">59,871<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">12,862,398<span></span>
</td>
<td class="nump">13,399,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(2,427,709)<span></span>
</td>
<td class="num">(2,226,853)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">10,434,689<span></span>
</td>
<td class="nump">11,172,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">41,765<span></span>
</td>
<td class="nump">25,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">34,530<span></span>
</td>
<td class="nump">8,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">261,976<span></span>
</td>
<td class="nump">275,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">374,841<span></span>
</td>
<td class="nump">311,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">655,826<span></span>
</td>
<td class="nump">592,368<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,803,627<span></span>
</td>
<td class="nump">12,637,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">5,148,153<span></span>
</td>
<td class="nump">4,994,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">195,884<span></span>
</td>
<td class="nump">211,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">230,601<span></span>
</td>
<td class="nump">229,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease liabilities</a></td>
<td class="nump">75,199<span></span>
</td>
<td class="nump">74,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">177,293<span></span>
</td>
<td class="nump">202,984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,828,935<span></span>
</td>
<td class="nump">5,714,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">3,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 364,327 and 380,964 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">3,643<span></span>
</td>
<td class="nump">3,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">9,340,028<span></span>
</td>
<td class="nump">9,602,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">6,986<span></span>
</td>
<td class="num">(10,741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CumulativeNetIncomeAttributableToCommonStockholders', window );">Cumulative net income attributable to common stockholders</a></td>
<td class="nump">574,178<span></span>
</td>
<td class="nump">1,028,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeDividends', window );">Cumulative dividends</a></td>
<td class="num">(4,037,693)<span></span>
</td>
<td class="num">(3,801,793)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">5,887,142<span></span>
</td>
<td class="nump">6,822,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">83,675<span></span>
</td>
<td class="nump">96,252<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">5,970,817<span></span>
</td>
<td class="nump">6,918,914<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 11,803,627<span></span>
</td>
<td class="nump">$ 12,637,131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CumulativeNetIncomeAttributableToCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative net income attributable to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CumulativeNetIncomeAttributableToCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PersonalProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personal property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PersonalProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative cash dividends distributed to shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAvailableForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of land available for development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAvailableForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of finite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherFiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548261456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">364,327,000<span></span>
</td>
<td class="nump">380,964,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">364,327,000<span></span>
</td>
<td class="nump">380,964,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549362320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 308,135<span></span>
</td>
<td class="nump">$ 329,680<span></span>
</td>
<td class="nump">$ 626,211<span></span>
</td>
<td class="nump">$ 653,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss', window );">Interest income</a></td>
<td class="nump">3,865<span></span>
</td>
<td class="nump">4,233<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
<td class="nump">8,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Other operating</a></td>
<td class="nump">4,322<span></span>
</td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">8,513<span></span>
</td>
<td class="nump">8,847<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">316,322<span></span>
</td>
<td class="nump">338,143<span></span>
</td>
<td class="nump">643,127<span></span>
</td>
<td class="nump">671,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment', window );">Property operating</a></td>
<td class="nump">117,719<span></span>
</td>
<td class="nump">125,395<span></span>
</td>
<td class="nump">238,798<span></span>
</td>
<td class="nump">247,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,002<span></span>
</td>
<td class="nump">15,464<span></span>
</td>
<td class="nump">28,788<span></span>
</td>
<td class="nump">30,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Transaction costs</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">669<span></span>
</td>
<td class="nump">826<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerRelatedCosts', window );">Merger-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,670)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,815)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">173,477<span></span>
</td>
<td class="nump">183,193<span></span>
</td>
<td class="nump">351,596<span></span>
</td>
<td class="nump">367,671<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_OperatingExpensesandCostofGoodsSold', window );">Expenses</a></td>
<td class="nump">305,629<span></span>
</td>
<td class="nump">309,051<span></span>
</td>
<td class="nump">620,008<span></span>
</td>
<td class="nump">635,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain on sales of real estate properties and other assets</a></td>
<td class="nump">38,338<span></span>
</td>
<td class="nump">7,156<span></span>
</td>
<td class="nump">38,360<span></span>
</td>
<td class="nump">8,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(62,457)<span></span>
</td>
<td class="num">(65,334)<span></span>
</td>
<td class="num">(123,510)<span></span>
</td>
<td class="num">(129,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentOfRealEstateAndCreditLossReserves', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="num">(132,118)<span></span>
</td>
<td class="num">(55,215)<span></span>
</td>
<td class="num">(148,055)<span></span>
</td>
<td class="num">(86,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(250,530)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other (expense) income, net</a></td>
<td class="num">(248)<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">1,139<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(156,631)<span></span>
</td>
<td class="num">(112,818)<span></span>
</td>
<td class="num">(484,276)<span></span>
</td>
<td class="num">(207,225)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(145,938)<span></span>
</td>
<td class="num">(83,726)<span></span>
</td>
<td class="num">(461,157)<span></span>
</td>
<td class="num">(171,804)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interests</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">967<span></span>
</td>
<td class="nump">6,541<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (143,780)<span></span>
</td>
<td class="num">$ (82,759)<span></span>
</td>
<td class="num">$ (454,616)<span></span>
</td>
<td class="num">$ (169,884)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">372,477,299<span></span>
</td>
<td class="nump">378,896,677<span></span>
</td>
<td class="nump">375,962,033<span></span>
</td>
<td class="nump">378,860,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">372,477,299<span></span>
</td>
<td class="nump">378,896,677<span></span>
</td>
<td class="nump">375,962,033<span></span>
</td>
<td class="nump">378,860,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentOfRealEstateAndCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Real Estate and Credit Loss Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentOfRealEstateAndCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_OperatingExpensesandCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses and Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_OperatingExpensesandCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized acquisition cost incurred during period and excluded from amortization for oil- and gas-producing activities accounted for under full cost method. Excludes exploration and development costs and capitalized interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477385/932-360-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479664/932-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(c))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477875/944-360-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477875/944-360-45-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478586/944-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from financing receivable before allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547166432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (145,938)<span></span>
</td>
<td class="num">$ (83,726)<span></span>
</td>
<td class="num">$ (461,157)<span></span>
</td>
<td class="num">$ (171,804)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Interest rate derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in interest expense</a></td>
<td class="num">(3,662)<span></span>
</td>
<td class="num">(3,419)<span></span>
</td>
<td class="num">(7,528)<span></span>
</td>
<td class="num">(5,703)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">5,891<span></span>
</td>
<td class="nump">21,523<span></span>
</td>
<td class="nump">25,501<span></span>
</td>
<td class="nump">12,981<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">18,104<span></span>
</td>
<td class="nump">17,973<span></span>
</td>
<td class="nump">7,278<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(143,709)<span></span>
</td>
<td class="num">(65,622)<span></span>
</td>
<td class="num">(443,184)<span></span>
</td>
<td class="num">(164,526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive loss attributable to non-controlling interests</a></td>
<td class="nump">2,124<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="nump">6,295<span></span>
</td>
<td class="nump">1,830<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to common stockholders</a></td>
<td class="num">$ (141,585)<span></span>
</td>
<td class="num">$ (64,877)<span></span>
</td>
<td class="num">$ (436,889)<span></span>
</td>
<td class="num">$ (162,696)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547698752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Cumulative Net Income</div></th>
<th class="th"><div>Cumulative Dividends</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 7,679,818<span></span>
</td>
<td class="nump">$ 7,571,076<span></span>
</td>
<td class="nump">$ 3,806<span></span>
</td>
<td class="nump">$ 9,587,637<span></span>
</td>
<td class="nump">$ 2,140<span></span>
</td>
<td class="nump">$ 1,307,055<span></span>
</td>
<td class="num">$ (3,329,562)<span></span>
</td>
<td class="nump">$ 108,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(1,596)<span></span>
</td>
<td class="num">(1,596)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1,595)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,916<span></span>
</td>
<td class="nump">8,916<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(171,804)<span></span>
</td>
<td class="num">(169,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(169,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,920)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(5,703)<span></span>
</td>
<td class="num">(5,635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">12,981<span></span>
</td>
<td class="nump">12,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(239,273)<span></span>
</td>
<td class="num">(236,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(236,379)<span></span>
</td>
<td class="num">(2,894)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">7,283,417<span></span>
</td>
<td class="nump">7,179,399<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">9,595,033<span></span>
</td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">1,137,171<span></span>
</td>
<td class="num">(3,565,941)<span></span>
</td>
<td class="nump">104,018<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">2,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Jun. 30, 2023</a></td>
<td class="nump">2,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">7,464,839<span></span>
</td>
<td class="nump">7,358,628<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">9,591,194<span></span>
</td>
<td class="num">(8,554)<span></span>
</td>
<td class="nump">1,219,930<span></span>
</td>
<td class="num">(3,447,750)<span></span>
</td>
<td class="nump">106,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(83,726)<span></span>
</td>
<td class="num">(82,759)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,759)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(967)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(3,419)<span></span>
</td>
<td class="num">(3,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">21,523<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(119,639)<span></span>
</td>
<td class="num">(118,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,191)<span></span>
</td>
<td class="num">(1,448)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">7,283,417<span></span>
</td>
<td class="nump">7,179,399<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">9,595,033<span></span>
</td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">1,137,171<span></span>
</td>
<td class="num">(3,565,941)<span></span>
</td>
<td class="nump">104,018<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Mar. 31, 2023</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Jun. 30, 2023</a></td>
<td class="nump">2,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">6,918,914<span></span>
</td>
<td class="nump">6,822,662<span></span>
</td>
<td class="nump">3,810<span></span>
</td>
<td class="nump">9,602,592<span></span>
</td>
<td class="num">(10,741)<span></span>
</td>
<td class="nump">1,028,794<span></span>
</td>
<td class="num">(3,801,793)<span></span>
</td>
<td class="nump">96,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,944<span></span>
</td>
<td class="nump">6,944<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(273,053)<span></span>
</td>
<td class="num">(273,053)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(272,881)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of OP Units to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,412<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(461,157)<span></span>
</td>
<td class="num">(454,616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(454,616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,541)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(7,528)<span></span>
</td>
<td class="num">(7,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">25,501<span></span>
</td>
<td class="nump">25,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(238,770)<span></span>
</td>
<td class="num">(235,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(235,900)<span></span>
</td>
<td class="num">(2,870)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">5,970,817<span></span>
</td>
<td class="nump">5,887,142<span></span>
</td>
<td class="nump">3,643<span></span>
</td>
<td class="nump">9,340,028<span></span>
</td>
<td class="nump">6,986<span></span>
</td>
<td class="nump">574,178<span></span>
</td>
<td class="num">(4,037,693)<span></span>
</td>
<td class="nump">83,675<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2023</a></td>
<td class="nump">3,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Adjustments to redemption value of redeemable non-controlling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Jun. 30, 2024</a></td>
<td class="nump">3,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2024</a></td>
<td class="nump">6,503,138<span></span>
</td>
<td class="nump">6,415,895<span></span>
</td>
<td class="nump">3,815<span></span>
</td>
<td class="nump">9,609,530<span></span>
</td>
<td class="nump">4,791<span></span>
</td>
<td class="nump">717,958<span></span>
</td>
<td class="num">(3,920,199)<span></span>
</td>
<td class="nump">87,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3,382<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(273,053)<span></span>
</td>
<td class="num">(273,053)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(272,881)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(145,938)<span></span>
</td>
<td class="num">(143,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(3,662)<span></span>
</td>
<td class="num">(3,611)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,611)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">5,891<span></span>
</td>
<td class="nump">5,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(118,938)<span></span>
</td>
<td class="num">(117,494)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,494)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">5,970,817<span></span>
</td>
<td class="nump">$ 5,887,142<span></span>
</td>
<td class="nump">$ 3,643<span></span>
</td>
<td class="nump">$ 9,340,028<span></span>
</td>
<td class="nump">$ 6,986<span></span>
</td>
<td class="nump">$ 574,178<span></span>
</td>
<td class="num">$ (4,037,693)<span></span>
</td>
<td class="nump">$ 83,675<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Mar. 31, 2024</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Adjustments to redemption value of redeemable non-controlling interests</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Jun. 30, 2024</a></td>
<td class="nump">$ 3,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227642899344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548131936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (461,157)<span></span>
</td>
<td class="num">$ (171,804)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">351,596<span></span>
</td>
<td class="nump">367,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Other amortization</a></td>
<td class="nump">23,390<span></span>
</td>
<td class="nump">23,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">6,944<span></span>
</td>
<td class="nump">8,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightLineRentReceivable', window );">Amortization of straight-line rent receivable (lessor)</a></td>
<td class="num">(14,198)<span></span>
</td>
<td class="num">(19,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightlineRentLiability', window );">Amortization of straight-line rent on operating leases (lessee)</a></td>
<td class="nump">1,998<span></span>
</td>
<td class="nump">3,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain on sales of real estate properties and other assets</a></td>
<td class="num">(38,360)<span></span>
</td>
<td class="num">(8,162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="nump">148,055<span></span>
</td>
<td class="nump">86,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">250,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions from unconsolidated joint ventures</a></td>
<td class="nump">2,649<span></span>
</td>
<td class="nump">3,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InterestIncomeFinancingReceivableNoncash', window );">Non-cash interest from financing and notes receivable</a></td>
<td class="num">(478)<span></span>
</td>
<td class="num">(488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets, including right-of-use-assets</a></td>
<td class="num">(4,257)<span></span>
</td>
<td class="num">(17,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(23,131)<span></span>
</td>
<td class="num">(38,601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">16,673<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">244,304<span></span>
</td>
<td class="nump">254,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Acquisitions of real estate</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(39,301)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development of real estate</a></td>
<td class="num">(31,901)<span></span>
</td>
<td class="num">(17,594)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Additional long-lived assets</a></td>
<td class="num">(117,775)<span></span>
</td>
<td class="num">(94,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Funding of mortgages and notes receivable</a></td>
<td class="num">(3,466)<span></span>
</td>
<td class="num">(11,503)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sales of real estate properties and additional long-lived assets</a></td>
<td class="nump">303,475<span></span>
</td>
<td class="nump">160,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable', window );">Proceeds from notes receivable repayments</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">151,388<span></span>
</td>
<td class="num">(6,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net borrowings (repayments) on unsecured credit facility</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="num">(31,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Repayment on term loan</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of notes and bonds payable</a></td>
<td class="num">(17,746)<span></span>
</td>
<td class="num">(1,340)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(235,618)<span></span>
</td>
<td class="num">(236,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock redemptions</a></td>
<td class="num">(321)<span></span>
</td>
<td class="num">(1,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PaymentsForRepurchasesOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(273,053)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interest holders</a></td>
<td class="num">(2,399)<span></span>
</td>
<td class="num">(2,546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance and assumption costs</a></td>
<td class="num">(563)<span></span>
</td>
<td class="num">(438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments made on finance leases</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(379,626)<span></span>
</td>
<td class="num">(273,234)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">16,066<span></span>
</td>
<td class="num">(25,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">25,699<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">41,765<span></span>
</td>
<td class="nump">35,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">103,708<span></span>
</td>
<td class="nump">106,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoanRelatedToPropertySales1', window );">Mortgage note receivables taken in connection with sale of real estate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Invoices accrued for construction, tenant improvements and other capitalized costs</a></td>
<td class="nump">39,016<span></span>
</td>
<td class="nump">30,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Capitalized interest</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ProceedsFromDispositionsHeldInEscrow', window );">Proceeds from dispositions held in escrow</a></td>
<td class="nump">96,008<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture', window );">Contribution of real estate properties into unconsolidated joint venture</a></td>
<td class="nump">$ 66,547<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution of Real Estate Properties into Unconsolidated Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Real Estate, Continuing and Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InterestIncomeFinancingReceivableNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Financing Receivable, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InterestIncomeFinancingReceivableNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PaymentsForRepurchasesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Repurchases Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PaymentsForRepurchasesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Contributions from Redeemable Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ProceedsFromDispositionsHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Dispositions Held In Escrow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ProceedsFromDispositionsHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightLineRentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightLineRentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightlineRentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightlineRentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477875/944-360-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477875/944-360-45-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478586/944-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoanRelatedToPropertySales1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage loan related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoanRelatedToPropertySales1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227633966208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated (the "Company") is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June&#160;30, 2024, the Company had gross investments of approximately $12.9&#160;billion in 629 con</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">solidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property, excluding held for sale assets. </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of June&#160;30, 2024, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 36% in 44 </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in unconsolidated joint ventures. See Note 2 below for more details regarding the Company's unconsolidated joint ventures. </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in 35 states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 37.2 million square feet. The Company provided leasing and property management services to 92% of its portfolio</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">nationwide as of June&#160;30, 2024.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022, by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#8220;OP&#8221;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;). The combined company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is structured as an umbrella partnership REIT under which substantially all of its business is conducted through the OP, the day-to-day management of which is exclusively controlled by the Company.  As of June&#160;30, 2024, the Company owned 98.6% of the issued and outstanding units of the OP, with other investors owning the remaining 1.4% of the OP's issued and outstanding units.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2024 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events, such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The OP is 98.6% owned by the Company.  Other holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June&#160;30, 2024, there were approximately 5.3&#160;million OP Units, or 1.4% of OP Units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had four consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.318%"><tr><td style="width:1.0%"></td><td style="width:68.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total real estate properties, net</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">112,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">118,455&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,848&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Partners' equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">108,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net loss </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total partners' equity</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107,413&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">118,455&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economic interests to direct the activities of these VIEs on a </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">59,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">59,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 2 below for more details regarding the Company's unconsolidated joint ventures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Redeemable Non-Controlling Interests</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of June&#160;30, 2024, the Company had redeemable non-controlling interests of $3.9&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Asset Impairment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.  During the three and six months ended June&#160;30, 2024, the Company recognized real estate impairments totaling $120.9&#160;million and $136.9&#160;million, respectively, as a result of completed and planned disposition activity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, 16 real estate properties totaling $265.6&#160;million were measured at fair value using level 3 fair value hierarchy.  The level 3 fair value techniques included brokerage estimates, letters of intent, and unexecuted purchase and sale agreements, less estimated closing costs. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Goodwill Impairment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment. As a result, a goodwill evaluation was performed. The Company's current operations are carried out through a single reporting unit with a carrying value of approximately $12.0&#160;billion. The Company determined that the carrying value exceeded estimated fair value and therefore an impairment of goodwill was recorded. The Company recorded a $250.5&#160;million full impairment of its goodwill, which is recorded as a non-cash charge in &#8220;Impairment of goodwill&#8221; in the Condensed Consolidated Statements of Operations. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.629%"><tr><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.72%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">115,056&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.48%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,357&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">122,413&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held to maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of June&#160;30, 2024, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $168.8&#160;million.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>JUN 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RECEIVABLE (OTHER ASSETS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/21/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/20/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,036&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,119&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,119&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">942&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">52,798&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/02/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">551&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">154,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">124,906&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,472&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,201)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(134)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">116,043&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">214,969&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">185,025&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,414&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16,397)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,201)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">168,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid, and on July 15, 2024, the senior lender on the construction loans associated with the underlying projects provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">During the second quarter of 2024, the Company determined that an allowance for credit loss of $11.2&#160;million was needed on this mortgage loan. The reserve amount consists of approximately $10.7&#160;million of principal and approximately $0.5&#160;million of interest. Additionally, the maturity date on this mortgage loan was extended to December 2, 2024.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Outstanding principal and interest due upon maturity.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326: Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the first quarter of 2023, the Company determined that the risk of credit loss on two of its mezzanine loans were no longer remote and recorded a credit loss reserve of $5.2&#160;million.   During the three and six months ended June 30, 2024, the Company determined that the risk of credit loss on one of its mortgage note receivables was no longer remote and recorded a credit loss reserve of $11.2&#160;million.  The Company utilized the level 3 fair value hierarchy, which included a brokerage estimate on the underlying collateral of the loan, to determine the amount of credit loss reserve.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.061%"><tr><td style="width:1.0%"></td><td style="width:59.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.426%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16,397&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2023, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized interest income related to real estate notes receivable of $1.8 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.2 million and $4.3 million, respectively, for the three and six months ended  June&#160;30, 2023. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  In 2023, the Company placed two of its real estate notes receivable with principal balances, net of credit loss, of $48.9&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and six month periods ended June&#160;30, 2024.  In 2024, the Company placed one of its real estate notes receivable with a principal balance, net of credit loss, of $20.5&#160;million on non-accrual status.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of ASC Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of ASC Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Revenue that is accounted for under ASC Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.960%"><tr><td style="width:1.0%"></td><td style="width:37.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income/other</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,859&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,860&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,322&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,230&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,513&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,847&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">New Accounting Pronouncements </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">Topic 280)</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">. Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update. </span></div>The update is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. At this time, the Company does not expect that the adoption of this ASU will have a material impact on its consolidated financial statements other than compliance with these new disclosure requirements, which will begin with the Company's Annual Report on Form 10-K for the year ending December 31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550296480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AcquisitionsAndDispositionsTextBlock', window );">Real Estate Investments</a></td>
<td class="text">Real Estate Investments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2024 Acquisition Activity</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had no real estate acquisition activity for the six months ended June&#160;30, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and six months ended June&#160;30, 2024 and 2023 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"></td><td style="width:55.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">311,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(146)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(568)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(484)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,649)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,030)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">In the second quarter of 2024, the Company contributed 11 properties into a new joint venture in which it retained a 20% ownership interest.  See 2024 "Real Estate Asset Dispositions" below for additional information. In 2023, there was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's contribution of a property in Dallas, Texas to the joint venture. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2024 Real Estate Asset Dispositions </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions and joint venture contributions for the six months ended June&#160;30, 2024.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/1/24</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(60)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(82)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,800&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">San Angelo, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/12/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,085&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(128)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,917&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/20/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Multiple </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/23/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">284,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">270,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">254,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,934)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">556,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Denver, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/30/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(628)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,372&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(315)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Austin, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/6/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">54,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">53,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,964&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129,879&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Minneapolis, MN</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/21/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(144)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Greensboro/Raleigh, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2, 3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/28/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99,518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,835)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">96,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">86,810&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309,424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">464,866&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(19,649)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">445,217&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,170&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,037&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,010&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,159,418&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt">The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; two medical outpatient properties in Los Angeles and four in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $256.8&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt">The Company sold seven medical outpatient properties in Greensboro, NC and two medical outpatient properties in Raleigh, NC to a single buyer in a single transaction.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.33pt">The amount in the net proceeds column for this portfolio disposition includes the receivable for the cash held in escrow that closed on June 28, 2024 and was received by the Company on July 1, 2024.  These proceeds were recorded as a receivable in other assets, net as of June 30, 2024. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had three properties classified as assets held for sale as of June&#160;30, 2024 and one property classified as assets held for sale as of December&#160;31, 2023.  The table below reflects the assets and liabilities classified as held for sale as of June&#160;30, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43,342&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,689&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,646&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(13,600)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(913)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33,089&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,733&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34,530&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,834&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">272&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,805&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">295&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AcquisitionsAndDispositionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions and dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AcquisitionsAndDispositionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547999760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the Consumer Price Index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2024 was $308.1 million and $626.2 million, respectively.  Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2023 was $329.7 million and $653.8 million, respectively.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">441,170&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">827,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">734,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">614,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">500,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,629,794&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,748,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of June&#160;30, 2024, the Company had 221 properties totaling 16.5 million square feet that were held under ground leases. Some of the Company's ground lease renewal terms are based on fixed rent renewal terms, and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally stated in the lease or based on CPI. The Company had 73 prepaid ground leases as of June&#160;30, 2024. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5&#160;million and $0.3&#160;million of the Company's rental expense for the three months ended June 30, 2024 and 2023, respectively, and $0.9 million and $0.7&#160;million for the six months ended June&#160;30, 2024 and 2023, respectively.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,912&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,644&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">693,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">750,846&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">404,178&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520,245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(328,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">230,601&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,199&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,436&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">774&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,248&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,874&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,266&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,422&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">45.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the Consumer Price Index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2024 was $308.1 million and $626.2 million, respectively.  Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2023 was $329.7 million and $653.8 million, respectively.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">441,170&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">827,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">734,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">614,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">500,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,629,794&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,748,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of June&#160;30, 2024, the Company had 221 properties totaling 16.5 million square feet that were held under ground leases. Some of the Company's ground lease renewal terms are based on fixed rent renewal terms, and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally stated in the lease or based on CPI. The Company had 73 prepaid ground leases as of June&#160;30, 2024. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5&#160;million and $0.3&#160;million of the Company's rental expense for the three months ended June 30, 2024 and 2023, respectively, and $0.9 million and $0.7&#160;million for the six months ended June&#160;30, 2024 and 2023, respectively.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,912&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,644&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">693,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">750,846&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">404,178&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520,245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(328,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">230,601&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,199&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,436&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">774&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,248&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,874&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,266&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,422&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">45.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549698640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes and Bonds Payable</a></td>
<td class="text">Notes and Bonds Payable<div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of June&#160;30, 2024 and December 31, 2023.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATE </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 6/30/2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">6/30/2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$250 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">582,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">579,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">485,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">483,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">580,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">575,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">658,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">649,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/24-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">70,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57% - 6.88%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,148,153&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,994,859&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.      </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">As of June&#160;30, 2024, the Company had $1.3 billion available to be drawn on its $1.5&#160;billion Unsecured Credit Facility.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">In April 2024, the Company exercised its option to extend the maturity date for one year to May 2025 for a fee of approximately $0.3&#160;million.   </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">In June 2024, the Company repaid $100&#160;million of the initial $350&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for one year to July 2025 for a fee of approximately $0.3&#160;million.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Changes in Debt Structure</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 6, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">4.77% per annum with an outstanding principal balance of $11.3&#160;million.</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> The mortgage note encumbered a 63,012 square foot property in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">California</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On February 1, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.12%</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> per annum with an outstanding principal balance of $5.6&#160;million. T</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">he mortgage note encumbered a 40,324</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> squ</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">are foot property in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Georgia</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549684256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2026</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,075,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the fair value of the Company's derivative financial instruments and their classification on the Condensed Consolidated Balance Sheet as of June&#160;30, 2024.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,699&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June&#160;30, 2024 and 2023 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,523)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,811)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,568)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,523)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,662)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,419)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>six months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>six months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,501)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,981)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,825)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,501)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,981)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,528)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,703)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $10.5 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender should the Company&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$0.3&#160;million. As of June&#160;30, 2024, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550081088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">From time to time, the Company is involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the six months ended June&#160;30, 2024, the Company invested $35.6 million and $8.5 million toward active development and redevelopment of properties, respectively, and $22.3 million toward recently completed development and redevelopment projects.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227546709056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June&#160;30, 2024 and the twelve months ended December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,964,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Conversion of OP units to common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">194,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">190,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares Repurchased</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(17,242,237)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares and forfeitures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">401,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">175,368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">364,327,234&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,964,433&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company declared and paid common stock dividends totaling $0.62 per share.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On Jul</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 30, 2024, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on August 28, 2024 to stockholders of record on August 12, 2024.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Repurchases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On May 31, 2023, the Company&#8217;s Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company&#8217;s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. In April 2024, </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">the Company repurch</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ased 2,966,764 shares of its common stock at a weighted average price of $14.07 for a total of $41.7&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">under this authorization.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On April 30, 2024, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. The stock repurchase authorization expires on April 29, 2025, and the Company may suspend or terminate repurchases at any time without prior notice. Under the Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In May and June 2024, the Company repurchased an aggregate of 14,275,473 shares of its common stock at a weighted average price of $16.18 for a total of $231.0&#160;million under this authorization. As of June&#160;30, 2024, the Company was authorized to repurchase an additional $269.0&#160;million of the Company's common stock. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Subsequent to June 30, 2024, the Company repurchased 1,296,985 shares of its common stock for a total of $21.8&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June&#160;30, 2024 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,498,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,829,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">377,916,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,812,981&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,021,471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,932,334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,954,956)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,952,350)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(145,938)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(461,157)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(171,804)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(917)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,830)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(717)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss applicable to common stockholders - basic</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(145,414)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,442)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(458,482)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(170,560)</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP Units redeemable for 3,657,682 shares and 3,669,454 shares for the three and six months ended June&#160;30, 2024, respectively, were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during those periods.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Stock Incentive Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's stock incentive plan ("Incentive Plan") permits the grant of incentive awards to its employees and directors in any of the following forms: options, stock appreciation rights, restricted stock, restricted or deferred stock units, performance awards, dividend equivalents, or other stock-based awards, including units in the OP.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the six months ended June&#160;30, 2024, the Company made the following equity awards:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">Restricted Stock </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the first quarter of 2024, the Company granted non-vested stock awards to its named executive officers and other members of senior management with an aggregate grant date fair value of $5.6&#160;million, which consisted of an aggregate of 361,712 non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:f-1149">three</span> to eight years.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the second quarter of 2024, the Company granted to independent directors an aggregate of 58,910 shares of non-vested stock awards with a grant date fair value of $0.9&#160;million, and an aggregate of 45,982 LTIP Series D units with a grant date fair value of $0.7&#160;million. The Company also granted </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">non-vested stock awards to other members of senior management with an aggregate grant date fair value of $0.1&#160;million, which consisted of an aggregate of 9,350 non-vested shares.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">Restricted Stock Units ("RSUs")</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">On February 13, 2024, the Company granted an aggregate of 208,055 RSUs to members of senior management, with an aggregate grant date fair value of $3.5 million and a five-year vesting period. </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">On April 30, 2024, the Company granted an aggregate of 21,816 RSUs to members of senior management, with an aggregate grant date fair value of $0.3&#160;million and a five-year vesting period.</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 36% of the RSUs vest based on relative total shareholder return ("TSR") and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $19.10 for the relative TSR component for the February 2024 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$15.22</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 64% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $15.22 based on the Company's share price on the date of grant. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">&#8226;</span><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt">LTIP Series C Units</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On February 13, 2024, the Company granted an aggregate of 906,044 LTIP Series C units ("LTIP-C units) in the OP to its named executive officers with three-year forward-looking performance targets, a five-year vesting period and an aggregate grant date fair value of $7.5&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 36% of the LTIP-C units vest based on relative TSR and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $9.62 for the relative TSR component for the February 2024 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$15.22</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 64% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $15.22 based on the Company's share price on the date of grant. The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,043,154&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,946,242&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,615,562&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,090,060&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">135,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,611,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,118,537&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(46,660)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(74,304)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(75,074)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188,070)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Change in awards based on performance assessment</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,202)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,202)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(79,250)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,860)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(19,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(29,923)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,085,059&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,911,354&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,085,059&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,911,354&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-right:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested awards issued as of June&#160;30, 2024:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550307168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The carrying amount approximates fair value (level 1 inputs) due to the short-term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements using level 2 inputs in the hierarchy.  However, the fair value of one note receivable was determined utilizing the fair value of the receivables' collateral, as the receivables are collateral-dependent, and were classified as level 3 inputs in the hierarchy.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, which consider forward yield curves and discount rates. See Note 5 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June&#160;30, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.532%"><tr><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,148.2&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,984.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,994.9&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,872.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">168.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">163.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">173.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227664901104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (143,780)<span></span>
</td>
<td class="num">$ (82,759)<span></span>
</td>
<td class="num">$ (454,616)<span></span>
</td>
<td class="num">$ (169,884)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549263776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549029568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NatureOfOperationsPolicyTextBlock', window );">Business Overview</a></td>
<td class="text"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated (the "Company") is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June&#160;30, 2024, the Company had gross investments of approximately $12.9&#160;billion in 629 con</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">solidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property, excluding held for sale assets. </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of June&#160;30, 2024, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 36% in 44 </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in unconsolidated joint ventures. See Note 2 below for more details regarding the Company's unconsolidated joint ventures. </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in 35 states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tel</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 37.2 million square feet. The Company provided leasing and property management services to 92% of its portfolio</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">nationwide as of June&#160;30, 2024.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022, by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#8220;OP&#8221;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;). The combined company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is structured as an umbrella partnership REIT under which substantially all of its business is conducted through the OP, the day-to-day management of which is exclusively controlled by the Company.  As of June&#160;30, 2024, the Company owned 98.6% of the issued and outstanding units of the OP, with other investors owning the remaining 1.4% of the OP's issued and outstanding units.</span></div>Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2024 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events, such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div>The OP is 98.6% owned by the Company.  Other holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June&#160;30, 2024, there were approximately 5.3&#160;million OP Units, or 1.4% of OP Units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">As of June&#160;30, 2024, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in the Condensed Consolidated Financial Statements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Redeemable Non-Controlling Interests</span></div>The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Asset Impairment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Asset Impairment</span></div>The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Goodwill Impairment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Goodwill Impairment</span></div>During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment. As a result, a goodwill evaluation was performed. The Company's current operations are carried out through a single reporting unit with a carrying value of approximately $12.0&#160;billion. The Company determined that the carrying value exceeded estimated fair value and therefore an impairment of goodwill was recorded. The Company recorded a $250.5&#160;million full impairment of its goodwill, which is recorded as a non-cash charge in &#8220;Impairment of goodwill&#8221; in the Condensed Consolidated Statements of Operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div>In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.<div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div>Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held to maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.<div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326: Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2023, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contracts with Customers (ASC Topic 606)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of ASC Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of ASC Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. </span></div>Revenue that is accounted for under ASC Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">New Accounting Pronouncements </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">Topic 280)</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">. Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update. </span></div>The update is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. At this time, the Company does not expect that the adoption of this ASU will have a material impact on its consolidated financial statements other than compliance with these new disclosure requirements, which will begin with the Company's Annual Report on Form 10-K for the year ending December 31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature Of Operations Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Paragraph 2AA<br> -Subparagraph (a)<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-2AA<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549482928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Condensed Balance Sheet</a></td>
<td class="text">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.318%"><tr><td style="width:1.0%"></td><td style="width:68.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total real estate properties, net</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">112,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">118,455&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,848&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Partners' equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">108,612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net loss </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,199)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total partners' equity</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107,413&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">118,455&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text">As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">59,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">59,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">See below for additional information regarding the Company's financing receivables.<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.629%"><tr><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.72%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">115,056&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.48%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,357&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">122,413&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>JUN 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RECEIVABLE (OTHER ASSETS)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of JUNE 30, 2024</span></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/21/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/20/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,036&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,119&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,119&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">942&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">52,798&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/02/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">551&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,211&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/28/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">154,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">124,906&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,472&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,201)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(134)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">116,043&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">214,969&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">185,025&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,414&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16,397)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,201)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">168,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid, and on July 15, 2024, the senior lender on the construction loans associated with the underlying projects provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">During the second quarter of 2024, the Company determined that an allowance for credit loss of $11.2&#160;million was needed on this mortgage loan. The reserve amount consists of approximately $10.7&#160;million of principal and approximately $0.5&#160;million of interest. Additionally, the maturity date on this mortgage loan was extended to December 2, 2024.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Outstanding principal and interest due upon maturity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Company's Allowance For Credit Losses</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.061%"><tr><td style="width:1.0%"></td><td style="width:59.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.426%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16,397&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of revenue</a></td>
<td class="text">Below is a detail of the amounts by category:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.960%"><tr><td style="width:1.0%"></td><td style="width:37.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income/other</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,859&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,860&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,322&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,230&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,513&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,847&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div>1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550256288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and six months ended June&#160;30, 2024 and 2023 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"></td><td style="width:55.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">311,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66,547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(146)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(568)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(484)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,649)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,030)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,841&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span>In the second quarter of 2024, the Company contributed 11 properties into a new joint venture in which it retained a 20% ownership interest.  See 2024 "Real Estate Asset Dispositions" below for additional information. In 2023, there was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's contribution of a property in Dallas, Texas to the joint venture.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetDispositionsTableTextBlock', window );">Schedule of dispositions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions and joint venture contributions for the six months ended June&#160;30, 2024.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/1/24</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(60)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(82)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,800&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">San Angelo, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4/12/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,085&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(128)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,917&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/20/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Multiple </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/23/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">284,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">270,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">254,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,934)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">556,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Denver, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/30/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(628)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,372&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(315)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Austin, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/6/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">54,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">53,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,964&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129,879&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Minneapolis, MN</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/21/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(144)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50,291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Greensboro/Raleigh, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2, 3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/28/24</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99,518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,835)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">96,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">86,810&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">309,424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">464,866&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(19,649)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">445,217&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,170&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,037&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,010&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,159,418&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt">The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; two medical outpatient properties in Los Angeles and four in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $256.8&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt">The Company sold seven medical outpatient properties in Greensboro, NC and two medical outpatient properties in Raleigh, NC to a single buyer in a single transaction.</span></div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%">3</span>The amount in the net proceeds column for this portfolio disposition includes the receivable for the cash held in escrow that closed on June 28, 2024 and was received by the Company on July 1, 2024.  These proceeds were recorded as a receivable in other assets, net as of June 30, 2024.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock', window );">Schedule of Assets and Liabilities Held for Sale</a></td>
<td class="text">The table below reflects the assets and liabilities classified as held for sale as of June&#160;30, 2024 and December&#160;31, 2023:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43,342&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,689&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,646&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(13,600)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(913)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33,089&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,733&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34,530&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,834&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">272&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,805&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">295&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetDispositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetDispositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Assets and Liabilities Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549208688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments Receivable</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">441,170&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">827,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">734,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">614,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">500,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,629,794&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,748,784&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,912&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,644&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">693,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">750,846&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">404,178&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520,245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(328,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">230,601&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,199&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Financing Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,912&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,644&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">693,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">394,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">750,846&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">404,178&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(520,245)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(328,979)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">230,601&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,199&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>June 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED <br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,436&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">774&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">923&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,248&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,874&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,266&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,422&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">45.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227633743216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of June&#160;30, 2024 and December 31, 2023.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATE </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 6/30/2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">6/30/2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$250 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">582,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">579,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">485,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">483,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">580,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">575,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">658,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">649,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/24-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">70,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57% - 6.88%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,148,153&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,994,859&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.      </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">As of June&#160;30, 2024, the Company had $1.3 billion available to be drawn on its $1.5&#160;billion Unsecured Credit Facility.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">In April 2024, the Company exercised its option to extend the maturity date for one year to May 2025 for a fee of approximately $0.3&#160;million.   </span></div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span>In June 2024, the Company repaid $100&#160;million of the initial $350&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for one year to July 2025 for a fee of approximately $0.3&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549697456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of June&#160;30, 2024, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2026</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,075,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June&#160;30, 2024 and 2023 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,523)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,811)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,568)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,523)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,662)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,419)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>six months ended June 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>six months ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,501)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,981)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,825)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25,501)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,981)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,528)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,703)</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the fair value of the Company's derivative financial instruments and their classification on the Condensed Consolidated Balance Sheet as of June&#160;30, 2024.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT JUNE 30, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,699&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549472208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Reconciliation of Common Stock Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June&#160;30, 2024 and the twelve months ended December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,964,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Conversion of OP units to common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">194,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">190,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares Repurchased</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(17,242,237)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares and forfeitures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">401,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">175,368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">364,327,234&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,964,433&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) per Share</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June&#160;30, 2024 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">374,498,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,829,011&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">377,916,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,812,981&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,021,471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,932,334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,954,956)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,952,350)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">372,477,299&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,896,677&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">375,962,033&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,860,631&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(145,938)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(461,157)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(171,804)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(917)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(606)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,830)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(717)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net loss applicable to common stockholders - basic</span></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(145,414)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,442)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(458,482)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(170,560)</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net loss</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1.22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$15.22</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$15.22</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of the Activity Under the Incentive Plan and RSU Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and six months ended June&#160;30, 2024 and 2023:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED JUNE 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">SIX MONTHS ENDED JUNE 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,043,154&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,946,242&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,615,562&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,090,060&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">135,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,611,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,118,537&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(46,660)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(74,304)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(75,074)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188,070)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Change in awards based on performance assessment</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,202)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,202)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(79,250)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,860)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(19,805)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(29,923)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,085,059&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,911,354&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,085,059&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,911,354&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-right:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of Unrecognized Compensation Cost, Nonvested Awards</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested awards issued as of June&#160;30, 2024:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (i)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227634073008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June&#160;30, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.532%"><tr><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">June 30, 2024</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,148.2&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,984.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,994.9&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,872.7&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">168.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">163.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">173.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227546803824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ / shares in Units, $ in Thousands, shares in Millions, ft&#178; in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>loan </div>
<div>property </div>
<div>variable_interest_entity </div>
<div>financing_receivable </div>
<div>note_receivable </div>
<div>state </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property </div>
<div>variable_interest_entity </div>
<div>financing_receivable </div>
<div>note_receivable </div>
<div>loan </div>
<div>joint_venture </div>
<div>state </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>financing_receivable </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 20, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes', window );">Gross investment amount, total</a></td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateInvestments', window );">Number of real estate properties | property</a></td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures', window );">Number of properties held in unconsolidated joint ventures | property</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates', window );">Number of states that the company owns real estate in, whole units | state</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ApproximateSquareFeetInvestedInByCompany', window );">Approximate square feet invested in by company | ft&#178;</a></td>
<td class="nump">37.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio', window );">Nationwide portfolio (percent)</a></td>
<td class="nump">92.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityOwnershipForConsolidationPercent', window );">Equity ownership for consolidation (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract', window );"><strong>Redeemable Non-Controlling Interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">$ 3,875<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 3,875<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
<td class="nump">$ 3,868<span></span>
</td>
<td class="nump">$ 3,880<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Asset Impairment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfRealEstate', window );">Impairment of real estate assets</a></td>
<td class="nump">120,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAbstract', window );"><strong>Goodwill Impairment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateNotesReceivableNet', window );">Investment in financing receivable, net</a></td>
<td class="nump">$ 168,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfMezzanineLoans', window );">Number of mezzanine loans | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfMortgageLoans', window );">Number of mortgage loans | loan</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">$ 11,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRecognizedLeaseFinancialReceivables', window );">Number of recognized lease financial receivables | financing_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable', window );">Income from financing receivables</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateNotesReceivable', window );">Number of real estate notes receivable | financing_receivable</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual', window );">Financing receivable, nonaccrual</a></td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Asset Impairment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertiesMeasuredAtFairValue', window );">Number of properties measured at fair value | property</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure', window );">Properties measured at fair value</a></td>
<td class="nump">$ 265,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=hr_OneMember', window );">One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAbstract', window );"><strong>Goodwill Impairment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReportingUnitCarryingValue', window );">Reporting unit, carrying value</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfNotesReceivable', window );">Number of notes receivable | note_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfJointVentures', window );">Number of joint ventures | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember', window );">HealthCare Realty Trust Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=hr_HealthCareRealtyTrustIncorporatedMember', window );">HealthCare Realty Trust Incorporated | Other Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Subsidiary, ownership percentage, noncontrolling owner</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember', window );">Non-Controlling Interest Holders | Healthcare Trust of America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding', window );">Limited partner's capital, units outstanding (in shares) | shares</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember', window );">Property Entities Not Determined to be VIEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember', window );">Healthcare Trust of America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">98.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember', window );">Real Estate Properties Held in Joint Ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Joint venture ownership (percent)</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ApproximateSquareFeetInvestedInByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Approximate Square Feet Invested in by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ApproximateSquareFeetInvestedInByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessOverviewAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Overview [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessOverviewAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityOwnershipForConsolidationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Ownership for Consolidation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityOwnershipForConsolidationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in real estate properties and mortgage notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentInRealEstatePropertiesAndMortgageNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leasing and Property Management Services Provided as Percentage of Nationwide Portfolio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfMezzanineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Mezzanine Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfMezzanineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Mortgage Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Properties Held in Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertiesMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Properties Measured at Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertiesMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Real Estate Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRecognizedLeaseFinancialReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Recognized Lease Financial Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRecognizedLeaseFinancialReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Variable Interest Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investments property owned in number of states.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateNotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Notes Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateNotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReportingUnitCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reporting Unit, Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReportingUnitCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets classified as held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable on nonaccrual status. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period to reduce the carrying amount of real property to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of limited partner units outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from lease receivable of sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=hr_OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=hr_OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_HealthCareRealtyTrustIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_HealthCareRealtyTrustIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_OtherInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_OtherInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_NonControllingInterestHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548596880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">$ 10,434,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,172,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">41,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,803,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,637,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,828,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,714,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">$ 3,880<span></span>
</td>
<td class="nump">3,868<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Partners' equity</a></td>
<td class="nump">5,887,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,822,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">5,970,817<span></span>
</td>
<td class="nump">$ 6,503,138<span></span>
</td>
<td class="nump">6,918,914<span></span>
</td>
<td class="nump">$ 7,283,417<span></span>
</td>
<td class="nump">$ 7,464,839<span></span>
</td>
<td class="nump">$ 7,679,818<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">11,803,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,637,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable interest entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">112,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">3,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReceivablesAndOtherAssets', window );">Other assets, net</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">118,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">7,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">7,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Partners' equity</a></td>
<td class="nump">108,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CumulativeNetLossAttributableToCommonStockholders', window );">Cumulative net loss</a></td>
<td class="num">(1,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">107,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 118,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CumulativeNetLossAttributableToCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Net loss Attributable to Common Stockholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CumulativeNetLossAttributableToCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReceivablesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReceivablesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227551556880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Variable interest entity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>note_receivable </div>
<div>property</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfNotesReceivable', window );">Number of notes receivable | note_receivable</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember', window );">Houston, TX | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">$ 20,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">20,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NC', window );">North Carolina | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">7,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">7,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureCarryingAmount', window );">Joint venture, carrying amount</a></td>
<td class="nump">59,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">$ 59,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_HoustonTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227551456224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 122,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">214,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">185,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(16,397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,397)<span></span>
</td>
<td class="num">$ (5,196)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(3,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">168,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">11,201<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoanMember', window );">Mezzanine loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">60,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">60,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(5,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(3,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">52,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">154,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">124,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(11,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 116,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_PowayCAMember', window );">Poway, CA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 115,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_ColumbusOHMember', window );">Columbus, OH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 7,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Mezzanine loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(5,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(3,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 46,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(11,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease', window );">Allowance for credit loss</a></td>
<td class="nump">10,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossInterest', window );">Allowance for credit loss, interest</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_AZ', window );">Arizona | Mezzanine loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 6,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NC', window );">North Carolina | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 7,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">35,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 36,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 45,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_Florida1Member', window );">Florida 1 | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">7,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">INTEREST RECEIVABLE (OTHER ASSETS)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 7,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableMaximumLoanCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Maximum Loan Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableMaximumLoanCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss and unamortized deferred fee, premium, and discount, of financing receivable covered under loss sharing agreement and financing receivable not covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-3B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest receivable and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481266/840-40-55-50<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481266/840-40-55-52<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481266/840-40-55-51<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479741/842-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_PowayCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_PowayCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_ColumbusOHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_ColumbusOHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AZ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AZ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_Florida1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_Florida1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227633730464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit losses, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">11,201<span></span>
</td>
<td class="nump">5,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit losses, end of period</a></td>
<td class="nump">$ 16,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,397<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550682000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 4,322<span></span>
</td>
<td class="nump">$ 4,230<span></span>
</td>
<td class="nump">$ 8,513<span></span>
</td>
<td class="nump">$ 8,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember', window );">Parking income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">2,463<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
<td class="nump">5,009<span></span>
</td>
<td class="nump">4,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember', window );">Management fee income/other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 1,859<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
<td class="nump">$ 3,504<span></span>
</td>
<td class="nump">$ 4,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ParkingIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227554118320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">$ (146)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="num">$ (797)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, end of period</a></td>
<td class="nump">374,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="nump">309,754<span></span>
</td>
<td class="nump">327,746<span></span>
</td>
<td class="nump">311,511<span></span>
</td>
<td class="nump">327,248<span></span>
</td>
<td class="nump">327,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod', window );">New investments during the period</a></td>
<td class="nump">66,547<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">66,547<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared', window );">Owner distributions</a></td>
<td class="num">(1,314)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
<td class="num">(2,649)<span></span>
</td>
<td class="num">(3,030)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, end of period</a></td>
<td class="nump">$ 374,841<span></span>
</td>
<td class="nump">$ 327,245<span></span>
</td>
<td class="nump">$ 374,841<span></span>
</td>
<td class="nump">$ 327,245<span></span>
</td>
<td class="nump">$ 311,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages | Los Angeles, California | Limited Liability Company One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227542098080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Dispositions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 21, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 06, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>May 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>May 23, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>May 20, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 12, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 01, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember', window );">Real Estate Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 464,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,649)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,159,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_AlbanyNYMember', window );">Albany, NY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_SanAngeloTXMember', window );">San Angelo, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_HoustonTXMember', window );">Houston, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_MultipleMember', window );">Multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_MultipleMember', window );">Multiple | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_DenverCOMember', window );">Denver, CO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (315)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_AustinTXMember', window );">Austin, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_MinneapolisMNMember', window );">Minneapolis, MN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_GreensboroRaleighNCMember', window );">Greensboro/Raleigh, NC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="nump">$ 99,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="num">(2,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="nump">96,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="nump">86,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="nump">$ 8,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="nump">309,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember', window );">Los Angeles, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_SeattleWAMember', window );">Seattle, WA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_GreensboroNCMember', window );">Greensboro, NC | Real Estate Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_RaleighNCMember', window );">Raleigh, NC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_RaleighNCMember', window );">Raleigh, NC | Real Estate Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_AtlantaGAMember', window );">Atlanta, GA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_PhiladelphiaPAMember', window );">Philadelphia, PA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_NewYorkNYMember', window );">New York, NY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area covered under real estate investment sold in measurement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ClosingAdjustmentsDisposedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ClosingAdjustmentsDisposedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DispositionSalesPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposition Sales Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DispositionSalesPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investment net disposed of during the Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentNetDisposedOfDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_AlbanyNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_AlbanyNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_SanAngeloTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_SanAngeloTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_HoustonTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_HoustonTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_MultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_MultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_DenverCOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_DenverCOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_AustinTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_AustinTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_MinneapolisMNMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_MinneapolisMNMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_GreensboroRaleighNCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_GreensboroRaleighNCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_SeattleWAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_SeattleWAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_GreensboroNCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_GreensboroNCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_RaleighNCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_RaleighNCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_AtlantaGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_AtlantaGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_PhiladelphiaPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_PhiladelphiaPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_NewYorkNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_NewYorkNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227552655408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Real Estate Investments - Narrative (Details) - property<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertiesClassifiedAsHeldForSale', window );">Number of owned real estate properties</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertiesClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Properties Classified as Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertiesClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550019504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Real Estate Investments - Assets Held for Sale (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,287,532<span></span>
</td>
<td class="nump">$ 1,343,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">10,436,218<span></span>
</td>
<td class="nump">10,881,373<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">12,862,398<span></span>
</td>
<td class="nump">13,399,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(2,427,709)<span></span>
</td>
<td class="num">(2,226,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">10,434,689<span></span>
</td>
<td class="nump">11,172,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">41,765<span></span>
</td>
<td class="nump">25,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">261,976<span></span>
</td>
<td class="nump">275,975<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">34,530<span></span>
</td>
<td class="nump">8,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">230,601<span></span>
</td>
<td class="nump">229,714<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">1,805<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">2,330<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">43,342<span></span>
</td>
<td class="nump">6,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LeaseIntangibles', window );">Lease intangibles</a></td>
<td class="nump">1,017<span></span>
</td>
<td class="nump">1,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">46,689<span></span>
</td>
<td class="nump">9,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(13,600)<span></span>
</td>
<td class="num">(913)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Real estate assets held for sale, net</a></td>
<td class="nump">33,089<span></span>
</td>
<td class="nump">8,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets, net</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">34,530<span></span>
</td>
<td class="nump">8,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">$ 1,805<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LeaseIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LeaseIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550201008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Income - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 308,135<span></span>
</td>
<td class="nump">$ 329,680<span></span>
</td>
<td class="nump">$ 626,211<span></span>
</td>
<td class="nump">$ 653,773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227645166656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lessor Accounting (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract', window );"><strong>OPERATING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">2024</a></td>
<td class="nump">$ 441,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2025</a></td>
<td class="nump">827,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2026</a></td>
<td class="nump">734,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">2027</a></td>
<td class="nump">614,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">2028</a></td>
<td class="nump">500,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour', window );">2029 and thereafter</a></td>
<td class="nump">1,629,794<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total</a></td>
<td class="nump">$ 4,748,784<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Payment to be Received, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227540856032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Ground Leases (Details)<br> ft&#178; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>lease </div>
<div>property</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>lease </div>
<div>property</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases', window );">Number of properties subject to ground leases | property</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_SquareFeetSubjecttoGroundLeases', window );">Square feet subject to ground leases | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesPrepaid', window );">Number of prepaid ground leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AmortizationofPrepaidRent', window );">Amortization of prepaid rent | $</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesExcludingPrepaidLeases', window );">Number of non-prepaid ground leases</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">99 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">99 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AmortizationofPrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Prepaid Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AmortizationofPrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesExcludingPrepaidLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases, Excluding Prepaid Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesExcludingPrepaidLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesPrepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases Prepaid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesPrepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_SquareFeetSubjecttoGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Square Feet Subject to Ground Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_SquareFeetSubjecttoGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of separate real estate development properties located on land subject to ground leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfPropertiesSubjectToGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548121008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>OPERATING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024</a></td>
<td class="nump">$ 5,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">12,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">12,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">12,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">13,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">2029 and thereafter</a></td>
<td class="nump">693,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">750,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(520,245)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">230,601<span></span>
</td>
<td class="nump">$ 229,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>FINANCING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024</a></td>
<td class="nump">1,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">2,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">2,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">2,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">2029 and thereafter</a></td>
<td class="nump">394,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">404,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(328,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">$ 75,199<span></span>
</td>
<td class="nump">$ 74,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547991840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 4,599<span></span>
</td>
<td class="nump">$ 5,329<span></span>
</td>
<td class="nump">$ 9,065<span></span>
</td>
<td class="nump">$ 10,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">2,235<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
<td class="nump">4,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,841<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">7,248<span></span>
</td>
<td class="nump">8,874<span></span>
</td>
<td class="nump">14,266<span></span>
</td>
<td class="nump">17,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows outflows related to operating leases</a></td>
<td class="nump">4,889<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
<td class="nump">8,929<span></span>
</td>
<td class="nump">11,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows outflows related to financing leases</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">541<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="nump">1,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeasePrincipalOnlyPayments', window );">Financing cash flows outflows related to financing leases</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 2,561<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,561<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - operating leases</a></td>
<td class="text">45 years 10 months 24 days<span></span>
</td>
<td class="text">47 years 3 months 18 days<span></span>
</td>
<td class="text">45 years 10 months 24 days<span></span>
</td>
<td class="text">47 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - finance leases</a></td>
<td class="text">57 years 4 months 24 days<span></span>
</td>
<td class="text">58 years 4 months 24 days<span></span>
</td>
<td class="text">57 years 4 months 24 days<span></span>
</td>
<td class="text">58 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - operating leases</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - finance leases</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeasePrincipalOnlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Principal Only Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeasePrincipalOnlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227540831120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 5,148,153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,994,859,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DebtInstrumentExtensionPeriodForMaturityDate', window );">Extension period for maturity date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt fees</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | $1.5 billion Unsecured Credit Facility 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Available to be drawn debt amount</a></td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 199,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,903,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $350 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 249,659,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,798,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 299,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,958,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $150 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 149,716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,643,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 199,571,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,502,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 298,498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,288,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">6.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Repaid amount</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 249,674,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,484,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 582,873,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,017,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 485,889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,727,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 297,726,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,429,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 580,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,443,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 296,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,780,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">2.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 296,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,832,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 658,263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649,521,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">5.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgages | Mortgage notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">$ 52,828,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,534,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DebtInstrumentExtensionPeriodForMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period for Maturity Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DebtInstrumentExtensionPeriodForMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDueMay2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDueMay2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDueJuly2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDueJuly2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548171376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes and Bonds Payable - Narrative (Details) - Mortgages<br> $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 01, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 06, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.12%<span></span>
</td>
<td class="nump">4.77%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Outstanding principal repaid | $</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="nump">$ 11.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ExtinguishmentOfDebtEncumberedSquareFootage', window );">Encumbered square footage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember', window );">Georgia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ExtinguishmentOfDebtEncumberedSquareFootage', window );">Encumbered square footage</a></td>
<td class="nump">40,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ExtinguishmentOfDebtEncumberedSquareFootage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extinguishment of Debt, Encumbered Square Footage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ExtinguishmentOfDebtEncumberedSquareFootage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_GA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_GA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547991808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of instruments | derivative</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 1,075,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.92%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member', window );">Interest Rate Swap, Expiring May 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 275,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.74%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member', window );">Interest Rate Swap, Expiring June 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member', window );">Interest Rate Swap, Expiring December 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.84%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member', window );">Interest Rate Swap, Expiring June 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">4.27%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member', window );">Interest Rate Swap, Expiring December 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">3.93%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227546297664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) - Designated as hedging instrument - Interest Rate Swaps<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="nump">$ 9,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="num">(1,839)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="nump">$ 11,538<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227549160880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="num">$ (5,891)<span></span>
</td>
<td class="num">$ (21,523)<span></span>
</td>
<td class="num">$ (25,501)<span></span>
</td>
<td class="num">$ (12,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(3,662)<span></span>
</td>
<td class="num">(3,419)<span></span>
</td>
<td class="num">(7,528)<span></span>
</td>
<td class="num">(5,703)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(3,662)<span></span>
</td>
<td class="num">(3,419)<span></span>
</td>
<td class="num">(7,528)<span></span>
</td>
<td class="num">(5,703)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="num">(5,891)<span></span>
</td>
<td class="num">(21,523)<span></span>
</td>
<td class="num">(25,501)<span></span>
</td>
<td class="num">(12,981)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(3,811)<span></span>
</td>
<td class="num">(3,568)<span></span>
</td>
<td class="num">(7,825)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227551048832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue', window );">Derivatives in net liability position</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember', window );">Active Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember', window );">Settled Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="num">$ (0.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetLiabilityPositionAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227548116096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember', window );">Active Development Properties</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="nump">$ 35.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember', window );">Redevelopment Properties</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember', window );">Completed Develpoment and Redevelopment Properties</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="nump">$ 22.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ConstructionActivityTotalFundingDuringthePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Construction Activity, Total Funding During the Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ConstructionActivityTotalFundingDuringthePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227541939520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares Repurchased (in shares)</a></td>
<td class="num">(17,242,237)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">364,327,000<span></span>
</td>
<td class="nump">380,964,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,964,433<span></span>
</td>
<td class="nump">380,589,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">8,623<span></span>
</td>
<td class="nump">8,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued during period, shares, conversion of units</a></td>
<td class="nump">194,767<span></span>
</td>
<td class="nump">190,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Non-vested share-based awards, net of withheld shares and forfeitures (in shares)</a></td>
<td class="nump">401,648<span></span>
</td>
<td class="nump">175,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">364,327,234<span></span>
</td>
<td class="nump">380,964,433<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of the beginning and ending common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227540536768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Transactions - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Feb. 13, 2024</div></th>
<th class="th"><div>Aug. 02, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per common share, during the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock, shares, acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,966,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,275,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares acquired, average cost per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions', window );">Common stock repurchases, excluding commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StockRepurchaseProgramAuthorizedAdditionalAmount', window );">Additional authorized amount for share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269.0<span></span>
</td>
<td class="nump">$ 269.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock, shares, acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions', window );">Common stock repurchases, excluding commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_LTIPSeriesCUnitsMember', window );">LTIP Series C Units | Directors | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,276<span></span>
</td>
<td class="nump">1,611,578<span></span>
</td>
<td class="nump">1,118,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | LTIP Series C Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,910<span></span>
</td>
<td class="nump">361,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | LTIP Series D Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Other Members Of Senior Management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Executive Incentive Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,816<span></span>
</td>
<td class="nump">208,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan | Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average incremental shares of common stock excluded from the computation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,657,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,669,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PercentageOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Restricted Stock Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PercentageOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockRepurchaseProgramAuthorizedAdditionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Authorized, Additional Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockRepurchaseProgramAuthorizedAdditionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Excluding Commissions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_LTIPSeriesCUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_LTIPSeriesCUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=hr_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=hr_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_MarketCondition2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_MarketCondition2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_LTIPSeriesDUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_LTIPSeriesDUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_OtherMembersOfSeniorManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_OtherMembersOfSeniorManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227551042080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">374,498,770<span></span>
</td>
<td class="nump">380,829,011<span></span>
</td>
<td class="nump">377,916,989<span></span>
</td>
<td class="nump">380,812,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Non-vested shares (in shares)</a></td>
<td class="num">(2,021,471)<span></span>
</td>
<td class="num">(1,932,334)<span></span>
</td>
<td class="num">(1,954,956)<span></span>
</td>
<td class="num">(1,952,350)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">372,477,299<span></span>
</td>
<td class="nump">378,896,677<span></span>
</td>
<td class="nump">375,962,033<span></span>
</td>
<td class="nump">378,860,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits', window );">Dilutive effect of OP Units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">372,477,299<span></span>
</td>
<td class="nump">378,896,677<span></span>
</td>
<td class="nump">375,962,033<span></span>
</td>
<td class="nump">378,860,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (145,938)<span></span>
</td>
<td class="num">$ (83,726)<span></span>
</td>
<td class="num">$ (461,157)<span></span>
</td>
<td class="num">$ (171,804)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Income allocated to participating securities</a></td>
<td class="num">(917)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="num">(1,819)<span></span>
</td>
<td class="num">(1,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Loss attributable to non-controlling interest</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">967<span></span>
</td>
<td class="nump">6,541<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</a></td>
<td class="num">(717)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(2,047)<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic', window );">Net loss applicable to common stockholders - basic</a></td>
<td class="num">$ (145,414)<span></span>
</td>
<td class="num">$ (83,442)<span></span>
</td>
<td class="num">$ (458,482)<span></span>
</td>
<td class="num">$ (170,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share - net loss (in dollars per share)</a></td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share- net loss (in dollars per share)</a></td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of OP Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 65<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-65<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 66<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-66<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547910096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="nump">$ 15.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227541939680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details) - Stock incentive plan - shares<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Summary of the activity under the incentive plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, beginning of period (in shares)</a></td>
<td class="nump">4,043,154<span></span>
</td>
<td class="nump">2,615,562<span></span>
</td>
<td class="nump">2,946,242<span></span>
</td>
<td class="nump">2,615,562<span></span>
</td>
<td class="nump">2,090,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">135,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,276<span></span>
</td>
<td class="nump">1,611,578<span></span>
</td>
<td class="nump">1,118,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested/Forfeited (in shares)</a></td>
<td class="num">(46,660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,304)<span></span>
</td>
<td class="num">(75,074)<span></span>
</td>
<td class="num">(188,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease', window );">Change in awards based on performance assessment (in shares)</a></td>
<td class="num">(47,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(47,202)<span></span>
</td>
<td class="num">(79,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,860)<span></span>
</td>
<td class="num">(19,805)<span></span>
</td>
<td class="num">(29,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, ending of period (in shares)</a></td>
<td class="nump">4,085,059<span></span>
</td>
<td class="nump">4,043,154<span></span>
</td>
<td class="nump">2,911,354<span></span>
</td>
<td class="nump">4,085,059<span></span>
</td>
<td class="nump">2,911,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227547474544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear', window );">2024</a></td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths', window );">2025</a></td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo', window );">2026</a></td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree', window );">2027</a></td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total</a></td>
<td class="nump">$ 39.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140227550864960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">CARRYING VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">$ 5,148.2<span></span>
</td>
<td class="nump">$ 4,994.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">168.8<span></span>
</td>
<td class="nump">173.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">FAIR VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">4,984.7<span></span>
</td>
<td class="nump">4,872.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">$ 163.6<span></span>
</td>
<td class="nump">$ 172.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M%J6QIT#3B09IF 9OBT+VIG2,, \$7A1=#\6C/K-L#H[+XC2-ENAM.TH(X/>
MGYB0AIEPEE9(;L9-<$HV3MR.AB[%2TIT6-',4ZWI1(@T3(A+ECDWQ3;74883
M2_.[[&C&?6*#3JQ(PZRX[%3.X;59CL<D6ZHCEUD48X^HHQ,7TC 7'DKV.8R.
MGHYSFEF;SK:CF&:I;TXGPJ-APCN4[',H;5H#6DDS9N6IPQ 6GD6^VC 1(#W7
M\S5--2J+06_*UF2N@'SP8 [Z<U=>Y"SA_[^CTW.MB4Y9F$X_B5*(9JB$K6PO
M3<B=K&NS 4!("7B:FV:939XLY<NU<EKY- ";Z)6%Z?5!R^+S5M:EZ-0_AH[
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M%719W6L)K383&@#_+SA7^X%V,#3OD\]02P,$%     @ $30"61):HQ"E#@
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M;XWA&ND[5G+K+&.)QWY/6 %6EFF$@I-''A_0>)JZI>\H"9PU:D%$+"T:AM:
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MD*A$88D#Q]]W<2&JBAA!C6]+GH->)!&NWW?<WSG;8<LM-^)"5;_+TLY.!]F
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MA;],3#L!_.Z8/[PX ]N?L.-_ 5!+ P04    "  1- )9.&Y D!D)  #^&
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M*REG,%)]DS=3HS$DJTQ;O&=2-5FSS-6@!:X#U/Z:,;DWM$ WNN._4$L#!!0
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MZ52RU$2^2.\ITP(CM!P?GN/;MPB'&_H ;DH,L-.IVY4KBLT^):<<S\R]S6W
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M75,-1]=))LQYB"==0EAW=GT>EZE/;FTS]>0(>&3H$//:Z1R&RL%41990V"Y
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M%C3;[L^ZN@26C6([E@]B?8><,L"2:;F^*^' R24+FW[G9Z#("]I$X+JZ:OV
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MXC2AZ:O^>*@CYK0A/^0''>A:T^!\/==&RJ5&/I,RT1H_5.RN/<"RDH>>HL_
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MB]G@=[J#6F54ANHR]-0G:>K9)_4[&K]T+D%ZIOB?DC2Q98:?VR".[2#![VX
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MKNP&?#^3TCQ.K(*^OQ__!5!+ P04    "  1- )92Q++-[P$  !\"@  &0
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MT*$UMW+W"SO$DUE[M6RU>\)NU$T2#^I!&]D=P,B@XV*4].%P#D\ 970$0 X
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MG%;<ZQ;'0Z:L G[?2,ROP\(ZF ;.V3]02P,$%     @ $30"62/U<$[7!
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METJ5N2:7/ 9*T@:\7Y2E6CV0@OY#XO&?4$L#!!0    ( !$T EGKF^]=.@,
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M D73\Z-V(1VKC7/+ZT4&85PO7B+UXJ5+$DMC[5*1M2OVQ^K,_'B<MO>@<PY
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M65$UD)]O.!?/!]6C%J?'@Q;_ E!+ P04    "  1- )9]'X&-'X#  !^#0
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6RUE_M/VS 0Q_^54X8FD#KR
MZ M8&XG7!(A'18$A3=/DIM?6(K$[VVE!XH^?[8:T0!H&HK^T=N([?\[^VG=I
M3;FXDR-$!?=)S&3;&2DUWG%=&8TP(7*3CY'I-P,N$J)T5PQ=.19(^M8HB=W
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MV^9(?R"A, /T^P'75TO6,35[_LD5_@-02P,$%     @ $30"6>$00G:[#@
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M9KC=M<:TLJDY.I(,*LE1--D:T49$T,4@D5H)= ]GM*"Q(X."#"K(4339#U%
M1-@E(%'/'224^\73FL:6:$@RJ"1'T6131 L1?>LRD$A=D>$&MM/-N[2.L1%:
MH@PJRE$TV0K1/$0#S4.ZR&^+<I7K95Z:9AIVH+0$2F-0&D?19)=%K1'YKYIY
M(VCU :4E4!J#TCB*)N\&HOJ(=#_C]87,VXX?R+RTBK%?.IH,JLE1--D'T3U$
M=/=@D'DC]1-,O)[,2PL:6Z(ERJ"B'$63/1$]1$3W$'MFWDC]>-5>?Z"=A)XH
M@XIR%$WV1W02D>Y2#*/,J[8#=MB=LD(K&YNC(<F@DAQ%DZR)11T1TW6$8>:-
MU5*@^^=""YHZ,BS(H((<19/]$!U$//"Y)(:9-QXN(6A%8T.&2PBH($?19$-$
M"1$/? K)8-YM ?(95SU2T3K&-FB),J@H1]%D*T3U$ ],@&@O\-I:<9>&F>8<
M*"V!TAB4QE$TV611:L3>J\;=&-IZ0&D)E,:@-(ZBR;N!:#UB>C+'8-QMQP^L
MWJ55C/W2T61038ZBR3Z(VB&F:P>#N!NK=[H(U?N5T'K&CNAH,J@F1]%D1T0!
M$=,%Q)YAMZ7NOF\+;;=[?9?6-G9'1Y-!-3F*)KLCJHA8=R6&2=2-U5) ^;N!
MMA##@@PJR%$TV1;10,1T V$:<]4>0/$#6CP,"S*H($?1)#_LL>@=FJ^10?<K
MC_)D0-/4% U)AI7D,%S'%WO'%[J &,Z[7PD!?2H9$#(W0T>5854Y#/?LQ^'Z
M/LNJ)*W2DZ-E5MYETVRQ6%N;Q',\:CJ)[:-6F=TV=KV;.*-#Y?'W]KNIW3Q^
M*# G1P]U(#Y/R[N\#DR+[+9&CM\V,W;+_.Y^^TU5/-1[Q,CZ7%15L=Q\>9^E
M-UG9/*'^^6U1YZ[VFT;@J2A_V[SLD_\#4$L#!!0    ( !$T EFA#[])- ,
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M7T8>*X_!RAM!E\6QS2T5@N;%Y0+!%#%E(,=GE(J'&S5!?1@Y_@]02P,$%
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M*EQN[]FH%E[=.^)HZ8UJ M4DJBE4TZAF4,U2FC\-KO2NJD=Z^(16X*A6HYI
M-8EJ"M4TJAE4LY3FS4D\<!WX^NU'?P"UYR)]QX;E:I83+"=93K&<9CG#<O:.
M.^#P]G@0;\U$N/#^F>/;]]C]1P%MNEE.L)QD.<5RFN4,R]D[[J!SW.-!LC4,
MX=)[ZXE%SY=L]\C]1P%MQ%E.L)QD.<5RFN4,RUF,:\U,NC4SCU2-W\'8R*#E
M.,L)EI,LIUA.LYQA.8MQK9')MD;F;VC)]URD__B@/3G+"9:3+*=83K.<83E[
MQQWPTX;Q(-^:B7!A?KJ<C%;/-(XCM?/G#?<L[Y]VM!1G.<%RDN44RVF6,RQG
M,:XU&,768#Q2.WX'8R.#]N,L)UA.LIQB.<URAN4LQK5&9K@U,G]#4;[G(OW'
M!ZW*64ZPG&0YQ7*:Y0S+V3ONH-=YRZV9"'?F/_<Z+]JHLUS-<H+E),LIEM,L
M9UC.WG$'OLY;;0U#>)_XV\OQ9'313*XOQZMG'&\?>,:!UN,L5[.<8#G)<HKE
M-,L9EK,8YT]'O%63QX^T5_P.ID8&Y6J6$RPG64ZQG&8YPW(6XUHCL]6BQW_#
MMO$]%^D_/FR=CG*"Y23+*9;3+&=8SMYQASSCB+?*]#A<IO_4,XZPW7\4V#H=
MY03+2993+*=9SK"<O>,.>\81;[7D<?C\\//F6_3G;/[7<73^Y^[ LV4XRM4L
M)UA.LIQB.<URAN4LQK4F8ZL,C[/'>K;!%N H5[.<8#G)<HKE-,L9EK,8UQJ9
MK:X\WG-J.?-L@VW44:YF.<%RDN44RVF6,RQG[[B#GFULU>1Q^$SSGWNVP3;E
M*%>SG& YR7**Y33+&9:S=USXV<;)XK)IEO5H.7KQ[*J9?VG.FLED$7V:W4Q7
MJ]:O4=W_[>H[P>?UK/QVFAR=K%:Z#W_Q['J5_M>C^9?QZJ'5I/F\6CKX=?U;
MY.?C+Y?W[RQGUVLR^CA;+F=7MV]>-J.+9K[^@-6_?Y[-EG?OK"_P;?64YO;F
MO?A_4$L#!!0    ( !$T EDVMV4C3P(  #X%   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;*U4P6[;, S]%<$#A@WH:L=NNZ%+#*3IAK7 BJ#%NL.P
M@V(SB5!9<D4Z;O]^E.P8*984.^QBBQ3?$TD]:MQ:]X!K !)/E38XB=9$]7D<
M8[&&2N*QK<'PSM*Z2A*;;A5C[4"6 53I.$V2L[B2RD3Y./CF+A_;AK0R,'<"
MFZJ2[OD"M&TGT2C:.F[5:DW>$>?C6J[@#NA'/7=LQ0-+J2HPJ*P1#I:3:#HZ
MGV4^/@3<*VAQ9RU\)0MK'[QQ54ZBQ"<$&@KR#))_&YB!UIZ(TWCL.:/A2 _<
M76_9OX;:N9:%1)A9_5.5M)Y$GR)1PE(VFFYM^PWZ>DX]7V$UAJ]H^]@D$D6#
M9*L>S!E4RG1_^=3W80<P.CD 2'M ^J^ K >$SL5=9J&L2TDR'SO;"N>CF<TO
M0F\"FJM1QM_B'3G>58RC_!:D%E^0)(&X,AM XBLB%!_$C71.^AZ+=Y= 4FE\
MS][:L8 </8]CXM,]1UST)UUT)Z4'3KINS+'(DB.1)NG)'OCL=?@E% P?!7CV
M$AYSS4/AZ5!X&OBR WP7#;('4<QLM5!&>E$=B2DB3\ZT>&P4JLXE32FNK3(D
M[KDSC0/1Z<>+\-=T@>18BK_W]:-+X&1_ GX\S[&6!4PBGC\$MX$H?_MF=)9\
MWM>=_T3VHE?9T*OL-?;\IJD6X(1="ML:*'EZ6330B:87A +<UX*.]S3P^@=E
MD_/=;7;K^CMB-$1TR<8[ZO8ORW?I5LJ@T+!D3'+\D<&NF];.(%L'P2\L\?B$
MY9H?.' ^@/>7UM+6\#,T/)GY'U!+ P04    "  1- )9^WDPE#@%  "Y%@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RUF&UOVS80Q[\*X15#"\2Q
M2.HQ<PRDR;9FR-8@:;<7PUXP,AT3E417I.SVVX^4%4D6*68.LC>V9-^=?CP>
M^3]QON/E%[&F5()O>5:(\\E:RLW9;";2-<V)..4;6JA_5KS,B52WY>-,;$I*
MEK53GLV0YX6SG+!BLIC7O]V6BSFO9,8*>EL"4>4Y*;^_IQG?G4_@Y.F'._:X
MEOJ'V6*^(8_TGLK/F]M2W<W:*$N6TT(P7H"2KLXG%_#L$L7:H;;XD]&=Z%T#
M/90'SK_HF^OE^<331#2CJ=0AB/K:TDN:93J2XOC:!)VTS]2._>NGZ+_4@U>#
M>2""7O+L+[:4Z_-)/ %+NB)5)N_X[@-M!A3H>"G/1/T)=HVM-P%I)23/&V=%
MD+-B_TV^-8GH.4!_Q $U#NB_.N#& =<#W9/5P[HBDBSF)=^!4ENK:/JBSDWM
MK4;#"CV-][)4_S+E)Q=WE&3@9R&)I."ZV%(AU1Q) :;@0@BJ+C[0; E4N8![
MDE'P]HI*PC+Q3AE\OK\";]^\ V\ *\"G-:\$*99B/I,*2P>?I0W"^ST"&D'X
MK2I. ?9. /*0;W&_=+M?T52YP]H='[K/5#+:C* V(ZB.AT?BW?#B$=RHVEKV
M4S!5*9@*G8*_;Y0#N)8T%__8!KN/[MNCZU5Y)C8DI><3M>P$+;=TLOCQ!QAZ
M/]F&_DK!#A*!VT1@5_3%C9I.VP#W7F'MI7>)[0*B. HPFL^V?7:+'?8Q"H/6
M[@#+;[%\)];[BF5+IN9(X0&6;TJ^I77-VECWH8(^@^?C$,%X &LSC&.((VRG
M#5K:P$G[B4NUP$J]RNA^E2G@#2TEHU;@P.1 <8AP,@2V&&*<)%X8V8'#%CAT
M E^D:957F2)=JNU0E57*B-YP;;"AP3!%/HHB+QG V@P1"N-@)+M1"QLY8>]Z
M>27[Q;I^VJ_T8CT!!94V\LA:%WX8#\DMAA!&"$'?3AZWY+&3_)*(=5W!J;Z@
M7RNV5;PC51P;$#Z,>NMHCVI:H2!,$CMGTG(F3LZ/JE;5_*OEEE&EEJ#4LCCE
MJVDEGE)N(TY,EA F43A MIA%01*-[!#0ZT3-<Q?Q,;70Q.I38#_ WH#58A;'
M>*0,8$]_X5$)SAAY8!D;VQ^:: <IPU[HP2&MQ0XET5C9PDX=H5-S%C<='^ K
MZZJS<B-S(<7>L(0M5B@9JX9.QZ!;R*Z8V' %!GXM>;4Y.=3S$_ 'ET"9I+Q0
MTU"I;:^9$E[89\#YL&,%_K6B'::FTU+H_Z_-#G1J]=')>*5HA\GHI!JZM7JL
MX8&FUB)L[@\618X#;Z1X.SF&;CT^JMV!IM#Z&/O#SLQB%D;1B%+ 3HRA6XUO
MZ@V,%9(4C^PA&]G ;-(+HR'A,U:'A)WH0K?J'MN-08ORAF:38#%+0C\<H>VD
M%[JU]YA6#)I2.H4X](PJM=@E<*0-0YW@(K?@OK@10Q;QQ9Z188M9'.$Q[$Y\
MD5M\C^K"D"FIP^PZ30X9>Z^C;L%]80>&3"GM[T8-KVDTQMNI+7*K[4>YIF4#
M-C[MV'APD Q[&(L1[#4ZAWR=Y"'W^^-1O2$RWPMMO:'%;+PW1)T@(;<@J0V
M5_HT9D.^$[6AUJ5*TK347<HSC2(RY2C 1H9MRC9"W2D6<BO6D1TM,L4H,->_
M:316J)U<(;=<[0OU.3I3B-1KZY#.-$(1&N'KQ JYQ>J%G783]>#<Q>RT+59F
MISWKG2OJ0]W?2?G("J'F=:6\O--(C;C<GY/N;R3?U$>-#UQ*GM>7:TJ6M-0&
MZO\5Y_+I1I]>MJ?5BW\!4$L#!!0    ( !$T EGZ<-<!CP(  +<'   9
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M$8K1FDL**+X>T1+%L602?GRM2(W:I@0VGP_L[XK@13 KR-"2Q'_@B._FQL0
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M6+PBTO).M1QPDA67ABO".4F*QQV"$:)R@?A]0P@_#*2!^F;;_P]02P,$%
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MOT#KU:/9ZCS3*9W#V,'RTZ#6X$3(-?1JM;<$MB.\6PKO-J%'GQ8+R(L-+]P
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MI7B<O6Z +D&8"7I\Q;EZ:IB[I?)J</X=4$L#!!0    ( !$T ED+WBZPJ0(
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M=H#"04!_RNKB@6N+J&7R!(?PJ"<7,)EH$/>"FR)"FOJ>[P<]"J@P#-(PZD'
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M@YEK!?!](:79/M@&NHO#R7]02P,$%     @ $30"6=!1_CJM P  , \  !D
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MH"NF[\3Z=Z@$]0S?7#!E?\FZ&AMX9+Y26N05&"/(,U[^T^<J$3L %-H.B"I
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MC?62?4RQI 5I!N#[A1#ZI6$FJ(ODX;]02P,$%     @ $30"64B&H*_W P
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M0Z.8:(B$<NZ<!V<7B=EO-_QDL%4[8V(J60IQ;R9?B[GCFT# (4?C0/5E Y?
MN3'2,1YZ3V= &N'N^-G]LZU=U[*D"BX%_\4*K.9.XI "2KKF>"NV7Z"O)S)^
MN>#*_I)MO]=W2+Y6*.I>K!/4K.FN]+%_#CN",'Q!$/:"T.;N0#;E%46:I5)L
MB32[M9L9V%*M6H=CC7DI"Y1ZE6D=9@L4^7TE> %2O2.?'M8,G\@'<EX+B>PO
MM4].E.12U/H8J&ZNCP+Y+IH-*(2"+"HJ09'C*T#*N#HA1X0UY)IQKO>JU$.=
MTK"\O$]TT24*7TCT;=VX9.*_)Z$?3LG=XHH<'YW\;^/I(H=*PZ'2T/I.7O#M
M:_M]OE0H]6'X,Q:MLYB.6Y@/Y$RU-(>YH[\ !7(#3O;V31#['U\).!D"3EYS
MSTR]8YDZ56Q5YAO;9$GJ;49 TP$T/02*QD"=*MD!!1-W.LZ*!E9TB!6/L:)]
MEN\&XZQX8,6'6+,Q5KS'BMQH'#4;4+-#J(30IB!8@>Z%)8(<(\_VR*%[.DY.
M!G+R*OF'0,K'6)TL"'9@D],]FK?3*DS7O:9RQ1I%.)1:YKLS_6)DU\FZ"8K6
M=H^E0-V+[+#2S1^DV:#72R'P>6(:TO!WDOT#4$L#!!0    ( !$T EG1 K4]
MW0(  -8)   9    >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;*U6:V_:,!3]
M*U9639VTY0V$#B)1&!M36U54[31-^V#"!:PZ=F8;:/_]["2-0AO0)N4+\>.>
MXW.N?;$'>RX>Y09 H:>4,CFT-DIE%XXCDPVD6-H\ Z9G5ERD6.FN6#LR$X"7
M.2BECN^Z72?%A%GQ(!^[%?& ;Q4E#&X%DMLTQ>+Y$BC?#RW/>AF8D_5&F0$G
M'F1X#7>@[K-;H7M.Q;(D*3!).$,"5D-KY%V,^R8^#W@@L)>U-C).%IP_FLYL
M.;1<(P@H),HP8/W9P1@H-41:QI^2TZJ6-,!Z^X5]FGO77A98PIC3'V2I-D,K
MLM 25GA+U9SOOT'IIV/X$DYE_HOV16S/M5"RE8JG)5@K2 DKOOBIS$,-X(5'
M 'X)\/\5$)2 (#=:*,MM3;#"\4#P/1(F6K.91IZ;'*W=$&9V\4X)/4LT3L53
M3 1ZP'0+B*_0E##,$H(IFC&IQ%9OEY+H? (*$RH_H$_H_FZ"SL\^H#-$&+HF
ME.J]D -':2F&T$G*92^+9?TCRW[?,AL%[D?DNW[8 !^?AD\@T7 OAP>'<$<G
MH,J"7V7!S_G"(WSCT7S^<W;S%3V,KNZ_--DYB3>E=B$SG,#0TK4D0>S BM^_
M\[KNYR9S+9$=6 TJJT'.'AQ-G2 [;&H'_;K2<VBF()6_FSP';7INB>S <UAY
M#D]N[PU7(!%F2[3@;"E1AI_Q@D*3YX+(*\K%_ 7NXHX71K8_<'9U.PUQ8;\?
MVOTJ[D!IIU+:.:ET#KKV0"JL +%<M8 $](8=D5NP13457C>RHU=B&Z)Z@=UM
MEMJMI'9/2IV.9O/C]7(2^[]GIR6R YN]RF:OK7KIM>FY);(#SU'E.6JK7J(W
M1ROL1Z'=>W4"&\*BGE\+.]#9KW3V6ZV6_MNB];KU0BC$-H5IL9U78IW:K6M>
M/-=8K F3B,)*XUR[I\M.%*^(HJ-XEE_$"Z[TM9XW-_KA!<($Z/D5UQ[*CKG;
MJZ=<_!=02P,$%     @ $30"63TC/A\R P  )!,   T   !X;"]S='EL97,N
M>&ULW5A=3]LP%/TKD1D32!-IFQ&:T5;:*B%-VB8D>-@;<ALGM>38F>.PEE^/
M;YRF'_@BQL-&EXK&OL?GW&/[AAA&E5D)=K-@S 3+0LAJ3!;&E)_"L)HO6$&K
M,U4R:9%,Z8(:V]5Y6)6:T;0"4B'"0:\7AP7EDDQ&LBZN"E,%<U5+,R9Q%PK<
M[6LZ)OWX(PF<W%2E;$SN3M[_JI6Y?!>X^]&'HZ/>W>GE?ORD 4Y)Z!4]?X'H
M60_7M1@F'>]*M\.MTIJ)$2\\Q...=XS1AMY\6TSH8.3D1>OPS#(TPF&[DY-1
MIN1F0R/B C8S+5AP3\683*G@,\V!E=&"BY4+#R P5T+IP-A*LE;Z$*D>'-QW
M/2BR5J?@4NDFM\O@OF?M\#U@W0.#7(C.X("XP&144F.8EE>VTPQN@D^@H&W?
MKDKK,-=TU1^<DPVAN=DD,Z53IKLT?;(.34:"96!'\WP!=Z/*$$!C5&$;*:>Y
MDK3QL&:T#2L[9T+<P!/X,]O17F9;>]J#'95=TQIJFT[&=4!_6\UI;\L.7J4;
ME/Q>F2^UG8YL^E K[%JSC"^;_C+K#&#J?5R=EJ58?18\EP5SDW]QPLF(KGG!
M0FG^8+-!J<QM@&D2W#-M^'P[\EO3\I8MS;J<EAGN>7" GO_N.N=,,DW%MFE;
M^V]YE5_M.+KX5Y:;WRK[AKT>V]?J6S=Y?@@FXT,P>1 U.3P$D\F;-!FV+_"M
M4\+.&:&+!G 6&Y,?<.H3FZ3!K.;"<-GV%CQ-F7QR5+#RAL[LGP [^G9\RC):
M"W/;@6.R:7]G*:^+I!MU#0O1CMJTO\'T^G%W$+2YN$S9DJ73MJOS6=,,;,-F
M;2\@["-7S>5',([#_ A@6![, <9Q+"S/_S2?(3H?AV'>AEYDB'*&*,>Q?,BT
M^6!Y_)S$7OZ9)DD4Q3&VHM.IU\$46[<XAA^_&N8-&%@>R/1G:XWO-EXAS]<!
MMJ?/50@V4[P2L9GB:PV(?]V D23^W<;R  /;!:QV(+\_#]24GQ-%L*N8-^P)
MQI$DP1"H17^-QC&R.C%\_/N#/251E"1^!#"_@RC"$'@:<01S !XP)(J:]^#>
M^RA<OZ?"S?_%)H]02P,$%     @ $30"69>*NQS     $P(   L   !?<F5L
M<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5Q
MD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC
M0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W
M\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ
M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  1- )954\<?'0$   ")0
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !$T EF'GN$^^@4  -(?   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  1- )9@&P3=<D'  "R(   &               @($\#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ $30"62\OT"_Z @  .PH
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M965T-RYX;6Q02P$"% ,4    "  1- )96#C=7M<)  "H+   &
M    @(&E-P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M$30"67IO@ :=(   QV   !@              ("!LD$  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( !$T EG/,/_2"PD  /D4   9
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M970Q-"YX;6Q02P$"% ,4    "  1- )9\NZVP4\-   ;*   &0
M    @($LAP  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M !$T EF6YC,N3 4  #4-   9              " @;*4  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ $30"6;?B-T"' @  Q@<  !D
M             ("!-9H  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    "  1- )9$,+L0$0"  "*!@  &0              @('SG   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( !$T EGE/&/[3!,
M  $Y   9              " @6Z?  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ $30"6;N$0F1J"0  9Q8  !D              ("!
M\;(  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  1- )9
MJMRQ7P,(  #2$0  &0              @(&2O   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( !$T EGR!C<BC04  .L/   9
M      " @<S$  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ $30"64L2RS>\!   ? H  !D              ("!D,H  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  1- )9(_5P3M<$  !Z#
M&0              @(&#SP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( !$T EFH#7\6O@<  %04   9              " @9'4  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ $30"6>N;[UTZ
M P  (P<  !D              ("!AMP  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    "  1- )9%M(M+< /   PN@  &0
M@('WWP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( !$T
M EG\OJC#8 8  "HT   9              " @>[O  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ $30"6?1^!C1^ P  ?@T  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( !$T EEL#^+!9!0  &]> 0 9
M  " @8@5 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M$30"63:W92-/ @  /@4  !D              ("!(RH! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    "  1- )9^WDPE#@%  "Y%@  &0
M            @(&I+ $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( !$T EGZ<-<!CP(  +<'   9              " @1@R 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ $30"6?-B1LQT @
MI08  !D              ("!WC0! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    "  1- )9@,@,1AH$  #E%@  &0              @(&)
M-P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( !$T EE_
MOP.@RP,  +<2   9              " @=H[ 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ $30"615@8($?!0  K!@  !D
M     ("!W#\! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !$T EFI72UL2@4  'TF   9              "
M@1A: 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ $30"
M6>^)P[O7 @  L @  !D              ("!F5\! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    "  1- )9//R>AL<"  """0  &0
M        @(&G8@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( !$T ED^PD4YOP,  +@-   9              " @:5E 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ $30"66VKM_%#$P  2D$!
M !D              ("!FVD! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    "  1- )96F C<2,%  !$%   &0              @($5?0$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( !$T EG04?XZ
MK0,  # /   9              " @6^" 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ $30"64B&H*_W P  D0\  !D
M ("!4X8! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  1
M- )95?$3[GH"  !:!@  &0              @(&!B@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( !$T EG1 K4]W0(  -8)   9
M          " @3*- 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ $30"63TC/A\R P  )!,   T              ( !1I ! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    "  1- )9EXJ[',     3 @  "P
M    @ &CDP$ 7W)E;',O+G)E;'-02P$"% ,4    "  1- )954\<?'0$   "
M)0  #P              @ &,E $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ $30"6;P!UL'@ 0  ["   !H              ( !+9D! 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ $30"6134<>30 0  K2
M !,              ( !19L! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ #\ /P P$0  1IT!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>297</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>113</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests</Role>
      <ShortName>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Real Estate Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestments</Role>
      <ShortName>Real Estate Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Notes and Bonds Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayable</Role>
      <ShortName>Notes and Bonds Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Real Estate Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsTables</Role>
      <ShortName>Real Estate Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/RealEstateInvestments</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/Leases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Notes and Bonds Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableTables</Role>
      <ShortName>Notes and Bonds Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayable</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/StockholdersEquity</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Variable interest entity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails</Role>
      <ShortName>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Real Estate Investments - Dispositions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails</Role>
      <ShortName>Real Estate Investments - Dispositions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Real Estate Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails</Role>
      <ShortName>Real Estate Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails</Role>
      <ShortName>Real Estate Investments - Assets Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Leases - Lease Income - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseIncomeDetails</Role>
      <ShortName>Leases - Lease Income - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Leases - Lessor Accounting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLessorAccountingDetails</Role>
      <ShortName>Leases - Lessor Accounting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Leases - Ground Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesGroundLeasesDetails</Role>
      <ShortName>Leases - Ground Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Notes and Bonds Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableDetails</Role>
      <ShortName>Notes and Bonds Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayableTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Notes and Bonds Payable - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails</Role>
      <ShortName>Notes and Bonds Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails</Role>
      <ShortName>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Stock Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails</Role>
      <ShortName>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails</Role>
      <ShortName>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hr-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="hr-20240630.htm">hr-20240630.htm</File>
    <File>hr-20240630.xsd</File>
    <File>hr-20240630_cal.xml</File>
    <File>hr-20240630_def.xml</File>
    <File>hr-20240630_lab.xml</File>
    <File>hr-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="988">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hr-20240630.htm": {
   "nsprefix": "hr",
   "nsuri": "http://healthcarerealty.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "hr-20240630.htm"
     ]
    },
    "schema": {
     "local": [
      "hr-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "hr-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hr-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "hr-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hr-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 284,
   "keyCustom": 76,
   "axisStandard": 31,
   "axisCustom": 2,
   "memberStandard": 39,
   "memberCustom": 71,
   "hidden": {
    "total": 10,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 297,
   "entityCount": 1,
   "segmentCount": 113,
   "elementCount": 716,
   "unitCount": 14,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 988,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://fasb.org/srt/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://healthcarerealty.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests",
     "shortName": "Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952157 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestments",
     "longName": "9952159 - Disclosure - Real Estate Investments",
     "shortName": "Real Estate Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://healthcarerealty.com/role/Leases",
     "longName": "9952160 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayable",
     "longName": "9952161 - Disclosure - Notes and Bonds Payable",
     "shortName": "Notes and Bonds Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstruments",
     "longName": "9952162 - Disclosure - Derivative Financial Instruments",
     "shortName": "Derivative Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://healthcarerealty.com/role/CommitmentsandContingencies",
     "longName": "9952163 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://healthcarerealty.com/role/StockholdersEquity",
     "longName": "9952164 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstruments",
     "longName": "9952165 - Disclosure - Fair Value of Financial Instruments",
     "shortName": "Fair Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsTables",
     "longName": "9954473 - Disclosure - Real Estate Investments (Tables)",
     "shortName": "Real Estate Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://healthcarerealty.com/role/LeasesTables",
     "longName": "9954474 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableTables",
     "longName": "9954475 - Disclosure - Notes and Bonds Payable (Tables)",
     "shortName": "Notes and Bonds Payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables",
     "longName": "9954476 - Disclosure - Derivative Financial Instruments (Tables)",
     "shortName": "Derivative Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityTables",
     "longName": "9954477 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables",
     "longName": "9954478 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9954479 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:InvestmentInRealEstatePropertiesAndMortgageNotes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "hr:NatureOfOperationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ImpairmentOfRealEstate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
     "longName": "9954480 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "shortName": "Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails",
     "longName": "9954481 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "shortName": "Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-88",
      "name": "hr:NumberOfNotesReceivable",
      "unitRef": "note_receivable",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "hr:NotesReceivableCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
     "longName": "9954482 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:SaleLeasebackTransactionNetBookValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-106",
      "name": "hr:FinancingReceivableAllowanceForCreditLossReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
     "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R32": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
     "longName": "9954485 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "shortName": "Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-121",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
     "longName": "9954486 - Disclosure - Real Estate Investments - Dispositions (Details)",
     "shortName": "Real Estate Investments - Dispositions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-149",
      "name": "hr:DispositionSalesPrice",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hr:AssetDispositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-149",
      "name": "hr:DispositionSalesPrice",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hr:AssetDispositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails",
     "longName": "9954487 - Disclosure - Real Estate Investments - Narrative (Details)",
     "shortName": "Real Estate Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
     "longName": "9954488 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)",
     "shortName": "Real Estate Investments - Assets Held for Sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
     "longName": "9954489 - Disclosure - Leases - Lease Income - (Details)",
     "shortName": "Leases - Lease Income - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://healthcarerealty.com/role/LeasesLessorAccountingDetails",
     "longName": "9954490 - Disclosure - Leases - Lessor Accounting (Details)",
     "shortName": "Leases - Lessor Accounting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
     "longName": "9954491 - Disclosure - Leases - Ground Leases (Details)",
     "shortName": "Leases - Ground Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfPropertiesSubjectToGroundLeases",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:SquareFeetSubjecttoGroundLeases",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails",
     "longName": "9954492 - Disclosure - Leases - Future Minimum Lease Payments (Details)",
     "shortName": "Leases - Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://healthcarerealty.com/role/LeasesLeaseCostDetails",
     "longName": "9954493 - Disclosure - Leases - Lease Cost (Details)",
     "shortName": "Leases - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "us-gaap:LeaseCostTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "us-gaap:LeaseCostTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
     "longName": "9954494 - Disclosure - Notes and Bonds Payable (Details)",
     "shortName": "Notes and Bonds Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-208",
      "name": "hr:DebtInstrumentExtensionPeriodForMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
     "longName": "9954495 - Disclosure - Notes and Bonds Payable - Narrative (Details)",
     "shortName": "Notes and Bonds Payable - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
     "longName": "9954496 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "shortName": "Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "unitRef": "derivative",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "unitRef": "derivative",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
     "longName": "9954497 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "shortName": "Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-223",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-223",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
     "longName": "9954498 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "shortName": "Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "longName": "9954499 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "shortName": "Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
     "longName": "9954500 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-254",
      "name": "hr:ConstructionActivityTotalFundingDuringthePeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-254",
      "name": "hr:ConstructionActivityTotalFundingDuringthePeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
     "longName": "9954501 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "shortName": "Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
     "longName": "9954502 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)",
     "shortName": "Stockholders' Equity - Stock Transactions - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-259",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails",
     "longName": "9954503 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "shortName": "Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
     "longName": "9954504 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-275",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-275",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails",
     "longName": "9954505 - Disclosure - Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of the Activity Under the Incentive Plan and RSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-284",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-285",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails",
     "longName": "9954506 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "shortName": "Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails",
     "longName": "9954507 - Disclosure - Fair Value of Financial Instruments (Details)",
     "shortName": "Fair Value of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-294",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-294",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20240630.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "stpr_AZ": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "AZ",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arizona",
        "label": "ARIZONA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r935"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities",
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r23",
      "r116",
      "r961"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14",
      "r23",
      "r469",
      "r472",
      "r539",
      "r626",
      "r627",
      "r913",
      "r914",
      "r915",
      "r928",
      "r929",
      "r930",
      "r931"
     ]
    },
    "us-gaap_AcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "label": "Oil and Gas, Full Cost Method, Capitalized Cost Excluded from Amortization, Acquisition Cost, Period Cost",
        "documentation": "Amount of capitalized acquisition cost incurred during period and excluded from amortization for oil- and gas-producing activities accounted for under full cost method. Excludes exploration and development costs and capitalized interest."
       }
      }
     },
     "auth_ref": [
      "r1028",
      "r1029"
     ]
    },
    "hr_AcquisitionsAndDispositionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AcquisitionsAndDispositionsTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Real Estate Investments",
        "label": "Acquisitions and Dispositions [Text Block]",
        "documentation": "Acquisitions and dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "hr_ActiveDevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ActiveDevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Active Development Properties",
        "label": "Active Development Properties [Member]",
        "documentation": "Active Development Properties"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ActiveInterestRateSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ActiveInterestRateSwapsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Active Interest Rate Swap",
        "label": "Active Interest Rate Swaps [Member]",
        "documentation": "Active Interest Rate Swaps [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r928",
      "r929",
      "r930",
      "r931",
      "r994",
      "r1070"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r415"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r831",
      "r841",
      "r873"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r834",
      "r844",
      "r876"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "hr_AlbanyNYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AlbanyNYMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Albany, NY",
        "label": "Albany, NY [Member]",
        "documentation": "Albany, NY"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r869",
      "r877",
      "r881",
      "r889"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company's Allowance For Credit Losses",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r938"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "hr_AmortizationofPrepaidRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AmortizationofPrepaidRent",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of prepaid rent",
        "label": "Amortization of Prepaid Rent",
        "documentation": "Amortization of Prepaid Rent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average incremental shares of common stock excluded from the computation (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "hr_ApproximateSquareFeetInvestedInByCompany": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ApproximateSquareFeetInvestedInByCompany",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approximate square feet invested in by company",
        "label": "Approximate Square Feet Invested in by Company",
        "documentation": "Approximate Square Feet Invested in by Company"
       }
      }
     },
     "auth_ref": []
    },
    "hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SQUARE FOOTAGE",
        "label": "Area Covered Under Real Estate Investment Sold in Measurement Units",
        "documentation": "Area covered under real estate investment sold in measurement units."
       }
      }
     },
     "auth_ref": []
    },
    "hr_AssetDispositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AssetDispositionsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of dispositions",
        "label": "Asset Dispositions [Table Text Block]",
        "documentation": "Asset Dispositions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentChargesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentChargesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Impairment:",
        "label": "Asset Impairment Charges [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r167",
      "r223",
      "r254",
      "r282",
      "r286",
      "r294",
      "r295",
      "r307",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r457",
      "r461",
      "r502",
      "r597",
      "r665",
      "r744",
      "r745",
      "r782",
      "r812",
      "r954",
      "r955",
      "r1020"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "terseLabel": "Assets:",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AssetsHeldForSaleAndDiscontinuedOperationsNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets held for sale, net",
        "totalLabel": "Assets held for sale, net",
        "label": "Assets Held-for-sale and Discontinued Operations Net",
        "documentation": "Assets held for sale and discontinued operations, net."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Properties measured at fair value",
        "label": "Long-Lived Asset, Held-for-Sale, Fair Value Disclosure",
        "documentation": "Fair value portion of assets classified as held for sale."
       }
      }
     },
     "auth_ref": [
      "r770",
      "r771",
      "r773",
      "r995"
     ]
    },
    "hr_AtlantaGAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AtlantaGAMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atlanta, GA",
        "label": "Atlanta, GA [Member]",
        "documentation": "Atlanta, GA"
       }
      }
     },
     "auth_ref": []
    },
    "hr_AustinTXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "AustinTXMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Austin, TX",
        "label": "Austin, TX [Member]",
        "documentation": "Austin, TX"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r82",
      "r330",
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r453",
      "r764",
      "r765"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r453",
      "r764",
      "r765"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest owned (percent)",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]",
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessOverviewAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "BusinessOverviewAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Overview:",
        "label": "Business Overview [Abstract]",
        "documentation": "Business Overview [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Invoices accrued for construction, tenant improvements and other capitalized costs",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CARRYING VALUE",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r220",
      "r738"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r128",
      "r250"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r128"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedging",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r285",
      "r379",
      "r380",
      "r381",
      "r383",
      "r386",
      "r391",
      "r393",
      "r631",
      "r632",
      "r633",
      "r634",
      "r753",
      "r899",
      "r924"
     ]
    },
    "hr_ClosingAdjustmentsDisposedEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ClosingAdjustmentsDisposedEntity",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "CLOSING ADJUSTMENTS",
        "label": "Closing Adjustments Disposed Entity",
        "documentation": "Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "hr_ColumbusOHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ColumbusOHMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Columbus, OH",
        "label": "Columbus, OH [Member]",
        "documentation": "Columbus, OH"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r160",
      "r600",
      "r653"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r332",
      "r333",
      "r718",
      "r945",
      "r950"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)",
        "terseLabel": "Dividends paid per common share, during the period (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per common share, during the period (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r799",
      "r800",
      "r801",
      "r803",
      "r804",
      "r805",
      "r808",
      "r928",
      "r929",
      "r931",
      "r994",
      "r1067",
      "r1070"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r654"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, outstanding (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)",
        "periodEndLabel": "Balance, end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r108",
      "r654",
      "r671",
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 364,327 and 380,964 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r602",
      "r782"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "hr_CompletedDevelpomentAndRedevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "CompletedDevelpomentAndRedevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Completed Develpoment and Redevelopment Properties",
        "label": "Completed Develpoment and Redevelopment Properties [Member]",
        "documentation": "Completed Develpoment and Redevelopment Properties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss attributable to common stockholders",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r233",
      "r235",
      "r243",
      "r589",
      "r611",
      "r613"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: comprehensive loss attributable to non-controlling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r60",
      "r72",
      "r233",
      "r235",
      "r242",
      "r588",
      "r611",
      "r612"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r145",
      "r233",
      "r235",
      "r241",
      "r587",
      "r611"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r206",
      "r255",
      "r457",
      "r458",
      "r461",
      "r462",
      "r542",
      "r723",
      "r906",
      "r907",
      "r908",
      "r953",
      "r956",
      "r957"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r206",
      "r255",
      "r457",
      "r458",
      "r461",
      "r462",
      "r542",
      "r723",
      "r906",
      "r907",
      "r908",
      "r953",
      "r956",
      "r957"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r741"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-Controlling Interests",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r64",
      "r66"
     ]
    },
    "hr_ConstructionActivityTotalFundingDuringthePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ConstructionActivityTotalFundingDuringthePeriod",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction activity and development properties",
        "label": "Construction Activity, Total Funding During the Period",
        "documentation": "Construction Activity, Total Funding During the Period"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution of real estate properties into unconsolidated joint venture",
        "label": "Contribution of Real Estate Properties into Unconsolidated Joint Venture",
        "documentation": "Contribution of Real Estate Properties into Unconsolidated Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateJointVentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateJointVentureMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint Venture",
        "label": "Corporate Joint Venture [Member]",
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CumulativeDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CumulativeDividends",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cumulative dividends",
        "label": "Cumulative Dividends",
        "documentation": "Amount of cumulative cash dividends distributed to shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeDividendsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "CumulativeDividendsMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Dividends",
        "label": "Cumulative Dividends [Member]",
        "documentation": "Cumulative Dividends [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeNetIncomeAttributableToCommonStockholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "CumulativeNetIncomeAttributableToCommonStockholders",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cumulative net income attributable to common stockholders",
        "label": "Cumulative Net Income Attributable to Common Stockholders",
        "documentation": "Cumulative net income attributable to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeNetIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "CumulativeNetIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Net Income",
        "label": "Cumulative Net Income [Member]",
        "documentation": "Cumulative Net Income [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeNetLossAttributableToCommonStockholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "CumulativeNetLossAttributableToCommonStockholders",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cumulative net loss",
        "label": "Cumulative Net loss Attributable to Common Stockholders",
        "documentation": "Cumulative Net loss Attributable to Common Stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and Bonds Payable",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r252",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r338",
      "r339",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r365",
      "r372",
      "r373",
      "r375",
      "r511"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r97",
      "r98",
      "r155",
      "r159",
      "r255",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r780",
      "r925",
      "r946",
      "r947",
      "r948",
      "r1010",
      "r1011"
     ]
    },
    "hr_DebtInstrumentExtensionPeriodForMaturityDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "DebtInstrumentExtensionPeriodForMaturityDate",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extension period for maturity date",
        "label": "Debt Instrument, Extension Period for Maturity Date",
        "documentation": "Debt Instrument, Extension Period for Maturity Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r511",
      "r512",
      "r749",
      "r750",
      "r780"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and bonds payable",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r501",
      "r749",
      "r750",
      "r995",
      "r996",
      "r997",
      "r998",
      "r1005"
     ]
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt fees",
        "label": "Debt Instrument, Fee Amount",
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r377",
      "r511",
      "r512",
      "r780"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r780",
      "r925",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r255",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r780",
      "r925",
      "r946",
      "r947",
      "r948",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repaid amount",
        "label": "Debt Instrument, Repaid, Principal",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r46",
      "r49",
      "r93",
      "r139",
      "r140",
      "r255",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r780",
      "r925",
      "r1010",
      "r1011"
     ]
    },
    "hr_DenverCOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "DenverCOMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denver, CO",
        "label": "Denver, CO [Member]",
        "documentation": "Denver, CO"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r40"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r282",
      "r291",
      "r295",
      "r744",
      "r745"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r644",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r680",
      "r681",
      "r682",
      "r683",
      "r686",
      "r687",
      "r688",
      "r689",
      "r705",
      "r706",
      "r707",
      "r708",
      "r799",
      "r801",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability derivatives",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r115",
      "r149",
      "r150",
      "r227",
      "r739"
     ]
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate (percent)",
        "label": "Derivative, Fixed Interest Rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r83",
      "r84",
      "r151",
      "r642",
      "r644",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r680",
      "r681",
      "r682",
      "r683",
      "r686",
      "r687",
      "r688",
      "r689",
      "r705",
      "r706",
      "r707",
      "r708",
      "r739",
      "r799",
      "r801",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r466",
      "r474"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r80",
      "r83"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNetLiabilityPositionAggregateFairValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives in net liability position",
        "label": "Derivative, Net Liability Position, Aggregate Fair Value",
        "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AMOUNT",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTable",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r73",
      "r74",
      "r76",
      "r78",
      "r81",
      "r83",
      "r86",
      "r87",
      "r89",
      "r474"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as hedging instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DevelopmentInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopmentInProcess",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Development in Process",
        "documentation": "The current amount of expenditures for a real estate project that has not yet been completed."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DirectCostsOfLeasedAndRentedPropertyOrEquipment",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property operating",
        "label": "Direct Costs of Leased and Rented Property or Equipment",
        "documentation": "Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "hr_DirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "DirectorsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Directors",
        "label": "Directors [Member]",
        "documentation": "Directors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of the Activity Under the Incentive Plan and RSU Activity",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51"
     ]
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations",
        "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r17",
      "r218"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r94",
      "r95",
      "r133"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r94",
      "r95",
      "r133"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r94",
      "r95",
      "r133"
     ]
    },
    "hr_DispositionSalesPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "DispositionSalesPrice",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SALE PRICE",
        "label": "Disposition Sales Price",
        "documentation": "Disposition Sales Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Owner distributions",
        "label": "Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared",
        "documentation": "Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r284"
     ]
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends to common stockholders and distributions to non-controlling interest holders",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic earnings per common share (in dollars per share)",
        "verboseLabel": "Basic earnings per common share - net loss (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r270",
      "r272",
      "r275",
      "r278",
      "r279",
      "r281",
      "r451",
      "r455",
      "r477",
      "r478",
      "r590",
      "r614",
      "r742"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted earnings per common share (in dollars per share)",
        "verboseLabel": "Diluted earnings per common share- net loss (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r272",
      "r275",
      "r278",
      "r279",
      "r281",
      "r451",
      "r455",
      "r477",
      "r478",
      "r590",
      "r614",
      "r742"
     ]
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options under the Employee Stock Option Plan",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r216",
      "r236",
      "r237",
      "r238",
      "r256",
      "r257",
      "r258",
      "r260",
      "r265",
      "r267",
      "r269",
      "r284",
      "r308",
      "r309",
      "r323",
      "r394",
      "r445",
      "r446",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r476",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r513",
      "r516",
      "r539",
      "r610",
      "r626",
      "r627",
      "r628",
      "r637",
      "r692"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r447",
      "r900",
      "r901",
      "r902",
      "r988",
      "r989",
      "r990",
      "r991"
     ]
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions from unconsolidated joint ventures",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r11",
      "r117",
      "r606"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture ownership (percent)",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "hr_EquityMethodInvestmentsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EquityMethodInvestmentsRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments [Roll Forward]",
        "label": "Equity Method Investments [Roll Forward]",
        "documentation": "Equity Method Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments",
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "hr_EquityOwnershipForConsolidationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "EquityOwnershipForConsolidationPercent",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity ownership for consolidation (percent)",
        "label": "Equity Ownership for Consolidation, Percent",
        "documentation": "Equity Ownership for Consolidation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r831",
      "r841",
      "r873"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r501",
      "r749",
      "r750"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "hr_ExecutiveIncentiveProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ExecutiveIncentiveProgramMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Incentive Program",
        "label": "Executive Incentive Program [Member]",
        "documentation": "Executive Incentive Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExtinguishmentOfDebtAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding principal repaid",
        "label": "Extinguishment of Debt, Amount",
        "documentation": "Gross amount of debt extinguished."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExtinguishmentOfDebtAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extinguishment of Debt [Axis]",
        "label": "Extinguishment of Debt [Axis]",
        "documentation": "Information by type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "hr_ExtinguishmentOfDebtEncumberedSquareFootage": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ExtinguishmentOfDebtEncumberedSquareFootage",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Encumbered square footage",
        "label": "Extinguishment of Debt, Encumbered Square Footage",
        "documentation": "Extinguishment of Debt, Encumbered Square Footage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extinguishment of Debt, Type [Domain]",
        "label": "Extinguishment of Debt, Type [Domain]",
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "stpr_FL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "FL",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Florida",
        "label": "FLORIDA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r494",
      "r774"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r494",
      "r774"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r492",
      "r493",
      "r495",
      "r544",
      "r545",
      "r546",
      "r749",
      "r750",
      "r761",
      "r762",
      "r763",
      "r771",
      "r776"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r749",
      "r750"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r749",
      "r750"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r490",
      "r491",
      "r492",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r584",
      "r771",
      "r777"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r480",
      "r481",
      "r482",
      "r483",
      "r493",
      "r546",
      "r749",
      "r750",
      "r761",
      "r762",
      "r763",
      "r771",
      "r776"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r492",
      "r493",
      "r495",
      "r544",
      "r545",
      "r546",
      "r749",
      "r750",
      "r761",
      "r762",
      "r763",
      "r771",
      "r776"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r525",
      "r781"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows outflows related to financing leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r528"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "verboseLabel": "Lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Financing Lease Payments",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "hr_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Discount",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "hr_FinanceLeasePrincipalOnlyPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "FinanceLeasePrincipalOnlyPayments",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows outflows related to financing leases",
        "label": "Finance Lease, Principal Only Payments",
        "documentation": "Finance Lease, Principal Only Payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments made on finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r528"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r525",
      "r781"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate - finance leases",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r781"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - finance leases",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r781"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "ALLOWANCE FOR CREDIT LOSSES",
        "periodStartLabel": "Allowance for credit losses, beginning of period",
        "periodEndLabel": "Allowance for credit losses, end of period",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "hr_FinancingReceivableAllowanceForCreditLossInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "FinancingReceivableAllowanceForCreditLossInterest",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss, interest",
        "label": "Financing Receivable, Allowance for Credit Loss, Interest",
        "documentation": "Financing Receivable, Allowance for Credit Loss, Interest"
       }
      }
     },
     "auth_ref": []
    },
    "hr_FinancingReceivableAllowanceForCreditLossReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "FinancingReceivableAllowanceForCreditLossReserves",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit loss reserves",
        "label": "Financing Receivable, Allowance for Credit Loss, Reserves",
        "documentation": "Financing Receivable, Allowance for Credit Loss, Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "FAIR VALUE DISCOUNT AND FEES",
        "label": "Financing Receivable, Covered and Not Covered, after Allowance for Credit Loss, Fee, Premium, and Discount",
        "documentation": "Amount, after allowance for credit loss and unamortized deferred fee, premium, and discount, of financing receivable covered under loss sharing agreement and financing receivable not covered under loss sharing agreement."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable, net",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss",
        "label": "Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REAL ESTATE NOTES RECEIVABLE, GROSS",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r937"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableExcludingAccruedInterestNonaccrual",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, nonaccrual",
        "label": "Financing Receivable, Excluding Accrued Interest, Nonaccrual",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable on nonaccrual status. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "hr_Florida1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "Florida1Member",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Florida 1",
        "label": "Florida 1 [Member]",
        "documentation": "Florida 1"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "stpr_GA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "GA",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Georgia",
        "label": "GEORGIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "GAIN/(IMPAIRMENT)",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r922",
      "r942",
      "r944"
     ]
    },
    "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnSalesOfInvestmentRealEstate",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sales of real estate properties and other assets",
        "negatedLabel": "Gain on sales of real estate properties and other assets",
        "label": "Gains (Losses) on Sales of Investment Real Estate",
        "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r175",
      "r917",
      "r918",
      "r922",
      "r1030",
      "r1069"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r676"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r313",
      "r585",
      "r745",
      "r747",
      "r772",
      "r782",
      "r939",
      "r940"
     ]
    },
    "us-gaap_GoodwillImpairedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairedAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill Impairment",
        "label": "Goodwill, Impaired [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impairment of goodwill",
        "verboseLabel": "Impairment of goodwill",
        "terseLabel": "Impairment of goodwill",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r314",
      "r315",
      "r317",
      "r747",
      "r772"
     ]
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "hr_GreensboroNCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "GreensboroNCMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greensboro, NC",
        "label": "Greensboro, NC [Member]",
        "documentation": "Greensboro, NC"
       }
      }
     },
     "auth_ref": []
    },
    "hr_GreensboroRaleighNCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "GreensboroRaleighNCMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greensboro/Raleigh, NC",
        "label": "Greensboro/Raleigh, NC [Member]",
        "documentation": "Greensboro/Raleigh, NC"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HealthCareRealtyTrustIncorporatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "HealthCareRealtyTrustIncorporatedMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HealthCare Realty Trust Incorporated",
        "label": "HealthCare Realty Trust Incorporated [Member]",
        "documentation": "HealthCare Realty Trust Incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HealthcareTrustofAmericaHoldingsLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "HealthcareTrustofAmericaHoldingsLPMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Healthcare Trust of America Holdings L P",
        "label": "Healthcare Trustof America Holdings L P [Member]",
        "documentation": "Healthcare Trustof America Holdings L P"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r465"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "hr_HoustonTXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "HoustonTXMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Houston, TX",
        "label": "Houston, TX [Member]",
        "documentation": "Houston, TX"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HoustonTexasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "HoustonTexasMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Houston, TX",
        "label": "Houston, Texas [Member]",
        "documentation": "Houston, Texas [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfRealEstate",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of real estate assets",
        "label": "Impairment of Real Estate",
        "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value."
       }
      }
     },
     "auth_ref": [
      "r922",
      "r943"
     ]
    },
    "hr_ImpairmentOfRealEstateAndCreditLossReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ImpairmentOfRealEstateAndCreditLossReserves",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment of real estate properties and credit loss reserves",
        "label": "Impairment of Real Estate and Credit Loss Reserves",
        "documentation": "Impairment of Real Estate and Credit Loss Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ImpairmentOfRealEstateContinuingAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of real estate properties and credit loss reserves",
        "label": "Impairment of Real Estate, Continuing and Discontinued Operations",
        "documentation": "Impairment of Real Estate, Continuing and Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill Impairment",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Impairment",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r134"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity loss from unconsolidated joint ventures",
        "negatedTerseLabel": "Equity loss from unconsolidated joint ventures",
        "verboseLabel": "Equity loss recognized during the period",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r117",
      "r163",
      "r282",
      "r292",
      "r295",
      "r302",
      "r606"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r330",
      "r331",
      "r485",
      "r489",
      "r494",
      "r623",
      "r625",
      "r677",
      "r731",
      "r775",
      "r1038"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r485",
      "r489",
      "r494",
      "r623",
      "r625",
      "r677",
      "r731",
      "r775",
      "r1038"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets, including right-of-use-assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-controlling Interests",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of OP Units (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of OP Units",
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of OP Units"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r869",
      "r877",
      "r881",
      "r889"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r893"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r893"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r893"
     ]
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r919"
     ]
    },
    "us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Financing Receivable, before Allowance for Credit Loss",
        "documentation": "Amount of interest income from financing receivable before allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185"
     ]
    },
    "hr_InterestIncomeFinancingReceivableNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestIncomeFinancingReceivableNoncash",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash interest from financing and notes receivable",
        "label": "Interest Income, Financing Receivable, Noncash",
        "documentation": "Interest Income, Financing Receivable, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOperating",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating",
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r674",
      "r710",
      "r711",
      "r744",
      "r809",
      "r810",
      "r916",
      "r1072"
     ]
    },
    "us-gaap_InterestPaidCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized interest",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity."
       }
      }
     },
     "auth_ref": [
      "r740",
      "r923"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r248",
      "r249"
     ]
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_InterestRateContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateContractMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate swaps",
        "label": "Interest Rate Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r739",
      "r761",
      "r771"
     ]
    },
    "hr_InterestRateSwapExpiringDecember12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestRateSwapExpiringDecember12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2026",
        "label": "Interest Rate Swap, Expiring December 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring December 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringDecember12027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestRateSwapExpiringDecember12027Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2027",
        "label": "Interest Rate Swap, Expiring December 1, 2027 [Member]",
        "documentation": "Interest Rate Swap, Expiring December 1, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringJune12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestRateSwapExpiringJune12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2026",
        "label": "Interest Rate Swap, Expiring June 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring June 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringJune12027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestRateSwapExpiringJune12027Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2027",
        "label": "Interest Rate Swap, Expiring June 1, 2027 [Member]",
        "documentation": "Interest Rate Swap, Expiring June 1, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringMay12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InterestRateSwapExpiringMay12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring May 1, 2026",
        "label": "Interest Rate Swap, Expiring May 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring May 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest Rate Swaps",
        "terseLabel": "Settled interest rate swaps",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r806",
      "r807"
     ]
    },
    "us-gaap_InterestReceivableAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestReceivableAndOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTEREST RECEIVABLE (OTHER ASSETS)",
        "label": "Interest Receivable and Other Assets",
        "documentation": "Amount of interest receivable and assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentBuildingAndBuildingImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentBuildingAndBuildingImprovements",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Buildings and improvements",
        "terseLabel": "Building and improvements",
        "label": "Investment Building and Building Improvements",
        "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "hr_InvestmentInRealEstatePropertiesAndMortgageNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InvestmentInRealEstatePropertiesAndMortgageNotes",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross investment amount, total",
        "label": "Investment in Real Estate Properties and Mortgage Notes",
        "documentation": "Investment in real estate properties and mortgage notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in unconsolidated joint ventures",
        "periodStartLabel": "Investments in unconsolidated joint ventures, beginning of period",
        "periodEndLabel": "Investments in unconsolidated joint ventures, end of period",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New investments during the period",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period",
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period"
       }
      }
     },
     "auth_ref": []
    },
    "hr_JointVentureCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "JointVentureCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture, carrying amount",
        "label": "Joint Venture, Carrying Amount",
        "documentation": "Joint Venture, Carrying Amount"
       }
      }
     },
     "auth_ref": []
    },
    "hr_JointVentureOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "JointVentureOwnershipPercentage",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture, ownership (in percentage)",
        "label": "Joint Venture, Ownership Percentage",
        "documentation": "Joint Venture, Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "hr_LTIPSeriesCUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LTIPSeriesCUnitsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LTIP Series C Units",
        "label": "LTIP Series C Units [Member]",
        "documentation": "LTIP Series C Units"
       }
      }
     },
     "auth_ref": []
    },
    "hr_LTIPSeriesDUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LTIPSeriesDUnitsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LTIP Series D Units",
        "label": "LTIP Series D Units [Member]",
        "documentation": "LTIP Series D Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Land": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Land",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Land",
        "terseLabel": "Land",
        "label": "Land",
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_LandAvailableForDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LandAvailableForDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land held for development",
        "label": "Land Available for Development",
        "documentation": "Carrying amount of land available for development."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease expense",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r781"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "hr_LeaseIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LeaseIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangibles",
        "label": "Lease Intangibles",
        "documentation": "Lease Intangibles"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesOperatingAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other information",
        "label": "Leases, Operating [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nationwide portfolio (percent)",
        "label": "Leasing and Property Management Services Provided as Percentage of Nationwide Portfolio",
        "documentation": "Leasing and Property Management Services Provided as Percentage of Nationwide Portfolio"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost",
        "label": "Lessee, Finance Lease, Description [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r533"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r533"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ground lease, initial term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorLeasesPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income",
        "label": "Lessor, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r535"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessor, Operating Lease, Payment to be Received",
        "documentation": "Amount of lease payments to be received by lessor for operating lease."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments Receivable",
        "label": "Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LessorOperatingLeasePaymenttobeReceivedafterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Lessor, Operating Lease, Payment to be Received, after Year Four",
        "documentation": "Lessor, Operating Lease, Payment to be Received, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "terseLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r97",
      "r98",
      "r99",
      "r102",
      "r103",
      "r104",
      "r105",
      "r254",
      "r307",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r458",
      "r461",
      "r462",
      "r502",
      "r652",
      "r743",
      "r812",
      "r954",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r162",
      "r604",
      "r782",
      "r926",
      "r936",
      "r1009"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "terseLabel": "Liabilities:",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities of assets held for sale",
        "totalLabel": "Liabilities of assets held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r94",
      "r95",
      "r133",
      "r218",
      "r219"
     ]
    },
    "hr_LimitedLiabilityCompanyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LimitedLiabilityCompanyOneMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited Liability Company One",
        "label": "Limited Liability Company One [Member]",
        "documentation": "Limited Liability Company One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LimitedPartnersCapitalAccountUnitsOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited partner's capital, units outstanding (in shares)",
        "label": "Limited Partners' Capital Account, Units Outstanding",
        "documentation": "The number of limited partner units outstanding."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r101"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available to be drawn debt amount",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r101",
      "r339"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsHeldForSaleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongLivedAssetsHeldForSaleLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long Lived Assets Held-for-sale [Line Items]",
        "label": "Long-Lived Assets Held-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and bonds payable",
        "terseLabel": "Notes and bonds payable",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r159",
      "r362",
      "r376",
      "r749",
      "r750",
      "r780",
      "r1033"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r946",
      "r947",
      "r948"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r41",
      "r946",
      "r947",
      "r948"
     ]
    },
    "hr_LosAngelesCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "LosAngelesCaliforniaMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Los Angeles, California",
        "label": "Los Angeles, California [Member]",
        "documentation": "Los Angeles, California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ManagementFeeIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ManagementFeeIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee income/other",
        "label": "Management Fee Income [Member]",
        "documentation": "Management Fee Income [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MarketCondition2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MarketCondition2Member",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Relative TSR Component",
        "label": "Market Condition 2 [Member]",
        "documentation": "Market Condition 2"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r191",
      "r192",
      "r194",
      "r214",
      "r215",
      "r334",
      "r335",
      "r336",
      "r337",
      "r413",
      "r444",
      "r483",
      "r552",
      "r622",
      "r624",
      "r629",
      "r643",
      "r644",
      "r698",
      "r700",
      "r702",
      "r703",
      "r709",
      "r729",
      "r730",
      "r746",
      "r753",
      "r766",
      "r776",
      "r777",
      "r778",
      "r779",
      "r792",
      "r958",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_MediumTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MediumTermNotesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medium-term notes",
        "label": "Medium-Term Note [Member]",
        "documentation": "Debt instruments with maturities ranging from five to ten years."
       }
      }
     },
     "auth_ref": []
    },
    "hr_MergerRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MergerRelatedCosts",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger-related costs",
        "label": "Merger Related Costs",
        "documentation": "Merger Related Costs"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MezzanineLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MezzanineLoanMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine loans",
        "label": "Mezzanine Loan [Member]",
        "documentation": "Mezzanine Loan"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r191",
      "r192",
      "r194",
      "r214",
      "r215",
      "r334",
      "r335",
      "r336",
      "r337",
      "r413",
      "r444",
      "r483",
      "r552",
      "r622",
      "r624",
      "r629",
      "r643",
      "r644",
      "r698",
      "r700",
      "r702",
      "r703",
      "r709",
      "r729",
      "r730",
      "r746",
      "r753",
      "r766",
      "r776",
      "r777",
      "r778",
      "r792",
      "r958",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "hr_MinneapolisMNMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MinneapolisMNMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minneapolis, MN",
        "label": "Minneapolis, MN [Member]",
        "documentation": "Minneapolis, MN"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r161",
      "r254",
      "r307",
      "r340",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r502",
      "r603",
      "r655"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, ownership percentage, noncontrolling owner",
        "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "hr_MortgageLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MortgageLoanMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans",
        "label": "Mortgage Loan [Member]",
        "documentation": "Mortgage Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MortgageLoanRelatedToPropertySales1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MortgageLoanRelatedToPropertySales1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage note receivables taken in connection with sale of real estate",
        "label": "Mortgage Loan Related to Property Sales",
        "documentation": "Mortgage loan related to property sales in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real estate notes receivable",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r594",
      "r796",
      "r798"
     ]
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate, Type of Property [Axis]",
        "label": "Real Estate, Type of Property [Axis]",
        "documentation": "Information by type of real estate property."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r717",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ]
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Domain]",
        "label": "Real Estate [Domain]",
        "documentation": "Land and any structures permanently fixed to it."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ]
    },
    "hr_MortgageNotesPayableNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MortgageNotesPayableNetMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage notes payable",
        "label": "Mortgage Notes Payable, Net [Member]",
        "documentation": "Mortgage Notes Payable, Net [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MortgagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MortgagesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgages",
        "label": "Mortgages [Member]",
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "hr_MultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "MultipleMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Multiple",
        "label": "Multiple [Member]",
        "documentation": "Multiple"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_NC": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "NC",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North Carolina",
        "label": "NORTH CAROLINA"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "hr_NatureOfOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NatureOfOperationsPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Overview",
        "label": "Nature of Operations [Policy Text Block]",
        "documentation": "Nature Of Operations Policy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r130"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss attributable to common stockholders",
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r130",
      "r164",
      "r219",
      "r231",
      "r234",
      "r238",
      "r254",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r273",
      "r307",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r451",
      "r455",
      "r478",
      "r502",
      "r609",
      "r673",
      "r690",
      "r691",
      "r810",
      "r954"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss attributable to non-controlling interests",
        "negatedTerseLabel": "Loss attributable to non-controlling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r146",
      "r231",
      "r234",
      "r265",
      "r268",
      "r269",
      "r608",
      "r915"
     ]
    },
    "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss applicable to common stockholders - basic",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic",
        "documentation": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "hr_NewYorkNYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NewYorkNYMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York, NY",
        "label": "New York, NY [Member]",
        "documentation": "New York, NY"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NonControllingInterestHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NonControllingInterestHoldersMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Controlling Interest Holders",
        "label": "Non-Controlling Interest Holders [Member]",
        "documentation": "Non-Controlling Interest Holders"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r869",
      "r877"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "hr_NonVestedStockAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NonVestedStockAwardMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested Stock Award",
        "label": "Non Vested Stock Award [Member]",
        "documentation": "Non Vested Stock Award"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r394",
      "r928",
      "r929",
      "r930",
      "r931",
      "r1070"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense)",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NotesReceivableCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NotesReceivableCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes receivable, carrying amount",
        "label": "Notes Receivable, Carrying Amount",
        "documentation": "Notes Receivable, Carrying Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CARRYING VALUE",
        "label": "Notes Receivable, Fair Value Disclosure",
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "hr_NotesReceivableInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NotesReceivableInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTEREST RATE",
        "label": "Notes Receivable, Interest Rate",
        "documentation": "Notes Receivable, Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NotesReceivableMaximumLoanCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NotesReceivableMaximumLoanCommitment",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAXIMUM LOAN COMMITMENT",
        "label": "Notes Receivable, Maximum Loan Commitment",
        "documentation": "Notes Receivable, Maximum Loan Commitment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Receivable",
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76"
     ]
    },
    "hr_NumberOfJointVentures": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfJointVentures",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of joint ventures",
        "label": "Number of Joint Ventures",
        "documentation": "Number of Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfMezzanineLoans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfMezzanineLoans",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of mezzanine loans",
        "label": "Number Of Mezzanine Loans",
        "documentation": "Number Of Mezzanine Loans"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfMortgageLoans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfMortgageLoans",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of mortgage loans",
        "label": "Number Of Mortgage Loans",
        "documentation": "Number Of Mortgage Loans"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfNotesReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfNotesReceivable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of notes receivable",
        "label": "Number of Notes Receivable",
        "documentation": "Number of Notes Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfPropertiesClassifiedAsHeldForSale": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfPropertiesClassifiedAsHeldForSale",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of owned real estate properties",
        "label": "Number of Properties Classified as Held for Sale",
        "documentation": "Number of Properties Classified as Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfPropertiesHeldInUnconsolidatedJointVentures": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfPropertiesHeldInUnconsolidatedJointVentures",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of properties held in unconsolidated joint ventures",
        "label": "Number of Properties Held in Unconsolidated Joint Ventures",
        "documentation": "Number of Properties Held in Unconsolidated Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfPropertiesMeasuredAtFairValue": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfPropertiesMeasuredAtFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of properties measured at fair value",
        "label": "Number of Properties Measured at Fair Value",
        "documentation": "Number of Properties Measured at Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfPropertiesSubjectToGroundLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfPropertiesSubjectToGroundLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of properties subject to ground leases",
        "label": "Number of Properties Subject to Ground Leases",
        "documentation": "Number of separate real estate development properties located on land subject to ground leases."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "hr_NumberOfRealEstateInvestments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfRealEstateInvestments",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate properties",
        "label": "Number of Real Estate Investments",
        "documentation": "Number of real estate investments."
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfRealEstateNotesReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfRealEstateNotesReceivable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate notes receivable",
        "label": "Number of Real Estate Notes Receivable",
        "documentation": "Number of Real Estate Notes Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfRealEstateProperties",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of owned real estate properties",
        "label": "Number of Real Estate Properties",
        "documentation": "The number of real estate properties owned as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfRecognizedLeaseFinancialReceivables": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfRecognizedLeaseFinancialReceivables",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of recognized lease financial receivables",
        "label": "Number of Recognized Lease Financial Receivables",
        "documentation": "Number of Recognized Lease Financial Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfVariableInterestEntities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberOfVariableInterestEntities",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of variable interest entities",
        "label": "Number of Variable Interest Entities",
        "documentation": "Number of Variable Interest Entities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberofGroundLeasesExcludingPrepaidLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberofGroundLeasesExcludingPrepaidLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of non-prepaid ground leases",
        "label": "Number of Ground Leases, Excluding Prepaid Leases",
        "documentation": "Number of Ground Leases, Excluding Prepaid Leases"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberofGroundLeasesPrepaid": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "NumberofGroundLeasesPrepaid",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of prepaid ground leases",
        "label": "Number of Ground Leases Prepaid",
        "documentation": "Number of Ground Leases Prepaid"
       }
      }
     },
     "auth_ref": []
    },
    "hr_OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "OneMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One",
        "label": "One [Member]",
        "documentation": "One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_OperatingExpensesandCostofGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "OperatingExpensesandCostofGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Expenses",
        "label": "Operating Expenses and Cost of Goods Sold",
        "documentation": "Operating Expenses and Cost of Goods Sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r781"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLeaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rental income",
        "label": "Operating Lease, Lease Income",
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r534",
      "r537"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows outflows related to operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r528"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate - operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r781"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r781"
     ]
    },
    "hr_OperatingPartnershipPerformanceUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "OperatingPartnershipPerformanceUnitsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Partnership Performance Units",
        "label": "Operating Partnership Performance Units [Member]",
        "documentation": "Operating Partnership Performance Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation:",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAmortizationOfDeferredCharges",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other amortization",
        "label": "Amortization of Other Deferred Charges",
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r119"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets, net",
        "label": "Other Assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r222",
      "r596",
      "r745",
      "r812"
     ]
    },
    "us-gaap_OtherAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other assets."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r88"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Axis]",
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Domain]",
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate derivatives",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gains arising during the period on interest rate swaps",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)/loss recognized in AOCI on derivative",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r463",
      "r464",
      "r467"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reclassification adjustments for gains included in interest expense",
        "negatedTerseLabel": "Reclassification adjustments for gains included in net income (interest expense)",
        "negatedNetLabel": "(Gain) Loss, Reclassified from AOCI into income",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r20",
      "r232",
      "r235",
      "r240",
      "r265",
      "r503",
      "r504",
      "r509",
      "r586",
      "r610",
      "r913",
      "r914"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherFiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherFiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangibles",
        "label": "Other Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r911",
      "r941"
     ]
    },
    "hr_OtherInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "OtherInvestorsMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Investors",
        "label": "Other Investors [Member]",
        "documentation": "Other Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r598",
      "r648",
      "r649",
      "r812",
      "r1034",
      "r1068"
     ]
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r88"
     ]
    },
    "hr_OtherMembersOfSeniorManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "OtherMembersOfSeniorManagementMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Members Of Senior Management",
        "label": "Other Members Of Senior Management [Member]",
        "documentation": "Other Members Of Senior Management"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other (expense) income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "srt_OtherPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OtherPropertyMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parking Garages",
        "label": "Other Property [Member]",
        "documentation": "Property classified as other."
       }
      }
     },
     "auth_ref": [
      "r736",
      "r737",
      "r1073",
      "r1074"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r833",
      "r843",
      "r875"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r836",
      "r846",
      "r878"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r836",
      "r846",
      "r878"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ParentMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Stockholders\u2019 Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "hr_ParkingIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ParkingIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parking income",
        "label": "Parking Income [Member]",
        "documentation": "Parking Income [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock redemptions",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "hr_PaymentsForRepurchasesOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PaymentsForRepurchasesOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock repurchases",
        "label": "Payments For Repurchases Of Common Stock",
        "documentation": "Payments For Repurchases Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt issuance and assumption costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_PaymentsToAcquireFinanceReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireFinanceReceivables",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment in financing receivable",
        "label": "Payments to Acquire Finance Receivables",
        "documentation": "The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investments in unconsolidated joint ventures",
        "label": "Payments to Acquire Interest in Joint Venture",
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Funding of mortgages and notes receivable",
        "label": "Payments to Acquire Notes Receivable",
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additional long-lived assets",
        "label": "Payments to Acquire Other Productive Assets",
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_PaymentsToAcquireRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireRealEstate",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisitions of real estate",
        "label": "Payments to Acquire Real Estate",
        "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_PaymentsToDevelopRealEstateAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToDevelopRealEstateAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Development of real estate",
        "label": "Payments to Develop Real Estate Assets",
        "documentation": "Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distributions to non-controlling interest holders",
        "label": "Payments to Noncontrolling Interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "hr_PercentageOfRestrictedStockUnits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PercentageOfRestrictedStockUnits",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of restricted stock units",
        "label": "Percentage Of Restricted Stock Units",
        "documentation": "Percentage Of Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "hr_PerformanceConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PerformanceConditionsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance conditions",
        "label": "Performance Conditions [Member]",
        "documentation": "Performance Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "hr_PersonalProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PersonalProperty",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personal property",
        "label": "Personal Property",
        "documentation": "Personal property."
       }
      }
     },
     "auth_ref": []
    },
    "hr_PhiladelphiaPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PhiladelphiaPAMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Philadelphia, PA",
        "label": "Philadelphia, PA [Member]",
        "documentation": "Philadelphia, PA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "hr_PowayCAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PowayCAMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Poway, CA",
        "label": "Poway, CA [Member]",
        "documentation": "Poway, CA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r379"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r654"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r379"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r654",
      "r671",
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r601",
      "r782"
     ]
    },
    "us-gaap_ProceedsFromCollectionOfFinanceReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromCollectionOfFinanceReceivables",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable",
        "label": "Proceeds from Collection of Finance Receivables",
        "documentation": "The cash inflow associated with the collection of receivables arising from the financing of goods and services."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ProceedsFromContributionsFromRedeemableNoncontrollingInterests",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contributions from redeemable non-controlling interests",
        "label": "Proceeds from Contributions from Redeemable Noncontrolling Interests",
        "documentation": "Proceeds from Contributions from Redeemable Noncontrolling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ProceedsFromDispositionsHeldInEscrow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ProceedsFromDispositionsHeldInEscrow",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from dispositions held in escrow",
        "label": "Proceeds From Dispositions Held In Escrow",
        "documentation": "Proceeds From Dispositions Held In Escrow"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net borrowings (repayments) on unsecured credit facility",
        "label": "Proceeds from (Repayments of) Lines of Credit",
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndCollectionOfNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from notes receivable repayments",
        "label": "Proceeds from Sale and Collection of Notes Receivable",
        "documentation": "The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable)."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales of real estate properties and additional long-lived assets",
        "label": "Proceeds from Sale, Property, Held-for-Sale",
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET PROCEEDS",
        "label": "Proceeds from Sale, Real Estate, Held-for-Investment",
        "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r213",
      "r296",
      "r553",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r734",
      "r754",
      "r791",
      "r792",
      "r793",
      "r795",
      "r797",
      "r909",
      "r951",
      "r952",
      "r960",
      "r1035",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r213",
      "r296",
      "r553",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r734",
      "r754",
      "r791",
      "r792",
      "r793",
      "r795",
      "r797",
      "r909",
      "r951",
      "r952",
      "r960",
      "r1035",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r231",
      "r234",
      "r246",
      "r254",
      "r259",
      "r265",
      "r268",
      "r269",
      "r307",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r451",
      "r455",
      "r456",
      "r459",
      "r460",
      "r478",
      "r502",
      "r591",
      "r607",
      "r636",
      "r673",
      "r690",
      "r691",
      "r768",
      "r769",
      "r811",
      "r915",
      "r954"
     ]
    },
    "hr_PropertyEntitiesNotDeterminedToBeVIEsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "PropertyEntitiesNotDeterminedToBeVIEsMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Entities Not Determined to be VIEs",
        "label": "Property Entities Not Determined to be VIEs [Member]",
        "documentation": "Property Entities Not Determined to be VIEs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "hr_RaleighNCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RaleighNCMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raleigh, NC",
        "label": "Raleigh, NC [Member]",
        "documentation": "Raleigh, NC"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r191",
      "r192",
      "r194",
      "r214",
      "r215",
      "r334",
      "r335",
      "r336",
      "r337",
      "r405",
      "r413",
      "r439",
      "r440",
      "r441",
      "r444",
      "r483",
      "r547",
      "r551",
      "r552",
      "r622",
      "r624",
      "r629",
      "r643",
      "r644",
      "r698",
      "r700",
      "r702",
      "r703",
      "r709",
      "r729",
      "r730",
      "r746",
      "r753",
      "r766",
      "r776",
      "r777",
      "r778",
      "r779",
      "r792",
      "r801",
      "r949",
      "r958",
      "r997",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r191",
      "r192",
      "r194",
      "r214",
      "r215",
      "r334",
      "r335",
      "r336",
      "r337",
      "r405",
      "r413",
      "r439",
      "r440",
      "r441",
      "r444",
      "r483",
      "r547",
      "r551",
      "r552",
      "r622",
      "r624",
      "r629",
      "r643",
      "r644",
      "r698",
      "r700",
      "r702",
      "r703",
      "r709",
      "r729",
      "r730",
      "r746",
      "r753",
      "r766",
      "r776",
      "r777",
      "r778",
      "r779",
      "r792",
      "r801",
      "r949",
      "r958",
      "r997",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_RealEstateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Notes Receivable:",
        "label": "Real Estate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateDispositionsLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions [Line Items]",
        "label": "Real Estate Dispositions [Line Items]",
        "documentation": "Real estate dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateDispositionsMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions",
        "label": "Real Estate Dispositions [Member]",
        "documentation": "Real Estate Dispositions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateInvestmentNetDisposedOfDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateInvestmentNetDisposedOfDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "NET REAL ESTATE INVESTMENT",
        "label": "Real Estate Investment Net Disposed of During Period",
        "documentation": "Real estate investment net disposed of during the Period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Real Estate Investment Property, Accumulated Depreciation",
        "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyAtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateInvestmentPropertyAtCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate properties",
        "label": "Real Estate Investment Property, at Cost",
        "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r595"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateInvestmentPropertyNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate properties, net",
        "verboseLabel": "Total real estate properties, net",
        "terseLabel": "Real estate assets held for sale, net",
        "label": "Real Estate Investment Property, Net",
        "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateInvestmentPropertyNetAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Real estate properties",
        "label": "Real Estate Investment Property, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateInvestmentsPropertyOwnedInNumberOfStates",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of states that the company owns real estate in, whole units",
        "label": "Real Estate Investments Property Owned in Number of States",
        "documentation": "Real estate investments property owned in number of states."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Line Items]",
        "label": "Real Estate [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "hr_RealEstateNotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateNotesReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable, net",
        "label": "Real Estate Notes Receivable, Net",
        "documentation": "Real Estate Notes Receivable, Net"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstateOther",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER (INCLUDING RECEIVABLES)",
        "label": "Real Estate Other",
        "documentation": "Real estate other."
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstatePropertiesHeldInJointVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RealEstatePropertiesHeldInJointVenturesMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Properties Held in Joint Ventures",
        "label": "Real Estate Properties Held in Joint Ventures [Member]",
        "documentation": "Real Estate Properties Held in Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstatePropertiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstatePropertiesLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Properties [Line Items]",
        "label": "Real Estate Properties [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Table]",
        "label": "Real Estate [Table]",
        "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "hr_ReceivablesAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ReceivablesAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, net",
        "label": "Receivables And Other Assets",
        "documentation": "Receivables And Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reconciliation of the beginning and ending common stock outstanding",
        "label": "Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]",
        "documentation": "Reconciliation of the beginning and ending common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "hr_RedevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "RedevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redevelopment Properties",
        "label": "Redevelopment Properties [Member]",
        "documentation": "Redevelopment Properties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r412",
      "r540",
      "r541",
      "r599",
      "r605",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r670",
      "r672",
      "r697"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r412",
      "r540",
      "r541",
      "r599",
      "r605",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r670",
      "r672",
      "r697",
      "r1019"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of notes and bonds payable",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfMediumTermNotes",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment on term loan",
        "label": "Repayments of Medium-Term Note",
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ReportingUnitAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Axis]",
        "label": "Reporting Unit [Axis]",
        "documentation": "Information by reporting unit."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r747"
     ]
    },
    "hr_ReportingUnitCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ReportingUnitCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting unit, carrying value",
        "label": "Reporting Unit, Carrying Value",
        "documentation": "Reporting Unit, Carrying Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReportingUnitDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reporting Unit [Domain]",
        "label": "Reporting Unit [Domain]",
        "documentation": "Level of reporting at which goodwill is tested for impairment."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r747"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r829",
      "r839",
      "r871"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r830",
      "r840",
      "r872"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r837",
      "r847",
      "r879"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other operating",
        "terseLabel": "Type of Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r282",
      "r287",
      "r288",
      "r293",
      "r295",
      "r296",
      "r297",
      "r299",
      "r403",
      "r404",
      "r553"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contracts with Customers (ASC Topic 606)",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r732"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r239",
      "r254",
      "r282",
      "r287",
      "r288",
      "r293",
      "r295",
      "r296",
      "r297",
      "r299",
      "r307",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r502",
      "r591",
      "r744",
      "r954"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r781"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_SaleLeasebackTransactionNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleLeasebackTransactionNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, carrying value",
        "label": "Sale Leaseback Transaction, Net Book Value",
        "documentation": "The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r1017"
     ]
    },
    "us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesTypeLeaseInterestIncomeLeaseReceivable",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income from financing receivables",
        "label": "Sales-type Lease, Interest Income, Lease Receivable",
        "documentation": "Amount of interest income from lease receivable of sales-type lease."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r538"
     ]
    },
    "hr_SanAngeloTXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SanAngeloTXMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "San Angelo, TX",
        "label": "San Angelo, TX [Member]",
        "documentation": "San Angelo, TX"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r114",
      "r301",
      "r935"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r114"
     ]
    },
    "hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Held for Sale",
        "label": "Schedule of Assets and Liabilities Held for Sale [Table Text Block]",
        "documentation": "Schedule of Assets and Liabilities Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Common Stock Outstanding",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Condensed Balance Sheet",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r905",
      "r927"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings (Loss) per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r447",
      "r900",
      "r901",
      "r902",
      "r988",
      "r989",
      "r990",
      "r991"
     ]
    },
    "us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLongLivedAssetsHeldForSaleTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long Lived Assets Held-for-sale [Table]",
        "label": "Long-Lived Asset, Held-for-Sale [Table]",
        "documentation": "Disclosure of information about long-lived asset held for sale. Includes, but is not limited to, description of fact and circumstance leading to expected disposal, manner and timing of disposal, amount of asset held for sale, gain (loss) recognized in statement of income, and statement of income caption that includes gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r17"
     ]
    },
    "hr_ScheduleOfRealEstateDispositionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ScheduleOfRealEstateDispositionsTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Dispositions [Table]",
        "label": "Schedule of Real Estate Dispositions [Table]",
        "documentation": "Schedule of real estate dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRealEstatePropertiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRealEstatePropertiesTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Properties [Table]",
        "label": "Real Estate Property, Ownership [Table]",
        "documentation": "Disclosure of information about real estate property by ownership of property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options, Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r137",
      "r139",
      "r140",
      "r141",
      "r224",
      "r225",
      "r226",
      "r285",
      "r379",
      "r380",
      "r381",
      "r383",
      "r386",
      "r391",
      "r393",
      "r631",
      "r632",
      "r633",
      "r634",
      "r753",
      "r899",
      "r924"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r65",
      "r67",
      "r69",
      "r457",
      "r458",
      "r461",
      "r462",
      "r548",
      "r549",
      "r550"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r65",
      "r67",
      "r69"
     ]
    },
    "hr_SeattleWAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeattleWAMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seattle, WA",
        "label": "Seattle, WA [Member]",
        "documentation": "Seattle, WA"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r190",
      "r193",
      "r195",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r297",
      "r298",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r639",
      "r640",
      "r641",
      "r699",
      "r701",
      "r704",
      "r712",
      "r717",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r735",
      "r755",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r794",
      "r801",
      "r960",
      "r1035",
      "r1039",
      "r1040",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066"
     ]
    },
    "hr_SeniorNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesDue2026Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2026",
        "label": "Senior Notes due 2026 [Member]",
        "documentation": "Senior Notes due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesDue2027Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2027",
        "label": "Senior Notes due 2027 [Member]",
        "documentation": "Senior Notes due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2030",
        "label": "Senior Notes due 2030, Net of Discount and Issuance Costs [Member]",
        "documentation": "Senior Notes due 2030, Net of Discount and Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesDue2031Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2031",
        "label": "Senior Notes due 2031 [Member]",
        "documentation": "Senior Notes due 2031"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2031",
        "label": "Senior Notes due 2031, Net of Discount and Issuance Costs [Member]",
        "documentation": "Senior Notes due 2031, Net of Discount and Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesdue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesdue2025Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2025",
        "label": "Senior Notes due 2025 [Member]",
        "documentation": "Senior Notes due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesdue2028Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2028",
        "label": "Senior Notes due 2028 [Member]",
        "documentation": "Senior Notes due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesdue2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SeniorNotesdue2030Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2030",
        "label": "Senior Notes due 2030 [Member]",
        "documentation": "Senior Notes due 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SettledInterestRateSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SettledInterestRateSwapsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settled Interest Rate Swaps",
        "label": "Settled Interest Rate Swaps [Member]",
        "documentation": "Settled Interest Rate Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award performance period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date fair value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Share-based awards, beginning of period (in shares)",
        "periodEndLabel": "Share-based awards, ending of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of the activity under the incentive plans",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in awards based on performance assessment (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)",
        "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested/Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price (in dollar per share)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Nonemployee",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r251"
     ]
    },
    "hr_SquareFeetSubjecttoGroundLeases": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "SquareFeetSubjecttoGroundLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Square feet subject to ground leases",
        "label": "Square Feet Subject to Ground Leases",
        "documentation": "Square Feet Subject to Ground Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r108",
      "r111",
      "r112",
      "r216",
      "r236",
      "r237",
      "r238",
      "r256",
      "r257",
      "r258",
      "r260",
      "r265",
      "r267",
      "r269",
      "r284",
      "r308",
      "r309",
      "r323",
      "r394",
      "r445",
      "r446",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r476",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r513",
      "r516",
      "r539",
      "r610",
      "r626",
      "r627",
      "r628",
      "r637",
      "r692"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r190",
      "r193",
      "r195",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r297",
      "r298",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r639",
      "r640",
      "r641",
      "r699",
      "r701",
      "r704",
      "r712",
      "r717",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r735",
      "r755",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r794",
      "r801",
      "r960",
      "r1035",
      "r1039",
      "r1040",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r257",
      "r258",
      "r284",
      "r516",
      "r553",
      "r630",
      "r638",
      "r645",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r654",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r672",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r692",
      "r802"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r257",
      "r258",
      "r284",
      "r300",
      "r516",
      "r553",
      "r630",
      "r638",
      "r645",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r654",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r672",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r692",
      "r802"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r832",
      "r842",
      "r874"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "hr_StockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StockIncentivePlanMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock incentive plan",
        "label": "Stock Incentive Plan [Member]",
        "documentation": "Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_StockIssuanceProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StockIssuanceProgramAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issuance Program [Axis]",
        "label": "Stock Issuance Program [Axis]",
        "documentation": "Stock Issuance Program [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_StockIssuanceProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StockIssuanceProgramDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issuance Program [Domain]",
        "label": "Stock Issuance Program [Domain]",
        "documentation": "[Domain] for Stock Issuance Program [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued during period, shares, conversion of units",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46",
      "r107",
      "r108",
      "r141"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r107",
      "r108",
      "r141",
      "r631",
      "r692",
      "r713"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested share-based awards, net of withheld shares and forfeitures (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r107",
      "r108",
      "r141"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of OP Units to common stock",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r108",
      "r111",
      "r112",
      "r141"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r107",
      "r108",
      "r141",
      "r637",
      "r692",
      "r713",
      "r811"
     ]
    },
    "hr_StockRepurchaseProgramAuthorizedAdditionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StockRepurchaseProgramAuthorizedAdditionalAmount",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional authorized amount for share repurchase program",
        "label": "Stock Repurchase Program, Authorized, Additional Amount",
        "documentation": "Stock Repurchase Program, Authorized, Additional Amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock redemptions",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r107",
      "r108",
      "r141"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares Repurchased (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r107",
      "r108",
      "r141",
      "r634",
      "r692",
      "r714"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "terseLabel": "Partners' equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r111",
      "r112",
      "r132",
      "r655",
      "r671",
      "r693",
      "r694",
      "r782",
      "r812",
      "r926",
      "r936",
      "r1009",
      "r1070"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Total equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r70",
      "r216",
      "r217",
      "r237",
      "r256",
      "r257",
      "r258",
      "r260",
      "r265",
      "r267",
      "r308",
      "r309",
      "r323",
      "r394",
      "r445",
      "r446",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r476",
      "r503",
      "r505",
      "r509",
      "r514",
      "r539",
      "r627",
      "r628",
      "r635",
      "r655",
      "r671",
      "r693",
      "r694",
      "r715",
      "r811",
      "r926",
      "r936",
      "r1009",
      "r1070"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r253",
      "r378",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r475",
      "r695",
      "r696",
      "r716"
     ]
    },
    "hr_StraightLineRentReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StraightLineRentReceivable",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of straight-line rent receivable (lessor)",
        "label": "Straight-line Rent Receivable",
        "documentation": "Straight-line rent receivable."
       }
      }
     },
     "auth_ref": []
    },
    "hr_StraightlineRentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "StraightlineRentLiability",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of straight-line rent on operating leases (lessee)",
        "label": "Straight-line Rent Liability",
        "documentation": "Straight-line rent liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r543"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r543"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r543"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Cash Flow Information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_TX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "TX",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Texas",
        "label": "TEXAS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Adjustments to redemption value of redeemable non-controlling interests",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "documentation": "Value of accretion of temporary equity to its redemption value during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable non-controlling interests",
        "periodStartLabel": "Redeemable Non-controlling Interests, beginning balance",
        "periodEndLabel": "Redeemable Non-controlling Interests, ending balance",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r254",
      "r307",
      "r502"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-Controlling Interests:",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions from redeemable non-controlling interests",
        "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)",
        "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r43"
     ]
    },
    "hr_TermLoanDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoanDue2025Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$300 million Unsecured Term Loan",
        "label": "Term Loan due 2025 [Member]",
        "documentation": "Term Loan due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoanDue2027Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$200 million Unsecured Term Loan",
        "label": "Term Loan due 2027 [Member]",
        "documentation": "Term Loan due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoanDue2028Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$300 million Unsecured Term Loan",
        "label": "Term Loan due 2028 [Member]",
        "documentation": "Term Loan due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDueJuly2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoanDueJuly2024Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$350 million Unsecured Term Loan",
        "label": "Term Loan due July 2024 [Member]",
        "documentation": "Term Loan due July 2024"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDueMay2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoanDueMay2025Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$200 million Unsecured Term Loan",
        "label": "Term Loan due May 2025 [Member]",
        "documentation": "Term Loan due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoandue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TermLoandue2026Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$150 million Unsecured Term Loan",
        "label": "Term Loan due 2026 [Member]",
        "documentation": "Term Loan due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r1018"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_TreasuryLockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryLockMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Settled treasury hedges",
        "label": "Treasury Lock [Member]",
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares acquired, average cost per share (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares, acquired (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r108",
      "r141"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock repurchases",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r50",
      "r141"
     ]
    },
    "hr_TreasuryStockValueAcquiredCostMethodExcludingCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "TreasuryStockValueAcquiredCostMethodExcludingCommissions",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock repurchases, excluding commissions",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Excluding Commissions",
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Excluding Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRevenueExtensibleList",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Product and Service [Extensible List]",
        "label": "Revenue, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income allocated to participating securities",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r276",
      "r277"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "hr_UnsecuredCreditFacilityOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "UnsecuredCreditFacilityOneMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$1.5 billion Unsecured Credit Facility 2",
        "label": "Unsecured Credit Facility One [Member]",
        "documentation": "Unsecured Credit Facility One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates in the Condensed Consolidated Financial Statements",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r176",
      "r177",
      "r178",
      "r179"
     ]
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAXIMUM EXPOSURE TO LOSS",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r147"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r461",
      "r462",
      "r548",
      "r549",
      "r550"
     ]
    },
    "hr_VariableInterestEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20240630",
     "localname": "VariableInterestEntityMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity",
        "label": "Variable Interest Entity [Member]",
        "documentation": "Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable interest entity",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r457",
      "r458",
      "r461",
      "r462"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expense",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r781"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic)."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "totalLabel": "Weighted average common shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r279"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-vested shares (in shares)",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-13"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481244/470-50-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Paragraph": "2AA",
   "Subparagraph": "(a)",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AA"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481266/840-40-55-50"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481266/840-40-55-51"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481266/840-40-55-52"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477875/944-360-45-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477875/944-360-45-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478586/944-360-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-14"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3A"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "65",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-65"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "66",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-66"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479016/842-30-45-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-12"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-39"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(c))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-12"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479741/842-40-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0001360604-24-000093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001360604-24-000093-xbrl.zip
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ME<N@2F507B7\13CO(/S%2P\C?"Y#)F^CY/O$B]UQ&0G&:W2O%D+W&I?QD*J
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MU JH)G>1@YETP+WXBFPMG- ;9SKUAT_>36QLITO^[\:7J,\*4'=7GF9^\;?
M?XQQ.*(+H(6]RT+KF^OCFT'R\OI@F;N@!6"Y>*UC<A<IR0;L[P3*D]$#^9U-
M"R@*PUM(B[Z'UO*?3_!W]$I0H->'C;D+T@""B^5@[D(LV6']V\2CP-:.(Z#S
MD11'+,Q=* 4P7# /<QLUX51(UTL%<QMV>:_8+91WN8O;\(Q=AV'7J _O<A=
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M#]\,K@B1/[G.9#K0FKSMW UQ/P["H\P8KX ":Q2FX^-P.-<D>,4N!DO<AM-
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MH9E;'*(8"]$S&D?@& /; = JR,TJW"_^C(ENPH5I+KG15F11V7#H C0!C 1
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MV>%5+TTM5G:.+3ZD$=2F>=2IPYUS"K6Y$9J?D<?F!J-8^&WB8T&51$&1: +
M1L#FV7GFT>-Y]U_AZ/%=6SZ(A?B</:YI&5KBIZ&6-'JYQ\#QW**4]02UI'4-
MF7W>^&[.W4?: J>\6T[1N>04I=&V1=W614G-F=<%W +<4AZW9!FU<GQN42FW
M$-<:. 4XA1=.,;GD%(W&*&35%&5S/?X$W +<4MQ>\P7IUB;4;.G-5A'?Z-1S
MT0U=M+7L<5M@&6"9\A1,EJF/QV<4H]&FRH688W;.NC3@%N"6TKA%7^M%S06W
MT&->21,E&5P7X!5N>&7'@6E%O&)1S:)8M%50SJ19X!;@ELJX925+O(O"\)7
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MO$;O.E3^OH1[5VL@KL8NTS_QF2B,+%V:2&2B&S-!4A5U,C'(9# =")I!ANI
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M;1>HJU"YB%->L;(C'N]*I6S8/PAK.QR3=49*I9_L3<QN*DT]!-=)#6:=1-W
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MHLAAIEL RMW$PTG+_\8N \IC(0X,)V^Q;FIIO8LTLY;J.CV?0Z+HQ3DD;=&
M=XF49SECR39;*9+RHJ&.$HP41!"FP*Z<Q"\(G\M3%XW%&;BU. ,])$<ZRQ[I
ML !QX@KB[4# &<\JM.C]->9,9J/VF1(*M9+/K:@FM-#D [."14'PC 1YDGE_
MX2-I6LQTCM(L<2(7!.@D8A/@+.Z[RX0! C,ZK,"#+.*!2B+A$V/'E+;1!0/
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M/&U.HVQAO(3N&T480!,6A8DP2#!^=&3!,+=:8M@ #&JP5O +\IV%/ZG%$YH
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M5_?B\U2S9A-_^=K"4]G,'35ZI-P D3!LU\W)'H+OI^C]LJ;;<4N04I**Z\F
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MV!Z%5?F'%8E8J.?@^**D)+&XPXN/LQ=MVC@@K-M(%5TD8SD+BBJ2_RI6:24
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MZ2Y!V(TWX-+=AWJL P;KQ@5HP ^Q5Y7#&![^ZG, Z[AS(0#G&1NE.=FKL_U
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MLX#;-0G#>47,3N]8WV>)0&/;,18NB(>_&*!#3HJ>PS(&U[/EUL5NOM,_)M[
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M,$:3^'0<<MEI$I\J\KD[3(4W#&QAJ$@=\TAS7MZ-$.PP%=Y@;4.[4ENNQ5Y
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M4#I<4/1.5^IT-ZN\:<"$5I0C!D'$#DWGPLPUS.<[$GMYA=@S@4=2QKDR?/>
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MS<)M!/:F0?B>@[Q=[&7>T9#'V,P 9/*B[CPWQ8%;P8#RVJ\CWI.L+VK@U+B
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MR&Y',)= HK54!4EQ:05CQMD!_D+_BFP@</I8>3\21\Y9H\"!Y?MO*'/6Q(M
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M,55!DF'U&/DN EAQT# ./L,^X]DI,Z>5>CT$(D,DN^T&#.D$R,'&'O\-@5)
M,]9Y8 416Q=XLS)[825!:Y@3Y,8'5J*6[3/6 Q7\9UZ*CT8P73B=&DMB<V(M
M%[7\H.M.3F[ GX*I"3ZE_/DB]Y>2UT5NPPO0E 1@Y?KH*I#,X+(YHA;^.UO/
M@M%B.ERP;$VO6JD3T%=TY;%1FC?#$#1SR!7F>5"H@KD8.NO69L*XV<H]6VW>
M0I 1ZC%8I.7$PQ"3;;6GQ=WFODZ$/."]L+<197(,JP5/4'Q>B9:$54()."@-
M4#-BJL:-=PRV XS V]"GO_"XVF,6(K50@9%PWC&&IDQ)BZ.9+!X!+BF2=G_H
M(D$E!GS1PF<&7WLNSC3QX;BT)<AB!)+RY[Y "X-6,.2+G7#IVR4V(Q%2O+$7
MXHH95)E3E[U=N%%$,GC+,$,HU2N%-79($RW"I3B?=GPA$^+0^LXB%0A0'?N9
MSQ (&4W9=- S1=.IPRTVWK2$9LQ,L9:)<RR3"+J3U,)/BJTSYYR4-L-VTDQ+
MN)?$# QL?Q!-X(5\'V/,X@0;]R)PJWS& VM.2I<,F6%L\>4C_3&@TY"%8+'5
M!L(ZUFOYKFL'7KP_8B@W!D/.#KC8(D)$A1QQS(J0L# _U%GDM3N,'(Q7'"8\
MS)\LH]D89).*TS=AC=*+>M$2;2;H:YBZ3(2%9L^+1(0EY"59,O' GZ\$F7CX
MR?;+?"=.$(*4LX]O"N8M%WCE((+[CX[/-VAE!(()'::WIQ>$^FC3X]U9"59/
M+%YD6X-Q@) .<3B3%ON@[ Y1T?LJ\4P;GQCH1<"]0/[!.:RH,,3[&$038.W;
MIUJ@^7ZQP>H,XS71I5@+/=# @ZB1[JRIY0K4*'.U<.:FHS(CQ(?-)O-'P ,'
MA%;=A9)5@ DT+[JP9$;1((+Z?'D:C),M/9\O@B".GH8B#L]%LB#T(\^QO12V
M)8S%%[XQ@UW)M P?D*PXLS$^@W%E(3Z+[(O"98G\V[,QOX$1 _\6EC+UF&D$
M3G[ USCV"]X_I/T0_Z:LBS<\?82Q_C-B>/86=*24YG9_A^0GN:62/D>"2,4E
M?'-VZ%NO;AR41 F$XH!#*(YB",5?SA;"*Y[]RL_;D@<C)V" ]18E$<2PL"C>
MHL3?)Q2Q$^%S)U%X%SF4.4$#E\S@[-+ 7@E.KX3;"_Q \@7W@8>"U_%=C*<!
M1X1'9OE>]#R>(? )64@63UQ'9Z,1(C^_X%C(GE;JO)B(S6(1GF5=BI.Q<!G-
M$AL_N%X?XHHU9*1Z7RDRA:ZI%GDSZN[S9O:: K.,XH<@\"P_)C,B^F-L]^WP
M4Y,T4Q\#CQTS@M$;/])&BYK>K\PNKP>6"PLLB8QCO&EPAF(G);&.N%\[LX-H
MP -^.ME/+_#Q3)+O.[']F"DNT?& "I;9N&:-G6UF78/K.-PMM=G"G:'_!LO<
MSQ+P]YI&F+?,(Z)[ZN'!&M\WKV%,<#ESO!"-H<=F.PMV,GQK-OQX6138/\C$
MPZZ18G%4@!W)]BY2@,ZP>O])UN66%H-RM<AGAG$)"S4P,-R\Q4O#HK<7B$"E
MQG -3N<HJ(IDB]AE[R23HL*@;\B&BM$^VP1D ;_=C\1>N96-T8FBI_>[AY$?
M!UOK\)\AO\)3,7+B:X/DG.\GS=!:W5@.)/),W?@(C!FM9%6 UZIFIV7.KG4I
M.XS+#C29![(@'1G^U#5:[?AFO"]Y-#-Q3$;'B&8+!@GWTQ$ FB.A)JB#$,EG
M\^RX04LAL^)F?$H$RFA)"1C5O8.D&G*KW>Z6!4E5Y5:W4Q%(:J=E=+MU>Y1B
MM!2E^*O]PY'N%IDM!:2(6Y[PI.$Z2(K' SUWA2NY*V$33VIFCV!QR3<TN*<U
M+5A\@\F^\<"M/&>G5I,&C#M;!K&U8\_IL\/@NW^MCY58>LKUK8/4/L@?\CC
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M)95DXOHI8O8)<*DLD1C@"[\\^SQ172@&^E8"4J>>$J_40>*UEB;/2SSB])&
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M"R7[5 (=H>%$,2<4I:7.<P+!J1W* (I+,*/AQ=:\T&98%S$O1K8//BK&.V!
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MIW-VD +3@]:0-N6B2\*84NY_G3"FLQJ(F/'G"4+((;=:7RV(DV'1=)OXV%E
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M%/!K?!A,:9A"1Q(C2(%Q^'1BV1P(:B2V-4@O<YAC8DUQ[''%*VDLGLN>Q,\
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MS/?KBQF=E<[?@*<U(?0+:X7A01B/&O_,%)Z1F01Q4IU86AR08H:&%'NI"<F
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MW\"9/<>@2!Q=.7,-3)0R +_9\T:41^:IJ\ G#KZ?]P44\00!W?@38PP\KLQ
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M5=WB<<"RY&JKTKHFU5PO'8]>FM:(XBE5VB.%'U-15E?$MF)RR5">7*JU](B
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M& E??-@"6-F*E:[P):[P#*#S3"L1O7H[9[XBY5;D&OYQ(N&CW<6XXV1V60K
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M$.F$*/>BH%XHG5/:DZ4QM70M@#M>;);1T2.#@."AVU-,->_T, U?TX\#9JC
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MCU/ <.'I\I^;=X%1C$7B S9\]Q*H&H!9]YYU<IM\:)I,,27A]N?0Z2# W/2
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MN_=KWW7\W@3^9QB-W'_\?U!+ P04    "  1- )9Y3"&DUX7  "I_P  #P
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M[)PERDC][ST1KN"!07/M3P2?4!'Z5.9W785@).@ H/4(<%?X]T30-T!'TJ"
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M&<W[E%\NF'V,X9.(/$2"D4(!91@#'\B\^>B9\EJ0/5.M5YT;D>RX5_ 0.=%
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MJF<OP#$K^W-NB,+&Q%N?*CL4\XX>^##73H^$?T?5?S/6?B6YK:Z?2@I#"B6
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M=AH<ES1;IGS.7Z]?(F'^VY_^/U!+ P04    "  1- )9$\C<6MIE  " /@0
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M@#B\EG?725-3H!V\O6<IM;+S@X^^G]X.S_UU?^('4W!>T 3:<<*MQZE*X4C
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MI,:OC"*.<V22"&!LC8WO6.\ [6H!5Y'W 3@P9?4FJ+ZW.T!;:6JS>R"[B/F
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M=("@%LL5+<;/MQGQN,G0I7@KYH"N6.%@ML E35W6UA,F:6E;ZW"IR\:2P$2
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MC7Q\Z-QM@JVS+CRK<3U7)YY:6EQ)CTHJ.#1-L@)JO0H$VJ(.+ ?B2W^1P*G
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MQ$KJB9!4JLP8AT>MC?92WO)++U!Y>\NL\LK[U)\6@_YV&/O?^O$&!K/MQ+D
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M\Y=ULWK)E(D7!X12"BD)$XC2E$,24PPYB3,2LPQCK!6PU2,WL19IJ)D7R!O
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M'1*8MR_920$/&I*=?M+6@VO'V5;KCSB+0BD%Q!P3B AGD&0XA3@BPN=Q%-#
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MG1_QLR]AB=N81$S2B FBZHM%TM-C*8)$W1/A L51BH*0LDC3T].C.-=NJ;@
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MU?'> *5YS_K&13XX^--X96JC87O:[#.>I3R*H>=%B5SB+(%81)'J@\L%2N.
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M@/0\!H<D!NNKEGEW'E:7MQ3;ZS JLVVEU+[T6SH.M0\-M6$>5D6N4;,+T'8
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MTL-.&(\8#:6_;5)0JC>VD3HT+R!UKU[97MS-3<M#]$' ,4<,ISY,4I%"A/T
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M=>;I!7A?%&M5M%8_U'T*@?%8MP/A#0V-<;DGN/$R(J95^/O4F+/%OT>$Z@?
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M]F8*1C$B&)MROURH*(1I3J\XCU&C/QG2=KIWBE\I3!'7'#0]^67U5P/@EQV
MK4!W*X[B3S=#A?>DJ*W)SJJUH6 <JW#P^^!0N(FU5(<$\4_TS\732]W:QK35
M6M1T'K-(1I3E$C&%M1JG2O\)8X:2@I$T)T2$B6W+*QMZ$VOO3Y?_^^;3KY^"
MC[>7GX.KVT^?;AX^77]^L ZZ6D$V&+#V#01,0=347Y6H;!EHLJP/+/A%Q3KR
M[!L=MT#S>)0@,66(S)TA9*M%YHH80R1J!8A!K\'KD>6__TU7BU6=H;ZM4>4B
MYU)ACO*DKD?F.2*9T!94%"6$"9YQ;MM@Z\SR4^NS'<5@J4G:-Z\_!\2@VAHI
M'DQ+'22K]QN\'/F,A/;ER.,D=2Q'?B6QGVKD;CFZJY'/O#-;-7(WO^UJY)ZG
MP"KA8%)5-V:JT*7X;D+6#^M+I1;+A3:PJB\OK%J(!2VUMW%956M>_ZU^]C_7
MB]7F-_VJ&>EYLVIJYAX%YE2[73&B419KA1)IA1*G1+MD'.,T3PL:VC8X\,[<
MQ.KHL_PC6!QX#L1+:8*YVCD+GFOZUMO7_V<95&]O"C8TV'; >-$,6-MR:[)@
M#_Q>!&V.+X(#SQ?U2S7;P8YOL]3=6W\F:QW]II_+3<._V6>#G!F3X=IYXOBG
M.-=Y-1E6K=-N.AJN]SBO:\)O5G5#_=M=?/GC@C+-EPG-/;(XC6,9"I0P@A&F
M)HR0<86$5!(KQ;'(8U@:,H Z9#^/&#6Q/%"$7O38 VE[\3,).-"SZ:1CA=%0
M#5A[5H*/%K Y7 Z! ?!V661/>>;+(S DIY=)\"7<JT<?MM5OCUD8<RIIC'A"
MN"G$2A'#3*!49:D("R$HXS#ET5Y^<NW0!)#,<<W6*U$%S_2'B6C JT7W@"09
MQB(6,4HI90@3E6D7@TA49-K?T$ E,@=UWW6%P\4Q\ Z&G49T%1&F\EZ7ROJM
MCCWFWF-5['[IV:MACX4Z5P5[\@R\8\3=JEI=BG]4=V7YY3N_JC;;.)!EMXB.
MUR?>*G=F*O)ZI3V#?[SLG(4[;;>5P1=9?E]H7^%J75G&YOM Z-] GN2'[2,[
MT3UVC[>0TJDG1->:L_6#&!"JW0MBZ%'8MA-R\?A^ZQQ_6%2<+ANGXX/^N^HQ
M3F)5'UY<*C,_)\6H,#6=1:Q= 1H6>1%9Q=I[J4R\/W=T@X;PKE%;3=IN5_9C
MU+\OO4D.VYE.0EMO0RNA>C:B?K_9B/H/AXW8O^HL6]%*L-UFM'MX["W_%2W+
M'Z8+W)/I#O](6$%4HIWSO @SA''"$9$I1S3G(2TBGLE"N5WOOR8TBWU9MFYK
M^99\0&OZKG?91W -!I&]@0#;GZ>WU3O*P:5/^5TO\=UQ\'5[;XO'B%O[\T+:
M7M<?O?U&]_3G9>B^H.]X'FZK7RZ7^_FV5W0COZY--!-FL/>M,;$"TJ1;$Y,/
MQ.WM]%X AHUU7[+#]$Z7V)YM=!OAG SUWH5GL]9MQ&N;[%;/^RN6W!57B21)
M1$Y0&.4,X2C-$9.<H(CE,F8"<Q&#NKAUDYIXKW853#I56/4 9A>B\@,#;-LZ
ME$UZK\$:EGO"TLFWJ,,:%MBF?-)++1:@/?0[J=:E/-\D^I%3(3 I4J0$I]I[
M4&8>;L*0XCR/XCRG-.83==OOXVMB_7%_??DQN/[R</EP'7R^?;C^$MQ?7UW?
M_';Y[N/U1?#+_>V7+Y/UV>_]''8*YPU AFDG>!]]5O/9W4[_35KFVX W?XO\
M7JY^UI;X-E".:(%OM3PX\'+)C7WV7GZ7R_5SJW_1P:HO6$[#*):(1TF&<)X(
M1*)0(97(D$:$Q"RSK:T8)#:U_U/3#UH,! <.K(,/PY -!F"\ @%TAOHP@&<P
M#X-A'8WQ"HI;1,;M!P*)QE@+V1F1&5YAKJB,M2RMR(S]._#HS-4W_2VEN).R
M_*5<OSQ_6!VFVEH&9WJ6F%@W;2D'AG10T[X(/JS7&S./PSX^TP?!<'C&D_0P
MA=0G>/"[UQF^EC(Z!6GZUITM1F,A7#M$8_.XF^]V61<Y7[)J4U)N&I5F49'E
ML;$A3"OO1*$BP3G*HB05>1XE+ *F6+XF /EU.N5)77[Y<OT =)B.,"BXI&%*
M4R2$X@C3A"":Y HE(<E2EJ<Y3T MN]T1<+&<:F+_<Q0 =HZ?NUA .ZCI,/O[
MCI+'H-%Y$3QY44>+S^H,G1?LV*?I>,I-D=1)G&;R1RF_F<2;[_)FQ==/TG@]
MG^7F5CW0/Q^)P"*B.$&<LP3AHLBU>LF$5B\Y+C")<L432!=N&Z*@#0=OQ=UD
M(O,V#\&B9@*V!ZWPL]N9OE&![=<&D%?D@X9^TT;BKW4W9!,JUFSXV\L0H3WM
M<"N2L^Y[" C'V@#TKGL:EQE#\I@S:H:G%HBGIA]ZH2+$(IZ@(BNPXJ(@7%KE
MB1PO//'ANL];,K3@V5FUZ/U;>(Q L&UJ)XM3TE6;\5%Y5O5"LZ=6M=D_ETWU
MZK^['9;O9;GX3NL+U_6J/GW-HMN+OD2EE.&4H$(?EB:)"B.6T0)%,HT*1F0B
M(]#-:!^QJ3?,GG2PH^UX,=J+F-VQZ L'X#YS@0!\^MG(YNG4ZR4UZVEG(_3Q
M*6?UCNNF9IN;E3:F:RVQNPVXIQMYK92LPVEW4O](5AOZ53Z&&/.8:R<[2S(S
MQ2Y3B$1%C"2)(QR16":P=M$@ZA-O^SU%;0EO^SB6X*&S,#AM5<!$($%U ML$
M!SXN]G>/@6'E(CC@=^#&IZYP ,&;\H#0GEF;.,!RJEY<%G&K17JW4MI[%_]P
MB)YWO#ZQ6M@5Y+R3*ZD6FZI=F>,20^\"83A^[D%^V(ZW$WV"*/J I,[U2.?6
MG+4>J4>HXWJDOD?A6Z\>'?;E&]5N<CV_[GZS^JW:1^;!6]%RN8FW9C,/K<5&
M<"\W+^4J^*UJW??8;TU;D(:WZ@3XP+:N'303;%V@Y$Y;V9;&;%L;*'1[JT-?
M=;/R'TS3@I?R1SW!\I+_ZV512G'Y79;Z0#?UI/IXKWEX9%*;\4(*[<9SI=WX
MB"(2X@2Q@B8T3&@N"6AZA"WAB35%3:,*Z):!BX V+ 3<%-,^Z_U0F2>"ORQ6
M@5@OE[2L#G_[5Y@+8(VUG?4_!8(P7;(%[W(/WI9Z4XFLZ3=ZQI^M#Q79DYEO
M3796"Q\*QK%Q#W[?L6V)Z8I2[?NA[*]E.4T2E6<%XD1F"+,H0S2E C$:<RJ8
M("R$S;T_3V=B_=%<#RU6:ET^U3E?P*X='>#8:0 /(L,V?$/PHM6I:(I[[ &Q
M?#7YZ* R;[^/?E%/6G\,/.ZV0_^77'S]MMGO_<\O)A_N5C7:_5X[_.6"Z_]<
MZXE'D9&<<$E1PJ-Z KS4=@"52!9<2%ID>9:ENYD*#_:[%\*#U>_[]7"%!Y>J
MZ14RS>6D: [[JK8!FC\"#WX0P'9;WSM>3OI@Q\7^X&_X,+?A#2<7P8&7H&;&
MGYIP@<"3[@"1GE6AN(!RK&6<UG#ME]CNWPCLV?B81Y@F7&"49-H3Q+10B&:2
M(\8*F40Q*=+<JF.*%VXF-C2.VJ.^K/0/HEHO%\*HM^ ?==/3[UM6H*T6QWP#
M42C*S8C0B$<QTFYAW=I9(J%"0G#.:(')8]/?^,N&EIN?[$L<<S;)]S U6%\7
MJY4QF+1JA'1[]O.1:"+#@BF"8JI"?6@KA@H5IRC!44I5QA-*H^U'NEY9#Y&;
M]1/M^)KH TDS)^DM/HW=<3\;V+#S?YJ>S3Y;GGJ S5L3U#&\S-P6U0-LIXU2
M?2PZIJ1;UN[3KB'KC[O='.T7^7=)RP?]G>5C$0H5"1$B2M,(885CQ,(D09CC
MJ @3EB09*%O>FO+$YH/^.>8N==<VF-FIL$F0@*FK+0M!S</%OLORCPNCK9@,
M[NA"7 2&D:#FQ'=E-$!XK[7/-G3?H+H9 ,?Y^F7( FZ*X].ZW'S5/I 9IE+=
MK@Z#Y<S )5F:QB!:55UIR^)%_^MGN7FD/*2*9AQ%D: (BY@CPE2&(B:RL)",
MD81 % B8@XD5R7UKSN3JJ+$<3,' L;53-),B!E,X.U;JH465&3?9&BUY$1P8
MJJV@'4MU18$_W>.,AR<=!*<_JRYRAN=8)[DOY*:;ZGC,.ZT A2ESD*NJOG^X
M+$M37&D4X;L?AT>VNO'R#UJ*ZW^]:&UYR.NJZDN,AV]T=?MLEJA^J\.>^ZDS
ME#.1%*%$/,$<X2S#B#%ANF**E(=Y0B01L#&Z<['N$"F&:<.&W/_XL"Z57!B_
MTCE&/-O7M%.B/]47<K^<1C5_05N&H"5$P'X$[>>V@@2U)!=!(TLKM;7:3NK8
M:'&"K3P702.1STE#;_45/&G\V=B>]:"8^V,<GR^STX<=2U6Y>?S"OTGQLI2W
M2A]S0K,H1;M-VX,Q$@_9<E%"PER:1")),<(1CY'))4(T#AF+B$CS,+8QE<&4
MI\XIVO)B HI[;H)7C17MS@8XI/W*?5*@8-JY Y?@]YJ!P&OVH;/8?>I0+]I2
MA?K?#FH03F\6/>8,PTX1N2_@9N#>:66VVDWD$'D8$9D*E$EE>K%+A2CG&8IQ
MC"/":13;34<XM_@\V<CFNK1)Y:S^[_^KB*/\_]D:&#!#\14J=L:<JZRP+=U0
M\=C<N(]]3Y;*JZ5GM2;."75\XI]]9F9G\0-=E+_1Y8N\K+3?VM@+]XOJGQ]*
M*=L%08\XXVG(0XYXH03"(>&(BK! +,&%N:;'E((&<$W.\=2!,DT2*4W3H5AP
M^J\UL1<XQ3>8W?TS0@2U%$%+C(O "!(825X7.OX$;A\4]K?V]ZSY_:_AZ$'A
M]^;A@0G#7;M/],_%T\O3SAI+BRA.%$%9:*8M,A6C(DPYRG+)!*>YZ7AOZ[J]
M6GEBI;RE9>]^O19[V+UR%@9XL="0\6AL=3(_P@EZO=YL3LY9,=I.S/D'X+63
MC?EN-EZS4?>;[_U"*;WI3+MD>#4S;-6)-\PV!+KGIG42!@=^7,J=@>#U;[UI
M<8/M32AD$]1:ND'A5'())#5;Y:4;!.T"3,<5P*W0_R;I<O.-ZW/]H7RI-FMU
M^23+!:=_6R]-._;JX]WV]%%YB'&>242PRA'.\PRQ/*8HQT)E.4LBIJQRDP T
M)]8N!S:"F@\3,=UR$NQ8"3X&=]9MP:VQ[%<G$R$$TR/'X'1@ ^^=;@V2=0OU
M*<!RZZ1N"9J7GNI0J3M;JULO-%>'=:ADK4;KX%<=&SVO-@NQ6-93OKY(_E(N
M3"OW9H:%%!^T,,:%>FE^/;?JFI8F^[[:U;2^^W%^@<L_%]5CEE).TE"B, I-
M#B@O$!&8(IG+3&18Q#))01V3I^-U8OW<)AP<* >_&]K EG=3?C&[:-9/\AU@
MIX#C)X WCYX>'%^=J"?D=-ZVUM-#?M(C>P:2C@J=<S,D55.[6R\7W"RZ[^+/
MN0H)Y4APINU>FJ:H4(0BAM,LX7'$TA244MM-:FIUNB<<["C;%-!#\;+4AEY0
M "HS-P#@RFQ0-E^ZJ)O0O*ID4. 333#\AF._CVTZ?OL76>",$$%#%!<L1I@H
MC$B*B3:K$A86!0E%)&%S.,Y0@?QLG89QM&@"NWR<@<1NDXX4$[8[6\2FZ>O1
M+8ROGAYG*,S;SZ-;Q)->'CV/NNV\>_E=KEY:OS&:%+R(A$#ZG!0(YU&D=QPM
M$*<"XR2/HT)%L&UW3&+R/;<C"-MP)TC8[;8QTL&VVH[2)/NL2PQ/F^QD^5EW
M6)=PQ]NK\SEP?/9!ED^FIN/]BS15E-O8F$9%_UNHD* LU4=:DB.BX@BI4 H2
M%S1EF=7,ARX"$YNB_TV_'3PMEDMS*_'KJC*FO!2!8:4N5K(.)IY'9S"\.EIF
MV'[;RQ6(%QD8BO"PZ7E)K6.DHR5V"XB>2NXE]MDK36>@\_Q;<T4U>WENA3#[
MGP/KC^NGY^7ZA]3N<OE]8?)DSR5Y?%ZOFBS\.I^C:O\GTXOO\WKS=[FYEWS]
M=;7XMQ1U?>L?ZT<:IUB[P 5*XOI*B$>HR$6,0J)X*E@6IGENJ84F9'-B7:8_
M4F:]BZ?\&H-:[R?!&*8[=TP'6ZZW*7/L)+7N(M"L[ZJA&N8O7N?>U7U!M0#!
M#[D)#B+L:N[_6/\4G]%:I?\DG]/M8/@I/BODR)D![<Z#:TK:<QU_,^#7.D3G
MH 8^BG>M[ ZUV9]-"X/[?0>#QUP4.,59CL(D-9&J)$5%S&/$%18%"Q,<V[64
MLR$V\;%XZ,58CN[98(7=X/'G%1'8(78 H]6!(:C)!_=3@&%]B'@%Q>TH& D.
M1(E;2]NIBH=7F$NA6LO24HOV[SA.[5KHK;TQRK.Z575[''&Y$O?Z)R'%=N3]
MC]O2I+8]F]_)(T\4UDY$B"*3OEWG.K P)BB-XH)3%1,2 R/S0 XFCR#N: ;K
M7=MDX. N(*)VH<8)48(IQH:1VH2KC 9H>*G[T33<! < RV#/D,?Y76Y(^)K@
M!:0^[PPO-VA.IG@Y+N-8:;BO$#Y?JU+7P>X:#YPFUU9'%>TQRZ2@*D5)$6&$
M8ZX0H8PAD9.(BT21- /-'?'+WL0F7+N30,U8J^G(F?1RX"V)YR]EI_C>#G^8
M7GP%?7>-H,U7F:2IP;1X^BH,],O<O%6 DP![4O(W#168ZC;CH*]>2E-L_F%1
M<;HTCO;U2KPWE<(DE5G"<X82EJ4(FYX+!0X+%-.,%C'-&<NLNK3T$9E8C6[)
M!@W=)BJE*0?OK0NS>Q'J5WR^Y(:I+R>10>/1AV1R&I7>N>AL8].'Q&J/4!]\
MUG5B4E5)N9_R\KK)Z:\KH<F9U"TIKO_D^M'+)_-OCU&1)#S$#(4)UYY<FE!4
M%'F*"-/N<\0)CT3D,)C%B1FKW_7H"2WOM[2A(Y=<T+4S;J8#RW%<DV&G/:[I
MM/-QFZN@82MH^/(YT&D$+-[&/;GP,/,PJ!$PG8Z*&K/8B%%OQL]\)%QBD2<9
MBK7V03C2Y@-3#&NO35"N=9,B4?:X,7V1;+70=F60I;!?WSY;HF[5M#34 OFG
MN8P =FXY0&"K,1P$@VJ!>L\;(IYGM+7Y]CF5K5YW_CEL;7'.3EY[]0"\A<:]
M:>-1URMQ*<,,APHE>1(C3#-M4[.(H2P6H521,A-T;-MG[%>=.A9A+A6JS<*8
MDY_JR9%-#QU(+=AK%/IWB+-L0#_?32Q07XT3,4;TU#BL-5L_C1/VV[TT3O\C
MO(_&G5Q_ID]6O_C6XQ/_WN^N;P-#QKZCQ4Z,_M^UHP2P7_4@\Z!V$D?L.O6)
MV*TQ6P.((Z;;G1V._Q/\%_MYO;I_6<HH9&ET698/Y=-J(SXLZ5?;WW#G E,G
M!:Q7R! .#&44O>J&9O(>%ROCC-G_YKN!&-X%7C" [0L[\8/?#1>>>K$,2NFT
MG;I7G6V##0K6WG+##[OVB&UFOCRL/RU6ZU+[-G4<==MG]3%3*B]R4J""DAQA
MK#\ZH4P@3D*5<Y9J:XLX!$7ZJ<X6_=B4"_;27#%LUL%*_[;U9]OH=9?&UU_L
MFA-NV8*VF>T%ULZ[\8"38RO:AJZ!1?_RVJCLVN%YG#)G)Z6WCK6]Q&;N86LC
M^&E76ZNWW/3!+UJ?;Z0T5OU+]7[]1!>KQS!.(EP4(>)2U".K.2HPQ2@7(E<J
MXH0I4&?:,S0F/K6W%(.&9/![0Q18,7X.&KMM/%)@V-Z%R@K>KCW2>-JCYRC,
MNC%[1#S>C7V/.MG%QKB6Z\OO7^M8FDGIO7S: ,SBL^_/8!77+I/^O]TH\R84
M^+IU<']<W!X-*]MX-!!PTW@\!E#3N%=(5\OX_*)S&L:]8AW9Q?W/3M3NO>IJ
M)5S_XT%3O5R)._T#,8[R]K#@B2I$8;IAQ>:&D8>Y-JNI/DP3+FB:YS'CH-FH
M4S YL:*H"0>&LN,A/,F'L3O%WQINF#J"(.V_P?H(*.;JJ>["XL_51GT$R.#.
MZ6-HN6=QK,O7%[ 'U^>=;%+^I?@L_]P\_"&7W^4G[:9^JQY9JF*5"HEBS)5V
M5PA%-*8F)5\4*L]()E-0QJLK(Q.K4OV+3^&9&TZ(VNG'.7""Z<"&HS/Y&[LD
MU&9L]8ZQ;;WE[<KC*(JQH'C,WG!B8_8$CC%@G<OA&+4>W(&[?=E4&[HRK5I-
MW:7V W[<K 3D=JY[A:F=.-!E78^@P]Z9'QEARJ!%,]@1O0@TV<7WA7C1;IJ_
M^[YA\9P\LYYE9_/-AD5K>V<63[N6Z57TZ]?2!/_K1IO;;D4?%RMYLY%/U2,A
M@L<TRI",)$$XQ06B."Z02DB6YC+-9))!C( A@A/OS=?DFTK3FH'@=\-"4/,
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MG">A4!*E+$X13LU,;*UN4";2B(5,XEB!2B5M"4^LC?2OHH#Y%]:(V3D<4^
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MB411&&+&\RQ4HH"$VH8(3AQ@:^HWEP<FZK"TK$D#V_\,(6>G8GWB 5.4'X]
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M+Z)._ L,.]8F>R=&@PZ-#\EA.VLO7=T>0!,U5G8*=U,Z9;;V27S([N: O,;
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M/ C,=N[;1.#!5,*K;(2+8,^'N9_5;I<&:R$N@AU7D^8\.N#AR:F"4)[587*
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M8U87_STT)E:D.[+!CN[_M-[XG:@,*D8?LL)TX(F88!.S3V!KI>9#<#?]Y00
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M-,24*-U*PC3A#N=)Q$"M30&T)U:XIEZR*I0\U[T46)T+ =7L&#D15##MK9C
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M PI-!#^=3&CT%CRL_DG)D6=Z4&JNM.C]XT8\Y4U;RGMYF\E<?56JIM?FE;R
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MEOIC+$T[<<?\)8M8)>=+_7'3%7&\MW/WBZ;ARKZ%IHY8[N@CQ<!/;S^C/0^
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MG]AZ-A25%=0DC3VI<SCT.I(#I8/>/-2"-7UAP641YR0T]@X'2FKG#T(EACB
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MNPQ!UG"G&ADHRW8%&I46%]5YJN%C>TU1<Z('N2A>QFQ?  9@M&X&YI1G;FX
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M][KX?P=$?<WR^[A F.=NCPB(92+W$&! 6=V&HEY.\>Y;8+9\;T-)VLG?IJ^
MC=EOF]5Z^;K:U8>H8UH<2H9ER-4)3NCT[U3$V(N]5(HP(8E9^O?)RA,;JBTQ
M8QT\DKO7]-A+ S,T6SIPW^A((F,;8B^9G<7H_:@@5N$\\Q=MP-'C<VG\>2Y;
M^GWA <M4D:;1Q+W4S0ZJ%@?[.7&>'[AA&%#MEB@%=SV!DY0'.'(<$4>Q'PEA
M=+@R(3:QSK<;:FCBP+2/+I3, K=CR0ZS$,=B-QU#T*AS\B BCI6ZT45JWEP-
M Z%/DC-,WK'3YU]$)@JZNL[X-7]99DM],Z2GV=S6->"+T*$I8W&,>4(9)FD<
M8>HP!SN"I([#4L<+4[-!%884(=]MRT$6%?TJ8XD>< #3\3[DS-1\1#1@FMZ&
MX9 T:FB/I^B&0HZDZWW49E5W0]&/-=[TM6']:)_R:_;OS;(0VVKRN^RPUZ1'
M_9#1 )/0)YA(Q\-I)%+LZP!$0&CL[IO2 G(]#<D;??<'YWGN;W!U@[W.1I*6
M?6O[4#8S%&."-JR#[3I'#0MHU\U"(3=R)T)+N4=N9MM']8=TM#6$XE);6]/7
M+0N_BV>:+?^[.K;=[%1)_479L@=%;7NDVUX9+^EJ-V=K/ZO-\ZGC4"&QK.9C
M)3+ E' /)U$:\#12'DED--AD5*ZFCH?6_916HJR[0K>X_"]@>?DHGX&979H=
M69C5:K-W=0AJ,QA\S^(^'T4QB?9<3I*)-BIN8Q7*C\+3O)7U8\)X4HH_ZN(P
M>ZK'HC\5_+HHO@JV*9:Z-^SU\W,UP>/Z96UB_'J6F-B<*4I%Y96AW=01,RO6
M)WFW71I1:)BE>2IH-49(45:_KKX#5VC/ SJ#![KN'KIB;%0,A>XH<E,K-!:"
M\;UAZ%MW%E4W%&ZKO*:/P]7Q]M_K]^OO!2^O^5_;>7^&:GCFU8G5KTFBOOY.
M%55UPO]KTYQRS)7PG+S]RC=05)C2791RQ*Y//4)9*=6Y]693I@YAVDK4]9CE
MV>"@TN-_B^7S-W7(OGY3OWT6'Y<ET]90=[1KKB075(9<>L3%OIOZF*14G0#T
MK4*8QJ&7,C^4/ 4= X ,3*RC6P8PK3E O&&A;N&)4;XK@()T.[:&V]#CGQ!$
MH'-_7!^V908UW* M.U6[S2O4<#2B%V^)Q5@..Y3\O+ZY)3@G;KCM.F-8J5V.
MU\*1?LBIC/688T<9(R_%L4\EYH0'1#HNE0XL)G&>SL0VY_[0I*!50W<YS+KL
M88JD1T/)4NSZ;JA@4EL?Y56G/S=,/-^C3##8C=$(0%G=%'V>!B ;*VLE]$!C
MNJ,YE;D\$6H2J[BG\@.-WXFHW3;N]/$QYKU\$J(^<"X"[E-*),&,!2DF'F<X
M#?P4BT2RT OBR($UXKQ 9V)35B4H2 '5RTN@F.GE"*+"]/)HB,L54C1'"QP8
M2C7)+)<]E1\XS^5$U.Z9+J>/VRGF%['67;L?BOQMR07_\/Y[*?A=MAN#<LW6
MR[=JSUE(Z;M.'%#,!!&8Z(;:-/4CG.B2%:[.12&3BW6^IBLS734G#5+?'0/&
M7VS%2#VE8*,;R!R4S](=#S#5!L!JINW3@ 4S !JG:E# E@N4OJ.??J]!^QGM
M>$'7_:B!#0,<@)%L!8#PK.8##LBQ1;%8 1ZKK")BOV>\6+T_M^*@YA<'%Q>8
M>%-7)(6BJ;_/>[+F,<O+<O='+D<1&:;;%4ET5N91+P=Z1;.*8EY>=;989J]@
M[8AF_\/@$H??LU(O)/CA*/%6P2EU/!I[1)U_A3H.>RS!L>]IISM5OQ4ZC\JH
M>Y4!K8DU\W^X_QD@=2Q9Z:OR'2^H9@9MN4&><5%!+W;=*CLR(C#%O2R_5>UI
M+Q3&%1=C0F)7@]$)S2B%&:8R7BS5Z%U@KN(-4TE:Y1S&KUB&#);:*\EXV1IW
MKMV511SZ,O&DQ E-)"9)[.&4\@B3*(F=-(C2F#L6R:"7Z!E]3P=G?^ZHZZQ&
MUFKY^2U?*<S**D>(Z_3;9FAO]6"69YCI2;ZY,H;5S* F#;)Y"QB/N(2X84!B
M"(!V$8DMQ2O4=$FMB%Y5IY018Q(]@HT5E+A$9MZH1(^P)V&)ON?AK3.>[AZ^
MBD(Y1!^KLL]FXQ&>2#CU$RS25"N[X'H6B(-C-V"!*XDKF*G_<I["Q%Z+)HIJ
MJN@CL);Z B2];LEP06$*>49&B_87YX4U;WHQ6&C+5A> #QC4X*)3GLMM+<Z_
M-ELSBTZNVRTLNA^$F0\NEHMK]='Q*D:ZHL^+)/)=SZ^*NV.BO 4GQ#&-?!QZ
ML1XL3]V <!.S<;+RQ.9B1PMI8F;*<RI]MX48)!,POF FCK%>7&2](WZ@WJGW
M8?7#?OL]76D6%;DHP%8U+C]@YT_?T*+0D9U'\9H7.FVABNI\HLNB:J:MTQ=6
M>:G\^<;>$B<17D(D9I&;8B)"M=\Z-,*4R%3P*.94@*[F@/0G5J^;Z\?'?]U]
M^07]<?WY]UN8GPQ%TLQ]GA ?F*IN&:C[Y:/?!-54*]T=+Y=QH-0CN=Q0ZK-Z
MXI;0'#OHMLO -][;;*W._X_BN:H2S=9?Z(M8.(&?J)W6Q2&ANFE^JB>@*X/"
M(R=DGA=$4>28[K_G"$QL)VJ2:$\3::+FV_%93/IWY:&2PC0>*"1HD^Z2Q&JO
M/KO@;%MVESCMG;OS.?"1>-]WX5'0U6VI:WN4XK[FY;**!56=&!:>]"@+=3M:
M-T@PX4&,4]]7GJ]#TR@)DIA'IAW9C A.K'KM%B":"U2S@=I\-&U!S ^79DCV
M'JQ'QP>FL#\0&N-C^.@0V9W*VU 5&BI10\5;K/SG*.=TD, 7C^UFJ\QUB@?)
MU#K4P]ZS.]!<LRK?NGR@[WJUZXQ7$XO5KXO-OB6F3K%Q/>&G<>SA)'1UYE+D
MXE3H^*'@U D8(\2-($<98\I3QPAJ@DC4S3CJ2X*\FI1MG2QLCJK9L682K("Q
MAX8%U/!0P50/%-\B^-D +O#9!BSZ2*<:<[JSGF? <!R?9. +6*0K\;^>\B]Y
M]B#R+R+7[70_9?N.::8I2UV+3&T3=J6'^H)0,8$?;N_1%_5_S8<R$W6'@4]Y
MOL[R-: 2NAN9;F,P*BA Y8?AH;RF,3O,&0MNE_;4N?)\J4\F AZD/QF],&"$
MZ/7K:R'8LOIH'W655OGU^O&K>:6T\6)3'X&J]L)M!E#- ?I)\5#^;#$#M!,:
MLRU]5%2 !Y\>0":(4!I+.^9PSTYZ\X_T-!'_["!/HQ=M2XKV2ZN?5Z+IAW+]
MDA?KIE?*(J0L2DGL8ID2G2OD)C@-/8F3@(8!)8'@3@BK 30A"_G^6Q4$MIFH
M^T>VJ$.+D Q@-+,+8T,#,PUMZE=H1[_N*VD"CT6MDKF\HQ4N&9"<N8K)'(33
MDB; NW96XBYCA2YD_"CJ/^^4H_'RFA>T>*];=CSFJ]6GO- )V0N'"C<*_$@9
MBC3&Q$TC3!.=.A#1F*=25S@9W578$)_8DW@47(B7ZO3[Y2AI<-M]#Q@H "%K
M9D"FP@MF2+9<H)^V?/RLB\)VK*#M6%#-#6K8&='AL$%A)/,"(CVKF;$!Y=C<
M6*UA6?'TB[[T^4C78G?1"JIW.GU]8ON@Z307_K1J^UAQ@#0+P)JG,Y(;! >&
M"PT,"U3U3GLAT1Z $0N=+DMD7^9T9LUYBYPN"W52XM3QJ-UVWDSWK'H35.>)
M>_E[*:[+4JP/'%:21*[OB@@+YGJ8,*EV\D!W;I*,T=AA/(P89"<WI#MU;*]%
MJKK/TIS@7.)-J=56,0/<PTWA--N^)P )IM3;&;Y-WY#'+3R*"U2Q<37120 H
M^4B[M2G563=J(!3'>S3T=3LS\CG/GC\OWP2O%BY_%2NN]OVO="4^+S-QMQ8O
MY2()N"O=6.*4*CM,HC#"J>LQ[!-/R*!J30(R(08T)S8?F@-4L5!K0XDT$UCF
M!2ZI'L:D&4$5)X99 Q \S6S(R"C![(<FCL\#]-48(+#Q (@\DN$PH3BKT0!
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MSY2^?EN^-CE2Q%5'9A8)3'W=:]^A%*=NXF/%34Q=5T;<-QI >V;MJ4_*6VK
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M#3\#,^,Q!:XP.])P@-HLH"T/*-VLJU+.=[%&FH\QI_W")!]MX*\AV9EG_L+
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M8@JM%%=">>&I>%YFF8Z$Y1*]=A>03/394!JQF"0Q]E/E0A(6QCCEOH=3QJ/
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M>U#N9ZB4"Y8*+IF(,:&$J_^HLR8-)<>"!T$8N%$<QT9QP3Y"$P<N]KU/A[2
M[46KU_R/A@',L)]O_=HB/9+\QE9X-!SL[.OYK\-RS\(XUM-(RHMVL?OMN2R>
MD0PM6V;VO%V@Y\.F7&:B+*^9\MOK:Y$JR=&A#G="3UFE.!+*2(4A3ITHQ$Z2
M>A%+HB!Q09<7%^A,;*.V5%&+K%6EZ"68S,(=(P@/,TXV<H,#!SU2C73(OT1E
MU@-YCZC'A^>^Q^$'7;K24YZ_W#0M6:7R%$)"4IPR7_D1Q*4X9GZ W<B-:<JH
MYX1&U=NG2T^=_U!3NT)?;LS/,D?"]Q\([44"'N[VTL ;[!Z+97[<LA?/\NAD
M\*&!3D#G!;A\FCEZ?K:3R7D^VZ>,"T_ [RMO_[U^O_Y>\/*:_U65B3W_05>/
MK\6:WV5?-R\OQ;N.PY7K["E=-5\8PPM-^,H3VX FZ%U%"]4.Q?_:-*Y,NXBR
M3M5\_/^Z^[KFN''E[/O\"MQEMVJ0X@<(@KE(E2S;>W3*EA1+ZR2U%U,  4H\
M&0T5<F1;[Z]_ 7Z,J-&0!# @[:1JUQ\RB.Y^R&X W8UN\5B4K=_[E8O=,"QJ
M@>YTW'1>8,TLD26FR@7R%M=I6V84B;7'R2I4:T%NL5BN/13]8.\)LQCO//ZN
MVA]_%77WXZOO6ZGM]_GCM9!?H5Q%[L2:>AXF) IA1(0/49H)F 2>@(*E*&,!
M47L1S9W(!*F9K=+?^WV>5W5SFYJ!.NSZN.=",_2J@=SD-L8A'F;&I('B:P?%
MGC9X(>X,!>U=CT,T['9!IZ!BLCO2%'1PMS3U_%*[)TTY>KLIW2?,=U?OOW'5
MM/IJ=U]^*+=WU36_VNZMZ.5._?Q[]27;I,J$WNXVRGZJB_O?2OY?I=EVRP&I
MF2W=OJJ8JIW8I!M\H*7RC5=UT6(@]P&O]Q/;8M<,_)Y7:@.1;43:[B!NU1W_
MUWN(NC2&:J,H1Z@2N?K;-!>O:7K?MO ;,K.]2[\<QWL]A]A:;?Y<T%]L-^@0
MK/[VT.6TMO5V/^8;T;BMUQ'C :;JQDXB,$0BQI!QN4TD&,="A$D2,VQ6:/=E
M\KE/JDW!644/- 1-Z^KV<!@W3*=*9WA<U!?,HG[N6PE.*)S;FVSABKEOQ7A;
M*O?(&+LXS!]%P;_GF\W%PR/-I7$^8]6NI.EN'05A0GF:PCB)$$0)09"I @()
M0E&LBNCZ+#,)Q P1FEF5.K*@H?LP5L7%#""]$(P+L<UTK*.X AU-\%='U6$4
M9DHP1V&803*+QF&FA#T,Q$R./Z6LIWC5&"(75:\UQ/[KI(1G'O:IRNZ0JU^(
M(D@#+B"/F4\(YDF"$J.K]=JD9U;HCQ>79Y?G%Y=_V)06U().3['G <1,U5L>
M)EK!?,RK5&['ZUWW9RH/N6H)GL,DF$/BM!Z@%N&?4/C/!)#C%?Z,9C!VM9Z5
M@K9'LS^W\HECZ1XWQ49NVC]+-I[*.@W[SVV^J]8>B7' O!0&,4T@BD-UZ52D
MD*(X2AA+8HIUVZG:<S&SP;GY]S_/OJA"P%>W9W]\T'9 GH#JI(=V&:S,;)'B
M:7_"K[D:2% #BC/E)>CQ!FKFEL!6V^^[#,9V+N$:Z[3%^JG&^GCR&ZA:K!]Z
M6#\I)MUDQ9T.TJ [^82IE_(TGRY]SPGM8+(3RI_T$OO:MO7/RA,NJ75)@#=J
M6+5.O%0$B/F0<%] Q",/DC22QT*2(I9Q%'#$#*ZMF-(WT2VK6RHOZ:0U7Y6Z
M$;>KX]5I(3?SVV<5H:L.U&T%OM]+BHUF650/T49_<F68%U&S%6$@/QET[-2A
MK-HZO8#>\#0GA!8U6>: \O0R+;T4YR[[O?XX&TBW!]^QZT(NIIAHU';1GG+Y
M<B^FTAZM &,\B9D]K\K=^KS8RA4_Y^JZ=^THE&>%MM@C\X( 8\1ADE(/(AI2
MR!#",(P0"B/?1]C72I@8)S/S7KQ/&'24#6MB3N T;F+=26]F2RT%U]9M/;G&
MCNMRAMY17?[MY9@^,?DBZJPG8*>WFJ/-HU3O6[/?^&242^:C_$FU]JF/1!K%
MD 4X@BA!"4R8"*!(&:'"4U>%0]U@U0"-N:/[+=57[J::L'[L:@B=Z1"6 YG-
M%-)"7*.(UH1 5H&MH3D7BV]-"-4/<TT-M6Q8(7DLMCO)KQQTUW7!Z!+A68 P
MBCADV),Z2$DJCS;(@TG,L\ CA#-?RYFE0VQF992D88_VOB6,:>^*,;CTW.2N
M0##3SM=4]^([3#HQD<]57X<Q4LNV>= 0^DW7!YUG[+2ZZ291;Y[K<B!=((?A
MT/=CKLK?<PY12 )(B5Q9!>-^FO(H26.M#) ).C/K<MN89$]6)W1C!).>(CL0
MWDR';>0V5M\)J1QI[A"5195V0M1#?9T:?F)']/:W3_E6^&N>QB+&-(-!$OL0
M(13)W2].(&=A2CR.<(:U@M6C5);)V=HW"6__ !1M<+75S%P?QVEZ'^Q$>C,]
MM1;<OD/Z,<%.[Y'^:M:?TR7]F&"#?=*/#CZA9DA:W&WS_R=X'6QN6\O1S4MS
M@6K-8\2YYR<P%AA#A'FF^EUZ, UB&F<H2#)/-]QK0';NO7*O@$3'"]@H9D#6
M<:/^J6/'HK[&-+*3COV9\#+<5O=JC^RAJOD >T9ZW2CF@<JB,(E3R$XM4W(B
M='9%2[01T"AA,CW7\@5-M.4[6MY$_VG+JK9M0YA^*97K?<&BIBAY*,\G<2@M
M:L;#3.Z!2 8))QZ,$LP\&F#"B%9I!0.:<R?.]-K@]&.!+US8%77705/O3.,8
M(S-C>@22Y_[U/N?EWPVD=54H58/BL@5.]2%X4YC4X%$[*_'AQR[?WCWEU;U:
M7JZR]X+MSAZ*I^UNG028)R)AD'M,E:KF K),FHDX]8F' ^K[3"MX-TUJ9IO0
M+S'Y6.;2SC[6NZM'FAOV"A]!2T_YW6!@>%9Z15,91D55GIEJNNY4?5HV1QH^
M0FA1Q9X6^%"?-9ZP4^/;LL[/>JXK/-:E+^IR3*6J:*P<GKO[@J\#+V'"1PF4
M:BU7>X(3R%2./DIY%G+$XP E7>WY6WV]UJ&M]76_KAQ_:Q.I[]4RE?HMA]W+
MS95A $(+2SUU=P:-9<?<AGI3:7?5-:GK6%@!Q01HN'!G!DQD=F00M$@N:AI,
M0#@T$D;/&KM>/CP\;HIG(6Y$^2U7S>V.E3Z_++9?1265L+EVW?\GQ<-EL?LO
ML7LYPJA(Z:U\EV+-4YYXA%.(:23W#)S(/4-($22">UZ,11PAK0M\<S,Z\XY#
M?J&QMA]BWC<RZ>3Y97 VW-6T;(.6[[;S!'O3H6(%)/.@X;XM([!Z72:@-H-2
M!/ L=CU/R:K)KZCE^$5>IK8;ZI=YJ7:.JU_DY9JXO19!?-!1-B_UI5QKBV#8
M<\8M0\]=T#)8$S] + P#R".N:J%F$4P0X9"0T,,1\UD6:54J'J7R,X.6M]^+
MTX.6P0E!2R/I'08MQP1W$K0,1C;=]D'+X.<'+8-#S=8;;'?05B?VEWX_E_1!
MM"G<&/N<"^)#&F(&420/UX0@'S(BXH3'(O7TDFFG",VLG(ILKT677%\E9<-D
M]TFL] [/+A P4U!+X8V/R%.2.3H6#Y)9]"@\)>SA\7=RO)WB?I(&0(BK1U%2
MY8.KHVZWHGRXRLY5AJ#*22/<]Y/4#R%),GEXC9A4X3CC, Q3&GN!/-BFW$2%
MITG.K,RJ:?VVS2M8@7R;[U3 5T[T8*;(&MCIJ;1;1,R4NZ&] GOJ704+Q8#R
MBG<LN--S?7$=:;P&P45U7Q^ 0RM@\*1YA<R/4IYB*]2F_9LHGR^V7)D9W:*7
MQY^>.V%(DM"O+3D@X+B2NI'-3"E;>J CN)+++U=5(9^DH1J5V:A2X[A85L47
M!Z9<K)[BN$C]$HD3(]TMI_M20%VEF"]"+=Q<Y;N\7*E9HTB>76./0\1% E'@
M)S")1 S3V",,Q3SRF%'2B3TK\WN!T>D+K2:J]@NP>ZP<+<P#I:7V[*E%NW<3
M;MYUVPRE&==S349^^CIO!IC.^F\XHW56\F6Q$]5+(M[:P\3G!'LP"T)IM3 B
MD"*&(<6I3]/4C_T@-LQ /B Q]^9AGP>Z571[B<7&R;*'V$R&EQQ(;&9.7H2M
M2?;R6T\6UC@+^ 2A3\WXU1;>)K=W0*[)/-[#YY;.V1W@^TA^[M!(N]W2:SOV
M'ZJ-D@HHR.T8O1.-%>L?<OQUB#@2H1>K$D=RCX0]!$G@I9 &)"!,A(&(C/9(
MI@S,;) Z!B!M. #/TG KN]0RTEZ%4)X*\)O8]_0IQ59\EZM]T317_QU 4.PW
M#?4CAJD^QN]%;Y<U)]IFQO#-GJIC!K3<@#T[[<6 VS'OD/%.RA8)1_LG8_*+
M[IILP3G<*UG/8U]*Y%J4>:%Z2[^G.['.6!K%.$A@$/M8'NL\'Q*?Q#!./9\G
M"<<DUMH@#5*8.^C1U=5HB*H^]4"1-2\B\AJ7<6OA1%K# (>IH%;E0XX*<U+Q
MD-<S+EXZY*A QPJ''!]H[J"L4PUN'^X^;Q_S\VW%2_YQ0^]T'93'GYY9AVJB
MX#9_4$O)Y\OK"^5/KW*N:DOJ.RX'!)]V7)XNLYDFC8D+_E*T'369&1?,RG4Y
M,.5BKLMQD?JNRXF1,[HNWS^)=2@"CN7_D*.0012S !*<9E!$49;%'"="D/5.
MM1URZ*B4A(TT=4]>^]-M&B4];7E>I>KJP?[F\6/+P@P^2P6G0P^E(4AS^B,7
M]CKV)%_2QZC(_GH>Q1X85O[#_O.6EVR/I@R>E:7\H.H2)N^>7X:T9&NCUK0U
M>\ESJ.JN9K?W='O5'&XOB[IRI^!M1R64XC@F/(89R4*(,.,P\:F #/D1\M*,
M1")>/];[CYL=+7=Z)FDQ_DW4]5 *;<WM9PG3-AF8B;M\6Y]OBPPT,]==3BLU
MMM+L<+K\ZTZHGT5>PF$<9($\4B$"&?<)3 1-4X%(Z*&D?=URN_F__F5W,IST
MJD5SQ?-_U7O66Q1_R3=GMJHV+^S=FPQ^T),"L&?0']=*TB3VK[I6D#UIVJ:1
M.RD/: 6J;P0T(JV<M7O[:>_!U9WXQ?A>]F;]TJ_CS?W\Q1FP[.%%\[*^2?CN
M^4SNBW;G&UI59S_R:HU%&B N3S88I02B+/(A(3B"'&?,#RE+L.\;M>P:HC2W
M^T$1 S4U\)>B9YBK/(R0GH5V(K>A"T)?9/.N6E/BN&JB-4AGV9Y94^*^:9$U
M^8"YT^^B\1_=EE1M8Z01^91OQ<5./$Q]@^,/S_<!MC1!2[2_DLLO4C$ :@X<
M><*F1;3RAHU,NYA';%JTOE=,8[1Q[DM7&_<+W8F;[_3QPX_'O)2S__UI*WQU
MG;FK5XVC./3B%*8)E><2S_<A\S&&.$!!&.&,I(GN!6]-DC,O'/LRS8H-H/B0
M&\V6$Z!8 ?X*&-WGUH5R7*GG <A4P36QF:YQ;?V]Z:;<S "670K.Z1^424:.
MH=B#&3JZ\RR5L6,H5R^#Q_3)7\WQU\00+[:I*@,BWHOF]S6//-\+J0JOI[[<
MJ*, 4L^G,/-QR/R,1S2(+(KW+"V'EOZ=7@CH7K&O6E(UOB'0.(J*K?(,947Y
M4'>PE5LV456UA^$7]!0-? <_VV%TPFO]Q?U&;4Y$)QKXK1-N^)/XA1Q(X^_E
ME_<C#;#_?\2=-/YREO,J3?!A?F;ME58\N[O;?2A+Q?+9PTXW5V5P@IFW_?V:
MD))P62\U0)(OMJ)XJ@Y,S7BE1 -4I@_R3@ Q,[$NL3 ZT4_*:G6@'YYUL?/\
MI&#]X_ST8+LMZDO)V'W7%1&P0![>4Z@J.T,D4@II'/E0<!'Y-!$!%D;-:=Z2
MF%EM^_6+#V\X_*O9SNT(/'I[J].$-E/-OKQSM*(9EL71CN$(@477]&$!#U?=
MD9'&WK1/MQ?7-W*M%=5YW2V[=6:P),.82?4+>9A"A!,!:1H%D/ DQAGE:4BU
M:L0,4IA9^Q11T% %Y^!/H\;3 Y!,.L%.%]1,XX[(:.[=&A!6VYEUNM!VOBN3
M%VSBI1J79] I-?#84CZH<:Y[+J>)@88ME7>/Y?KR?)UY0420M Z>$"%$(4MA
MDA$!4Q'(Q9L%<1PAK=[)S7PSFX;+HMS=@W,JG\^W5+,I<BOIN VPX-],XR^O
MOMS^#9R??;GZ='%YYJ"M\6N&1_:P:F2SB*H_]7H7MS,LTZ3X-;O[;L0'/YXW
MU_JEQ"G*<$")[T&:>9FZ;)W)-=*7^]0P2F,6A PCK<_>FH.9%44_E&2/H=X^
M=E9D#!==PQ(0+FNWG@S'PGG8"Y=E/1D>V\SL4PNIJJ/UM2C.TMT3W6R>U8=C
MZ)LZ_O3,]N'ZPQ7HJ-9?^VFNJ $$IOU0IPMO9@).D]O([30NFI7/:6#*Q1Q.
MXR+UO4T3(VV;(3<QUZ9_ZUZWURGG:4"B$+(@P1#Y60!9)/>PU$L#/\UB/S$K
M8S! 9ZD4D;PF:]H ^3@T>FNT X'-U' O:T.QMR2[['\\*I2S_L?'J2S<_WA4
MU+?]C\>'6]PDYO^X+6HE5[FLNA>(^P_-K%R2UE.UJ\.U<H?7M_F:_MRW4DXO
M;M8"FBG3L&S.$G8'I;&[&?QJIN4N!!\3X-4]X*,#[-:J2]&JUZ>BJLYVNS)G
M3SL5/[@M+B6KJKIHL9'/WW7*N*;RY$G"A$"5*:^B)@E,/$2A\(2' I]2/XF[
MU!N]=<R8!XNT&4/_C=B!C60&T!XWZJO=%EO88TBN@0U'AK>$S5$/"/-]CW 8
M1BB!R!,$DH0'4(21'X4\BGB*+1*>EH#>(F/IDPGV<T.OMS>9!TD[%Y[H-BS@
M-\7-[^#L ,K7'(&+*22--S76:#C:[IC37W0C9 W/X1;)?B*[Y>(K+7,U?3==
MTUBB^?4S_9$_/#TH3C[\>"RJIU*TW4#C0(0(QPGT0YJI;,T4,AQA*(\]"><!
M"EAL5$K>BHN9=VZ?S_[SXO.?G\&'_[R^NOGSRP=P>P4^7=W<F%DG.WSU+-3L
MJ)E9J8Z=O?4!#2NJI.UC4=9^S^8G<L2W8O---%TH6E9!O49TS+KOWWH26HZL
MF!T/BUJRDV ZM&:G369?O^VVI-LJ5R>1YM.3>]Q8X#A0%6ZP@,@7#-(P26"0
MTL@7**1Q&IF6<#LD,K,]VA<W>Z';*I9Y';<W^(P;'%=2F]D3"X&MZKD-2712
M2;<WDRY>U6U(K&.%W0;'VJO@OS_14G[EF^?V"XM\/Z")Y\&(Q*HG,V:0^%X&
MY<]"Y".<^9YQ$<4#&DLIX)ZLM?X=@J.O?B>(;*E]VM):*=^ /"?IWN&<BZO>
M@%#'-&]HJ&4A9I40KQQ)I;@74J._B9?#Q#FM[C]NBN]_$_Q._$'SK?KA%Y&J
MJ]UYEJ=-%GXFF;FE/]8\00GV60(]'BGW1(I@HK)UF)\AQA#%,49F3B%GO,WN
M+#HD#.C>T5F!K"C!G>2P4N&2S1,77-W#ZEP70/Q03E##((J[UQ:E:2R/7P(&
MC%*(D+2W22;W.:$7B4B:6S]-B857Z6>^.PMOD\4+W(HN_J4NR[U^F89WYMR]
M32^B7A!Y"$:<A1 Q3^H?"B/H$8^0D"8AI[1[FY="LR;:SWR7'9/:;_(WQ<3O
M]=%0'2,[1N0[4Y87G%V=7RC=*ZQBE^Y>E-YY?5GD[>[*U!<'7_'XVO.X HI3
MH%@%-:\KH+C=_^LARRM %=- <NVP[+IK(%W58W?&U[*%VEW#^::"NW,"QE<6
MSM)=3?;UY?DN<SWU_"CCE$!.U&['ERMF$F,!TT@>6U"<$"%TRWZ,$IH[V%S3
M?O&_[4LT:&?VC\,T;N9<"F]FM0;EMKC;,(Z ]A4'9TC8W70X!1&3FP]:8@Y>
M@!A_>JE[$%HR]*Y#Z(TW]YPT;M'SI[*4KWOO,K^1;_ZI6F-.0D%##K'J)8@0
MR6"2^ QF*,8>3ZCG<4_7?3)&:&8+U?K_6]J]P$!#7=^3,@K6M#O%%01F=LI6
M>B//BHYH5NZ5T8D7\['HB-=WM&B--^^E)Q\OQ576YK"IV@/%)D^?;\6/W3O)
MZG^OHRR@G*<8HBR0"NO)7V@8A3#VL$\")#*"F&Y7O2EB,ROMNZ<JWXJJ E??
M1/DM%]_U.\U-PC2YI7 JO)FZ-J15P>47XN"OACQ0]$'-@/[>8AH._19\+F&Q
M;,;7P'/U"IZ&BW]QTXY/5\;AQGR3,RS6HD]7EGZS/NUGC.W7QWQ+MZDTA"_U
M!<XV\A2F"D=]+,KS4O!\UYS$*JGSHEI3S"(:R".2R-01B5,,2902R A/"4N\
M@#&M2KHVQ&>V;PW!)C^P;$EJZ[0YDI,F;U9\S$S@GI5>(8H5V'-3.U-;^#H?
MW>SX:=O(67&TLYGN\30QJ-: #!I8\QF7,KC6LO8,L/T<=N&[S_FV*.L25\W9
M\NK[5EJS^_SQ6LC/27YK=^+=\^LTP&;(&G&&L/P/$AH3*,^$\D^Q3V", L$2
M+GR4:)7>.)F3F4WUS1.K<I[3\GD%BHXG5?6P96JEDHK[F;#U(+.P@/U;T L#
M+(*MF9GOP[IG!USW8#U(,+X:A=78H7\R)(X<^/9\+.JP/QFN0P?]Z1-:7%[>
M5MLS_H_JYEMZ7NU:_ZKNU>4CS\YL>:Y5X$+=U.V%DF_4<5BNVN>%[J6%0<''
M38<+F<TLPI2X#MW(4\+9W5@^-N%R]Y5'Q'EU6WELG/,B][C]UB*>>@2A%(84
M^Q"EJ0\3[!'H489B[I$(ZY7>T2<YLV[JUB3'SNJW8]V(V P F2FR-C;NB]QC
MTZ#9#&#-6^1^^(-R6>0>:X;3=.?Y58K<X\$0F^F3EE=EZ]Y35]EU6<@3Q"X7
ME=P'_T.DN]OBC[)XVO*Z>$NU#A#R8I(2B*75A(B' B:)"&#(0B\-19SX@5'-
M)DVZ,QO-AHNZG>">#U UC*@KA7<U*TWO7-/;L)K ZIV79H#+, ZP1^J%!7#S
M@E3#15/3R8&CQE)N5Q<M-:DN>[W2#(HWERH-'[<M2+Q1.8[7M-P]UQ<J:%H[
M[=\]]_^E+N'@,Y3@*,0P]9,(HBCDTJ($,209IEGJT<!+M2Y#F).>V:BTY "5
M^B#/BV7[5T5>*8U-ZSH#6/7LR3Q@F9F4TW"RJ(-L*K*S^LC:A!>NFVP*R-MZ
MRL8SV)F5_Q#YW;V<[^R;*.F=Z&Q9W2*AZA57?T>K/%UG6+#(\R@,$TZE94E3
MR")YRN,!YEQ@@9.(KN5,K-"U+4;T332FSX6VXG3< -JP ]+BX:'HNMN HE?K
M'ZJV.'EJW_S&#'D_BBGC7@A)1*5-SSB"A+ 0<NQ30F(_C"A9[XH=W?QDW%]X
M^#^ NI[)GPU+,ZN_A['E [SL+!M60(^7%:BY<;<(6('@:!TPH[WH4F %R^%J
M8#>)N=/\9O??UV5Z5=Y6Y8=JES_4;HW/8G=?\)<D(DTGNLY<<X?S=I*&/%4I
MKW)1@MN;+^"%%=#PHN]8UP)GVM'N&A?#4)P&). OG>PS(P>\B=!6#GDM HLY
MZ$W$[3OLC9XS=N!?W^<;RL7F\3ZGUV>M]]1C89+2-(,B"3V(?*IJA_L8LC"@
M+ I)C".MTA4#\\\=-NN17('KX?KS6EA,NMM/E= P2'8@G+D+_:B4VO[R4Z6U
M<XYKOU(3'_B8*(,.[Z,/+>7='N.XY\H>'69W(GR?5TU=,&5[Y-RWQ:?\(5?7
MW+LZX^JN'=T^?_ITWA!4E^SZ3U7OU06[4O U8X$7)9D'/2PM-@J]"+( A] /
MTH1R7WAABBPNC#MD4>N#/OG*>)W. 'B? ;-CB\N7HG>H61ICNS(B/7) <:D<
MYBV?+^T/0,LI^$WR^CMHN&VO&K]B&'0<NSL6S0"CHT.32\X6/5+- .GA@6L.
M$H:-C,K=^G-1[N[D>>]30;?5U?:EQ]I[4:5E7G<EO973[D,/C9^:9&F2^EB5
MY?!3B!(OA G)* Q2'W&"PH1X6GT*[5F8/0RP[^NW HIZ+WCV;!0%. 'E<2NZ
M#':F48$38--OX'2RY&/V3<[>LVWR;[V^3_:$EVD5=3(P^^Y2I\]D?'C\>Y%O
M=U_E;OZI%.>T+)]5P]6FG"A+!0W"P(,BHT)N\F(.$Y]P*((XI"%!S%>N::TC
MY#"5F4U*31A\:RBO0-K2!M2@8\PX2I.'2S>RFYF$1NROG=@=6:-&.>-B:Y\V
MW8AO=^:TA,'D!#HMWN Y=.31I4ZCT]SWSJ0:@^U.IK7S\K[8R">JKEN[JK$E
MY[]6%Z^+K5Y' A1% @4))$F,( I8 !EA'O2Y'\9!*OP$92:A-#=LS1QCNU6/
M %&S9W;T=(0Z1HP%+!.0^X1!%*,84H0#Z,4Q#Y,H]E!,UG*AR@M^LZ.E9KFQ
MY;$_9%'[#;P3=_EVJ\P*HQMUQ^NGO ;NJU)]F0=9E&00T2R"22C5@#"<)1D-
M_2@(V]?P8:M9>_%GO82.0>U7\*$)(O],_&FH_%Z<0R[D2T"1[T,6QBE,&"/(
M#VF:<:.F7C_!^)COKGZZ\=%S>2V/I=ENK>%I!?9<@9:MY1MVN(7*D4?+$5.+
M.K/< GGHQW(\NVWFJG*+I3O!:W;J)M]?;OYLPU&,X2 +(@3]A M5"CB!<I<0
MPTCX'DT2C$-NU.QCE-KLCJF.-F@"[35U\)ND;YJG- Z:GCUS!H6IGVD$!8<W
M^XS$=)9Q.D9KX213#;'?YI7J/&1>_W(GOX =_:.+,0?8#YA',>2$8XA8&L,D
M8 P&PB.1%^+ 0UKUY-Y./;,&M]16X _]7()#X2<]/2>(9*:)/6DL2E4>B*5?
MG-)>/,MRE!HOS:CLY'$!A@M-'HQ?K+3D<3[[Q20'1M@NY)V3^59M%]:J$Y>?
MB0!F"9=G&295/>%1#%% ?<2%/$[J:?G _,M%D<!?-4'CJR.OX=!=E*V%M [W
M3,IGL>8>E<+9*OMZ]H77U:.BO5U)CP^S4ZWS8EL5FYS7AF]?+R47U559E[>^
MV'X3;:&$EZ&"U^4GY:BF<MLZ")/()QA!E!$JU1!1R/R(02\(?!J'Q/.$5B3&
M*5>SJS$7XJ$^^,K3"SP_<NPUS+5Q\R[TK,'B")O9D%?LK4"?094^W-3S[_&X
M GTN0<?FJBW<:%3>TM@F.<72D25SP].B]L\IC(=6T^WD=K;V8IN6ZD;N>]'\
M?K%]ZR;Y(DW(QZ+\3DN^]C#.F#2KD,:Q@"A1AQDLSS8IRCR1(A(&R*CZF2']
MF>UGQPWXK>/G=]6QIL_2/X.&*?"78@NT?!GNEDQ1U[.?,V)I9BEG@-'8 %J"
MX<C4F5)?U*A90G-HOFRG,;^*]>&'2)]4)X!S:?_NBK)).M.\>W7TX9GMR)XF
MZ(C^J_[=JN/2CIL )X(:!F#>R.@L;6Y2&JMK4<=G7.P>U*A _8M/XP,MRYT*
MGC\]W(KRX;+8B:[%2J*:61 _@#1BJCH9SF 2)!@B#ZE2IE[&L-$1Z2B5F56M
MH0GEDP]@JZ@:5B ]"HS>>GNRN&8*UTJJZ %%<(;HP:A$K@I_'J6Q;%'/,3'?
M%.P<'6R^F)VIQ; ZWQ25N"T^;Q_S]WF57FSY)7W02G:8FF-F?5,D]->R46&G
MES17<AI&"FJJH":K]JVW^4.=2/#Y\OI"W9%)-W4+]4HE'_#\6\Z?Z :,XF*T
M\ND(;;4 CDZ\V#JH(UY_.=0:;[<JWJI]ZU/Y_$EN6UO+CXF'/>4KI 03B%#"
M((NS$.+49RS#.$!Q8%;4Y2T1DR_7JG++C=CM-H*#74L:W*N.?X8KXQ%P]);%
MTP0V4]6.%E#$9E@0AV5QM!H>(;#H4C@LX.$Z.#+2.$1^D\HO\FDCKK*SJA*[
MZFR[OTR6B^IO8L/EH?&&;IIPPDM%B9!X89I)Q609XA ED0]I*!CDV",>X@E.
ML&XHW9*%F5?7CBMU&ZGAJZY;UN,,*-;JYA6*.>T MBWBXRJ_#(YF)L$4PC8>
M:-5ERA95[?2!!="U2S-P]J&:Y"*<B,9@SH+MO$OE-IPH=R\'XM29;%MM?LPW
MZEIPX\]8>PFCJ0@(]+PH@R@*,*1"(!BF,6%)EJ7J^H-1A\U7\\_MW&M:2]8D
M][XOTW::KP$9M[(.Q#1T[1E):-$R\Z@<)W3*?#W?P@TRCPKSMB_F\6&6E[]4
ML3-&*\'5U7NQK9K6W64IWZ)0QOS=\\N0:_JL?E2?HZ[JN[#55U'M!+_87M=7
M1S[2O/Q*-T_"7V<BRKAJ/2=5%$$4)NI&3!I G!".PC2E =6J@#0WHS.K^!^2
MOQU0T5:029K@FR)J>%ECKE>D=PC[%8 WW+<I=N [Q0_H\PQZ3 /V#/KC6L9!
MS?D*M+RO0,.]\MTT_*^ D@!\'7V-YO<^9L;8U4V0N=A<]F[(S&"_N2TR-SWK
M?(WB0:B>RC43G]1'*LF]+QYHOEUS/^9)%";J0$PA(ID':2!/R@'V,I(E(O4S
M:IB=,4QM_EP,21OLB8...OBKH6^><S&"G)Y5=8:'H6G<8R!/6RTN'6U5N[:^
MP3D-BTT.Q;2X[C(F1F@MG1\Q+?:1; B-A^R4_I.HJJ)L>Q-O[^H6"JW)J6Z+
M=Z+IF2GX9]7%6&XU#[P-7DQY3.(,QF$8RN,6)Y#PV(=^'/DHI2CEOM$UV]/8
M6="#]O&I;IO].=_F#T\/8,]QTS^DVSU4O0:Q9B;EQ/>B9W.60]O,*#5\K0Y1
M7>TW9;L", $Z]E:@8]#$X69LLMR@Y<BFG<C,HD;/#7"'5M'1K,8!AJXB5!VR
MEP35M)>BZP"9(I9Y@G)(XE"><C'R( L]!*,P)HB(0 0>TPPCC!*:._6EI=WD
MO8#'AKJV\WH<HTG'OS/)S<S.7NB:+F@)KX D;7ZM;QP";2^],RCL?/$G06+B
M?]>2<]#+/O[T4KYT+1EZ'G.]\>9I0.?%C=@(=?GX<QU7%2;Y/T<?GMG:='5C
M.\J@)3V>^:(I][BU<2*RF9FQD]8HSV=4(JL$G^,S+I;9,RI0/Z5G?*#YA?O'
MQ[+XH3H$B)O_>:*E^"C$KKD\HSPP[[KZM&L:Q"Q02WZ,4J(Z-@60><*#7NJ%
M-/3]!.OU@C.@.;-2]M@ 5<T'R"0C(&\Y42Y0]JQZ""EF]*^[ZR(ZN4N8 R<S
M3>Y#U+  % _@XC5$YW-!I%\J8 :H+&L(N(',J,R H?##]0=T)UJL,(&A9/V*
M!::/6D83FV;S1DE^KYZ9T?/9D)DAL^^H *XB+J_F7C9,<DRL-[&-HX.&/IX^
MYI_DG_[MG[J?R%]4^./?_NG_ U!+ P04    "  1- )9'4>$N$RT  "-)0@
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MU1 -P>LHY?S37*F/'.,A"*I(,MU4E20(>@0,_YJTX,P'&=N\2A^V4U%#0!X
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M"Y0*ZMS..CE4M@W@XO7=^*LU U*IH+1'(02%X81#VAV(1 !T@H!G=Z_CQUI
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M)F^,[8\G6"S9J-0%3Q1PCV;=VU6[9,$L=S2R,E^U!VSN2693K4"/!62?*FH
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MCE+]#G Z7 _#GG/K;?;CID'?A]D20W.87R*'J92'_OW=VQNKJYC.-'I%1#)
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M#_5GP"OJH0%4W3&RF7X["D8%ZY,BWBL,_D/$71(DNFF>&I2/@@"U9UX]3LG
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M(XRNC52S-I(#+Q)!A:3!<5^(V8F;P&TIO'5M_$&$C1,*> []V5HJH\XQOI,
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M<U)$.?T^(SGLTI*_S2_2+[-?,RXO%^NZW-]G4]JB8BY$+BVPQ.H@V'7O>%5
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MS9TM)GB^/;.QS7WW%%7CO_H/I8L:2V1<-72E6.?E[A'YN,C?<9HFBAAAO"G
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M/8"K^9TJ^\VCUM5%8*R6,69'6S3$8FG)F)68(=/O%\<SAK1_=F<C8L8MOVN
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M*-8+Y3*+03Y.*.!WF!01V@28%F:U B!*(JP<6" 8$[R39([3$B+F3M=8"LA
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M/U!+ 0(4 Q0    ( !$T EF3V6LE]8(! ,YI%@ /              "  0
M  !H<BTR,#(T,#8S,"YH=&U02P$"% ,4    "  1- )9Y3"&DUX7  "I_P
M#P              @ $B@P$ :'(M,C R-# V,S N>'-D4$L! A0#%     @
M$30"6??'\NA#*   2Y$! !,              ( !K9H! &AR+3(P,C0P-C,P
M7V-A;"YX;6Q02P$"% ,4    "  1- )9$\C<6MIE  " /@0 $P
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E,#(T-C,P>&5X,S(N:'1M4$L%!@     *  H A (  ,,Y!     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>hr-20240630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:hr="http://healthcarerealty.com/20240630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hr-20240630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2024-07-26</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:OtherInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hr:OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PowayCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColumbusOHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AZ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:Florida1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SanAngeloTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SanAngeloTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-12</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-20</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-20</startDate>
            <endDate>2024-05-20</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-23</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DenverCOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DenverCOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-06</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-06</startDate>
            <endDate>2024-06-06</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MinneapolisMNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-21</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MinneapolisMNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroRaleighNCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroRaleighNCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-28</startDate>
            <endDate>2024-06-28</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:NewYorkNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PhiladelphiaPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:NewYorkNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AustinTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PhiladelphiaPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:SeattleWAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:MultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:GreensboroNCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:RaleighNCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-06</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-06</startDate>
            <endDate>2024-01-06</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-06</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-01</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:ActiveDevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:RedevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:CompletedDevelpomentAndRedevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-30</startDate>
            <endDate>2024-07-30</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-02</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesDUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:OtherMembersOfSeniorManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LTIPSeriesCUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="property">
        <measure>hr:property</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="state">
        <measure>hr:state</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="variable_interest_entity">
        <measure>hr:variable_interest_entity</measure>
    </unit>
    <unit id="note_receivable">
        <measure>hr:note_receivable</measure>
    </unit>
    <unit id="joint_venture">
        <measure>hr:joint_venture</measure>
    </unit>
    <unit id="loan">
        <measure>hr:loan</measure>
    </unit>
    <unit id="financing_receivable">
        <measure>hr:financing_receivable</measure>
    </unit>
    <unit id="lease">
        <measure>hr:lease</measure>
    </unit>
    <unit id="derivative">
        <measure>hr:derivative</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001360604</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-5" id="f-129">http://fasb.org/us-gaap/2024#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-1" id="f-130">http://fasb.org/us-gaap/2024#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-7" id="f-131">http://fasb.org/us-gaap/2024#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-6" id="f-132">http://fasb.org/us-gaap/2024#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-265" id="f-1149">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-35568</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">HEALTHCARE REALTY TRUST INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">20-4738467</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">3310 West End Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">269-8175</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Class A Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">HR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">363030249</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Land contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">1287532000</us-gaap:Land>
    <us-gaap:Land contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">1343265000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">10436218000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">10881373000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">764730000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">836302000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <hr:PersonalProperty contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">12501000</hr:PersonalProperty>
    <hr:PersonalProperty contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">12718000</hr:PersonalProperty>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">122413000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">122602000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">81401000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">82209000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:DevelopmentInProcess contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">97732000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">60727000</us-gaap:DevelopmentInProcess>
    <us-gaap:LandAvailableForDevelopment contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">59871000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:LandAvailableForDevelopment contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">59871000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">12862398000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">13399067000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">2427709000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">2226853000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">10434689000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">11172214000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">41765000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">25699000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">34530000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">8834000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">261976000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">275975000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">374841000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">311511000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">250530000</us-gaap:Goodwill>
    <us-gaap:OtherAssets contextRef="c-3" decimals="-3" id="f-63" unitRef="usd">655826000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">592368000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-65" unitRef="usd">11803627000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">12637131000</us-gaap:Assets>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-67" unitRef="usd">5148153000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">4994859000</us-gaap:LongTermDebt>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-3" decimals="-3" id="f-69" unitRef="usd">195884000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">211994000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-3" decimals="-3" id="f-71" unitRef="usd">1805000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">295000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-73" unitRef="usd">230601000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">229714000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-3" decimals="-3" id="f-75" unitRef="usd">75199000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">74503000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OtherLiabilities contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">177293000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">202984000</us-gaap:OtherLiabilities>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-79" unitRef="usd">5828935000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">5714349000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-81" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-82" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">3875000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">3868000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-85"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-86"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-87" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-88" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-89" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-90" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-91" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-92" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-93" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-94" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-95"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-97" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-98" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-3" id="f-99" unitRef="shares">364327000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-3" id="f-100" unitRef="shares">364327000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-3" id="f-101" unitRef="shares">380964000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-3" id="f-102" unitRef="shares">380964000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-103" unitRef="usd">3643000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">3810000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-105" unitRef="usd">9340028000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-106" unitRef="usd">9602592000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-3" decimals="-3" id="f-107" unitRef="usd">-6986000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">10741000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders contextRef="c-3" decimals="-3" id="f-109" unitRef="usd">574178000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders contextRef="c-4" decimals="-3" id="f-110" unitRef="usd">1028794000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <us-gaap:CumulativeDividends contextRef="c-3" decimals="-3" id="f-111" unitRef="usd">4037693000</us-gaap:CumulativeDividends>
    <us-gaap:CumulativeDividends contextRef="c-4" decimals="-3" id="f-112" unitRef="usd">3801793000</us-gaap:CumulativeDividends>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-113" unitRef="usd">5887142000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-114" unitRef="usd">6822662000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-3" decimals="-3" id="f-115" unitRef="usd">83675000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-116" unitRef="usd">96252000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-117" unitRef="usd">5970817000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-118" unitRef="usd">6918914000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-119" unitRef="usd">11803627000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">12637131000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">308135000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">329680000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">626211000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">653773000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">3865000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-6" decimals="-3" id="f-126" unitRef="usd">4233000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">8403000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-7" decimals="-3" id="f-128" unitRef="usd">8448000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">4322000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">4230000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">8513000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">8847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-5" decimals="-3" id="f-137" unitRef="usd">316322000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-3" id="f-138" unitRef="usd">338143000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">643127000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-3" id="f-140" unitRef="usd">671068000</us-gaap:Revenues>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-5" decimals="-3" id="f-141" unitRef="usd">117719000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-6" decimals="-3" id="f-142" unitRef="usd">125395000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">238798000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-7" decimals="-3" id="f-144" unitRef="usd">247436000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">14002000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">15464000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">28788000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-148" unitRef="usd">30399000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AcquisitionCosts contextRef="c-5" decimals="-3" id="f-149" unitRef="usd">431000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-6" decimals="-3" id="f-150" unitRef="usd">669000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">826000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-7" decimals="-3" id="f-152" unitRef="usd">956000</us-gaap:AcquisitionCosts>
    <hr:MergerRelatedCosts contextRef="c-5" decimals="-3" id="f-153" unitRef="usd">0</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-6" decimals="-3" id="f-154" unitRef="usd">-15670000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">0</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-7" decimals="-3" id="f-156" unitRef="usd">-10815000</hr:MergerRelatedCosts>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">173477000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-158" unitRef="usd">183193000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">351596000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-3" id="f-160" unitRef="usd">367671000</us-gaap:DepreciationAndAmortization>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-5" decimals="-3" id="f-161" unitRef="usd">305629000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-6" decimals="-3" id="f-162" unitRef="usd">309051000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">620008000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-7" decimals="-3" id="f-164" unitRef="usd">635647000</hr:OperatingExpensesandCostofGoodsSold>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-5" decimals="-3" id="f-165" unitRef="usd">38338000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-6" decimals="-3" id="f-166" unitRef="usd">7156000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">38360000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-7" decimals="-3" id="f-168" unitRef="usd">8162000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-169" unitRef="usd">62457000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-170" unitRef="usd">65334000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">123510000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-7" decimals="-3" id="f-172" unitRef="usd">129092000</us-gaap:InterestExpenseNonoperating>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-5" decimals="-3" id="f-173" unitRef="usd">132118000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-6" decimals="-3" id="f-174" unitRef="usd">55215000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">148055000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-7" decimals="-3" id="f-176" unitRef="usd">86637000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-5" decimals="-3" id="f-177" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-6" decimals="-3" id="f-178" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-3" id="f-179" unitRef="usd">250530000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-7" decimals="-3" id="f-180" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-181" unitRef="usd">-146000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-182" unitRef="usd">-17000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-183" unitRef="usd">-568000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-3" id="f-184" unitRef="usd">-797000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">-248000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-186" unitRef="usd">592000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-187" unitRef="usd">27000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-188" unitRef="usd">1139000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-189" unitRef="usd">-156631000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-190" unitRef="usd">-112818000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-191" unitRef="usd">-484276000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-192" unitRef="usd">-207225000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-193" unitRef="usd">-145938000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-194" unitRef="usd">-83726000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">-461157000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-196" unitRef="usd">-171804000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-197" unitRef="usd">-2158000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-198" unitRef="usd">-967000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">-6541000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-200" unitRef="usd">-1920000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-201" unitRef="usd">-143780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-202" unitRef="usd">-82759000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-454616000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-204" unitRef="usd">-169884000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-205"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-206"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-207"
      unitRef="usdPerShare">-1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-208"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-209"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-210"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-211"
      unitRef="usdPerShare">-1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-212"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-3" id="f-213" unitRef="shares">372477000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-214" unitRef="shares">378897000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-215" unitRef="shares">375962000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-3" id="f-216" unitRef="shares">378861000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-3" id="f-217" unitRef="shares">372477000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-218" unitRef="shares">378897000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-219" unitRef="shares">375962000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-3" id="f-220" unitRef="shares">378861000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-221" unitRef="usd">-145938000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-222" unitRef="usd">-83726000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">-461157000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-224" unitRef="usd">-171804000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-225" unitRef="usd">3662000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-226" unitRef="usd">3419000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">7528000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-228" unitRef="usd">5703000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-229" unitRef="usd">5891000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-230" unitRef="usd">21523000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">25501000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-232" unitRef="usd">12981000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-233" unitRef="usd">2229000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-234" unitRef="usd">18104000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">17973000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-3" id="f-236" unitRef="usd">7278000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-237" unitRef="usd">-143709000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-238" unitRef="usd">-65622000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">-443184000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-240" unitRef="usd">-164526000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-241" unitRef="usd">-2124000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-242" unitRef="usd">-745000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">-6295000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-244" unitRef="usd">-1830000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-245" unitRef="usd">-141585000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-246" unitRef="usd">-64877000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">-436889000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-248" unitRef="usd">-162696000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-249" unitRef="usd">3815000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-3" id="f-250" unitRef="usd">9609530000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-251" unitRef="usd">4791000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-252" unitRef="usd">717958000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-253" unitRef="usd">-3920199000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-254" unitRef="usd">6415895000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-255" unitRef="usd">87243000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-256" unitRef="usd">6503138000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-15" decimals="-3" id="f-257" unitRef="usd">3880000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-16" decimals="-3" id="f-258" unitRef="usd">3000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-17" decimals="-3" id="f-259" unitRef="usd">3000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-5" decimals="-3" id="f-260" unitRef="usd">3000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-3" id="f-261" unitRef="usd">3382000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-17" decimals="-3" id="f-262" unitRef="usd">3382000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-263" unitRef="usd">3382000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-18" decimals="-3" id="f-264" unitRef="usd">172000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-16" decimals="-3" id="f-265" unitRef="usd">272881000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-17" decimals="-3" id="f-266" unitRef="usd">273053000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-3" id="f-267" unitRef="usd">273053000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ProfitLoss contextRef="c-19" decimals="-3" id="f-268" unitRef="usd">-143780000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-269" unitRef="usd">-143780000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-20" decimals="-3" id="f-270" unitRef="usd">-2158000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-271" unitRef="usd">-145938000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-21" decimals="-3" id="f-272" unitRef="usd">3611000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-17" decimals="-3" id="f-273" unitRef="usd">3611000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-20" decimals="-3" id="f-274" unitRef="usd">51000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-275" unitRef="usd">3662000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-21" decimals="-3" id="f-276" unitRef="usd">5806000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-17" decimals="-3" id="f-277" unitRef="usd">5806000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-20" decimals="-3" id="f-278" unitRef="usd">85000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-279" unitRef="usd">5891000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue contextRef="c-5" decimals="-3" id="f-280" unitRef="usd">5000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-5"
      decimals="INF"
      id="f-281"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-22" decimals="-3" id="f-282" unitRef="usd">117494000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-17" decimals="-3" id="f-283" unitRef="usd">117494000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-20" decimals="-3" id="f-284" unitRef="usd">1444000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-5" decimals="-3" id="f-285" unitRef="usd">118938000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-286" unitRef="usd">3643000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-287" unitRef="usd">9340028000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-288" unitRef="usd">6986000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-289" unitRef="usd">574178000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-290" unitRef="usd">-4037693000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-291" unitRef="usd">5887142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-292" unitRef="usd">83675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-293" unitRef="usd">5970817000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-294" unitRef="usd">3875000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-295" unitRef="usd">3808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-296" unitRef="usd">9591194000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-297" unitRef="usd">-8554000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-298" unitRef="usd">1219930000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-299" unitRef="usd">-3447750000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-300" unitRef="usd">7358628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-301" unitRef="usd">106211000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-302" unitRef="usd">7464839000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-37" decimals="-3" id="f-303" unitRef="usd">2000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-38" decimals="-3" id="f-304" unitRef="usd">27000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-39" decimals="-3" id="f-305" unitRef="usd">27000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-6" decimals="-3" id="f-306" unitRef="usd">27000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-38" decimals="-3" id="f-307" unitRef="usd">112000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-39" decimals="-3" id="f-308" unitRef="usd">112000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-6" decimals="-3" id="f-309" unitRef="usd">112000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-38" decimals="-3" id="f-310" unitRef="usd">3924000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-39" decimals="-3" id="f-311" unitRef="usd">3924000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-312" unitRef="usd">3924000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c-40" decimals="-3" id="f-313" unitRef="usd">-82759000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-39" decimals="-3" id="f-314" unitRef="usd">-82759000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-41" decimals="-3" id="f-315" unitRef="usd">-967000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-316" unitRef="usd">-83726000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-42" decimals="-3" id="f-317" unitRef="usd">3377000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-39" decimals="-3" id="f-318" unitRef="usd">3377000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-41" decimals="-3" id="f-319" unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-320" unitRef="usd">3419000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-42" decimals="-3" id="f-321" unitRef="usd">21259000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-39" decimals="-3" id="f-322" unitRef="usd">21259000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-41" decimals="-3" id="f-323" unitRef="usd">264000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-324" unitRef="usd">21523000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="c-6" decimals="-3" id="f-325" unitRef="usd">487000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-6"
      decimals="INF"
      id="f-326"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-43" decimals="-3" id="f-327" unitRef="usd">118191000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-39" decimals="-3" id="f-328" unitRef="usd">118191000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-41" decimals="-3" id="f-329" unitRef="usd">1448000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-6" decimals="-3" id="f-330" unitRef="usd">119639000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-3" id="f-331" unitRef="usd">3808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-332" unitRef="usd">9595033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-333" unitRef="usd">9328000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-334" unitRef="usd">1137171000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-335" unitRef="usd">-3565941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-336" unitRef="usd">7179399000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-337" unitRef="usd">104018000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-338" unitRef="usd">7283417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-51" decimals="-3" id="f-339" unitRef="usd">2487000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-340" unitRef="usd">3810000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-341" unitRef="usd">9602592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-342" unitRef="usd">-10741000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-343" unitRef="usd">1028794000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-344" unitRef="usd">-3801793000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-345" unitRef="usd">6822662000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-346" unitRef="usd">96252000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-347" unitRef="usd">6918914000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-348" unitRef="usd">3868000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-59" decimals="-3" id="f-349" unitRef="usd">104000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-60" decimals="-3" id="f-350" unitRef="usd">104000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">104000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-59" decimals="-3" id="f-352" unitRef="usd">138000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-60" decimals="-3" id="f-353" unitRef="usd">138000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">138000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-61" decimals="-3" id="f-355" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-59" decimals="-3" id="f-356" unitRef="usd">3410000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-60" decimals="-3" id="f-357" unitRef="usd">3412000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-62" decimals="-3" id="f-358" unitRef="usd">-3412000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-61" decimals="-3" id="f-360" unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-59" decimals="-3" id="f-361" unitRef="usd">6941000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-60" decimals="-3" id="f-362" unitRef="usd">6944000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">6944000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-61" decimals="-3" id="f-364" unitRef="usd">172000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-59" decimals="-3" id="f-365" unitRef="usd">272881000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-60" decimals="-3" id="f-366" unitRef="usd">273053000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-3" id="f-367" unitRef="usd">273053000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ProfitLoss contextRef="c-63" decimals="-3" id="f-368" unitRef="usd">-454616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-60" decimals="-3" id="f-369" unitRef="usd">-454616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-62" decimals="-3" id="f-370" unitRef="usd">-6541000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-371" unitRef="usd">-461157000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-64" decimals="-3" id="f-372" unitRef="usd">7424000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-60" decimals="-3" id="f-373" unitRef="usd">7424000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-62" decimals="-3" id="f-374" unitRef="usd">104000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">7528000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-64" decimals="-3" id="f-376" unitRef="usd">25151000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-60" decimals="-3" id="f-377" unitRef="usd">25151000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-62" decimals="-3" id="f-378" unitRef="usd">350000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-379" unitRef="usd">25501000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="c-1" decimals="-3" id="f-380" unitRef="usd">13000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">6000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-382"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-65" decimals="-3" id="f-383" unitRef="usd">235900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-60" decimals="-3" id="f-384" unitRef="usd">235900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-62" decimals="-3" id="f-385" unitRef="usd">2870000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-3" id="f-386" unitRef="usd">238770000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-387" unitRef="usd">3643000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-388" unitRef="usd">9340028000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-389" unitRef="usd">6986000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-390" unitRef="usd">574178000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-391" unitRef="usd">-4037693000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-392" unitRef="usd">5887142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-393" unitRef="usd">83675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-394" unitRef="usd">5970817000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-395" unitRef="usd">3875000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-66" decimals="-3" id="f-396" unitRef="usd">3806000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-67" decimals="-3" id="f-397" unitRef="usd">9587637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-68" decimals="-3" id="f-398" unitRef="usd">2140000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-69" decimals="-3" id="f-399" unitRef="usd">1307055000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-70" decimals="-3" id="f-400" unitRef="usd">-3329562000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-71" decimals="-3" id="f-401" unitRef="usd">7571076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-72" decimals="-3" id="f-402" unitRef="usd">108742000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-73" decimals="-3" id="f-403" unitRef="usd">7679818000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-73" decimals="-3" id="f-404" unitRef="usd">2014000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-74" decimals="-3" id="f-405" unitRef="usd">78000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-75" decimals="-3" id="f-406" unitRef="usd">78000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-7" decimals="-3" id="f-407" unitRef="usd">78000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-76" decimals="-3" id="f-408" unitRef="usd">1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-74" decimals="-3" id="f-409" unitRef="usd">1595000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-75" decimals="-3" id="f-410" unitRef="usd">1596000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-7" decimals="-3" id="f-411" unitRef="usd">1596000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-76" decimals="-3" id="f-412" unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-74" decimals="-3" id="f-413" unitRef="usd">8913000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-75" decimals="-3" id="f-414" unitRef="usd">8916000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-3" id="f-415" unitRef="usd">8916000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c-77" decimals="-3" id="f-416" unitRef="usd">-169884000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-75" decimals="-3" id="f-417" unitRef="usd">-169884000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-78" decimals="-3" id="f-418" unitRef="usd">-1920000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-419" unitRef="usd">-171804000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-79" decimals="-3" id="f-420" unitRef="usd">5635000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-75" decimals="-3" id="f-421" unitRef="usd">5635000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-78" decimals="-3" id="f-422" unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-423" unitRef="usd">5703000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-79" decimals="-3" id="f-424" unitRef="usd">12823000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-75" decimals="-3" id="f-425" unitRef="usd">12823000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-78" decimals="-3" id="f-426" unitRef="usd">158000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-427" unitRef="usd">12981000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="c-7" decimals="-3" id="f-428" unitRef="usd">473000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-7"
      decimals="INF"
      id="f-429"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-80" decimals="-3" id="f-430" unitRef="usd">236379000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-75" decimals="-3" id="f-431" unitRef="usd">236379000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-78" decimals="-3" id="f-432" unitRef="usd">2894000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-7" decimals="-3" id="f-433" unitRef="usd">239273000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-3" id="f-434" unitRef="usd">3808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-435" unitRef="usd">9595033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-436" unitRef="usd">9328000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-437" unitRef="usd">1137171000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-438" unitRef="usd">-3565941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-439" unitRef="usd">7179399000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-440" unitRef="usd">104018000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-441" unitRef="usd">7283417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-51" decimals="-3" id="f-442" unitRef="usd">2487000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-443" unitRef="usd">-461157000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-444" unitRef="usd">-171804000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-445" unitRef="usd">351596000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-3" id="f-446" unitRef="usd">367671000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-1" decimals="-3" id="f-447" unitRef="usd">23390000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-7" decimals="-3" id="f-448" unitRef="usd">23405000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-449" unitRef="usd">6944000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-450" unitRef="usd">8916000</us-gaap:ShareBasedCompensation>
    <hr:StraightLineRentReceivable contextRef="c-1" decimals="-3" id="f-451" unitRef="usd">14198000</hr:StraightLineRentReceivable>
    <hr:StraightLineRentReceivable contextRef="c-7" decimals="-3" id="f-452" unitRef="usd">19313000</hr:StraightLineRentReceivable>
    <hr:StraightlineRentLiability contextRef="c-1" decimals="-3" id="f-453" unitRef="usd">1998000</hr:StraightlineRentLiability>
    <hr:StraightlineRentLiability contextRef="c-7" decimals="-3" id="f-454" unitRef="usd">3062000</hr:StraightlineRentLiability>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-1" decimals="-3" id="f-455" unitRef="usd">38360000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-7" decimals="-3" id="f-456" unitRef="usd">8162000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-457" unitRef="usd">148055000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations contextRef="c-7" decimals="-3" id="f-458" unitRef="usd">86637000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-3" id="f-459" unitRef="usd">250530000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-7" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-461" unitRef="usd">-568000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-3" id="f-462" unitRef="usd">-797000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-1" decimals="-3" id="f-463" unitRef="usd">2649000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-7" decimals="-3" id="f-464" unitRef="usd">3031000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <hr:InterestIncomeFinancingReceivableNoncash contextRef="c-1" decimals="-3" id="f-465" unitRef="usd">478000</hr:InterestIncomeFinancingReceivableNoncash>
    <hr:InterestIncomeFinancingReceivableNoncash contextRef="c-7" decimals="-3" id="f-466" unitRef="usd">488000</hr:InterestIncomeFinancingReceivableNoncash>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-467" unitRef="usd">4257000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-3" id="f-468" unitRef="usd">17502000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-469" unitRef="usd">-23131000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-3" id="f-470" unitRef="usd">-38601000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-471" unitRef="usd">155000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-7" decimals="-3" id="f-472" unitRef="usd">16673000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-473" unitRef="usd">244304000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-474" unitRef="usd">254322000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireRealEstate contextRef="c-1" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate contextRef="c-7" decimals="-3" id="f-476" unitRef="usd">39301000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToDevelopRealEstateAssets contextRef="c-1" decimals="-3" id="f-477" unitRef="usd">31901000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets contextRef="c-7" decimals="-3" id="f-478" unitRef="usd">17594000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="c-1" decimals="-3" id="f-479" unitRef="usd">117775000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="c-7" decimals="-3" id="f-480" unitRef="usd">94013000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireNotesReceivable contextRef="c-1" decimals="-3" id="f-481" unitRef="usd">3466000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable contextRef="c-7" decimals="-3" id="f-482" unitRef="usd">11503000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="c-1" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="c-7" decimals="-3" id="f-484" unitRef="usd">3824000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables contextRef="c-1" decimals="-3" id="f-485" unitRef="usd">475000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:PaymentsToAcquireFinanceReceivables contextRef="c-7" decimals="-3" id="f-486" unitRef="usd">780000</us-gaap:PaymentsToAcquireFinanceReceivables>
    <hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests contextRef="c-1" decimals="-3" id="f-487" unitRef="usd">13000</hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests>
    <hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests contextRef="c-7" decimals="-3" id="f-488" unitRef="usd">0</hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale contextRef="c-1" decimals="-3" id="f-489" unitRef="usd">303475000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale contextRef="c-7" decimals="-3" id="f-490" unitRef="usd">160870000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-1" decimals="-3" id="f-491" unitRef="usd">567000</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-7" decimals="-3" id="f-492" unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-493" unitRef="usd">151388000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-494" unitRef="usd">-6145000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-495" unitRef="usd">250000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="c-7" decimals="-3" id="f-496" unitRef="usd">-31000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-1" decimals="-3" id="f-497" unitRef="usd">100000000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-7" decimals="-3" id="f-498" unitRef="usd">0</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfDebt contextRef="c-1" decimals="-3" id="f-499" unitRef="usd">17746000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-7" decimals="-3" id="f-500" unitRef="usd">1340000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-3" id="f-501" unitRef="usd">235618000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-7" decimals="-3" id="f-502" unitRef="usd">236105000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-503" unitRef="usd">104000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-3" id="f-504" unitRef="usd">77000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-505" unitRef="usd">321000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-3" id="f-506" unitRef="usd">1842000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <hr:PaymentsForRepurchasesOfCommonStock contextRef="c-1" decimals="-3" id="f-507" unitRef="usd">273053000</hr:PaymentsForRepurchasesOfCommonStock>
    <hr:PaymentsForRepurchasesOfCommonStock contextRef="c-7" decimals="-3" id="f-508" unitRef="usd">0</hr:PaymentsForRepurchasesOfCommonStock>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-509" unitRef="usd">2399000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-7" decimals="-3" id="f-510" unitRef="usd">2546000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-3" id="f-511" unitRef="usd">563000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-7" decimals="-3" id="f-512" unitRef="usd">438000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-513" unitRef="usd">30000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-7" decimals="-3" id="f-514" unitRef="usd">40000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-515" unitRef="usd">-379626000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-516" unitRef="usd">-273234000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-517" unitRef="usd">16066000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-518" unitRef="usd">-25057000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-519" unitRef="usd">25699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-73" decimals="-3" id="f-520" unitRef="usd">60961000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-521" unitRef="usd">41765000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-51" decimals="-3" id="f-522" unitRef="usd">35904000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">103708000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-3" id="f-524" unitRef="usd">106985000</us-gaap:InterestPaidNet>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-1" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-7" decimals="-3" id="f-526" unitRef="usd">45000000</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-527" unitRef="usd">39016000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-3" id="f-528" unitRef="usd">30956000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:InterestPaidCapitalized contextRef="c-1" decimals="-3" id="f-529" unitRef="usd">1916000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized contextRef="c-7" decimals="-3" id="f-530" unitRef="usd">1282000</us-gaap:InterestPaidCapitalized>
    <hr:ProceedsFromDispositionsHeldInEscrow contextRef="c-1" decimals="-3" id="f-531" unitRef="usd">96008000</hr:ProceedsFromDispositionsHeldInEscrow>
    <hr:ProceedsFromDispositionsHeldInEscrow contextRef="c-7" decimals="-3" id="f-532" unitRef="usd">0</hr:ProceedsFromDispositionsHeldInEscrow>
    <hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture contextRef="c-1" decimals="-3" id="f-533" unitRef="usd">66547000</hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture>
    <hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture contextRef="c-7" decimals="-3" id="f-534" unitRef="usd">0</hr:ContributionOfRealEstatePropertiesIntoUnconsolidatedJointVenture>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-535">Summary of Significant Accounting Policies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Trust Incorporated (the "Company") is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June&#160;30, 2024, the Company had gross investments of approximately $12.9&#160;billion in 629 con&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;solidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property, excluding held for sale assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In addition, as of June&#160;30, 2024, the Company had a weighted average ownership interest of approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;y 36% in 44 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties held in unconsolidated joint ventures. See Note 2 below for more details regarding the Company's unconsolidated joint ventures. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties are located in 35 states and total approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;y 37.2 million square feet. The Company provided leasing and property management services to 92% of its portfolio&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;nationwide as of June&#160;30, 2024.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022, by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#x201c;Legacy HR&#x201d;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#x201c;Legacy HTA&#x201d;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#x201c;OP&#x201d;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#x201c;Merger Sub&#x201d;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#x201c;Merger&#x201d;). The combined company operates under the name &#x201c;Healthcare Realty Trust Incorporated&#x201d; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#x201c;HR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is structured as an umbrella partnership REIT under which substantially all of its business is conducted through the OP, the day-to-day management of which is exclusively controlled by the Company.  As of June&#160;30, 2024, the Company owned 98.6% of the issued and outstanding units of the OP, with other investors owning the remaining 1.4% of the OP's issued and outstanding units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2023. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2024 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events, such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The OP is 98.6% owned by the Company.  Other holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June&#160;30, 2024, there were approximately 5.3&#160;million OP Units, or 1.4% of OP Units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company had four consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.318%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total real estate properties, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;112,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;118,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Redeemable non-controlling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Partners' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;108,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cumulative net loss &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total partners' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;107,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;118,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economic interests to direct the activities of these VIEs on a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.067%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.246%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;59,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;59,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 2 below for more details regarding the Company's unconsolidated joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%"&gt;                                        &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Redeemable Non-Controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of June&#160;30, 2024, the Company had redeemable non-controlling interests of $3.9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#x2019;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.  During the three and six months ended June&#160;30, 2024, the Company recognized real estate impairments totaling $120.9&#160;million and $136.9&#160;million, respectively, as a result of completed and planned disposition activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, 16 real estate properties totaling $265.6&#160;million were measured at fair value using level 3 fair value hierarchy.  The level 3 fair value techniques included brokerage estimates, letters of intent, and unexecuted purchase and sale agreements, less estimated closing costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Goodwill Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment. As a result, a goodwill evaluation was performed. The Company's current operations are carried out through a single reporting unit with a carrying value of approximately $12.0&#160;billion. The Company determined that the carrying value exceeded estimated fair value and therefore an impairment of goodwill was recorded. The Company recorded a $250.5&#160;million full impairment of its goodwill, which is recorded as a non-cash charge in &#x201c;Impairment of goodwill&#x201d; in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Investments in Leases - Financing Receivables, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.629%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.058%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Poway, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5.72%&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;115,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;November 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Columbus, OH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;122,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held to maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of June&#160;30, 2024, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $168.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.685%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;JUN 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RECEIVABLE (OTHER ASSETS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE DISCOUNT AND FEES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Arizona&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/21/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/20/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;52,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/02/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;35,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/28/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/28/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;124,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;116,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;214,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;185,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(16,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;168,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid, and on July 15, 2024, the senior lender on the construction loans associated with the underlying projects provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;During the second quarter of 2024, the Company determined that an allowance for credit loss of $11.2&#160;million was needed on this mortgage loan. The reserve amount consists of approximately $10.7&#160;million of principal and approximately $0.5&#160;million of interest. Additionally, the maturity date on this mortgage loan was extended to December 2, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;Outstanding principal and interest due upon maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326: Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the first quarter of 2023, the Company determined that the risk of credit loss on two of its mezzanine loans were no longer remote and recorded a credit loss reserve of $5.2&#160;million.   During the three and six months ended June 30, 2024, the Company determined that the risk of credit loss on one of its mortgage note receivables was no longer remote and recorded a credit loss reserve of $11.2&#160;million.  The Company utilized the level 3 fair value hierarchy, which included a brokerage estimate on the underlying collateral of the loan, to determine the amount of credit loss reserve.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.061%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.850%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;16,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2023, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognized interest income related to real estate notes receivable of $1.8 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.2 million and $4.3 million, respectively, for the three and six months ended  June&#160;30, 2023. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  In 2023, the Company placed two of its real estate notes receivable with principal balances, net of credit loss, of $48.9&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and six month periods ended June&#160;30, 2024.  In 2024, the Company placed one of its real estate notes receivable with a principal balance, net of credit loss, of $20.5&#160;million on non-accrual status.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (ASC Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of ASC Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of ASC Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Revenue that is accounted for under ASC Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.960%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.755%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.758%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income/other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;New Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%"&gt;Topic 280)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;. Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update. &lt;/span&gt;&lt;/div&gt;The update is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. At this time, the Company does not expect that the adoption of this ASU will have a material impact on its consolidated financial statements other than compliance with these new disclosure requirements, which will begin with the Company's Annual Report on Form 10-K for the year ending December 31, 2024.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <hr:NatureOfOperationsPolicyTextBlock contextRef="c-1" id="f-536">&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Trust Incorporated (the "Company") is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June&#160;30, 2024, the Company had gross investments of approximately $12.9&#160;billion in 629 con&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;solidated real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property, excluding held for sale assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In addition, as of June&#160;30, 2024, the Company had a weighted average ownership interest of approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;y 36% in 44 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties held in unconsolidated joint ventures. See Note 2 below for more details regarding the Company's unconsolidated joint ventures. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties are located in 35 states and total approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;y 37.2 million square feet. The Company provided leasing and property management services to 92% of its portfolio&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;nationwide as of June&#160;30, 2024.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022, by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#x201c;Legacy HR&#x201d;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#x201c;Legacy HTA&#x201d;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#x201c;OP&#x201d;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#x201c;Merger Sub&#x201d;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#x201c;Merger&#x201d;). The combined company operates under the name &#x201c;Healthcare Realty Trust Incorporated&#x201d; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#x201c;HR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is structured as an umbrella partnership REIT under which substantially all of its business is conducted through the OP, the day-to-day management of which is exclusively controlled by the Company.  As of June&#160;30, 2024, the Company owned 98.6% of the issued and outstanding units of the OP, with other investors owning the remaining 1.4% of the OP's issued and outstanding units.&lt;/span&gt;&lt;/div&gt;Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review.</hr:NatureOfOperationsPolicyTextBlock>
    <hr:InvestmentInRealEstatePropertiesAndMortgageNotes contextRef="c-3" decimals="-8" id="f-537" unitRef="usd">12900000000</hr:InvestmentInRealEstatePropertiesAndMortgageNotes>
    <hr:NumberOfRealEstateInvestments
      contextRef="c-3"
      decimals="INF"
      id="f-538"
      unitRef="property">629</hr:NumberOfRealEstateInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-81" decimals="2" id="f-539" unitRef="number">0.36</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <hr:NumberOfPropertiesHeldInUnconsolidatedJointVentures
      contextRef="c-3"
      decimals="INF"
      id="f-540"
      unitRef="property">44</hr:NumberOfPropertiesHeldInUnconsolidatedJointVentures>
    <hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates contextRef="c-3" decimals="INF" id="f-541" unitRef="state">35</hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates>
    <hr:ApproximateSquareFeetInvestedInByCompany contextRef="c-3" decimals="-5" id="f-542" unitRef="sqft">37200000</hr:ApproximateSquareFeetInvestedInByCompany>
    <hr:LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio contextRef="c-3" decimals="2" id="f-543" unitRef="number">0.92</hr:LeasingAndPropertyManagementServicesProvidedAsPercentageOfNationwidePortfolio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-82"
      decimals="INF"
      id="f-544"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-83" decimals="3" id="f-545" unitRef="number">0.986</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="c-84" decimals="4" id="f-546" unitRef="number">0.014</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-547">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2023. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2024 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-548">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events, such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;The OP is 98.6% owned by the Company.  Other holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June&#160;30, 2024, there were approximately 5.3&#160;million OP Units, or 1.4% of OP Units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates its interests in the OP.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-85"
      decimals="INF"
      id="f-549"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <hr:EquityOwnershipForConsolidationPercent contextRef="c-3" decimals="INF" id="f-550" unitRef="number">1</hr:EquityOwnershipForConsolidationPercent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-83" decimals="3" id="f-551" unitRef="number">0.986</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="c-86" decimals="-5" id="f-552" unitRef="shares">5300000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners contextRef="c-84" decimals="4" id="f-553" unitRef="number">0.014</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <hr:NumberOfVariableInterestEntities
      contextRef="c-3"
      decimals="INF"
      id="f-554"
      unitRef="variable_interest_entity">4</hr:NumberOfVariableInterestEntities>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c-1" id="f-555">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.318%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total real estate properties, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;112,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;118,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Redeemable non-controlling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Partners' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;108,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cumulative net loss &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total partners' equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;107,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;118,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-87" decimals="-3" id="f-556" unitRef="usd">112694000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-87" decimals="-3" id="f-557" unitRef="usd">3205000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:ReceivablesAndOtherAssets contextRef="c-87" decimals="-3" id="f-558" unitRef="usd">2556000</hr:ReceivablesAndOtherAssets>
    <us-gaap:Assets contextRef="c-87" decimals="-3" id="f-559" unitRef="usd">118455000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="c-87" decimals="-3" id="f-560" unitRef="usd">7848000</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:Liabilities contextRef="c-87" decimals="-3" id="f-561" unitRef="usd">7848000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-87" decimals="-3" id="f-562" unitRef="usd">3194000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquity contextRef="c-87" decimals="-3" id="f-563" unitRef="usd">108612000</us-gaap:StockholdersEquity>
    <hr:CumulativeNetLossAttributableToCommonStockholders contextRef="c-87" decimals="-3" id="f-564" unitRef="usd">1199000</hr:CumulativeNetLossAttributableToCommonStockholders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-87" decimals="-3" id="f-565" unitRef="usd">107413000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-87" decimals="-3" id="f-566" unitRef="usd">118455000</us-gaap:LiabilitiesAndStockholdersEquity>
    <hr:NumberOfVariableInterestEntities
      contextRef="c-88"
      decimals="INF"
      id="f-567"
      unitRef="variable_interest_entity">3</hr:NumberOfVariableInterestEntities>
    <hr:NumberOfNotesReceivable
      contextRef="c-88"
      decimals="INF"
      id="f-568"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NumberOfJointVentures
      contextRef="c-89"
      decimals="INF"
      id="f-569"
      unitRef="joint_venture">1</hr:NumberOfJointVentures>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-570">As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.067%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.246%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;59,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;59,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <hr:NumberOfNotesReceivable
      contextRef="c-88"
      decimals="INF"
      id="f-571"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NotesReceivableCarryingAmount contextRef="c-90" decimals="-3" id="f-572" unitRef="usd">20500000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-90" decimals="-3" id="f-573" unitRef="usd">20500000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:NotesReceivableCarryingAmount contextRef="c-91" decimals="-3" id="f-574" unitRef="usd">7111000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-91" decimals="-3" id="f-575" unitRef="usd">7211000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:JointVentureCarryingAmount contextRef="c-92" decimals="-3" id="f-576" unitRef="usd">59239000</hr:JointVentureCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-92" decimals="-3" id="f-577" unitRef="usd">59239000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-92"
      decimals="INF"
      id="f-578"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-579">As of June&#160;30, 2024, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-580">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="c-1" id="f-581">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Redeemable Non-Controlling Interests&lt;/span&gt;&lt;/div&gt;The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-5" id="f-582" unitRef="usd">3900000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-583">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Asset Impairment&lt;/span&gt;&lt;/div&gt;The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#x2019;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfRealEstate contextRef="c-5" decimals="-5" id="f-584" unitRef="usd">120900000</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:ImpairmentOfRealEstate contextRef="c-1" decimals="-5" id="f-585" unitRef="usd">136900000</us-gaap:ImpairmentOfRealEstate>
    <hr:NumberOfPropertiesMeasuredAtFairValue
      contextRef="c-93"
      decimals="INF"
      id="f-586"
      unitRef="property">16</hr:NumberOfPropertiesMeasuredAtFairValue>
    <us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure contextRef="c-93" decimals="-5" id="f-587" unitRef="usd">265600000</us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-588">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Goodwill Impairment&lt;/span&gt;&lt;/div&gt;During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment. As a result, a goodwill evaluation was performed. The Company's current operations are carried out through a single reporting unit with a carrying value of approximately $12.0&#160;billion. The Company determined that the carrying value exceeded estimated fair value and therefore an impairment of goodwill was recorded. The Company recorded a $250.5&#160;million full impairment of its goodwill, which is recorded as a non-cash charge in &#x201c;Impairment of goodwill&#x201d; in the Condensed Consolidated Statements of Operations.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <hr:ReportingUnitCarryingValue contextRef="c-94" decimals="-8" id="f-589" unitRef="usd">12000000000</hr:ReportingUnitCarryingValue>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-5" id="f-590" unitRef="usd">250500000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:LessorLeasesPolicyTextBlock contextRef="c-1" id="f-591">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Investments in Leases - Financing Receivables, Net &lt;/span&gt;&lt;/div&gt;In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held to maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326: Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. The determination of the credit allowance is based on a quarterly &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;evaluation of all outstanding loans, including general economic conditions and estimated collectability of loan payments. The Company evaluates the collectability of loan receivables based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral. A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that the Company will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans identified as having deteriorated credit quality, the amount of credit loss is determined on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual status are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, the loan may return to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2024, and $2.1 million and $4.2 million, respectively, for the three and six months ended June&#160;30, 2023, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-592">See below for additional information regarding the Company's financing receivables.&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.629%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.058%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Poway, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5.72%&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;115,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;November 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Columbus, OH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;122,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.685%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;JUN 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RECEIVABLE (OTHER ASSETS)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE DISCOUNT AND FEES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Arizona&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/21/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/20/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;52,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/02/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;35,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/28/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/28/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;124,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(11,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;116,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;214,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;185,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(16,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;168,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;As of the date of these financial statements, the outstanding principal and interest on these loans had not been repaid, and on July 15, 2024, the senior lender on the construction loans associated with the underlying projects provided notice of foreclosure proceedings to the borrower.  The borrower is in negotiations with a third party to provide financing that will repay the senior lender. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;During the second quarter of 2024, the Company determined that an allowance for credit loss of $11.2&#160;million was needed on this mortgage loan. The reserve amount consists of approximately $10.7&#160;million of principal and approximately $0.5&#160;million of interest. Additionally, the maturity date on this mortgage loan was extended to December 2, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;Outstanding principal and interest due upon maturity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <hr:NotesReceivableInterestRate
      contextRef="c-95"
      decimals="INF"
      id="f-593"
      unitRef="number">0.0572</hr:NotesReceivableInterestRate>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-95" decimals="-3" id="f-594" unitRef="usd">115056000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <hr:NotesReceivableInterestRate
      contextRef="c-96"
      decimals="INF"
      id="f-595"
      unitRef="number">0.0648</hr:NotesReceivableInterestRate>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-96" decimals="-3" id="f-596" unitRef="usd">7357000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-3" decimals="-3" id="f-597" unitRef="usd">122413000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <hr:RealEstateNotesReceivableNet contextRef="c-3" decimals="-5" id="f-598" unitRef="usd">168800000</hr:RealEstateNotesReceivableNet>
    <hr:NotesReceivableInterestRate
      contextRef="c-97"
      decimals="INF"
      id="f-599"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-97" decimals="-3" id="f-600" unitRef="usd">54119000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-97" decimals="-3" id="f-601" unitRef="usd">54119000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-97" decimals="-3" id="f-602" unitRef="usd">906000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-97" decimals="-3" id="f-603" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-97" decimals="-3" id="f-604" unitRef="usd">3067000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-97" decimals="-3" id="f-605" unitRef="usd">46762000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-98"
      decimals="INF"
      id="f-606"
      unitRef="number">0.0900</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-98" decimals="-3" id="f-607" unitRef="usd">6000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-98" decimals="-3" id="f-608" unitRef="usd">6000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-98" decimals="-3" id="f-609" unitRef="usd">36000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-98" decimals="-3" id="f-610" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-98" decimals="-3" id="f-611" unitRef="usd">0</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-98" decimals="-3" id="f-612" unitRef="usd">6036000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-99" decimals="-3" id="f-613" unitRef="usd">60119000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-99" decimals="-3" id="f-614" unitRef="usd">60119000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-99" decimals="-3" id="f-615" unitRef="usd">942000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-99" decimals="-3" id="f-616" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-99" decimals="-3" id="f-617" unitRef="usd">3067000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-99" decimals="-3" id="f-618" unitRef="usd">52798000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-100"
      decimals="INF"
      id="f-619"
      unitRef="number">0.0700</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-100" decimals="-3" id="f-620" unitRef="usd">31150000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-100" decimals="-3" id="f-621" unitRef="usd">31150000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-100" decimals="-3" id="f-622" unitRef="usd">551000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-100" decimals="-3" id="f-623" unitRef="usd">11201000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-100" decimals="-3" id="f-624" unitRef="usd">0</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-100" decimals="-3" id="f-625" unitRef="usd">20500000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-101"
      decimals="INF"
      id="f-626"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-101" decimals="-3" id="f-627" unitRef="usd">6000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-101" decimals="-3" id="f-628" unitRef="usd">6000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-101" decimals="-3" id="f-629" unitRef="usd">1211000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-101" decimals="-3" id="f-630" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-101" decimals="-3" id="f-631" unitRef="usd">100000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-101" decimals="-3" id="f-632" unitRef="usd">7111000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-102"
      decimals="INF"
      id="f-633"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-102" decimals="-3" id="f-634" unitRef="usd">65000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-102" decimals="-3" id="f-635" unitRef="usd">35623000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-102" decimals="-3" id="f-636" unitRef="usd">532000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-102" decimals="-3" id="f-637" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-102" decimals="-3" id="f-638" unitRef="usd">34000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-102" decimals="-3" id="f-639" unitRef="usd">36121000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-103"
      decimals="INF"
      id="f-640"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-103" decimals="-3" id="f-641" unitRef="usd">45000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-103" decimals="-3" id="f-642" unitRef="usd">45000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-103" decimals="-3" id="f-643" unitRef="usd">178000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-103" decimals="-3" id="f-644" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-103" decimals="-3" id="f-645" unitRef="usd">0</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-103" decimals="-3" id="f-646" unitRef="usd">45178000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-104"
      decimals="INF"
      id="f-647"
      unitRef="number">0.0900</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-104" decimals="-3" id="f-648" unitRef="usd">7700000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-104" decimals="-3" id="f-649" unitRef="usd">7133000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-104" decimals="-3" id="f-650" unitRef="usd">0</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-104" decimals="-3" id="f-651" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-104" decimals="-3" id="f-652" unitRef="usd">0</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-104" decimals="-3" id="f-653" unitRef="usd">7133000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-105" decimals="-3" id="f-654" unitRef="usd">154850000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-105" decimals="-3" id="f-655" unitRef="usd">124906000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-105" decimals="-3" id="f-656" unitRef="usd">2472000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-105" decimals="-3" id="f-657" unitRef="usd">11201000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-105" decimals="-3" id="f-658" unitRef="usd">134000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-105" decimals="-3" id="f-659" unitRef="usd">116043000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-3" decimals="-3" id="f-660" unitRef="usd">214969000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-661" unitRef="usd">185025000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:InterestReceivableAndOtherAssets contextRef="c-3" decimals="-3" id="f-662" unitRef="usd">3414000</us-gaap:InterestReceivableAndOtherAssets>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-663" unitRef="usd">16397000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-3" decimals="-3" id="f-664" unitRef="usd">3201000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-3" decimals="-3" id="f-665" unitRef="usd">168841000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-106" decimals="-5" id="f-666" unitRef="usd">11200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease contextRef="c-106" decimals="-3" id="f-667" unitRef="usd">10700000</us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease>
    <hr:FinancingReceivableAllowanceForCreditLossInterest contextRef="c-106" decimals="-5" id="f-668" unitRef="usd">500000</hr:FinancingReceivableAllowanceForCreditLossInterest>
    <hr:NumberOfMezzanineLoans contextRef="c-107" decimals="INF" id="f-669" unitRef="loan">2</hr:NumberOfMezzanineLoans>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-107" decimals="-5" id="f-670" unitRef="usd">5200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <hr:NumberOfMortgageLoans contextRef="c-1" decimals="INF" id="f-671" unitRef="loan">1</hr:NumberOfMortgageLoans>
    <hr:NumberOfMortgageLoans contextRef="c-5" decimals="INF" id="f-672" unitRef="loan">1</hr:NumberOfMortgageLoans>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-1" decimals="-5" id="f-673" unitRef="usd">11200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-5" decimals="-5" id="f-674" unitRef="usd">11200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="c-1" id="f-675">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.061%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.850%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;16,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-676" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-73" decimals="-3" id="f-677" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-1" decimals="-3" id="f-678" unitRef="usd">11201000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-108" decimals="-3" id="f-679" unitRef="usd">5196000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-680" unitRef="usd">16397000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-681" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <hr:NumberOfRecognizedLeaseFinancialReceivables
      contextRef="c-3"
      decimals="INF"
      id="f-682"
      unitRef="financing_receivable">2</hr:NumberOfRecognizedLeaseFinancialReceivables>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-5" decimals="-5" id="f-683" unitRef="usd">2100000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-1" decimals="-5" id="f-684" unitRef="usd">4200000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-6" decimals="-5" id="f-685" unitRef="usd">2100000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-7" decimals="-5" id="f-686" unitRef="usd">4200000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:InterestIncomeOperating contextRef="c-109" decimals="-5" id="f-687" unitRef="usd">1800000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-110" decimals="-5" id="f-688" unitRef="usd">4200000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-111" decimals="-5" id="f-689" unitRef="usd">2200000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-112" decimals="-5" id="f-690" unitRef="usd">4300000</us-gaap:InterestIncomeOperating>
    <hr:NumberOfRealEstateNotesReceivable
      contextRef="c-4"
      decimals="INF"
      id="f-691"
      unitRef="financing_receivable">2</hr:NumberOfRealEstateNotesReceivable>
    <us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual contextRef="c-4" decimals="-5" id="f-692" unitRef="usd">48900000</us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual>
    <hr:NumberOfRealEstateNotesReceivable
      contextRef="c-3"
      decimals="INF"
      id="f-693"
      unitRef="financing_receivable">1</hr:NumberOfRealEstateNotesReceivable>
    <us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual contextRef="c-3" decimals="-5" id="f-694" unitRef="usd">20500000</us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-695">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (ASC Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of ASC Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of ASC Topic 606. To achieve the core principle, the Company applies the five-step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;Revenue that is accounted for under ASC Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-696">Below is a detail of the amounts by category:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.960%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.755%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.758%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income/other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; &lt;/span&gt;&lt;/div&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-697" unitRef="usd">2463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-698" unitRef="usd">2370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-699" unitRef="usd">5009000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-700" unitRef="usd">4761000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-701" unitRef="usd">1859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-702" unitRef="usd">1860000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-3" id="f-703" unitRef="usd">3504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-3" id="f-704" unitRef="usd">4086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-705" unitRef="usd">4322000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-706" unitRef="usd">4230000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-707" unitRef="usd">8513000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-708" unitRef="usd">8847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-709">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;New Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On November 27, 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%"&gt;Topic 280)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;. Some of the main provisions of this update to segment reporting include; (i) a requirement to disclose significant segment expenses, on an annual and interim basis, that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss; (ii) a requirement to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (iii) a requirement that an entity that has a single reportable segment provide all the disclosures required by the amendments in this update. &lt;/span&gt;&lt;/div&gt;The update is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. At this time, the Company does not expect that the adoption of this ASU will have a material impact on its consolidated financial statements other than compliance with these new disclosure requirements, which will begin with the Company's Annual Report on Form 10-K for the year ending December 31, 2024.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <hr:AcquisitionsAndDispositionsTextBlock contextRef="c-1" id="f-710">Real Estate Investments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2024 Acquisition Activity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company had no real estate acquisition activity for the six months ended June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Unconsolidated Joint Ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three and six months ended June&#160;30, 2024 and 2023 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;309,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;311,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(2,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;In the second quarter of 2024, the Company contributed 11 properties into a new joint venture in which it retained a 20% ownership interest.  See 2024 "Real Estate Asset Dispositions" below for additional information. In 2023, there was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's contribution of a property in Dallas, Texas to the joint venture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2024 Real Estate Asset Dispositions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions and joint venture contributions for the six months ended June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.615%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Albany, NY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4/1/24&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;San Angelo, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4/12/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/20/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Multiple &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/23/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;284,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(14,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;270,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;254,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;556,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Denver, CO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/30/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Austin, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/6/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;54,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;53,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;129,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Minneapolis, MN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/21/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;50,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Greensboro/Raleigh, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2, 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/28/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;96,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;86,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;309,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;464,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(19,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;445,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,159,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt"&gt;The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; two medical outpatient properties in Los Angeles and four in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $256.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt"&gt;The Company sold seven medical outpatient properties in Greensboro, NC and two medical outpatient properties in Raleigh, NC to a single buyer in a single transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.33pt"&gt;The amount in the net proceeds column for this portfolio disposition includes the receivable for the cash held in escrow that closed on June 28, 2024 and was received by the Company on July 1, 2024.  These proceeds were recorded as a receivable in other assets, net as of June 30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company had three properties classified as assets held for sale as of June&#160;30, 2024 and one property classified as assets held for sale as of December&#160;31, 2023.  The table below reflects the assets and liabilities classified as held for sale as of June&#160;30, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(13,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(913)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;33,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hr:AcquisitionsAndDispositionsTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="c-1" id="f-711">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three and six months ended June&#160;30, 2024 and 2023 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;309,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;311,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(2,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;In the second quarter of 2024, the Company contributed 11 properties into a new joint venture in which it retained a 20% ownership interest.  See 2024 "Real Estate Asset Dispositions" below for additional information. In 2023, there was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's contribution of a property in Dallas, Texas to the joint venture.</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-121" decimals="-3" id="f-712" unitRef="usd">309754000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-122" decimals="-3" id="f-713" unitRef="usd">327746000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-123" decimals="-3" id="f-714" unitRef="usd">311511000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-124" decimals="-3" id="f-715" unitRef="usd">327248000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-125" decimals="-3" id="f-716" unitRef="usd">66547000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-126" decimals="-3" id="f-717" unitRef="usd">0</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-127" decimals="-3" id="f-718" unitRef="usd">66547000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-128" decimals="-3" id="f-719" unitRef="usd">3824000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-125" decimals="-3" id="f-720" unitRef="usd">-146000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-126" decimals="-3" id="f-721" unitRef="usd">-17000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-127" decimals="-3" id="f-722" unitRef="usd">-568000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-128" decimals="-3" id="f-723" unitRef="usd">-797000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-125" decimals="-3" id="f-724" unitRef="usd">1314000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-126" decimals="-3" id="f-725" unitRef="usd">484000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-127" decimals="-3" id="f-726" unitRef="usd">2649000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-128" decimals="-3" id="f-727" unitRef="usd">3030000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-129" decimals="-3" id="f-728" unitRef="usd">374841000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-130" decimals="-3" id="f-729" unitRef="usd">327245000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-129" decimals="-3" id="f-730" unitRef="usd">374841000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-130" decimals="-3" id="f-731" unitRef="usd">327245000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:JointVentureOwnershipPercentage contextRef="c-131" decimals="2" id="f-732" unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <hr:JointVentureOwnershipPercentage contextRef="c-132" decimals="2" id="f-733" unitRef="number">0.40</hr:JointVentureOwnershipPercentage>
    <hr:AssetDispositionsTableTextBlock contextRef="c-1" id="f-734">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions and joint venture contributions for the six months ended June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.615%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Albany, NY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4/1/24&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;San Angelo, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4/12/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/20/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Multiple &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/23/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;284,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(14,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;270,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;254,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;556,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Denver, CO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/30/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Austin, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/6/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;54,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;53,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;129,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Minneapolis, MN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/21/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;50,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Greensboro/Raleigh, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2, 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/28/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;96,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;86,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;309,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;464,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(19,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;445,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;24,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,159,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:15.86pt"&gt;The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA and Austin, TX; two medical outpatient properties in Los Angeles and four in Seattle, WA.  Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $256.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%;padding-left:14.41pt"&gt;The Company sold seven medical outpatient properties in Greensboro, NC and two medical outpatient properties in Raleigh, NC to a single buyer in a single transaction.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;The amount in the net proceeds column for this portfolio disposition includes the receivable for the cash held in escrow that closed on June 28, 2024 and was received by the Company on July 1, 2024.  These proceeds were recorded as a receivable in other assets, net as of June 30, 2024.</hr:AssetDispositionsTableTextBlock>
    <hr:DispositionSalesPrice contextRef="c-133" decimals="-3" id="f-735" unitRef="usd">725000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-133" decimals="-3" id="f-736" unitRef="usd">60000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-134" decimals="-3" id="f-737" unitRef="usd">665000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-133" decimals="-3" id="f-738" unitRef="usd">765000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-133" decimals="-3" id="f-739" unitRef="usd">-82000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-134" decimals="-3" id="f-740" unitRef="usd">-18000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-133" decimals="0" id="f-741" unitRef="sqft">14800</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-135" decimals="-3" id="f-742" unitRef="usd">5085000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-135" decimals="-3" id="f-743" unitRef="usd">128000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-136" decimals="-3" id="f-744" unitRef="usd">4957000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-135" decimals="-3" id="f-745" unitRef="usd">4917000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-135" decimals="-3" id="f-746" unitRef="usd">66000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-136" decimals="-3" id="f-747" unitRef="usd">-26000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-135" decimals="0" id="f-748" unitRef="sqft">24580</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-137" decimals="-3" id="f-749" unitRef="usd">250000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-137" decimals="-3" id="f-750" unitRef="usd">9000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-138" decimals="-3" id="f-751" unitRef="usd">241000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-137" decimals="-3" id="f-752" unitRef="usd">713000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-137" decimals="-3" id="f-753" unitRef="usd">-520000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-138" decimals="-3" id="f-754" unitRef="usd">48000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-137" decimals="0" id="f-755" unitRef="sqft">37040</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-139" decimals="-3" id="f-756" unitRef="usd">284348000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-139" decimals="-3" id="f-757" unitRef="usd">14270000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-140" decimals="-3" id="f-758" unitRef="usd">270078000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-139" decimals="-3" id="f-759" unitRef="usd">254176000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-139" decimals="-3" id="f-760" unitRef="usd">25836000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-140" decimals="-3" id="f-761" unitRef="usd">-9934000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-139" decimals="0" id="f-762" unitRef="sqft">556274</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-141" decimals="-3" id="f-763" unitRef="usd">19000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-141" decimals="-3" id="f-764" unitRef="usd">628000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-142" decimals="-3" id="f-765" unitRef="usd">18372000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-141" decimals="-3" id="f-766" unitRef="usd">18522000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-141" decimals="-3" id="f-767" unitRef="usd">165000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-142" decimals="-3" id="f-768" unitRef="usd">-315000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-141" decimals="0" id="f-769" unitRef="sqft">37130</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-143" decimals="-3" id="f-770" unitRef="usd">54858000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-143" decimals="-3" id="f-771" unitRef="usd">1575000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-144" decimals="-3" id="f-772" unitRef="usd">53283000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-143" decimals="-3" id="f-773" unitRef="usd">27964000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-143" decimals="-3" id="f-774" unitRef="usd">623000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-144" decimals="-3" id="f-775" unitRef="usd">24696000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-143" decimals="0" id="f-776" unitRef="sqft">129879</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-145" decimals="-3" id="f-777" unitRef="usd">1082000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-145" decimals="-3" id="f-778" unitRef="usd">144000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-146" decimals="-3" id="f-779" unitRef="usd">938000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-145" decimals="-3" id="f-780" unitRef="usd">303000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-145" decimals="-3" id="f-781" unitRef="usd">43000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-146" decimals="-3" id="f-782" unitRef="usd">592000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-145" decimals="0" id="f-783" unitRef="sqft">50291</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-147" decimals="-3" id="f-784" unitRef="usd">99518000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-147" decimals="-3" id="f-785" unitRef="usd">2835000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-148" decimals="-3" id="f-786" unitRef="usd">96683000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-147" decimals="-3" id="f-787" unitRef="usd">86810000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-147" decimals="-3" id="f-788" unitRef="usd">906000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-148" decimals="-3" id="f-789" unitRef="usd">8967000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-147" decimals="0" id="f-790" unitRef="sqft">309424</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-149" decimals="-3" id="f-791" unitRef="usd">464866000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-149" decimals="-3" id="f-792" unitRef="usd">19649000</hr:ClosingAdjustmentsDisposedEntity>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-150" decimals="-3" id="f-793" unitRef="usd">445217000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-149" decimals="-3" id="f-794" unitRef="usd">394170000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-149" decimals="-3" id="f-795" unitRef="usd">27037000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-150" decimals="-3" id="f-796" unitRef="usd">24010000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-149" decimals="0" id="f-797" unitRef="sqft">1159418</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-151"
      decimals="INF"
      id="f-798"
      unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-152"
      decimals="INF"
      id="f-799"
      unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-153"
      decimals="INF"
      id="f-800"
      unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-154"
      decimals="INF"
      id="f-801"
      unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-155"
      decimals="INF"
      id="f-802"
      unitRef="number">0.20</hr:JointVentureOwnershipPercentage>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-156"
      decimals="INF"
      id="f-803"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-157"
      decimals="INF"
      id="f-804"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-158"
      decimals="INF"
      id="f-805"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-159"
      decimals="INF"
      id="f-806"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-160"
      decimals="INF"
      id="f-807"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-161"
      decimals="INF"
      id="f-808"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-162"
      decimals="INF"
      id="f-809"
      unitRef="property">4</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-163" decimals="-5" id="f-810" unitRef="usd">256800000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-164"
      decimals="INF"
      id="f-811"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-165"
      decimals="INF"
      id="f-812"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="c-3"
      decimals="INF"
      id="f-813"
      unitRef="property">3</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="c-4"
      decimals="INF"
      id="f-814"
      unitRef="property">1</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock contextRef="c-1" id="f-815">The table below reflects the assets and liabilities classified as held for sale as of June&#160;30, 2024 and December&#160;31, 2023:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(13,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(913)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;33,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock>
    <us-gaap:Land contextRef="c-166" decimals="-3" id="f-816" unitRef="usd">2330000</us-gaap:Land>
    <us-gaap:Land contextRef="c-167" decimals="-3" id="f-817" unitRef="usd">1850000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-166" decimals="-3" id="f-818" unitRef="usd">43342000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-167" decimals="-3" id="f-819" unitRef="usd">6779000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <hr:LeaseIntangibles contextRef="c-166" decimals="-3" id="f-820" unitRef="usd">1017000</hr:LeaseIntangibles>
    <hr:LeaseIntangibles contextRef="c-167" decimals="-3" id="f-821" unitRef="usd">1017000</hr:LeaseIntangibles>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-166" decimals="-3" id="f-822" unitRef="usd">46689000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-167" decimals="-3" id="f-823" unitRef="usd">9646000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-166" decimals="-3" id="f-824" unitRef="usd">13600000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-167" decimals="-3" id="f-825" unitRef="usd">913000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-166" decimals="-3" id="f-826" unitRef="usd">33089000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-167" decimals="-3" id="f-827" unitRef="usd">8733000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-166" decimals="-3" id="f-828" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-167" decimals="-3" id="f-829" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-166" decimals="-3" id="f-830" unitRef="usd">850000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-167" decimals="-3" id="f-831" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-166" decimals="-3" id="f-832" unitRef="usd">591000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-167" decimals="-3" id="f-833" unitRef="usd">101000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-166" decimals="-3" id="f-834" unitRef="usd">34530000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-167" decimals="-3" id="f-835" unitRef="usd">8834000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities contextRef="c-166" decimals="-3" id="f-836" unitRef="usd">531000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities contextRef="c-167" decimals="-3" id="f-837" unitRef="usd">23000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:OperatingLeaseLiability contextRef="c-166" decimals="-3" id="f-838" unitRef="usd">589000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-167" decimals="-3" id="f-839" unitRef="usd">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-166" decimals="-3" id="f-840" unitRef="usd">685000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-167" decimals="-3" id="f-841" unitRef="usd">272000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-166" decimals="-3" id="f-842" unitRef="usd">1805000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-167" decimals="-3" id="f-843" unitRef="usd">295000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-845">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the Consumer Price Index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2024 was $308.1 million and $626.2 million, respectively.  Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2023 was $329.7 million and $653.8 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;441,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;827,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;734,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;614,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;500,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,629,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,748,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of June&#160;30, 2024, the Company had 221 properties totaling 16.5 million square feet that were held under ground leases. Some of the Company's ground lease renewal terms are based on fixed rent renewal terms, and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally stated in the lease or based on CPI. The Company had 73 prepaid ground leases as of June&#160;30, 2024. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5&#160;million and $0.3&#160;million of the Company's rental expense for the three months ended June 30, 2024 and 2023, respectively, and $0.9 million and $0.7&#160;million for the six months ended June&#160;30, 2024 and 2023, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;693,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;750,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;404,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(328,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;230,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;45.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;57.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-844">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the Consumer Price Index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2024 was $308.1 million and $626.2 million, respectively.  Lease income for the Company's operating leases recognized for the three and six months ended June&#160;30, 2023 was $329.7 million and $653.8 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;441,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;827,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;734,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;614,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;500,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,629,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,748,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of June&#160;30, 2024, the Company had 221 properties totaling 16.5 million square feet that were held under ground leases. Some of the Company's ground lease renewal terms are based on fixed rent renewal terms, and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally stated in the lease or based on CPI. The Company had 73 prepaid ground leases as of June&#160;30, 2024. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5&#160;million and $0.3&#160;million of the Company's rental expense for the three months ended June 30, 2024 and 2023, respectively, and $0.9 million and $0.7&#160;million for the six months ended June&#160;30, 2024 and 2023, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;693,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;750,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;404,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(328,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;230,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;45.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;57.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-5" decimals="-5" id="f-846" unitRef="usd">308100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-1" decimals="-5" id="f-847" unitRef="usd">626200000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-6" decimals="-5" id="f-848" unitRef="usd">329700000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-7" decimals="-5" id="f-849" unitRef="usd">653800000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock contextRef="c-1" id="f-850">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;441,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;827,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;734,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;614,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;500,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,629,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,748,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-851" unitRef="usd">441170000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths contextRef="c-3" decimals="-3" id="f-852" unitRef="usd">827950000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears contextRef="c-3" decimals="-3" id="f-853" unitRef="usd">734851000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears contextRef="c-3" decimals="-3" id="f-854" unitRef="usd">614428000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears contextRef="c-3" decimals="-3" id="f-855" unitRef="usd">500591000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour contextRef="c-3" decimals="-3" id="f-856" unitRef="usd">1629794000</hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="c-3" decimals="-3" id="f-857" unitRef="usd">4748784000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:NumberOfPropertiesSubjectToGroundLeases
      contextRef="c-3"
      decimals="INF"
      id="f-858"
      unitRef="property">221</us-gaap:NumberOfPropertiesSubjectToGroundLeases>
    <hr:SquareFeetSubjecttoGroundLeases contextRef="c-1" decimals="-5" id="f-859" unitRef="sqft">16500000</hr:SquareFeetSubjecttoGroundLeases>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-168" id="f-860">P40Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-169" id="f-861">P99Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <hr:NumberofGroundLeasesPrepaid contextRef="c-1" decimals="INF" id="f-862" unitRef="lease">73</hr:NumberofGroundLeasesPrepaid>
    <hr:AmortizationofPrepaidRent contextRef="c-5" decimals="-5" id="f-863" unitRef="usd">500000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-6" decimals="-5" id="f-864" unitRef="usd">300000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-1" decimals="-5" id="f-865" unitRef="usd">900000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-7" decimals="-5" id="f-866" unitRef="usd">700000</hr:AmortizationofPrepaidRent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-868">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;693,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;750,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;404,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(328,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;230,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-867">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 148 non-prepaid ground leases) as of June&#160;30, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;693,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;394,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;750,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;404,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(520,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(328,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;230,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <hr:NumberofGroundLeasesExcludingPrepaidLeases contextRef="c-3" decimals="INF" id="f-869" unitRef="lease">148</hr:NumberofGroundLeasesExcludingPrepaidLeases>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-870" unitRef="usd">5912000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-871" unitRef="usd">1013000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-872" unitRef="usd">12644000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-873" unitRef="usd">2218000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-874" unitRef="usd">12739000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-875" unitRef="usd">2255000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-876" unitRef="usd">12934000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-877" unitRef="usd">2294000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-878" unitRef="usd">13061000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-879" unitRef="usd">2326000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-3" decimals="-3" id="f-880" unitRef="usd">693556000</hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <hr:FinanceLeaseLiabilityToBePaidAfterYearFour contextRef="c-3" decimals="-3" id="f-881" unitRef="usd">394072000</hr:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-882" unitRef="usd">750846000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-883" unitRef="usd">404178000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-884" unitRef="usd">520245000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-885" unitRef="usd">328979000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-886" unitRef="usd">230601000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-3" decimals="-3" id="f-887" unitRef="usd">75199000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-888">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and six months ended June&#160;30, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;45.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;57.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-889" unitRef="usd">4599000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-890" unitRef="usd">5329000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-891" unitRef="usd">9065000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-3" id="f-892" unitRef="usd">10436000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-5" decimals="-3" id="f-893" unitRef="usd">1315000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-6" decimals="-3" id="f-894" unitRef="usd">2235000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-895" unitRef="usd">2542000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-7" decimals="-3" id="f-896" unitRef="usd">4371000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-5" decimals="-3" id="f-897" unitRef="usd">392000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-6" decimals="-3" id="f-898" unitRef="usd">387000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-899" unitRef="usd">779000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-7" decimals="-3" id="f-900" unitRef="usd">774000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-5" decimals="-3" id="f-901" unitRef="usd">942000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-6" decimals="-3" id="f-902" unitRef="usd">923000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-903" unitRef="usd">1880000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-7" decimals="-3" id="f-904" unitRef="usd">1841000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-3" id="f-905" unitRef="usd">7248000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-3" id="f-906" unitRef="usd">8874000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-907" unitRef="usd">14266000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-7" decimals="-3" id="f-908" unitRef="usd">17422000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-3" id="f-909" unitRef="usd">4889000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-3" id="f-910" unitRef="usd">5230000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-911" unitRef="usd">8929000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-3" id="f-912" unitRef="usd">11190000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-5" decimals="-3" id="f-913" unitRef="usd">591000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-6" decimals="-3" id="f-914" unitRef="usd">541000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-915" unitRef="usd">1154000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-7" decimals="-3" id="f-916" unitRef="usd">1094000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-5" decimals="-3" id="f-917" unitRef="usd">4000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-6" decimals="-3" id="f-918" unitRef="usd">6000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-1" decimals="-3" id="f-919" unitRef="usd">30000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-7" decimals="-3" id="f-920" unitRef="usd">17000</hr:FinanceLeasePrincipalOnlyPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-921" unitRef="usd">2561000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-922" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-923" unitRef="usd">2561000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-924" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-925">P45Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-51" id="f-926">P47Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-927">P57Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-51" id="f-928">P58Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-929" unitRef="number">0.057</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-51" decimals="3" id="f-930" unitRef="number">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-931" unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-51" decimals="3" id="f-932" unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-933">Notes and Bonds Payable&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of June&#160;30, 2024 and December 31, 2023.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$250 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;582,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;579,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;485,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;483,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;580,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;575,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;658,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;649,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/24-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;70,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57% - 6.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,148,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,994,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.      &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;As of June&#160;30, 2024, the Company had $1.3 billion available to be drawn on its $1.5&#160;billion Unsecured Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;In April 2024, the Company exercised its option to extend the maturity date for one year to May 2025 for a fee of approximately $0.3&#160;million.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"&gt;In June 2024, the Company repaid $100&#160;million of the initial $350&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for one year to July 2025 for a fee of approximately $0.3&#160;million.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Changes in Debt Structure&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On January 6, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;4.77% per annum with an outstanding principal balance of $11.3&#160;million.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; The mortgage note encumbered a 63,012 square foot property in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;California&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On February 1, 2024, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 4.12%&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; per annum with an outstanding principal balance of $5.6&#160;million. T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;he mortgage note encumbered a 40,324&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; squ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;are foot property in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Georgia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-934">&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of June&#160;30, 2024 and December 31, 2023.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$250 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;582,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;579,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;485,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;483,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;580,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;575,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;658,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;649,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/24-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;70,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57% - 6.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,148,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,994,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.      &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;As of June&#160;30, 2024, the Company had $1.3 billion available to be drawn on its $1.5&#160;billion Unsecured Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;In April 2024, the Company exercised its option to extend the maturity date for one year to May 2025 for a fee of approximately $0.3&#160;million.   &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;In June 2024, the Company repaid $100&#160;million of the initial $350&#160;million Unsecured Term Loan and exercised its second option to extend the maturity date for one year to July 2025 for a fee of approximately $0.3&#160;million.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-170" decimals="INF" id="f-935" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt contextRef="c-170" decimals="-3" id="f-936" unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-171" decimals="-3" id="f-937" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-170" decimals="4" id="f-938" unitRef="number">0.0628</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-172" decimals="INF" id="f-939" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-172" decimals="-3" id="f-940" unitRef="usd">199750000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-173" decimals="-3" id="f-941" unitRef="usd">199903000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-172" decimals="4" id="f-942" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-174" decimals="INF" id="f-943" unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-174" decimals="-3" id="f-944" unitRef="usd">249659000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-175" decimals="-3" id="f-945" unitRef="usd">349798000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-174" decimals="4" id="f-946" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-176" decimals="INF" id="f-947" unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-176" decimals="-3" id="f-948" unitRef="usd">299970000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-177" decimals="-3" id="f-949" unitRef="usd">299958000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-176" decimals="4" id="f-950" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-178" decimals="INF" id="f-951" unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-178" decimals="-3" id="f-952" unitRef="usd">149716000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-179" decimals="-3" id="f-953" unitRef="usd">149643000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-178" decimals="4" id="f-954" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-180" decimals="INF" id="f-955" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-180" decimals="-3" id="f-956" unitRef="usd">199571000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-181" decimals="-3" id="f-957" unitRef="usd">199502000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-180" decimals="4" id="f-958" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-182" decimals="INF" id="f-959" unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-182" decimals="-3" id="f-960" unitRef="usd">298498000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-183" decimals="-3" id="f-961" unitRef="usd">298288000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-182" decimals="4" id="f-962" unitRef="number">0.0637</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-184" decimals="-3" id="f-963" unitRef="usd">249674000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-185" decimals="-3" id="f-964" unitRef="usd">249484000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-184" decimals="4" id="f-965" unitRef="number">0.0412</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-186" decimals="-3" id="f-966" unitRef="usd">582873000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-187" decimals="-3" id="f-967" unitRef="usd">579017000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-186" decimals="4" id="f-968" unitRef="number">0.0494</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-188" decimals="-3" id="f-969" unitRef="usd">485889000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-189" decimals="-3" id="f-970" unitRef="usd">483727000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-188" decimals="4" id="f-971" unitRef="number">0.0476</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-190" decimals="-3" id="f-972" unitRef="usd">297726000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-191" decimals="-3" id="f-973" unitRef="usd">297429000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-190" decimals="4" id="f-974" unitRef="number">0.0385</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-192" decimals="-3" id="f-975" unitRef="usd">580667000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-193" decimals="-3" id="f-976" unitRef="usd">575443000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-192" decimals="4" id="f-977" unitRef="number">0.0530</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-194" decimals="-3" id="f-978" unitRef="usd">296983000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-195" decimals="-3" id="f-979" unitRef="usd">296780000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-194" decimals="4" id="f-980" unitRef="number">0.0272</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-196" decimals="-3" id="f-981" unitRef="usd">296086000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-197" decimals="-3" id="f-982" unitRef="usd">295832000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-196" decimals="4" id="f-983" unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-198" decimals="-3" id="f-984" unitRef="usd">658263000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-199" decimals="-3" id="f-985" unitRef="usd">649521000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-198" decimals="4" id="f-986" unitRef="number">0.0513</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-200" decimals="-3" id="f-987" unitRef="usd">52828000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-201" decimals="-3" id="f-988" unitRef="usd">70534000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-202" decimals="4" id="f-989" unitRef="number">0.0357</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-203" decimals="4" id="f-990" unitRef="number">0.0688</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-991" unitRef="usd">5148153000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-992" unitRef="usd">4994859000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-170" decimals="-8" id="f-993" unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-170" decimals="INF" id="f-994" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <hr:DebtInstrumentExtensionPeriodForMaturityDate contextRef="c-204" id="f-995">P1Y</hr:DebtInstrumentExtensionPeriodForMaturityDate>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-205" decimals="-5" id="f-996" unitRef="usd">300000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentRepaidPrincipal contextRef="c-206" decimals="-6" id="f-997" unitRef="usd">100000000</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-207" decimals="-6" id="f-998" unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <hr:DebtInstrumentExtensionPeriodForMaturityDate contextRef="c-208" id="f-999">P1Y</hr:DebtInstrumentExtensionPeriodForMaturityDate>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-3" decimals="-5" id="f-1000" unitRef="usd">300000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-209"
      decimals="4"
      id="f-1001"
      unitRef="number">0.0477</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ExtinguishmentOfDebtAmount contextRef="c-210" decimals="-5" id="f-1002" unitRef="usd">11300000</us-gaap:ExtinguishmentOfDebtAmount>
    <hr:ExtinguishmentOfDebtEncumberedSquareFootage contextRef="c-211" decimals="0" id="f-1003" unitRef="sqft">63012</hr:ExtinguishmentOfDebtEncumberedSquareFootage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-212"
      decimals="4"
      id="f-1004"
      unitRef="number">0.0412</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ExtinguishmentOfDebtAmount contextRef="c-213" decimals="-5" id="f-1005" unitRef="usd">5600000</us-gaap:ExtinguishmentOfDebtAmount>
    <hr:ExtinguishmentOfDebtEncumberedSquareFootage contextRef="c-214" decimals="0" id="f-1006" unitRef="sqft">40324</hr:ExtinguishmentOfDebtEncumberedSquareFootage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-1007">Derivative Financial Instruments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Risk Management Objective of Using Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#x2019;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#x2019;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#x2019;s borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Cash Flow Hedges of Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,075,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the fair value of the Company's derivative financial instruments and their classification on the Condensed Consolidated Balance Sheet as of June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.608%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June&#160;30, 2024 and 2023 related to the Company's outstanding interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company estimates that an additional $10.5 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Credit-risk-related Contingent Features&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender should the Company&#160;default on the indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$0.3&#160;million. As of June&#160;30, 2024, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1008">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of June&#160;30, 2024, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,075,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June&#160;30, 2024 and 2023 related to the Company's outstanding interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(21,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(25,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-3"
      decimals="INF"
      id="f-1009"
      unitRef="derivative">15</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-215" decimals="-3" id="f-1010" unitRef="usd">275000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-215"
      decimals="4"
      id="f-1011"
      unitRef="number">0.0374</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-216" decimals="-3" id="f-1012" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-216"
      decimals="4"
      id="f-1013"
      unitRef="number">0.0383</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-217" decimals="-3" id="f-1014" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-217"
      decimals="4"
      id="f-1015"
      unitRef="number">0.0384</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-218" decimals="-3" id="f-1016" unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-218"
      decimals="4"
      id="f-1017"
      unitRef="number">0.0427</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-219" decimals="-3" id="f-1018" unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-219"
      decimals="4"
      id="f-1019"
      unitRef="number">0.0393</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-220" decimals="-3" id="f-1020" unitRef="usd">1075000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-220"
      decimals="4"
      id="f-1021"
      unitRef="number">0.0392</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-1022">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the fair value of the Company's derivative financial instruments and their classification on the Condensed Consolidated Balance Sheet as of June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.608%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-221" decimals="-3" id="f-1023" unitRef="usd">-1839000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-222" decimals="-3" id="f-1024" unitRef="usd">11538000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-223" decimals="-3" id="f-1025" unitRef="usd">9699000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-224" decimals="-3" id="f-1026" unitRef="usd">5891000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-225" decimals="-3" id="f-1027" unitRef="usd">21523000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-226" decimals="-3" id="f-1028" unitRef="usd">3811000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-227" decimals="-3" id="f-1029" unitRef="usd">3568000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-228" decimals="-3" id="f-1030" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-229" decimals="-3" id="f-1031" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-230" decimals="-3" id="f-1032" unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-231" decimals="-3" id="f-1033" unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-232" decimals="-3" id="f-1034" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-233" decimals="-3" id="f-1035" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-234" decimals="-3" id="f-1036" unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-235" decimals="-3" id="f-1037" unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-5" decimals="-3" id="f-1038" unitRef="usd">5891000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-6" decimals="-3" id="f-1039" unitRef="usd">21523000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-236" decimals="-3" id="f-1040" unitRef="usd">3662000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-237" decimals="-3" id="f-1041" unitRef="usd">3419000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-238" decimals="-3" id="f-1042" unitRef="usd">25501000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-239" decimals="-3" id="f-1043" unitRef="usd">12981000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-240" decimals="-3" id="f-1044" unitRef="usd">7825000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-241" decimals="-3" id="f-1045" unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-242" decimals="-3" id="f-1046" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-243" decimals="-3" id="f-1047" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-244" decimals="-3" id="f-1048" unitRef="usd">-213000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-245" decimals="-3" id="f-1049" unitRef="usd">-213000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-246" decimals="-3" id="f-1050" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-247" decimals="-3" id="f-1051" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-248" decimals="-3" id="f-1052" unitRef="usd">-84000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-249" decimals="-3" id="f-1053" unitRef="usd">-84000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="-3" id="f-1054" unitRef="usd">25501000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-7" decimals="-3" id="f-1055" unitRef="usd">12981000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-250" decimals="-3" id="f-1056" unitRef="usd">7528000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-251" decimals="-3" id="f-1057" unitRef="usd">5703000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet contextRef="c-252" decimals="-5" id="f-1058" unitRef="usd">10500000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet contextRef="c-253" decimals="-5" id="f-1059" unitRef="usd">-600000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeNetLiabilityPositionAggregateFairValue contextRef="c-3" decimals="-5" id="f-1060" unitRef="usd">300000</us-gaap:DerivativeNetLiabilityPositionAggregateFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1061">Commitments and Contingencies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;From time to time, the Company is involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Development and Redevelopment Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For the six months ended June&#160;30, 2024, the Company invested $35.6 million and $8.5 million toward active development and redevelopment of properties, respectively, and $22.3 million toward recently completed development and redevelopment projects.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-254" decimals="-5" id="f-1062" unitRef="usd">35600000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-255" decimals="-5" id="f-1063" unitRef="usd">8500000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-256" decimals="-5" id="f-1064" unitRef="usd">22300000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1065">Stockholders' Equity&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June&#160;30, 2024 and the twelve months ended December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.370%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,964,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Conversion of OP units to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;194,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;190,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares Repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(17,242,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;401,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;175,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;364,327,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,964,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the six months ended June&#160;30, 2024, the Company declared and paid common stock dividends totaling $0.62 per share.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On Jul&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;y 30, 2024, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on August 28, 2024 to stockholders of record on August 12, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On May 31, 2023, the Company&#x2019;s Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company&#x2019;s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. In April 2024, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;the Company repurch&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;ased 2,966,764 shares of its common stock at a weighted average price of $14.07 for a total of $41.7&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;under this authorization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On April 30, 2024, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. The stock repurchase authorization expires on April 29, 2025, and the Company may suspend or terminate repurchases at any time without prior notice. Under the Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In May and June 2024, the Company repurchased an aggregate of 14,275,473 shares of its common stock at a weighted average price of $16.18 for a total of $231.0&#160;million under this authorization. As of June&#160;30, 2024, the Company was authorized to repurchase an additional $269.0&#160;million of the Company's common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Subsequent to June 30, 2024, the Company repurchased 1,296,985 shares of its common stock for a total of $21.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Earnings Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June&#160;30, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED JUNE 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,498,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,829,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;377,916,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,812,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,021,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,932,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,954,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,952,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of OP Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(145,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(461,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(171,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(717)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net loss applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(145,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(458,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(170,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The effect of OP Units redeemable for 3,657,682 shares and 3,669,454 shares for the three and six months ended June&#160;30, 2024, respectively, were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during those periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Stock Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's stock incentive plan ("Incentive Plan") permits the grant of incentive awards to its employees and directors in any of the following forms: options, stock appreciation rights, restricted stock, restricted or deferred stock units, performance awards, dividend equivalents, or other stock-based awards, including units in the OP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the six months ended June&#160;30, 2024, the Company made the following equity awards:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt"&gt;Restricted Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;During the first quarter of 2024, the Company granted non-vested stock awards to its named executive officers and other members of senior management with an aggregate grant date fair value of $5.6&#160;million, which consisted of an aggregate of 361,712 non-vested shares with vesting periods ranging from &lt;span style="-sec-ix-hidden:f-1149"&gt;three&lt;/span&gt; to eight years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;During the second quarter of 2024, the Company granted to independent directors an aggregate of 58,910 shares of non-vested stock awards with a grant date fair value of $0.9&#160;million, and an aggregate of 45,982 LTIP Series D units with a grant date fair value of $0.7&#160;million. The Company also granted &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;non-vested stock awards to other members of senior management with an aggregate grant date fair value of $0.1&#160;million, which consisted of an aggregate of 9,350 non-vested shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt"&gt;Restricted Stock Units ("RSUs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;On February 13, 2024, the Company granted an aggregate of 208,055 RSUs to members of senior management, with an aggregate grant date fair value of $3.5 million and a five-year vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;On April 30, 2024, the Company granted an aggregate of 21,816 RSUs to members of senior management, with an aggregate grant date fair value of $0.3&#160;million and a five-year vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 36% of the RSUs vest based on relative total shareholder return ("TSR") and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $19.10 for the relative TSR component for the February 2024 grant using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$15.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 64% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $15.22 based on the Company's share price on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%;padding-left:14.2pt"&gt;LTIP Series C Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On February 13, 2024, the Company granted an aggregate of 906,044 LTIP Series C units ("LTIP-C units) in the OP to its named executive officers with three-year forward-looking performance targets, a five-year vesting period and an aggregate grant date fair value of $7.5&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 36% of the LTIP-C units vest based on relative TSR and were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $9.62 for the relative TSR component for the February 2024 grant using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$15.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 64% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the February 13, 2024 grant, the grant date fair value was $15.22 based on the Company's share price on the date of grant. The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"&gt;The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and six months ended June&#160;30, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED JUNE 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,043,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,946,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,615,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,090,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;135,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,611,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,118,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(46,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(74,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(75,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Change in awards based on performance assessment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(79,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(19,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(29,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,085,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,911,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,085,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,911,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-right:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested awards issued as of June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="c-1" id="f-1066">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June&#160;30, 2024 and the twelve months ended December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.370%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,964,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Conversion of OP units to common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;194,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;190,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares Repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(17,242,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;401,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;175,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;364,327,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,964,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-52"
      decimals="INF"
      id="f-1067"
      unitRef="shares">380964433</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-66"
      decimals="INF"
      id="f-1068"
      unitRef="shares">380589894</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-61"
      decimals="INF"
      id="f-1069"
      unitRef="shares">8623</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-257"
      decimals="INF"
      id="f-1070"
      unitRef="shares">8627</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c-61"
      decimals="INF"
      id="f-1071"
      unitRef="shares">194767</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c-257"
      decimals="INF"
      id="f-1072"
      unitRef="shares">190544</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-1"
      decimals="INF"
      id="f-1073"
      unitRef="shares">17242237</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-108"
      decimals="INF"
      id="f-1074"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-61"
      decimals="INF"
      id="f-1075"
      unitRef="shares">401648</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-257"
      decimals="INF"
      id="f-1076"
      unitRef="shares">175368</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-23"
      decimals="INF"
      id="f-1077"
      unitRef="shares">364327234</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-52"
      decimals="INF"
      id="f-1078"
      unitRef="shares">380964433</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-1079"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-258"
      decimals="INF"
      id="f-1080"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareDeclared>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-259" decimals="-5" id="f-1081" unitRef="usd">500000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-204"
      decimals="INF"
      id="f-1082"
      unitRef="shares">2966764</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-204"
      decimals="INF"
      id="f-1083"
      unitRef="usdPerShare">14.07</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions contextRef="c-204" decimals="-5" id="f-1084" unitRef="usd">41700000</hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-205" decimals="-5" id="f-1085" unitRef="usd">500000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-260"
      decimals="INF"
      id="f-1086"
      unitRef="shares">14275473</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-260"
      decimals="INF"
      id="f-1087"
      unitRef="usdPerShare">16.18</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions contextRef="c-260" decimals="-5" id="f-1088" unitRef="usd">231000000</hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions>
    <hr:StockRepurchaseProgramAuthorizedAdditionalAmount contextRef="c-3" decimals="-5" id="f-1089" unitRef="usd">269000000</hr:StockRepurchaseProgramAuthorizedAdditionalAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-261"
      decimals="INF"
      id="f-1090"
      unitRef="shares">1296985</us-gaap:TreasuryStockSharesAcquired>
    <hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions contextRef="c-261" decimals="-5" id="f-1091" unitRef="usd">21800000</hr:TreasuryStockValueAcquiredCostMethodExcludingCommissions>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1092">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June&#160;30, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED JUNE 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;374,498,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,829,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;377,916,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,812,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,021,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,932,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,954,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,952,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of OP Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;372,477,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,896,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;375,962,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,860,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(145,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(461,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(171,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(717)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net loss applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(145,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(458,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(170,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-5" decimals="0" id="f-1093" unitRef="shares">374498770</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-6" decimals="0" id="f-1094" unitRef="shares">380829011</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-1" decimals="0" id="f-1095" unitRef="shares">377916989</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-7" decimals="0" id="f-1096" unitRef="shares">380812981</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-5" decimals="0" id="f-1097" unitRef="shares">2021471</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-6" decimals="0" id="f-1098" unitRef="shares">1932334</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-1" decimals="0" id="f-1099" unitRef="shares">1954956</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-7" decimals="0" id="f-1100" unitRef="shares">1952350</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1101" unitRef="shares">372477299</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1102" unitRef="shares">378896677</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1103" unitRef="shares">375962033</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-1104" unitRef="shares">378860631</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1105" unitRef="shares">372477299</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1106" unitRef="shares">378896677</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1107" unitRef="shares">375962033</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-1108" unitRef="shares">378860631</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-5" decimals="0" id="f-1109" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-6" decimals="0" id="f-1110" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-1" decimals="0" id="f-1111" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-7" decimals="0" id="f-1112" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-1113" unitRef="shares">372477299</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-1114" unitRef="shares">378896677</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1115" unitRef="shares">375962033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-1116" unitRef="shares">378860631</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-1117" unitRef="usd">-145938000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-1118" unitRef="usd">-83726000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-1119" unitRef="usd">-461157000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-1120" unitRef="usd">-171804000</us-gaap:ProfitLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-5" decimals="-3" id="f-1121" unitRef="usd">917000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-6" decimals="-3" id="f-1122" unitRef="usd">606000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-1" decimals="-3" id="f-1123" unitRef="usd">1819000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-7" decimals="-3" id="f-1124" unitRef="usd">1830000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-1125" unitRef="usd">-2158000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-1126" unitRef="usd">-967000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1127" unitRef="usd">-6541000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-1128" unitRef="usd">-1920000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-5" decimals="-3" id="f-1129" unitRef="usd">-717000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-6" decimals="-3" id="f-1130" unitRef="usd">-77000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-1" decimals="-3" id="f-1131" unitRef="usd">-2047000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-7" decimals="-3" id="f-1132" unitRef="usd">1154000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-5" decimals="-3" id="f-1133" unitRef="usd">-145414000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-6" decimals="-3" id="f-1134" unitRef="usd">-83442000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-1135" unitRef="usd">-458482000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-7" decimals="-3" id="f-1136" unitRef="usd">-170560000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-1137"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-1138"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1139"
      unitRef="usdPerShare">-1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-1140"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-1141"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-1142"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1143"
      unitRef="usdPerShare">-1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-1144"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-262"
      decimals="INF"
      id="f-1145"
      unitRef="shares">3657682</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-263"
      decimals="INF"
      id="f-1146"
      unitRef="shares">3669454</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-264" decimals="-5" id="f-1147" unitRef="usd">5600000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-264"
      decimals="INF"
      id="f-1148"
      unitRef="shares">361712</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-266" id="f-1150">P8Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-267"
      decimals="INF"
      id="f-1151"
      unitRef="shares">58910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-267" decimals="-5" id="f-1152" unitRef="usd">900000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-268"
      decimals="INF"
      id="f-1153"
      unitRef="shares">45982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-268" decimals="-5" id="f-1154" unitRef="usd">700000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-269" decimals="-5" id="f-1155" unitRef="usd">100000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-269"
      decimals="INF"
      id="f-1156"
      unitRef="shares">9350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-270"
      decimals="INF"
      id="f-1157"
      unitRef="shares">208055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-270" decimals="-5" id="f-1158" unitRef="usd">3500000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-271" id="f-1159">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-272"
      decimals="INF"
      id="f-1160"
      unitRef="shares">21816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-272" decimals="-5" id="f-1161" unitRef="usd">300000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-273" id="f-1162">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-271"
      decimals="2"
      id="f-1163"
      unitRef="number">0.36</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-274"
      decimals="2"
      id="f-1164"
      unitRef="usdPerShare">19.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1165">&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$15.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$15.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-275"
      decimals="3"
      id="f-1166"
      unitRef="number">0.280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-275" id="f-1167">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-275"
      decimals="4"
      id="f-1168"
      unitRef="number">0.0444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="c-275"
      decimals="2"
      id="f-1169"
      unitRef="usdPerShare">15.22</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-276"
      decimals="2"
      id="f-1170"
      unitRef="number">0.64</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-276"
      decimals="2"
      id="f-1171"
      unitRef="usdPerShare">15.22</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-277"
      decimals="INF"
      id="f-1172"
      unitRef="shares">906044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod contextRef="c-278" id="f-1173">P3Y</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-279" decimals="-5" id="f-1174" unitRef="usd">7500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-280"
      decimals="2"
      id="f-1175"
      unitRef="number">0.36</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-281"
      decimals="2"
      id="f-1176"
      unitRef="usdPerShare">9.62</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-282"
      decimals="3"
      id="f-1177"
      unitRef="number">0.280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-282" id="f-1178">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-282"
      decimals="4"
      id="f-1179"
      unitRef="number">0.0444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="c-282"
      decimals="2"
      id="f-1180"
      unitRef="usdPerShare">15.22</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-283"
      decimals="2"
      id="f-1181"
      unitRef="number">0.64</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-283"
      decimals="2"
      id="f-1182"
      unitRef="usdPerShare">15.22</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-1183">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"&gt;The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and six months ended June&#160;30, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED JUNE 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;SIX MONTHS ENDED JUNE 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,043,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,946,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,615,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,090,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;135,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,611,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,118,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(46,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(74,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(75,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Change in awards based on performance assessment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(79,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(3,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(19,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(29,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,085,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,911,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,085,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,911,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-right:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-284"
      decimals="INF"
      id="f-1184"
      unitRef="shares">4043154</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-285"
      decimals="INF"
      id="f-1185"
      unitRef="shares">2946242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-286"
      decimals="INF"
      id="f-1186"
      unitRef="shares">2615562</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-287"
      decimals="INF"
      id="f-1187"
      unitRef="shares">2090060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-288"
      decimals="INF"
      id="f-1188"
      unitRef="shares">135767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-289"
      decimals="INF"
      id="f-1189"
      unitRef="shares">43276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-290"
      decimals="INF"
      id="f-1190"
      unitRef="shares">1611578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-291"
      decimals="INF"
      id="f-1191"
      unitRef="shares">1118537</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-288"
      decimals="INF"
      id="f-1192"
      unitRef="shares">46660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-289"
      decimals="INF"
      id="f-1193"
      unitRef="shares">74304</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-290"
      decimals="INF"
      id="f-1194"
      unitRef="shares">75074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-291"
      decimals="INF"
      id="f-1195"
      unitRef="shares">188070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="c-288"
      decimals="INF"
      id="f-1196"
      unitRef="shares">47202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="c-289"
      decimals="INF"
      id="f-1197"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="c-290"
      decimals="INF"
      id="f-1198"
      unitRef="shares">47202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="c-291"
      decimals="INF"
      id="f-1199"
      unitRef="shares">79250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-288"
      decimals="INF"
      id="f-1200"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-289"
      decimals="INF"
      id="f-1201"
      unitRef="shares">3860</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-290"
      decimals="INF"
      id="f-1202"
      unitRef="shares">19805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-291"
      decimals="INF"
      id="f-1203"
      unitRef="shares">29923</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-292"
      decimals="INF"
      id="f-1204"
      unitRef="shares">4085059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-293"
      decimals="INF"
      id="f-1205"
      unitRef="shares">2911354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-292"
      decimals="INF"
      id="f-1206"
      unitRef="shares">4085059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-293"
      decimals="INF"
      id="f-1207"
      unitRef="shares">2911354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock contextRef="c-1" id="f-1208">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested awards issued as of June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear contextRef="c-3" decimals="-5" id="f-1209" unitRef="usd">8000000.0</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths contextRef="c-3" decimals="-5" id="f-1210" unitRef="usd">13400000</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo contextRef="c-3" decimals="-5" id="f-1211" unitRef="usd">10100000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree contextRef="c-3" decimals="-5" id="f-1212" unitRef="usd">5500000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour contextRef="c-3" decimals="-5" id="f-1213" unitRef="usd">2900000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-3" decimals="-5" id="f-1214" unitRef="usd">39900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-1215">Fair Value of Financial Instruments&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; - The carrying amount approximates fair value (level 1 inputs) due to the short-term maturity of these investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt"&gt;Real estate notes receivabl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements using level 2 inputs in the hierarchy.  However, the fair value of one note receivable was determined utilizing the fair value of the receivables' collateral, as the receivables are collateral-dependent, and were classified as level 3 inputs in the hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt"&gt;Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt"&gt;Senior Notes and Mortgage Notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#x2019;s current interest rates for similar types of borrowing arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:140%;padding-left:14.32pt"&gt;Interest rate swap agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, which consider forward yield curves and discount rates. See Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June&#160;30, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,984.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,994.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,872.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;168.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;163.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;173.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="c-1" id="f-1216">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June&#160;30, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,984.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,994.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,872.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;168.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;163.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;173.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DebtInstrumentFairValue contextRef="c-294" decimals="-5" id="f-1217" unitRef="usd">5148200000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-295" decimals="-5" id="f-1218" unitRef="usd">4984700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-296" decimals="-5" id="f-1219" unitRef="usd">4994900000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-297" decimals="-5" id="f-1220" unitRef="usd">4872700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-294" decimals="-5" id="f-1221" unitRef="usd">168800000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-295" decimals="-5" id="f-1222" unitRef="usd">163600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-296" decimals="-5" id="f-1223" unitRef="usd">173600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-297" decimals="-5" id="f-1224" unitRef="usd">172500000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-1225">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-5" id="f-1226">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-1227">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-1228">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
